CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: troglitazone
Accession: CHEBI:9753
browse the term
Definition: A chromane that has formula C24H27NO5S.
Synonyms: related_synonym: (+-)-all-rac-5-(p-((6-Hydroxy-2,5,7,8-tetramethyl-2-chromanyl)methoxy)benzyl)-2,4-thiazolidinedione; 5-(4-(6-Hydroxy-2,5,7,8-tetramethylchroman-2-ylmethoxy)benzyl)thiazolidine-2,4-dione; 5-{4-[(6-hydroxy-2,5,7,8-tetramethyl-3,4-dihydro-2H-chromen-2-yl)methoxy]benzyl}-1,3-thiazolidine-2,4-dione; Rezulin (TN); Romglizone; troglitazona; troglitazonum
xref: Beilstein:4338399; CAS:97322-87-7; DrugBank:DB00197
xref_mesh: MESH:C057693
xref: Patent:US4572912; drugcentral:2767; kegg.drug:D00395; lincs.smallmolecule:LSM-4890; metacyc.compound:CPD-11439; wikipedia.en:Troglitazone
chemrof_formula: C24H27NO5S
chemrof_smiles: Cc1c(C)c2c(c(C)c1O)CCC(C)(COc1ccc(CC3SC(=O)NC3=O)cc1)O2
chemrof_inchikey: GXPHKUHSUJUWKP-UHFFFAOYSA-N
chemrof_inchi: InChI=1S/C24H27NO5S/c1-13-14(2)21-18(15(3)20(13)26)9-10-24(4,30-21)12-29-17-7-5-16(6-8-17)11-19-22(27)25-23(28)31-19/h5-8,19,26H,9-12H2,1-4H3,(H,25,27,28)
G
A3galt2
alpha 1,3-galactosyltransferase 2
decreases expression
EXP
troglitazone results in decreased expression of A3GALT2 mRNA
CTD
PMID:21515302
NCBI chr 5:146,385,725...146,398,156
Ensembl chr 5:146,385,746...146,400,043
G
Aadac
arylacetamide deacetylase
increases expression
ISO
troglitazone results in increased expression of AADAC mRNA
CTD
PMID:25572481
NCBI chr 2:146,293,449...146,351,061
Ensembl chr 2:146,313,279...146,324,525
G
Aasdh
aminoadipate-semialdehyde dehydrogenase
decreases expression
ISO
troglitazone results in decreased expression of AASDH mRNA
CTD
PMID:28973697
NCBI chr14:31,609,488...31,636,066
Ensembl chr14:31,609,528...31,636,500
G
Aatk
apoptosis-associated tyrosine kinase
increases expression
ISO
troglitazone results in increased expression of AATK mRNA
CTD
PMID:28973697
NCBI chr10:105,789,171...105,825,634
Ensembl chr10:105,785,469...105,825,618
G
Abat
4-aminobutyrate aminotransferase
decreases expression
EXP
troglitazone results in decreased expression of ABAT mRNA
CTD
PMID:21515302
NCBI chr10:7,503,351...7,599,474
Ensembl chr10:7,492,022...7,599,474
G
Abca1
ATP binding cassette subfamily A member 1
increases expression
ISO
troglitazone results in increased expression of ABCA1 mRNA
CTD
PMID:12759900
NCBI chr 5:72,473,676...72,596,563
Ensembl chr 5:72,473,676...72,596,473
G
Abca3
ATP binding cassette subfamily A member 3
decreases expression
ISO
troglitazone results in decreased expression of ABCA3 mRNA
CTD
PMID:28973697
NCBI chr10:13,886,948...13,944,286
Ensembl chr10:13,887,083...13,944,285
G
Abca9
ATP binding cassette subfamily A member 9
increases expression
ISO
troglitazone results in increased expression of ABCA9 mRNA
CTD
PMID:28973697
NCBI chr10:95,577,079...95,638,706
Ensembl chr10:95,578,350...95,636,405
G
Abcb10
ATP binding cassette subfamily B member 10
increases expression
ISO
troglitazone results in increased expression of ABCB10 mRNA
CTD
PMID:28973697
NCBI chr19:68,850,108...68,881,689
Ensembl chr19:68,850,134...68,880,203
G
Abcb11
ATP binding cassette subfamily B member 11
multiple interactions decreases activity decreases expression
ISO EXP
[Troglitazone results in decreased activity of ABCB11 protein] which results in decreased export of Taurodeoxycholic Acid; Enzymes and Coenzymes promotes the reaction [Troglitazone inhibits the reaction [ABCB11 protein results in increased transport of Taurodeoxycholic Acid]]; Troglitazone inhibits the reaction [ABCB11 protein results in increased transport of Taurocholic Acid]; Troglitazone inhibits the reaction [ABCB11 protein results in increased transport of Taurodeoxycholic Acid] [troglitazone results in decreased activity of ABCB11 protein] which results in decreased export of Taurodeoxycholic Acid; [troglitazone results in decreased activity of ABCB11 protein] which results in decreased secretion of Rosuvastatin Calcium; troglitazone binds to and results in decreased activity of ABCB11 protein; troglitazone inhibits the reaction [ABCB11 protein results in increased export of Bile Acids and Salts]; troglitazone inhibits the reaction [ABCB11 protein results in increased export of Taurocholic Acid] troglitazone results in decreased expression of ABCB11 troglitazone results in decreased expression of ABCB11 mRNA
CTD
PMID:11179459 PMID:11557132 PMID:15465654 PMID:15509663 PMID:19853032 PMID:20147439 PMID:20829430 PMID:22646477 PMID:22673116 PMID:23956101 PMID:24014644 PMID:27765674 PMID:28437613 PMID:29146462 PMID:35101544 More...
NCBI chr 3:74,424,620...74,520,646
Ensembl chr 3:74,424,979...74,520,581
G
Abcb1a
ATP binding cassette subfamily B member 1A
increases expression
ISO
troglitazone results in increased expression of ABCB1B mRNA
CTD
PMID:19022234
NCBI chr 4:26,312,403...26,488,456
Ensembl chr 4:26,312,409...26,397,135
G
Abcb1b
ATP-binding cassette, sub-family B member 1B
decreases expression
EXP
troglitazone results in decreased expression of ABCB1B mRNA
CTD
PMID:19022234
NCBI chr 4:26,197,706...26,280,156
Ensembl chr 4:26,106,903...26,279,567
G
Abcb4
ATP binding cassette subfamily B member 4
increases expression decreases activity
ISO EXP
troglitazone results in increased expression of ABCB4 mRNA troglitazone results in decreased activity of ABCB4 protein
CTD
PMID:19022234 PMID:28437613
NCBI chr 4:26,106,895...26,164,440
G
Abcb6
ATP binding cassette subfamily B member 6
increases expression
EXP
troglitazone results in increased expression of ABCB6 mRNA
CTD
PMID:25596134
NCBI chr 9:84,117,222...84,125,939
Ensembl chr 9:84,117,220...84,125,526
G
Abcb9
ATP binding cassette subfamily B member 9
increases expression
EXP
troglitazone results in increased expression of ABCB9 mRNA
CTD
PMID:25596134
NCBI chr12:38,146,659...38,192,862
Ensembl chr12:38,159,904...38,192,860
G
Abcc2
ATP binding cassette subfamily C member 2
multiple interactions decreases activity increases expression
ISO
[SLCO1B1 protein co-treated with ABCC2 protein] results in increased transport of troglitazone analog troglitazone results in decreased activity of ABCC2 protein troglitazone results in increased expression of ABCC2 mRNA
CTD
PMID:19022234 PMID:19628752 PMID:22646477
NCBI chr 1:252,613,875...252,672,459
Ensembl chr 1:252,614,017...252,673,471
G
Abcc3
ATP binding cassette subfamily C member 3
increases expression
ISO EXP
troglitazone results in increased expression of ABCC3 mRNA
CTD
PMID:19022234 PMID:27507784
NCBI chr10:79,793,571...79,839,528
Ensembl chr10:79,793,583...79,839,494
G
Abcc4
ATP binding cassette subfamily C member 4
increases expression
EXP ISO
troglitazone results in increased expression of ABCC4 mRNA
CTD
PMID:27765674 PMID:28973697
NCBI chr15:101,948,387...102,182,912
Ensembl chr15:101,949,433...102,181,375
G
Abcc6
ATP binding cassette subfamily C member 6
decreases expression
ISO
troglitazone results in decreased expression of ABCC6 mRNA
CTD
PMID:25572481
NCBI chr 1:105,583,681...105,637,895
Ensembl chr 1:105,583,682...105,637,895
G
Abcc8
ATP binding cassette subfamily C member 8
decreases expression
EXP
troglitazone results in decreased expression of ABCC8 mRNA
CTD
PMID:21515302
NCBI chr 1:105,734,992...105,816,272
Ensembl chr 1:105,734,992...105,815,982
G
Abcc9
ATP binding cassette subfamily C member 9
decreases expression
ISO
troglitazone results in decreased expression of ABCC9 mRNA
CTD
PMID:28973697
NCBI chr 4:177,262,848...177,386,837
Ensembl chr 4:177,262,848...177,386,348
G
Abcd3
ATP binding cassette subfamily D member 3
increases expression
EXP
troglitazone results in increased expression of ABCD3 mRNA
CTD
PMID:21515302
NCBI chr 2:212,536,791...212,590,379
Ensembl chr 2:212,536,791...212,590,504
G
Abcf1
ATP binding cassette subfamily F member 1
decreases expression
ISO
troglitazone results in decreased expression of ABCF1 mRNA
CTD
PMID:28973697
NCBI chr20:2,807,315...2,820,240
Ensembl chr20:2,807,106...2,820,240
G
Abcg1
ATP binding cassette subfamily G member 1
increases expression
EXP
troglitazone results in increased expression of ABCG1 mRNA
CTD
PMID:25596134
NCBI chr20:9,128,056...9,184,312
Ensembl chr20:9,127,803...9,186,563
G
Abcg2
ATP binding cassette subfamily G member 2
increases expression
ISO
troglitazone results in increased expression of ABCG2 mRNA
CTD
PMID:20804740
NCBI chr 4:89,006,056...89,132,915
Ensembl chr 4:89,005,969...89,132,493
G
Abcg5
ATP binding cassette subfamily G member 5
increases expression
EXP ISO
troglitazone results in increased expression of ABCG5 mRNA
CTD
PMID:21515302 PMID:28973697
NCBI chr 6:15,717,936...15,743,376
Ensembl chr 6:15,717,936...15,743,376
G
Abcg8
ATP binding cassette subfamily G member 8
decreases expression
ISO
troglitazone results in decreased expression of ABCG8 mRNA
CTD
PMID:28973697
NCBI chr 6:15,698,448...15,717,730
Ensembl chr 6:15,698,448...15,717,730
G
Abhd12
abhydrolase domain containing 12, lysophospholipase
increases expression
ISO
troglitazone results in increased expression of ABHD12 mRNA
CTD
PMID:28973697
NCBI chr 3:160,119,724...160,179,959
Ensembl chr 3:160,119,724...160,179,969
G
Abi2
abl-interactor 2
decreases expression
ISO
troglitazone results in decreased expression of ABI2 mRNA
CTD
PMID:28973697
NCBI chr 9:69,321,072...69,490,630
Ensembl chr 9:69,321,150...69,490,597
G
Ablim1
actin-binding LIM protein 1
decreases expression
ISO
troglitazone results in decreased expression of ABLIM1 mRNA
CTD
PMID:28973697
NCBI chr 1:266,088,868...266,377,169
Ensembl chr 1:266,088,870...266,377,098
G
Abo
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase
increases expression
EXP
troglitazone results in increased expression of ABO mRNA
CTD
PMID:21515302
NCBI chr 3:30,560,172...30,604,758
G
Acaa1a
acetyl-CoA acyltransferase 1A
decreases expression increases expression
ISO EXP
troglitazone results in decreased expression of ACAA1A protein troglitazone results in increased expression of ACAA1 mRNA
CTD
PMID:18495193 PMID:21515302
NCBI chr 8:127,956,126...127,966,348
Ensembl chr 8:127,956,129...127,966,241
G
Acaa1b
acetyl-Coenzyme A acyltransferase 1B
increases expression
ISO
troglitazone results in increased expression of ACAA1 mRNA; troglitazone results in increased expression of ACAA1B mRNA
CTD
PMID:28973697
NCBI chr 8:127,750,771...127,759,589
Ensembl chr 8:127,750,743...127,759,569
G
Acaa2
acetyl-CoA acyltransferase 2
increases expression
EXP
troglitazone results in increased expression of ACAA2 mRNA
CTD
PMID:21515302
NCBI chr18:70,620,310...70,648,417
Ensembl chr18:70,620,110...70,648,420
G
Acad8
acyl-CoA dehydrogenase family, member 8
increases expression
ISO
troglitazone results in increased expression of ACAD8 protein
CTD
PMID:18495193
NCBI chr 8:33,641,420...33,665,542
Ensembl chr 8:33,641,420...33,665,542
G
Acadl
acyl-CoA dehydrogenase, long chain
increases expression
EXP
troglitazone results in increased expression of ACADL protein
CTD
PMID:21315101
NCBI chr 9:75,783,689...75,822,077
Ensembl chr 9:75,783,689...75,822,164
G
Acadm
acyl-CoA dehydrogenase medium chain
increases expression decreases expression
ISO EXP
troglitazone results in increased expression of ACADM protein troglitazone results in decreased expression of ACADM mRNA troglitazone results in increased expression of ACADM mRNA
CTD
PMID:11056218 PMID:18495193 PMID:21515302
NCBI chr 2:245,518,693...245,542,864
Ensembl chr 2:245,518,693...245,542,864
G
Acads
acyl-CoA dehydrogenase short chain
increases expression
EXP
troglitazone results in increased expression of ACADS protein
CTD
PMID:21315101
NCBI chr12:47,154,259...47,163,580
Ensembl chr12:47,154,276...47,164,103
G
Acadvl
acyl-CoA dehydrogenase, very long chain
increases expression
EXP
troglitazone results in increased expression of ACADVL mRNA
CTD
PMID:21515302
NCBI chr10:55,231,558...55,236,786
Ensembl chr10:55,231,440...55,236,750
G
Acat1
acetyl-CoA acetyltransferase 1
increases expression
EXP
troglitazone results in increased expression of ACAT1 mRNA
CTD
PMID:21515302
NCBI chr 8:62,876,003...62,905,080
Ensembl chr 8:62,876,003...62,905,042
G
Acat2
acetyl-CoA acetyltransferase 2
increases expression
EXP
troglitazone results in increased expression of ACAT2 protein
CTD
PMID:21315101
NCBI chr 1:50,100,840...50,118,886
Ensembl chr 1:50,100,817...50,135,095
G
Accsl
1-aminocyclopropane-1-carboxylate synthase-like
increases expression
ISO
troglitazone results in increased expression of ACCSL mRNA
CTD
PMID:28973697
NCBI chr 3:100,281,817...100,296,514
Ensembl chr 3:100,261,941...100,296,514
G
Acd
ACD, shelterin complex subunit and telomerase recruitment factor
decreases expression
ISO
troglitazone results in decreased expression of ACD mRNA
CTD
PMID:19140230
NCBI chr19:50,496,634...50,499,397
Ensembl chr19:50,496,635...50,499,326
G
Acin1
apoptotic chromatin condensation inducer 1
decreases expression
ISO
troglitazone results in decreased expression of ACIN1 mRNA
CTD
PMID:28973697
NCBI chr15:32,072,121...32,117,004
Ensembl chr15:32,072,123...32,117,166
G
Ackr3
atypical chemokine receptor 3
decreases expression
ISO
troglitazone results in decreased expression of ACKR3 mRNA
CTD
PMID:28973697
NCBI chr 9:98,247,300...98,258,877
Ensembl chr 9:98,246,605...98,260,214
G
Acly
ATP citrate lyase
decreases expression
ISO
troglitazone results in decreased expression of ACLY mRNA
CTD
PMID:25572481
NCBI chr10:85,912,402...85,964,605
Ensembl chr10:85,912,402...85,963,631
G
Aco1
aconitase 1
increases expression
EXP
troglitazone results in increased expression of ACO1 mRNA
CTD
PMID:21515302
NCBI chr 5:60,055,895...60,111,920
Ensembl chr 5:60,055,866...60,112,600
G
Aco2
aconitase 2
decreases expression
ISO
troglitazone results in decreased expression of ACO2 protein
CTD
PMID:18495193
NCBI chr 7:115,265,816...115,308,931
Ensembl chr 7:115,265,791...115,308,892
G
Acot1
acyl-CoA thioesterase 1
decreases expression increases expression
ISO EXP
Troglitazone results in decreased expression of ACOT1 mRNA Troglitazone results in increased expression of ACOT1 mRNA; Troglitazone results in increased expression of ACOT1 protein
CTD
PMID:21315101 PMID:21515302 PMID:28973697
NCBI chr 6:109,367,274...109,375,268
Ensembl chr 6:109,367,268...109,380,749
G
Acot12
acyl-CoA thioesterase 12
increases expression
EXP ISO
troglitazone results in increased expression of ACOT12 mRNA
CTD
PMID:21515302 PMID:28973697
NCBI chr 2:24,721,648...24,763,686
Ensembl chr 2:24,721,910...24,765,298
G
Acot2
acyl-CoA thioesterase 2
increases expression
EXP
troglitazone results in increased expression of ACOT2 mRNA; troglitazone results in increased expression of ACOT2 protein
CTD
PMID:21315101 PMID:21515302
NCBI chr 6:109,341,426...109,352,818
Ensembl chr 6:109,342,646...109,350,502
G
Acot7
acyl-CoA thioesterase 7
increases expression
EXP
troglitazone results in increased expression of ACOT7 mRNA
CTD
PMID:21515302
NCBI chr 5:167,969,284...168,062,033
Ensembl chr 5:167,968,895...168,062,033
G
Acox1
acyl-CoA oxidase 1
decreases expression multiple interactions increases expression
ISO EXP
troglitazone results in decreased expression of ACOX1 mRNA; troglitazone results in decreased expression of ACOX1 protein [troglitazone results in increased expression of NR2F2 protein] which results in decreased expression of ACOX1 mRNA troglitazone results in increased expression of ACOX1 mRNA
CTD
PMID:12732648 PMID:12920214 PMID:18495193 PMID:21515302
NCBI chr10:101,905,083...101,930,136
Ensembl chr10:101,905,083...101,930,136
G
Acsl1
acyl-CoA synthetase long-chain family member 1
increases expression decreases expression
ISO EXP
troglitazone results in increased expression of ACSL1 mRNA troglitazone results in decreased expression of ACSL1 mRNA troglitazone results in increased expression of ACSL1 mRNA; troglitazone results in increased expression of ACSL1 protein
CTD
PMID:9452481 PMID:12732648 PMID:21315101 PMID:21515302 PMID:25596134
NCBI chr16:52,487,870...52,554,110
Ensembl chr16:52,487,870...52,554,023
G
Acsl3
acyl-CoA synthetase long-chain family member 3
increases expression decreases expression
EXP ISO
troglitazone results in increased expression of ACSL3 mRNA troglitazone results in decreased expression of ACSL3 mRNA
CTD
PMID:21515302 PMID:28973697
NCBI chr 9:87,563,601...87,613,078
Ensembl chr 9:87,563,601...87,613,097
G
Acsl4
acyl-CoA synthetase long-chain family member 4
increases expression decreases activity
EXP
troglitazone results in increased expression of ACSL4 mRNA Troglitazone results in decreased activity of ACSL4 protein
CTD
PMID:11319222 PMID:21515302
NCBI chr X:110,739,633...110,803,416
Ensembl chr X:110,739,648...110,803,261
G
Acsl5
acyl-CoA synthetase long-chain family member 5
increases expression
EXP
troglitazone results in increased expression of ACSL5 protein
CTD
PMID:21315101
NCBI chr 1:264,294,851...264,341,943
Ensembl chr 1:264,294,864...264,341,943
G
Acsl6
acyl-CoA synthetase long-chain family member 6
decreases expression
EXP
troglitazone results in decreased expression of ACSL6 mRNA
CTD
PMID:9452481
NCBI chr10:38,940,668...38,999,515
Ensembl chr10:38,940,747...39,002,873
G
Acsm2
acyl-CoA synthetase medium-chain family member 2
increases expression decreases expression
EXP ISO
troglitazone results in increased expression of ACSM2A mRNA troglitazone results in decreased expression of ACSM2A mRNA
CTD
PMID:21515302 PMID:28973697
NCBI chr 1:183,347,705...183,386,453
Ensembl chr 1:183,347,705...183,386,453
G
Acss2
acyl-CoA synthetase short-chain family member 2
decreases expression
ISO
troglitazone results in decreased expression of ACSS2 mRNA
CTD
PMID:25572481
NCBI chr 3:164,464,124...164,507,607
Ensembl chr 3:164,464,055...164,519,830
G
Acta2
actin alpha 2, smooth muscle
multiple interactions decreases expression
ISO EXP
troglitazone inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 mRNA] troglitazone results in decreased expression of ACTA2
CTD
PMID:15211114 PMID:18162602
NCBI chr 1:241,159,723...241,172,503
Ensembl chr 1:241,159,724...241,172,503
G
Actg1
actin, gamma 1
decreases expression
ISO
troglitazone results in decreased expression of ACTG1 mRNA
CTD
PMID:19140230
NCBI chr10:106,118,106...106,120,951
Ensembl chr10:106,118,108...106,120,951
G
Actn1
actinin, alpha 1
increases expression decreases expression
EXP
troglitazone results in increased expression of ACTN1 mRNA troglitazone results in decreased expression of ACTN1 mRNA
CTD
PMID:19022234 PMID:21515302
NCBI chr 6:104,731,485...104,826,312
Ensembl chr 6:104,731,485...104,826,172
G
Actr1b
actin related protein 1B
decreases expression
ISO
troglitazone results in decreased expression of ACTR1B mRNA
CTD
PMID:28973697
NCBI chr 9:46,424,677...46,434,341
Ensembl chr 9:46,424,678...46,434,341
G
Acvr2b
activin A receptor type 2B
decreases expression
ISO
troglitazone results in decreased expression of ACVR2B mRNA
CTD
PMID:28973697
NCBI chr 8:128,016,589...128,056,193
Ensembl chr 8:128,016,526...128,048,171
G
Acvrl1
activin A receptor like type 1
increases expression
ISO
troglitazone results in increased expression of ACVRL1 mRNA
CTD
PMID:17569031
NCBI chr 7:134,117,917...134,135,306
Ensembl chr 7:134,118,024...134,135,305
G
Acyp2
acylphosphatase 2
increases expression
ISO
troglitazone results in increased expression of ACYP2 mRNA
CTD
PMID:28973697
NCBI chr14:108,402,837...108,572,367
Ensembl chr14:108,402,544...108,633,318
G
Adam12
ADAM metallopeptidase domain 12
increases expression
ISO
troglitazone results in increased expression of ADAM12 mRNA
CTD
PMID:28973697
NCBI chr 1:198,116,968...198,443,680
Ensembl chr 1:198,116,975...198,447,552
G
Adam23
ADAM metallopeptidase domain 23
increases expression
ISO
troglitazone results in increased expression of ADAM23 mRNA
CTD
PMID:25572481
NCBI chr 9:72,356,479...72,503,545
Ensembl chr 9:72,356,479...72,503,545
G
Adam9
ADAM metallopeptidase domain 9
multiple interactions
ISO
troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ADAM9 mRNA]
CTD
PMID:20847119
NCBI chr16:73,725,186...73,804,284
Ensembl chr16:73,725,114...73,804,646
G
Adamts1
ADAM metallopeptidase with thrombospondin type 1 motif, 1
decreases expression
ISO
troglitazone results in decreased expression of ADAMTS1 mRNA
CTD
PMID:19140230
NCBI chr11:38,418,565...38,427,384
Ensembl chr11:38,418,101...38,427,390
G
Adamts12
ADAM metallopeptidase with thrombospondin type 1 motif, 12
increases expression
ISO
troglitazone results in increased expression of ADAMTS12 mRNA
CTD
PMID:28973697
NCBI chr 2:61,759,975...62,054,716
Ensembl chr 2:61,759,987...62,054,716
G
Adamts18
ADAM metallopeptidase with thrombospondin type 1 motif, 18
increases expression
ISO
troglitazone results in increased expression of ADAMTS18 mRNA
CTD
PMID:28934090
NCBI chr19:58,596,095...58,749,239
Ensembl chr19:58,597,761...58,749,138
G
Adarb1
adenosine deaminase, RNA-specific, B1
decreases expression
ISO
troglitazone results in decreased expression of ADARB1 mRNA
CTD
PMID:19140230
NCBI chr20:11,222,171...11,350,416
Ensembl chr20:11,222,164...11,350,415
G
Adcy10
adenylate cyclase 10
increases expression decreases expression
EXP ISO
troglitazone results in increased expression of ADCY10 mRNA troglitazone results in decreased expression of ADCY10 mRNA
CTD
PMID:21515302 PMID:28973697
NCBI chr13:80,280,595...80,366,939
Ensembl chr13:80,284,295...80,366,926
G
Adcy9
adenylate cyclase 9
decreases expression
ISO
troglitazone results in decreased expression of ADCY9 mRNA
CTD
PMID:28973697
NCBI chr10:11,645,373...11,768,462
Ensembl chr10:11,645,282...11,765,792
G
Adgre1
adhesion G protein-coupled receptor E1
decreases expression
EXP
troglitazone results in decreased expression of ADGRE1 mRNA
CTD
PMID:21515302
NCBI chr 9:2,329,398...2,484,959
Ensembl chr 9:2,329,438...2,484,959
G
Adgre5
adhesion G protein-coupled receptor E5
decreases expression
ISO
troglitazone results in decreased expression of ADGRE5 protein
CTD
PMID:15785241
NCBI chr19:41,302,687...41,332,183
Ensembl chr19:41,303,213...41,324,641
G
Adgrg1
adhesion G protein-coupled receptor G1
increases expression
ISO
troglitazone results in increased expression of ADGRG1 mRNA
CTD
PMID:19140230
NCBI chr19:10,009,983...10,047,138
Ensembl chr19:10,010,031...10,047,124
G
Adh1c
alcohol dehydrogenase 1C (class I), gamma polypeptide
decreases expression
ISO
troglitazone results in decreased expression of ADH1C mRNA
CTD
PMID:25572481
NCBI chr 2:229,470,703...229,482,291
Ensembl chr 2:229,470,703...229,482,291
G
Adh4
alcohol dehydrogenase 4 (class II), pi polypeptide
decreases expression
ISO
troglitazone results in decreased expression of ADH4 mRNA
CTD
PMID:25572481
NCBI chr 2:229,622,092...229,640,120
Ensembl chr 2:229,622,095...229,641,879
G
Adh7
alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide
increases expression
EXP
troglitazone results in increased expression of ADH7 mRNA
CTD
PMID:21515302
NCBI chr 2:229,422,125...229,436,584
Ensembl chr 2:229,421,252...229,436,691
G
Adipoq
adiponectin, C1Q and collagen domain containing
increases expression increases secretion decreases expression
ISO EXP
troglitazone results in increased expression of ADIPOQ mRNA; troglitazone results in increased expression of ADIPOQ protein troglitazone results in increased secretion of ADIPOQ protein troglitazone results in decreased expression of ADIPOQ mRNA
CTD
PMID:12732648 PMID:16076985 PMID:17452443 PMID:21515302 PMID:28934090
NCBI chr11:91,226,524...91,240,244
Ensembl chr11:91,226,180...91,240,169
G
Adipor1
adiponectin receptor 1
decreases expression
ISO
troglitazone results in decreased expression of ADIPOR1 protein
CTD
PMID:16023994
NCBI chr13:48,411,438...48,431,251
Ensembl chr13:48,411,826...48,431,255
G
Adm
adrenomedullin
multiple interactions
ISO
[troglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of ADM mRNA; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ADM mRNA]
CTD
PMID:20847119
NCBI chr 1:174,164,178...174,182,372
Ensembl chr 1:174,178,773...174,182,371
G
Adnp2
ADNP homeobox 2
decreases expression
ISO
troglitazone results in decreased expression of ADNP2 mRNA
CTD
PMID:28973697
NCBI chr18:75,846,860...75,871,638
Ensembl chr18:75,847,165...75,903,317
G
Adora2a
adenosine A2a receptor
increases expression
ISO
troglitazone results in increased expression of ADORA2A mRNA
CTD
PMID:28973697
NCBI chr20:13,315,270...13,332,802
Ensembl chr20:13,315,270...13,332,802
G
Adra1a
adrenoceptor alpha 1A
increases expression
ISO
troglitazone results in increased expression of ADRA1A mRNA
CTD
PMID:28934090 PMID:28973697
NCBI chr15:45,005,648...45,111,416
Ensembl chr15:45,005,799...45,102,534
G
Adra1b
adrenoceptor alpha 1B
increases expression
EXP
troglitazone results in increased expression of ADRA1B mRNA
CTD
PMID:21515302
NCBI chr10:28,756,461...28,874,831
Ensembl chr10:28,756,461...28,814,347
G
Adra2c
adrenoceptor alpha 2C
increases expression
EXP
troglitazone results in increased expression of ADRA2C mRNA
CTD
PMID:21515302
NCBI chr14:79,695,514...79,697,476
Ensembl chr14:79,694,995...79,706,656
G
Adrb1
adrenoceptor beta 1
decreases expression
ISO
troglitazone results in decreased expression of ADRB1 mRNA
CTD
PMID:28973697
NCBI chr 1:265,777,103...265,780,114
Ensembl chr 1:265,766,079...265,849,237
G
Adtrp
androgen-dependent TFPI-regulating protein
increases expression
EXP
troglitazone results in increased expression of ADTRP mRNA
CTD
PMID:21515302
NCBI chr17:23,113,578...23,199,616
Ensembl chr17:23,135,809...23,216,622
G
Afap1
actin filament associated protein 1
decreases expression
ISO
troglitazone results in decreased expression of AFAP1 mRNA
CTD
PMID:28973697
NCBI chr14:78,967,961...79,081,032
Ensembl chr14:78,967,961...79,080,939
G
Afap1l1
actin filament associated protein 1-like 1
decreases expression
ISO
troglitazone results in decreased expression of AFAP1L1 mRNA
CTD
PMID:28973697
NCBI chr18:57,454,120...57,514,584
Ensembl chr18:57,454,121...57,514,480
G
Afdn
afadin, adherens junction formation factor
decreases expression
ISO
troglitazone results in decreased expression of AFDN mRNA
CTD
PMID:28973697
NCBI chr 1:58,041,065...58,170,505
Ensembl chr 1:58,041,641...58,170,505
G
Aff4
ALF transcription elongation factor 4
decreases expression
ISO
troglitazone results in decreased expression of AFF4 mRNA
CTD
PMID:28973697
NCBI chr10:37,998,319...38,080,580
Ensembl chr10:37,999,579...38,080,580
G
Afg2a
AFG2 AAA ATPase homolog A
decreases expression
ISO
Troglitazone results in decreased expression of AFG2A mRNA
CTD
PMID:28973697
NCBI chr 2:122,234,619...122,425,808
Ensembl chr 2:122,234,738...122,425,808
G
Ager
advanced glycosylation end product-specific receptor
increases expression
ISO
Troglitazone results in increased expression of AGER mRNA
CTD
PMID:31294483
NCBI chr20:4,152,758...4,155,956
Ensembl chr20:4,151,965...4,155,685
G
Agfg1
ArfGAP with FG repeats 1
decreases expression
ISO
troglitazone results in decreased expression of AGFG1 mRNA
CTD
PMID:28973697
NCBI chr 9:91,572,962...91,630,688
Ensembl chr 9:91,573,157...91,626,910
G
Ago1
argonaute RISC component 1
decreases expression
ISO
troglitazone results in decreased expression of AGO1 mRNA
CTD
PMID:28973697
NCBI chr 5:144,006,618...144,064,740
Ensembl chr 5:144,006,618...144,041,624
G
Ago2
argonaute RISC catalytic component 2
decreases expression
ISO
troglitazone results in decreased expression of AGO2 mRNA
CTD
PMID:28973697
NCBI chr 7:106,907,209...106,994,124
Ensembl chr 7:106,918,125...106,993,980
G
Agpat3
1-acylglycerol-3-phosphate O-acyltransferase 3
decreases expression
ISO
troglitazone results in decreased expression of AGPAT3 mRNA
CTD
PMID:28973697
NCBI chr20:10,330,650...10,415,026
Ensembl chr20:10,394,465...10,410,632
G
Agrn
agrin
decreases expression
EXP
troglitazone results in decreased expression of AGRN mRNA
CTD
PMID:25596134
NCBI chr 5:172,031,528...172,064,429
Ensembl chr 5:172,031,528...172,064,539
G
Agt
angiotensinogen
multiple interactions
ISO
troglitazone inhibits the reaction [AGT protein modified form results in decreased secretion of Nitric Oxide]; troglitazone inhibits the reaction [AGT protein modified form results in increased expression of EDN1 protein]
CTD
PMID:17666345
NCBI chr19:69,426,540...69,447,017
Ensembl chr19:69,421,638...69,446,944
G
Agtr1a
angiotensin II receptor, type 1a
decreases expression
ISO
troglitazone results in decreased expression of AGTR1 mRNA
CTD
PMID:28973697
NCBI chr17:34,383,397...34,435,523
Ensembl chr17:34,381,467...34,435,660
G
Agtr1b
angiotensin II receptor, type 1b
decreases expression
EXP
troglitazone results in decreased expression of AGTR1B mRNA
CTD
PMID:21515302
NCBI chr 2:104,774,005...104,849,262
Ensembl chr 2:104,773,930...104,849,310
G
Agxt2
alanine-glyoxylate aminotransferase 2
decreases expression
EXP ISO
troglitazone results in decreased expression of AGXT2 mRNA
CTD
PMID:21515302 PMID:25572481
NCBI chr 2:61,063,416...61,104,828
Ensembl chr 2:61,063,419...61,105,090
G
Ahr
aryl hydrocarbon receptor
affects activity
EXP
troglitazone affects the activity of AHR protein
CTD
PMID:25596134
NCBI chr 6:57,961,423...57,998,901
Ensembl chr 6:57,961,423...57,998,901
G
Aifm2
AIF family member 2
increases expression
EXP
troglitazone results in increased expression of AIFM2 mRNA
CTD
PMID:25596134
NCBI chr20:30,195,781...30,222,014
Ensembl chr20:30,193,829...30,220,957
G
Ajuba
ajuba LIM protein
multiple interactions
ISO
[troglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of AJUBA mRNA; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of AJUBA mRNA]
CTD
PMID:20847119
NCBI chr15:31,989,796...32,000,042
Ensembl chr15:31,989,799...32,000,042
G
Ak2
adenylate kinase 2
decreases expression
ISO
troglitazone results in decreased expression of AK2 mRNA
CTD
PMID:12732648
NCBI chr 5:146,609,469...146,649,008
Ensembl chr 5:146,630,445...146,650,610
G
Ak3
adenylate kinase 3
increases expression
ISO
troglitazone results in increased expression of AK3 mRNA
CTD
PMID:28973697
NCBI chr 1:236,151,012...236,178,689
Ensembl chr 1:236,151,012...236,178,183
G
Ak4
adenylate kinase 4
decreases expression
ISO
troglitazone results in decreased expression of AK4 mRNA
CTD
PMID:28973697
NCBI chr 5:121,154,565...121,214,403
Ensembl chr 5:121,154,572...121,214,401
G
Akap12
A-kinase anchoring protein 12
decreases expression
ISO
troglitazone results in decreased expression of AKAP12 mRNA
CTD
PMID:25572481
NCBI chr 1:43,135,515...43,225,245
Ensembl chr 1:43,199,008...43,225,557
G
Akap13
A-kinase anchoring protein 13
decreases expression
ISO
troglitazone results in decreased expression of AKAP13 mRNA
CTD
PMID:28973697
NCBI chr 1:138,722,445...139,029,401
Ensembl chr 1:138,724,150...139,029,401
G
Akr1b10
aldo-keto reductase family 1 member B10
increases expression
ISO
troglitazone results in increased expression of AKR1B10 mRNA
CTD
PMID:25572481
NCBI chr 4:64,005,632...64,027,860
Ensembl chr 4:64,007,420...64,020,847
G
Akr1b15
aldo-keto reductase family 1 member B15
increases expression
ISO
Troglitazone results in increased expression of AKR1B15 mRNA
CTD
PMID:25572481
NCBI chr 4:63,964,421...63,976,995
Ensembl chr 4:63,960,880...63,978,349
G
Akr1c3
aldo-keto reductase family 1, member C3
increases expression
ISO
troglitazone results in increased expression of AKR1C3 mRNA
CTD
PMID:28973697
NCBI chr17:71,020,884...71,037,779
Ensembl chr17:70,970,900...71,048,438
G
Akr1d1
aldo-keto reductase family 1, member D1
increases expression
EXP
troglitazone results in increased expression of AKR1D1 mRNA; troglitazone results in increased expression of AKR1D1 protein
CTD
PMID:21315101 PMID:21515302
NCBI chr 4:67,121,288...67,154,543
Ensembl chr 4:67,120,024...67,154,540
G
Akt1
AKT serine/threonine kinase 1
multiple interactions
ISO
[troglitazone co-treated with Aspirin] results in decreased expression of AKT1 protein; [troglitazone co-treated with Aspirin] results in decreased expression of AKT1 protein modified form
CTD
PMID:19908241
NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:137,535,390...137,552,610
G
Alad
aminolevulinate dehydratase
increases expression
ISO
troglitazone results in increased expression of ALAD mRNA
CTD
PMID:28973697
NCBI chr 5:80,977,562...80,987,901
Ensembl chr 5:80,977,562...80,988,041
G
Alb
albumin
decreases expression
ISO
troglitazone results in decreased expression of ALB protein
CTD
PMID:25934330
NCBI chr14:17,891,564...17,907,043
Ensembl chr14:17,891,582...17,911,865
G
Alcam
activated leukocyte cell adhesion molecule
decreases expression
ISO
troglitazone results in decreased expression of ALCAM mRNA
CTD
PMID:28973697
NCBI chr11:61,804,932...62,005,250
Ensembl chr11:61,805,049...62,006,876
G
Aldh1a1
aldehyde dehydrogenase 1 family, member A1
increases expression
EXP
troglitazone results in increased expression of ALDH1A1 mRNA
CTD
PMID:21515302
NCBI chr 1:227,426,939...227,579,497
Ensembl chr 1:227,427,070...227,579,500
G
Aldh1a7
aldehyde dehydrogenase family 1, subfamily A7
increases expression
EXP
Troglitazone results in increased expression of ALDH1A7 mRNA
CTD
PMID:21515302
NCBI chr 1:227,627,977...227,667,877
Ensembl chr 1:227,627,448...227,672,523
G
Aldh1l1
aldehyde dehydrogenase 1 family, member L1
increases expression
ISO
troglitazone results in increased expression of ALDH1L1 mRNA
CTD
PMID:28973697
NCBI chr 4:124,617,182...124,663,674
Ensembl chr 4:124,617,217...124,664,704
G
Aldh2
aldehyde dehydrogenase 2 family member
increases expression decreases expression
ISO
troglitazone results in increased expression of ALDH2 protein troglitazone results in decreased expression of ALDH2 mRNA
CTD
PMID:18495193 PMID:28973697
NCBI chr12:40,610,244...40,643,220
Ensembl chr12:40,610,224...40,643,219
G
Aldh3a2
aldehyde dehydrogenase 3 family, member A2
increases expression
ISO
troglitazone results in increased expression of ALDH3A2 mRNA
CTD
PMID:28973697
NCBI chr10:46,427,789...46,448,449
Ensembl chr10:46,407,993...46,448,648
G
Aldh3b1
aldehyde dehydrogenase 3 family, member B1
decreases expression
EXP
troglitazone results in decreased expression of ALDH3B1 mRNA
CTD
PMID:21515302
NCBI chr 1:210,574,545...210,605,188
Ensembl chr 1:210,573,661...210,610,538
G
Aldh7a1
aldehyde dehydrogenase 7 family, member A1
increases expression
ISO
troglitazone results in increased expression of ALDH7A1 protein
CTD
PMID:18495193
NCBI chr18:52,208,035...52,240,293
Ensembl chr18:52,204,161...52,240,467
G
Aldoa
aldolase, fructose-bisphosphate A
increases expression
EXP
Troglitazone results in increased expression of ALDOA mRNA
CTD
PMID:25596134
NCBI chr 1:190,832,820...190,838,021
Ensembl chr 1:190,832,820...190,838,211
G
Aldob
aldolase, fructose-bisphosphate B
decreases expression
ISO
troglitazone results in decreased expression of ALDOB mRNA
CTD
PMID:25572481
NCBI chr 5:68,684,541...68,697,582
Ensembl chr 5:68,684,542...68,716,740
G
Alkbh8
alkB homolog 8, tRNA methyltransferase
decreases expression
ISO
troglitazone results in decreased expression of ALKBH8 mRNA
CTD
PMID:28973697
NCBI chr 6:6,121,402...6,198,226
Ensembl chr 6:6,124,253...6,198,080
G
Alox5
arachidonate 5-lipoxygenase
decreases activity multiple interactions
EXP
troglitazone results in decreased activity of ALOX5 protein [troglitazone results in decreased activity of ALOX5 protein] which results in decreased abundance of Leukotriene B4
CTD
PMID:10694244 PMID:17113579
NCBI chr 4:151,203,948...151,251,126
Ensembl chr 4:151,203,949...151,251,126
G
Alox5ap
arachidonate 5-lipoxygenase activating protein
increases expression
ISO
troglitazone results in increased expression of ALOX5AP mRNA
CTD
PMID:28973697
NCBI chr12:10,785,254...10,809,295
Ensembl chr12:10,785,257...10,817,038
G
Alpi
alkaline phosphatase, intestinal
decreases expression
EXP
troglitazone results in decreased expression of ALPI mRNA
CTD
PMID:21515302
NCBI chr 9:95,221,314...95,224,780
Ensembl chr 9:95,221,314...95,224,780
G
Alyref
Aly/REF export factor
decreases expression
ISO
troglitazone results in decreased expression of ALYREF mRNA
CTD
PMID:19140230
NCBI chr10:106,369,750...106,373,395
Ensembl chr10:106,369,750...106,373,395
G
Amdhd1
amidohydrolase domain containing 1
increases expression decreases expression
EXP ISO
troglitazone results in increased expression of AMDHD1 protein troglitazone results in decreased expression of AMDHD1 mRNA
CTD
PMID:21315101 PMID:28973697
NCBI chr 7:29,930,966...29,946,199
Ensembl chr 7:29,929,965...29,959,683
G
Amhr2
anti-Mullerian hormone receptor type 2
increases expression
EXP
troglitazone results in increased expression of AMHR2 mRNA
CTD
PMID:21515302
NCBI chr 7:135,454,517...135,470,183
Ensembl chr 7:135,457,922...135,471,104
G
Ammecr1l
AMMECR1 like
decreases expression
ISO
troglitazone results in decreased expression of AMMECR1L mRNA
CTD
PMID:28973697
NCBI chr18:23,661,649...23,685,391
Ensembl chr18:23,661,341...23,685,649
G
Amotl1
angiomotin-like 1
decreases expression
ISO
troglitazone results in decreased expression of AMOTL1 mRNA
CTD
PMID:28973697
NCBI chr 8:19,630,139...19,749,027
Ensembl chr 8:19,634,510...19,748,869
G
Amotl2
angiomotin like 2
multiple interactions increases expression
ISO
[troglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of AMOTL2 mRNA; troglitazone inhibits the reaction [tert-Butylhydroperoxide promotes the reaction [PPARG protein binds to AMOTL2 promoter]]; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of AMOTL2 mRNA] troglitazone results in increased expression of AMOTL2 mRNA
CTD
PMID:20847119 PMID:28973697
NCBI chr 8:112,182,060...112,198,032
Ensembl chr 8:112,181,863...112,198,030
G
Ang
angiogenin
decreases expression
ISO
troglitazone results in decreased expression of ANG mRNA
CTD
PMID:25572481
NCBI chr15:26,786,233...26,796,883
Ensembl chr15:26,786,065...26,801,106
G
Angpt2
angiopoietin 2
increases expression multiple interactions
ISO
troglitazone results in increased expression of ANGPT2 mRNA [Urethane co-treated with troglitazone] results in increased expression of ANGPT2 mRNA
CTD
PMID:17569031 PMID:18465119
NCBI chr16:77,790,760...77,841,241
Ensembl chr16:77,790,563...77,841,239
G
Angptl2
angiopoietin-like 2
multiple interactions decreases expression
ISO
troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ANGPTL2 mRNA] troglitazone results in decreased expression of ANGPTL2 mRNA
CTD
PMID:20847119 PMID:28973697
NCBI chr 3:36,914,876...36,944,715
Ensembl chr 3:36,914,745...36,945,876
G
Angptl3
angiopoietin-like 3
decreases expression
ISO
Troglitazone results in decreased expression of ANGPTL3 mRNA
CTD
PMID:32535746
NCBI chr 5:118,818,494...118,825,531
Ensembl chr 5:118,818,499...118,826,444
G
Angptl4
angiopoietin-like 4
increases expression decreases expression
EXP ISO
troglitazone results in increased expression of ANGPTL4 mRNA troglitazone results in decreased expression of ANGPTL4 mRNA
CTD
PMID:19140230 PMID:21515302 PMID:25572481 PMID:28973697
NCBI chr 7:15,252,450...15,259,971
Ensembl chr 7:15,252,473...15,258,681
G
Angptl8
angiopoietin-like 8
increases expression
ISO
troglitazone results in increased expression of ANGPTL8 mRNA
CTD
PMID:28973697
NCBI chr 8:28,652,555...28,654,581
Ensembl chr 8:28,652,555...28,654,581
G
Ankhd1
ankyrin repeat and KH domain containing 1
decreases expression
ISO
troglitazone results in decreased expression of ANKHD1 mRNA
CTD
PMID:28973697
NCBI chr18:28,436,296...28,534,954
Ensembl chr18:28,436,394...28,534,954
G
Ankrd1
ankyrin repeat domain 1
decreases expression
EXP
troglitazone results in decreased expression of ANKRD1 mRNA
CTD
PMID:21515302
NCBI chr 1:243,228,460...243,237,014
Ensembl chr 1:243,228,448...243,263,751
G
Ankrd11
ankyrin repeat domain containing 11
decreases expression
ISO
troglitazone results in decreased expression of ANKRD11 mRNA
CTD
PMID:28973697
NCBI chr19:67,848,836...68,007,491
Ensembl chr19:67,848,844...68,007,491
G
Ankrd12
ankyrin repeat domain 12
decreases expression
ISO
troglitazone results in decreased expression of ANKRD12 mRNA
CTD
PMID:28973697
NCBI chr 9:113,030,127...113,134,816
Ensembl chr 9:113,030,919...113,134,762
G
Ankrd17
ankyrin repeat domain 17
decreases expression
ISO
troglitazone results in decreased expression of ANKRD17 mRNA
CTD
PMID:28973697
NCBI chr14:18,007,342...18,145,980
Ensembl chr14:18,008,859...18,145,980
G
Ankrd33b
ankyrin repeat domain 33B
decreases expression
ISO
troglitazone results in decreased expression of ANKRD33B mRNA
CTD
PMID:28973697
NCBI chr 2:83,988,505...84,070,311
Ensembl chr 2:83,993,974...84,070,936
G
Ankrd37
ankyrin repeat domain 37
multiple interactions
ISO
[troglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of ANKRD37 mRNA; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ANKRD37 mRNA]
CTD
PMID:20847119
NCBI chr16:53,001,487...53,004,545
Ensembl chr16:52,994,740...53,004,545
G
Ankrd50
ankyrin repeat domain containing 50
increases expression
ISO
troglitazone results in increased expression of ANKRD50 mRNA
CTD
PMID:28973697
NCBI chr 2:123,394,311...123,428,788
Ensembl chr 2:123,396,606...123,427,340
G
Ankzf1
ankyrin repeat and zinc finger peptidyl tRNA hydrolase 1
decreases expression
ISO
troglitazone results in decreased expression of ANKZF1 mRNA
CTD
PMID:28973697
NCBI chr 9:84,136,862...84,143,830
Ensembl chr 9:84,136,862...84,145,091
G
Anln
anillin, actin binding protein
decreases expression
ISO
troglitazone results in decreased expression of ANLN mRNA
CTD
PMID:19140230
NCBI chr 8:29,134,222...29,197,513
Ensembl chr 8:29,134,222...29,197,513
G
Anp32b
acidic nuclear phosphoprotein 32 family member B
decreases expression
ISO
troglitazone results in decreased expression of ANP32B mRNA
CTD
PMID:28973697
NCBI chr 5:65,538,872...65,561,305
Ensembl chr 5:65,538,535...65,561,437
G
Anpep
alanyl aminopeptidase, membrane
increases expression
ISO
troglitazone results in increased expression of ANPEP mRNA
CTD
PMID:19140230
NCBI chr 1:143,176,645...143,219,447
Ensembl chr 1:143,176,645...143,195,101
G
Antxr1
ANTXR cell adhesion molecule 1
decreases expression
ISO
troglitazone results in decreased expression of ANTXR1 mRNA
CTD
PMID:28973697
NCBI chr 4:121,148,102...121,335,549
Ensembl chr 4:121,148,103...121,336,892
G
Anxa1
annexin A1
increases expression
ISO
troglitazone results in increased expression of ANXA1 mRNA
CTD
PMID:28973697
NCBI chr 1:227,287,713...227,306,739
Ensembl chr 1:227,287,717...227,306,831
G
Anxa10
annexin A10
decreases expression
ISO
troglitazone results in decreased expression of ANXA10 mRNA
CTD
PMID:25572481
NCBI chr16:32,505,025...32,571,961
Ensembl chr16:32,467,126...32,571,961
G
Anxa11
annexin A11
decreases expression
ISO
troglitazone results in decreased expression of ANXA11 mRNA
CTD
PMID:28973697
NCBI chr16:1,419,627...1,464,590
Ensembl chr16:1,418,351...1,464,839
G
Anxa3
annexin A3
decreases expression
EXP
troglitazone results in decreased expression of ANXA3 protein
CTD
PMID:21315101
NCBI chr14:13,031,675...13,085,678
Ensembl chr14:13,023,762...13,085,849
G
Anxa5
annexin A5
increases expression
ISO
troglitazone results in increased expression of ANXA5 mRNA
CTD
PMID:19631733
NCBI chr 2:121,242,133...121,272,935
Ensembl chr 2:121,242,136...121,281,400
G
Aoc3
amine oxidase, copper containing 3
decreases expression
ISO
troglitazone results in decreased expression of AOC3 mRNA
CTD
PMID:12732648
NCBI chr10:86,773,018...86,780,961
G
Aopep
aminopeptidase O
decreases expression
EXP
Troglitazone results in decreased expression of AOPEP mRNA
CTD
PMID:21515302
NCBI chr17:1,817,001...2,133,008
Ensembl chr17:1,817,001...2,133,104
G
Ap3b1
adaptor related protein complex 3 subunit beta 1
decreases expression
ISO
troglitazone results in decreased expression of AP3B1 mRNA
CTD
PMID:28973697
NCBI chr 2:27,331,241...27,535,683
Ensembl chr 2:27,334,900...27,537,702
G
Ap3s1
adaptor related protein complex 3 subunit sigma 1
decreases expression
ISO
troglitazone results in decreased expression of AP3S1 mRNA
CTD
PMID:12732648
NCBI chr18:41,649,321...41,718,221
Ensembl chr18:41,648,796...41,767,641
G
Ap5s1
adaptor related protein complex 5 subunit sigma 1
increases expression
ISO
troglitazone results in increased expression of AP5S1 mRNA
CTD
PMID:28973697
NCBI chr 3:138,882,634...138,885,940
Ensembl chr 3:138,882,634...138,888,899
G
Apaf1
apoptotic peptidase activating factor 1
decreases expression
EXP
troglitazone results in decreased expression of APAF1 mRNA
CTD
PMID:21515302
NCBI chr 7:27,381,392...27,466,772
Ensembl chr 7:27,381,855...27,466,772
G
Apbb2
amyloid beta precursor protein binding family B member 2
decreases expression
ISO
troglitazone results in decreased expression of APBB2 mRNA
CTD
PMID:28973697
NCBI chr14:41,849,638...42,232,930
Ensembl chr14:41,911,785...42,232,280
G
Apc
APC regulator of WNT signaling pathway
decreases expression
ISO
troglitazone results in decreased expression of APC mRNA
CTD
PMID:28973697
NCBI chr18:26,138,382...26,196,021
Ensembl chr18:26,102,679...26,197,022
G
Apcs
amyloid P component, serum
decreases expression
ISO
troglitazone results in decreased expression of APCS mRNA
CTD
PMID:25572481
NCBI chr13:87,905,532...87,906,508
Ensembl chr13:87,905,532...87,928,824
G
Apex2
apurinic/apyrimidinic endodeoxyribonuclease 2
decreases expression
ISO
troglitazone results in decreased expression of APEX2 mRNA
CTD
PMID:19140230
NCBI chr X:22,914,943...22,937,713
Ensembl chr X:22,914,944...22,936,011
G
Apln
apelin
decreases expression
EXP
troglitazone results in decreased expression of APLN mRNA
CTD
PMID:21515302
NCBI chr X:132,058,739...132,091,518
Ensembl chr X:132,081,759...132,091,246
G
Aplnr
apelin receptor
decreases expression
ISO
troglitazone results in decreased expression of APLNR mRNA
CTD
PMID:28973697
NCBI chr 3:90,624,055...90,627,700
Ensembl chr 3:90,624,012...90,627,908
G
Apoa2
apolipoprotein A2
increases expression
ISO
troglitazone results in increased expression of APOA2 mRNA
CTD
PMID:25572481
NCBI chr13:86,176,767...86,178,819
Ensembl chr13:86,174,741...86,179,410
G
Apoa4
apolipoprotein A4
decreases expression
ISO
troglitazone results in decreased expression of APOA4 mRNA
CTD
PMID:28973697
NCBI chr 8:55,435,779...55,438,160
Ensembl chr 8:55,434,168...55,438,164
G
Apoa5
apolipoprotein A5
decreases expression
EXP
troglitazone results in decreased expression of APOA5 mRNA
CTD
PMID:21515302
NCBI chr 8:55,446,329...55,460,509
Ensembl chr 8:55,456,899...55,460,507
G
Apob
apolipoprotein B
decreases secretion decreases expression
ISO
Troglitazone results in decreased secretion of APOB protein Troglitazone results in decreased expression of APOB mRNA
CTD
PMID:32535746
NCBI chr 6:36,563,704...36,603,300
Ensembl chr 6:36,563,704...36,611,814
G
Apoc3
apolipoprotein C3
decreases secretion decreases expression
ISO
Troglitazone results in decreased secretion of APOC3 protein Troglitazone results in decreased expression of APOC3 mRNA
CTD
PMID:32535746
NCBI chr 8:55,428,172...55,430,352
Ensembl chr 8:55,428,024...55,458,679
G
Apod
apolipoprotein D
increases expression
ISO
troglitazone results in increased expression of APOD mRNA
CTD
PMID:28973697
NCBI chr11:82,936,216...82,957,264
Ensembl chr11:82,936,038...82,957,263
G
Apoe
apolipoprotein E
increases expression
ISO
troglitazone results in increased expression of APOE mRNA
CTD
PMID:19140230
NCBI chr 1:88,481,889...88,485,816
Ensembl chr 1:88,481,385...88,485,855
G
App
amyloid beta precursor protein
increases expression
ISO
troglitazone results in increased expression of APP mRNA
CTD
PMID:19140230
NCBI chr11:37,506,207...37,724,351
Ensembl chr11:37,506,408...37,722,971
G
Appl2
adaptor protein, phosphotyrosine interacting with PH domain and leucine zipper 2
decreases expression
ISO
troglitazone results in decreased expression of APPL2 mRNA
CTD
PMID:28973697
NCBI chr 7:22,019,480...22,072,386
Ensembl chr 7:22,022,963...22,072,385
G
Aqp3
aquaporin 3 (Gill blood group)
increases expression
EXP
troglitazone results in increased expression of AQP3 mRNA
CTD
PMID:21515302
NCBI chr 5:61,035,165...61,040,683
Ensembl chr 5:61,035,166...61,040,685
G
Aqp7
aquaporin 7
increases expression
ISO EXP
troglitazone results in increased expression of AQP7 mRNA
CTD
PMID:12732648 PMID:21515302
NCBI chr 5:60,968,495...60,982,618
Ensembl chr 5:60,967,558...60,982,618
G
Aqp9
aquaporin 9
increases expression decreases expression
EXP ISO
troglitazone results in increased expression of AQP9 mRNA troglitazone results in decreased expression of AQP9 mRNA
CTD
PMID:21515302 PMID:25572481
NCBI chr 8:80,678,027...80,718,273
Ensembl chr 8:80,678,030...80,717,240
G
Ar
androgen receptor
multiple interactions decreases expression
ISO
[Troglitazone results in increased degradation of SP1 protein] which results in decreased expression of AR mRNA; Troglitazone inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein] troglitazone results in decreased expression of AR mRNA; troglitazone results in decreased expression of AR protein
CTD
PMID:17409431 PMID:25669987 PMID:33049310
NCBI chr X:67,135,317...67,304,476
Ensembl chr X:67,135,317...67,304,467
G
Arap1
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 1
decreases expression
ISO
troglitazone results in decreased expression of ARAP1 mRNA
CTD
PMID:28973697
NCBI chr 1:165,160,701...165,226,219
Ensembl chr 1:165,160,678...165,226,218
G
Arap2
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2
decreases expression
ISO
troglitazone results in decreased expression of ARAP2 mRNA
CTD
PMID:28973697
NCBI chr14:50,921,323...51,120,972
Ensembl chr14:50,921,713...51,120,962
G
Arg1
arginase 1
decreases expression
EXP
troglitazone results in decreased expression of ARG1 mRNA
CTD
PMID:21515302
NCBI chr 1:22,295,093...22,307,720
Ensembl chr 1:22,295,322...22,307,713
G
Arhgap12
Rho GTPase activating protein 12
decreases expression
ISO
troglitazone results in decreased expression of ARHGAP12 mRNA
CTD
PMID:28973697
NCBI chr17:56,284,282...56,397,630
Ensembl chr17:56,284,286...56,397,563
G
Arhgap24
Rho GTPase activating protein 24
decreases expression
ISO
troglitazone results in decreased expression of ARHGAP24 mRNA
CTD
PMID:28973697
NCBI chr14:7,105,200...7,488,437
Ensembl chr14:7,105,200...7,528,950
G
Arhgap26
Rho GTPase activating protein 26
decreases expression
ISO
troglitazone results in decreased expression of ARHGAP26 mRNA
CTD
PMID:28973697
NCBI chr18:30,702,602...31,489,047
Ensembl chr18:31,089,787...31,489,047
G
Arhgap29
Rho GTPase activating protein 29
decreases expression
ISO
troglitazone results in decreased expression of ARHGAP29 mRNA
CTD
PMID:28973697
NCBI chr 2:212,744,626...212,816,710
Ensembl chr 2:212,755,803...212,986,729
G
Arhgap35
Rho GTPase activating protein 35
decreases expression
ISO
troglitazone results in decreased expression of ARHGAP35 mRNA
CTD
PMID:28973697
NCBI chr 1:86,330,566...86,447,414
Ensembl chr 1:86,330,566...86,447,414
G
Arhgap6
Rho GTPase activating protein 6
decreases expression
ISO
troglitazone results in decreased expression of ARHGAP6 mRNA
CTD
PMID:28973697
NCBI chr X:28,525,912...29,062,344
Ensembl chr X:28,525,917...29,061,244
G
Arhgdig
Rho GDP dissociation inhibitor gamma
increases expression
ISO
troglitazone results in increased expression of ARHGDIG mRNA
CTD
PMID:28973697
NCBI chr10:15,723,525...15,725,719
Ensembl chr10:15,723,525...15,725,688
G
Arhgef12
Rho guanine nucleotide exchange factor 12
decreases expression
ISO
troglitazone results in decreased expression of ARHGEF12 mRNA
CTD
PMID:28973697
NCBI chr 8:52,247,047...52,373,158
Ensembl chr 8:52,247,047...52,372,376
G
Arhgef15
Rho guanine nucleotide exchange factor 15
decreases expression
ISO
troglitazone results in decreased expression of ARHGEF15 mRNA
CTD
PMID:28973697
NCBI chr10:54,149,372...54,162,128
Ensembl chr10:54,149,372...54,162,128
G
Arhgef2
Rho/Rac guanine nucleotide exchange factor 2
increases expression
ISO
troglitazone results in increased expression of ARHGEF2 mRNA
CTD
PMID:19140230
NCBI chr 2:176,358,909...176,416,178
Ensembl chr 2:176,358,904...176,417,646
G
Arhgef9
Cdc42 guanine nucleotide exchange factor 9
increases expression
ISO
troglitazone results in increased expression of ARHGEF9 mRNA
CTD
PMID:28973697
NCBI chr X:63,929,168...64,087,267
Ensembl chr X:63,929,176...64,087,104
G
Arid1a
AT-rich interaction domain 1A
decreases expression
ISO
troglitazone results in decreased expression of ARID1A mRNA
CTD
PMID:28973697
NCBI chr 5:151,192,014...151,269,291
Ensembl chr 5:151,192,014...151,265,386
G
Arid1b
AT-rich interaction domain 1B
decreases expression
ISO
troglitazone results in decreased expression of ARID1B mRNA
CTD
PMID:28973697
NCBI chr 1:47,973,199...48,328,793
Ensembl chr 1:47,973,997...48,328,793
G
Arid2
AT-rich interaction domain 2
decreases expression
ISO
troglitazone results in decreased expression of ARID2 mRNA
CTD
PMID:28973697
NCBI chr 7:129,326,371...129,443,813
Ensembl chr 7:129,324,137...129,443,187
G
Arid4a
AT-rich interaction domain 4A
decreases expression
ISO
troglitazone results in decreased expression of ARID4A mRNA
CTD
PMID:28973697
NCBI chr 6:95,258,429...95,335,987
Ensembl chr 6:95,258,429...95,329,840
G
Arid5a
AT-rich interaction domain 5A
decreases expression
EXP
troglitazone results in decreased expression of ARID5A mRNA
CTD
PMID:21515302
NCBI chr 9:46,030,513...46,058,729
Ensembl chr 9:46,030,548...46,045,363
G
Arl4a
ARF like GTPase 4A
increases expression
ISO
troglitazone results in increased expression of ARL4A mRNA
CTD
PMID:12732648 PMID:28973697
NCBI chr 6:62,809,287...62,811,297
Ensembl chr 6:62,804,548...62,820,760
G
Armc8
armadillo repeat containing 8
decreases expression
ISO
troglitazone results in decreased expression of ARMC8 mRNA
CTD
PMID:28973697
NCBI chr 8:108,916,274...109,010,877
Ensembl chr 8:108,916,274...109,010,717
G
Arnt2
aryl hydrocarbon receptor nuclear translocator 2
increases expression
ISO
troglitazone results in increased expression of ARNT2 mRNA
CTD
PMID:19140230
NCBI chr 1:147,645,354...147,801,986
Ensembl chr 1:147,599,058...147,801,997
G
Arrdc2
arrestin domain containing 2
decreases expression
ISO
troglitazone results in decreased expression of ARRDC2 mRNA
CTD
PMID:28973697
NCBI chr16:18,635,883...18,640,019
Ensembl chr16:18,635,883...18,640,158
G
Arrdc3
arrestin domain containing 3
decreases expression
ISO
troglitazone results in decreased expression of ARRDC3 mRNA
CTD
PMID:28973697
NCBI chr 2:12,873,202...12,885,716
Ensembl chr 2:12,873,202...12,885,875
G
Arsb
arylsulfatase B
increases expression
ISO
troglitazone results in increased expression of ARSB mRNA
CTD
PMID:28973697
NCBI chr 2:26,736,395...26,895,682
Ensembl chr 2:26,736,957...26,897,611
G
Art3
ADP-ribosyltransferase 3
increases expression
ISO
troglitazone results in increased expression of ART3 mRNA
CTD
PMID:28973697
NCBI chr14:15,921,540...16,003,764
Ensembl chr14:15,921,395...15,949,806
G
Arvcf
ARVCF, delta catenin family member
decreases expression
ISO
troglitazone results in decreased expression of ARVCF mRNA
CTD
PMID:28973697
NCBI chr11:96,092,451...96,150,144
Ensembl chr11:96,092,451...96,150,163
G
Asap1
ArfGAP with SH3 domain, ankyrin repeat and PH domain 1
decreases expression
ISO
troglitazone results in decreased expression of ASAP1 mRNA
CTD
PMID:28973697
NCBI chr 7:97,675,354...97,982,523
Ensembl chr 7:97,675,354...97,982,024
G
Asap2
ArfGAP with SH3 domain, ankyrin repeat and PH domain 2
decreases expression
ISO
troglitazone results in decreased expression of ASAP2 mRNA
CTD
PMID:28973697
NCBI chr 6:46,386,605...46,549,669
Ensembl chr 6:46,386,605...46,549,669
G
Asb10
ankyrin repeat and SOCS box-containing 10
decreases expression
ISO
troglitazone results in decreased expression of ASB10 mRNA
CTD
PMID:28973697
NCBI chr 4:11,522,531...11,531,946
Ensembl chr 4:11,522,887...11,531,505
G
Asb2
ankyrin repeat and SOCS box-containing 2
increases expression
EXP
troglitazone results in increased expression of ASB2 mRNA
CTD
PMID:21515302
NCBI chr 6:128,239,550...128,275,833
Ensembl chr 6:128,239,552...128,266,321
G
Asf1b
anti-silencing function 1B histone chaperone
increases expression
ISO
troglitazone results in increased expression of ASF1B mRNA
CTD
PMID:28973697
NCBI chr19:41,085,786...41,100,352
Ensembl chr19:41,086,114...41,100,352
G
Ash1l
ASH1 like histone lysine methyltransferase
decreases expression
ISO
troglitazone results in decreased expression of ASH1L mRNA
CTD
PMID:28973697
NCBI chr 2:176,644,393...176,780,848
Ensembl chr 2:176,644,924...176,780,847
G
Asic3
acid sensing ion channel subunit 3
decreases expression
EXP
troglitazone results in decreased expression of ASIC3 mRNA
CTD
PMID:21515302
NCBI chr 4:11,652,946...11,657,415
Ensembl chr 4:11,652,946...11,657,367
G
Asns
asparagine synthetase (glutamine-hydrolyzing)
increases expression
ISO
troglitazone results in increased expression of ASNS mRNA
CTD
PMID:19140230 PMID:20846491
NCBI chr 4:36,752,061...36,769,970
Ensembl chr 4:36,751,802...36,776,050
G
Aspa
aspartoacylase
increases expression
ISO
troglitazone results in increased expression of ASPA mRNA
CTD
PMID:25572481
NCBI chr10:58,390,204...58,443,790
Ensembl chr10:58,379,410...58,443,769
G
Aspg
asparaginase
increases expression
EXP
troglitazone results in increased expression of ASPG mRNA
CTD
PMID:21515302
NCBI chr 6:136,997,832...137,017,417
Ensembl chr 6:136,998,023...137,017,417
G
Aspm
assembly factor for spindle microtubules
decreases expression
ISO
troglitazone results in decreased expression of ASPM mRNA
CTD
PMID:19140230
NCBI chr13:53,625,584...53,674,489
Ensembl chr13:53,625,584...53,674,489
G
Ass1
argininosuccinate synthase 1
increases expression
ISO
troglitazone results in increased expression of ASS1 mRNA
CTD
PMID:19140230
NCBI chr 3:35,144,765...35,194,632
Ensembl chr 3:35,144,999...35,194,627
G
Asxl1
ASXL transcriptional regulator 1
decreases expression
ISO
troglitazone results in decreased expression of ASXL1 mRNA
CTD
PMID:28973697
NCBI chr 3:162,273,828...162,341,742
Ensembl chr 3:162,273,828...162,341,742
G
Asxl2
ASXL transcriptional regulator 2
decreases expression
ISO
troglitazone results in decreased expression of ASXL2 mRNA
CTD
PMID:28973697
NCBI chr 6:32,090,497...32,234,487
Ensembl chr 6:32,145,607...32,227,851
G
Atad2b
ATPase family, AAA domain containing 2B
decreases expression
ISO
troglitazone results in decreased expression of ATAD2B mRNA
CTD
PMID:28973697
NCBI chr 6:33,646,075...33,789,532
Ensembl chr 6:33,646,075...33,789,532
G
Atf3
activating transcription factor 3
multiple interactions increases expression decreases expression
ISO
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [troglitazone results in increased expression of ATF3 mRNA]; [troglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of ATF3 mRNA; [troglitazone results in increased phosphorylation of MAPK1 protein] which results in increased expression of ATF3 protein; [troglitazone results in increased phosphorylation of MAPK3 protein] which results in increased expression of ATF3 protein; EGR1 protein promotes the reaction [troglitazone results in increased expression of ATF3 mRNA]; MAP2K1 protein promotes the reaction [troglitazone results in increased expression of ATF3 mRNA]; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ATF3 mRNA] troglitazone results in increased expression of ATF3 mRNA; troglitazone results in increased expression of ATF3 protein troglitazone results in decreased expression of ATF3 mRNA
CTD
PMID:15897233 PMID:16079301 PMID:20847119 PMID:25572481 PMID:28973697
NCBI chr13:105,274,103...105,331,653
Ensembl chr13:105,282,440...105,295,750
G
Atf4
activating transcription factor 4
decreases expression
ISO
troglitazone results in decreased expression of ATF4 mRNA
CTD
PMID:28973697
NCBI chr 7:113,684,681...113,686,739
Ensembl chr 7:113,684,681...113,686,739
G
Atf6
activating transcription factor 6
decreases expression increases expression
ISO
troglitazone results in decreased expression of ATF6 mRNA Troglitazone results in increased expression of ATF6 mRNA
CTD
PMID:28973697 PMID:32535746
NCBI chr13:85,460,312...85,639,959
Ensembl chr13:85,462,840...85,640,033
G
Atf7ip
activating transcription factor 7 interacting protein
decreases expression
ISO
troglitazone results in decreased expression of ATF7IP mRNA
CTD
PMID:28973697
NCBI chr 4:171,117,122...171,202,871
Ensembl chr 4:171,117,122...171,202,867
G
Atg2a
autophagy related 2A
decreases expression
ISO
troglitazone results in decreased expression of ATG2A mRNA
CTD
PMID:28973697
NCBI chr 1:212,971,822...212,991,505
Ensembl chr 1:212,971,844...212,991,528
G
Atg2b
autophagy related 2B
decreases expression
ISO
troglitazone results in decreased expression of ATG2B mRNA
CTD
PMID:28973697
NCBI chr 6:130,286,979...130,357,109
Ensembl chr 6:130,286,986...130,357,109
G
Atg4a
autophagy related 4A, cysteine peptidase
increases expression
ISO
troglitazone results in increased expression of ATG4A mRNA
CTD
PMID:19140230
NCBI chr X:109,453,712...109,553,758
Ensembl chr X:109,453,689...109,553,760
G
Atl2
atlastin GTPase 2
decreases expression
ISO
troglitazone results in decreased expression of ATL2 mRNA
CTD
PMID:28973697
NCBI chr 6:20,891,220...20,932,644
Ensembl chr 6:20,891,227...20,933,320
G
Atm
ATM serine/threonine kinase
decreases expression
ISO
troglitazone results in decreased expression of ATM mRNA
CTD
PMID:28973697
NCBI chr 8:62,724,939...62,829,040
Ensembl chr 8:62,727,291...62,828,629
G
Atmin
ATM interactor
decreases expression
ISO
troglitazone results in decreased expression of ATMIN mRNA
CTD
PMID:28973697
NCBI chr19:61,905,343...61,922,443
Ensembl chr19:61,905,144...61,922,443
G
Atn1
atrophin 1
decreases expression
ISO
troglitazone results in decreased expression of ATN1 mRNA
CTD
PMID:28973697
NCBI chr 4:159,240,573...159,254,378
Ensembl chr 4:159,237,562...159,254,418
G
Atoh8
atonal bHLH transcription factor 8
decreases expression
ISO
troglitazone results in decreased expression of ATOH8 mRNA
CTD
PMID:19140230
NCBI chr 4:105,818,203...105,850,379
Ensembl chr 4:105,818,203...105,850,379
G
Atp5f1b
ATP synthase F1 subunit beta
multiple interactions decreases expression
ISO
benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [troglitazone results in decreased expression of ATP5F1B mRNA]; PPARGC1A protein inhibits the reaction [troglitazone results in decreased expression of ATP5F1B mRNA] Troglitazone results in decreased expression of ATP5F1B protein
CTD
PMID:18495193 PMID:20860658
NCBI chr 7:1,100,058...1,106,461
Ensembl chr 7:1,099,860...1,106,462
G
Atp5if1
ATP synthase inhibitory factor subunit 1
decreases expression
ISO
troglitazone results in decreased expression of ATP5IF1 mRNA
CTD
PMID:19140230
NCBI chr 5:150,022,960...150,026,677
Ensembl chr 5:150,022,960...150,026,677
G
Atp5pf
ATP synthase peripheral stalk subunit F6
decreases secretion decreases expression
ISO
troglitazone results in decreased secretion of ATP5PF protein troglitazone results in decreased expression of ATP5PF mRNA
CTD
PMID:15949477
NCBI chr11:37,368,045...37,375,721
Ensembl chr11:37,368,042...37,375,466
G
Atp6v0a1
ATPase H+ transporting V0 subunit a1
decreases expression
ISO
troglitazone results in decreased expression of ATP6V0A1 mRNA
CTD
PMID:28973697
NCBI chr10:86,436,089...86,490,185
Ensembl chr10:86,436,141...86,490,181
G
Atp7a
ATPase copper transporting alpha
decreases expression
ISO
troglitazone results in decreased expression of ATP7A mRNA
CTD
PMID:28973697
NCBI chr X:75,159,635...75,267,094
Ensembl chr X:75,159,782...75,267,093
G
Atrx
ATRX, chromatin remodeler
decreases expression
ISO
troglitazone results in decreased expression of ATRX mRNA
CTD
PMID:28973697
NCBI chr X:74,916,548...75,062,880
Ensembl chr X:74,916,548...75,062,880
G
Atxn2
ataxin 2
decreases expression
ISO
troglitazone results in decreased expression of ATXN2 mRNA
CTD
PMID:28973697
NCBI chr12:40,413,657...40,509,895
Ensembl chr12:40,414,904...40,510,473
G
Atxn7
ataxin 7
decreases expression
ISO
troglitazone results in decreased expression of ATXN7 mRNA
CTD
PMID:28973697
NCBI chr15:13,547,859...13,693,311
Ensembl chr15:13,547,862...13,693,526
G
Aurkb
aurora kinase B
decreases expression
ISO
troglitazone results in decreased expression of AURKB mRNA
CTD
PMID:19140230
NCBI chr10:54,243,116...54,249,675
Ensembl chr10:54,242,850...54,252,285
G
Avpi1
arginine vasopressin-induced 1
increases expression
ISO
troglitazone results in increased expression of AVPI1 mRNA
CTD
PMID:28973697
NCBI chr 1:250,879,530...250,885,448
Ensembl chr 1:250,879,530...250,885,704
G
Avpr1a
arginine vasopressin receptor 1A
decreases expression
EXP
troglitazone results in decreased expression of AVPR1A mRNA
CTD
PMID:21515302
NCBI chr 7:59,999,743...60,003,667
Ensembl chr 7:59,999,738...60,003,837
G
Axin2
axin 2
decreases expression
EXP
troglitazone results in decreased expression of AXIN2 mRNA
CTD
PMID:21515302
NCBI chr10:94,393,379...94,426,579
Ensembl chr10:94,395,909...94,426,575
G
Axl
Axl receptor tyrosine kinase
increases expression
ISO
troglitazone results in increased expression of AXL mRNA
CTD
PMID:28973697
NCBI chr 1:90,392,864...90,424,123
Ensembl chr 1:90,392,864...90,424,009
G
B3galt1
Beta-1,3-galactosyltransferase 1
decreases expression
ISO
troglitazone results in decreased expression of B3GALT1 mRNA
CTD
PMID:28973697
NCBI chr 3:72,661,410...73,234,447
Ensembl chr 3:72,660,801...73,235,276
G
B3galt2
Beta-1,3-galactosyltransferase 2
increases expression
ISO
troglitazone results in increased expression of B3GALT2 mRNA
CTD
PMID:28973697
NCBI chr13:57,939,724...57,948,735
Ensembl chr13:57,930,539...57,956,539
G
B4galnt1
beta-1,4-N-acetyl-galactosaminyl transferase 1
increases expression
ISO
troglitazone results in increased expression of B4GALNT1 mRNA
CTD
PMID:25572481
NCBI chr 7:64,873,909...64,881,512
Ensembl chr 7:64,874,022...64,881,516
G
B9d1
B9 domain containing 1
increases expression
ISO
troglitazone results in increased expression of B9D1 mRNA
CTD
PMID:28973697
NCBI chr10:46,685,410...46,698,580
Ensembl chr10:46,686,133...46,695,428
G
Bace1
beta-secretase 1
decreases expression
ISO
troglitazone results in decreased expression of BACE1 mRNA
CTD
PMID:28973697
NCBI chr 8:55,038,842...55,061,138
Ensembl chr 8:55,038,823...55,064,918
G
Bace2
beta-secretase 2
increases expression
ISO
troglitazone results in increased expression of BACE2 mRNA
CTD
PMID:28973697
NCBI chr11:50,176,852...50,258,948
Ensembl chr11:50,176,621...50,259,008
G
Bach2
BTB domain and CNC homolog 2
decreases expression
ISO
troglitazone results in decreased expression of BACH2 mRNA
CTD
PMID:28973697
NCBI chr 5:51,428,802...51,779,030
Ensembl chr 5:51,434,870...51,774,234
G
Bax
BCL2 associated X, apoptosis regulator
multiple interactions increases expression
ISO
[N-(4-methoxybenzyl)-N'-(5-nitro-1,3-thiazol-2-yl)urea results in decreased activity of GSK3B protein] results in increased susceptibility to [troglitazone results in increased expression of BAX protein]; GSK3B protein affects the susceptibility to [troglitazone results in increased expression of BAX protein] troglitazone results in increased expression of BAX mRNA; troglitazone results in increased expression of BAX protein
CTD
PMID:15100737 PMID:17143939 PMID:20540935
NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:105,076,473...105,086,429
G
Baz2b
bromodomain adjacent to zinc finger domain, 2B
decreases expression
ISO
troglitazone results in decreased expression of BAZ2B mRNA
CTD
PMID:28973697
NCBI chr 3:64,792,984...65,034,547
Ensembl chr 3:64,794,001...65,001,781
G
Bbox1
gamma-butyrobetaine hydroxylase 1
increases expression
EXP
troglitazone results in increased expression of BBOX1 mRNA
CTD
PMID:21515302
NCBI chr 3:117,277,226...117,326,383
Ensembl chr 3:117,277,226...117,326,064
G
Bcar1
BCAR1 scaffold protein, Cas family member
decreases expression
ISO
troglitazone results in decreased expression of BCAR1 mRNA
CTD
PMID:28973697
NCBI chr19:56,588,500...56,623,190
Ensembl chr19:56,588,500...56,623,190
G
Bcas3
BCAS3, microtubule associated cell migration factor
decreases expression
ISO
troglitazone results in decreased expression of BCAS3 mRNA
CTD
PMID:28973697
NCBI chr10:70,711,084...71,170,492
Ensembl chr10:70,711,525...71,170,803
G
Bcat2
branched chain amino acid transaminase 2
increases expression
EXP
troglitazone results in increased expression of BCAT2 mRNA
CTD
PMID:25596134
NCBI chr 1:105,175,157...105,196,474
Ensembl chr 1:105,176,977...105,196,463
G
Bccip
BRCA2 and CDKN1A interacting protein
decreases expression
ISO
troglitazone results in decreased expression of BCCIP mRNA
CTD
PMID:19140230
NCBI chr 1:197,942,535...197,954,948
Ensembl chr 1:197,942,190...197,956,378
G
Bcl2
BCL2, apoptosis regulator
multiple interactions decreases expression increases expression
ISO EXP
[troglitazone co-treated with Tretinoin] results in decreased expression of BCL2 protein troglitazone results in decreased expression of BCL2 mRNA troglitazone results in increased expression of BCL2 protein troglitazone results in decreased expression of BCL2 mRNA; troglitazone results in decreased expression of BCL2 protein
CTD
PMID:9671760 PMID:12840598 PMID:15100737 PMID:15767042 PMID:16149072 PMID:17143939 PMID:20540935 More...
NCBI chr13:23,204,464...23,366,900
Ensembl chr13:23,204,464...23,366,900
G
Bcl2a1
BCL2-related protein A1
decreases expression
EXP
troglitazone results in decreased expression of BCL2A1 mRNA
CTD
PMID:21515302
NCBI chr 8:98,596,806...98,604,890
Ensembl chr 8:98,596,650...98,604,890
G
Bcl2l1
Bcl2-like 1
decreases expression increases expression
ISO
troglitazone results in decreased expression of BCL2L1 mRNA; troglitazone results in decreased expression of BCL2L1 protein Troglitazone results in increased expression of BCL2L1 mRNA
CTD
PMID:12680223 PMID:19631733 PMID:31294483
NCBI chr 3:161,713,777...161,764,844
Ensembl chr 3:161,745,540...161,764,907 Ensembl chr 1:161,745,540...161,764,907
G
Bcl2l11
Bcl2-like 11
decreases expression
ISO
troglitazone results in decreased expression of BCL2L11 mRNA
CTD
PMID:28973697
NCBI chr 3:135,820,042...135,857,330
Ensembl chr 3:135,817,562...135,960,695
G
Bcl2l2
Bcl2-like 2
decreases expression
ISO
troglitazone results in decreased expression of BCL2L2 mRNA; troglitazone results in decreased expression of BCL2L2 protein
CTD
PMID:16149072
NCBI chr15:32,326,686...32,337,834
Ensembl chr15:32,326,020...32,335,379
G
Bcl7a
BAF chromatin remodeling complex subunit BCL7A
decreases expression
ISO
troglitazone results in decreased expression of BCL7A mRNA
CTD
PMID:28973697
NCBI chr12:38,872,851...38,904,770
Ensembl chr12:38,872,851...38,904,770
G
Bclaf1
BCL2-associated transcription factor 1
decreases expression
ISO
Troglitazone results in decreased expression of BCLAF1 mRNA
CTD
PMID:28973697
NCBI chr 1:16,904,572...16,937,106
Ensembl chr 1:16,914,118...16,936,801
G
Bco1
beta-carotene oxygenase 1
decreases expression
ISO
troglitazone results in decreased expression of BCO1 mRNA
CTD
PMID:28973697
NCBI chr19:62,058,061...62,094,923
Ensembl chr19:62,058,089...62,094,917
G
Bdh1
3-hydroxybutyrate dehydrogenase 1
decreases expression
EXP
troglitazone results in decreased expression of BDH1 mRNA
CTD
PMID:21515302
NCBI chr11:82,806,125...82,848,133
Ensembl chr11:82,807,503...82,842,636
G
Bdp1
BDP1 general transcription factor IIIB subunit
decreases expression
ISO
troglitazone results in decreased expression of BDP1 mRNA
CTD
PMID:28973697
NCBI chr 2:33,112,518...33,204,270
Ensembl chr 2:33,112,518...33,204,241
G
Bend7
BEN domain containing 7
decreases expression
ISO
troglitazone results in decreased expression of BEND7 mRNA
CTD
PMID:28973697
NCBI chr17:78,392,489...78,475,459
Ensembl chr17:78,393,601...78,475,223
G
Bfar
bifunctional apoptosis regulator
decreases expression
ISO
troglitazone results in decreased expression of BFAR mRNA
CTD
PMID:17569031
NCBI chr10:2,059,189...2,092,207
Ensembl chr10:2,059,058...2,094,183
G
Bglap
bone gamma-carboxyglutamate protein
decreases expression
EXP
troglitazone results in decreased expression of BGLAP mRNA
CTD
PMID:16813520
NCBI chr 2:176,136,341...176,137,318
Ensembl chr 2:176,136,341...176,137,318
G
Bgn
biglycan
increases expression decreases expression
ISO
troglitazone results in increased expression of BGN mRNA troglitazone results in decreased expression of BGN mRNA
CTD
PMID:28973697
NCBI chr X:156,348,633...156,360,797
Ensembl chr X:156,348,615...156,360,799
G
Bhlhe40
basic helix-loop-helix family, member e40
decreases expression
ISO
troglitazone results in decreased expression of BHLHE40 mRNA
CTD
PMID:25572481
NCBI chr 4:143,174,450...143,180,150
Ensembl chr 4:143,174,048...143,180,783
G
Bhlhe41
basic helix-loop-helix family, member e41
increases expression
EXP
troglitazone results in increased expression of BHLHE41 mRNA
CTD
PMID:21515302
NCBI chr 4:180,565,003...180,569,415
Ensembl chr 4:180,565,003...180,569,355
G
Bicc1
BicC family RNA binding protein 1
decreases expression
ISO
troglitazone results in decreased expression of BICC1 mRNA
CTD
PMID:28973697
NCBI chr20:17,448,745...17,685,887
Ensembl chr20:17,448,765...17,685,885
G
Bicral
BICRA like chromatin remodeling complex associated protein
decreases expression
ISO
troglitazone results in decreased expression of BICRAL mRNA
CTD
PMID:28973697
NCBI chr 9:21,597,886...21,682,985
Ensembl chr 9:21,597,855...21,682,983
G
Bid
BH3 interacting domain death agonist
decreases expression
ISO
troglitazone results in decreased expression of BID mRNA
CTD
PMID:17569031
NCBI chr 4:155,785,366...155,808,775
Ensembl chr 4:155,785,377...155,808,275
G
Bik
BCL2-interacting killer
decreases expression
EXP ISO
troglitazone results in decreased expression of BIK mRNA
CTD
PMID:21515302 PMID:28973697
NCBI chr 7:116,552,303...116,571,317
Ensembl chr 7:116,552,303...116,571,317
G
Birc3
baculoviral IAP repeat-containing 3
decreases expression
ISO
troglitazone results in decreased expression of BIRC3 mRNA
CTD
PMID:17569031
NCBI chr 8:13,285,702...13,313,329
Ensembl chr 8:13,285,703...13,298,590
G
Birc5
baculoviral IAP repeat-containing 5
affects localization decreases expression
ISO
troglitazone affects the localization of BIRC5 protein troglitazone results in decreased expression of BIRC5 mRNA; troglitazone results in decreased expression of BIRC5 protein
CTD
PMID:16820965 PMID:17143939 PMID:18407589 PMID:19140230
NCBI chr10:103,567,369...103,580,069
Ensembl chr10:103,572,080...103,582,155
G
Blm
BLM RecQ like helicase
decreases expression
ISO
troglitazone results in decreased expression of BLM mRNA
CTD
PMID:19140230
NCBI chr 1:143,819,072...143,905,300
Ensembl chr 1:143,819,090...143,905,210
G
Bltp3a
bridge-like lipid transfer protein family member 3A
decreases expression
ISO
Troglitazone results in decreased expression of BLTP3A mRNA
CTD
PMID:28973697
NCBI chr20:5,912,033...5,956,404
Ensembl chr20:5,912,106...5,956,403
G
Bmal2
basic helix-loop-helix ARNT like 2
decreases expression
EXP
Troglitazone results in decreased expression of BMAL2 mRNA
CTD
PMID:21515302
NCBI chr 4:181,429,097...181,478,384
Ensembl chr 4:181,430,159...181,478,382
G
Bmf
Bcl2 modifying factor
decreases expression
ISO
troglitazone results in decreased expression of BMF mRNA
CTD
PMID:28973697
NCBI chr 3:125,953,466...125,974,087
Ensembl chr 3:125,953,466...125,974,258
G
Bmp2
bone morphogenetic protein 2
decreases expression
EXP
troglitazone results in decreased expression of BMP2 mRNA
CTD
PMID:21515302
NCBI chr 3:141,264,648...141,275,416
Ensembl chr 3:141,264,646...141,274,760
G
Bmp6
bone morphogenetic protein 6
increases expression
ISO
Troglitazone results in increased expression of BMP6 mRNA
CTD
PMID:32816093
NCBI chr17:26,523,704...26,785,558
Ensembl chr17:26,523,704...26,675,261
G
Bmpr2
bone morphogenetic protein receptor type 2
decreases expression
ISO
troglitazone results in decreased expression of BMPR2 mRNA
CTD
PMID:28973697
NCBI chr 9:68,685,942...68,801,353
Ensembl chr 9:68,685,988...68,801,350
G
Bnip3
BCL2 interacting protein 3
increases expression
EXP
troglitazone results in increased expression of BNIP3 mRNA
CTD
PMID:25596134
NCBI chr 1:203,137,778...203,154,962
Ensembl chr 1:203,137,778...203,154,962
G
Bnip3l
BCL2 interacting protein 3 like
increases expression
ISO
troglitazone results in increased expression of BNIP3L mRNA
CTD
PMID:19140230
NCBI chr15:45,350,081...45,373,213
Ensembl chr15:45,334,537...45,373,282
G
Bod1l1
biorientation of chromosomes in cell division 1-like 1
decreases expression
ISO
troglitazone results in decreased expression of BOD1L1 mRNA
CTD
PMID:28973697
NCBI chr14:73,320,880...73,375,662
Ensembl chr14:73,320,832...73,375,658
G
Bpifb4
BPI fold containing family B, member 4
decreases expression
ISO
troglitazone results in decreased expression of BPIFB4 mRNA
CTD
PMID:28934090
NCBI chr 3:162,881,478...162,908,207
Ensembl chr 3:162,881,437...162,908,207
G
Bpnt2
3'(2'), 5'-bisphosphate nucleotidase 2
decreases expression
ISO
Troglitazone results in decreased expression of BPNT2 mRNA
CTD
PMID:28973697
NCBI chr 5:22,573,241...22,600,126
Ensembl chr 5:22,570,165...22,600,126
G
Bptf
bromodomain PHD finger transcription factor
decreases expression
ISO
troglitazone results in decreased expression of BPTF mRNA
CTD
PMID:28973697
NCBI chr10:92,480,007...92,582,485
Ensembl chr10:92,480,007...92,582,413
G
Braf
B-Raf proto-oncogene, serine/threonine kinase
decreases expression
ISO
troglitazone results in decreased expression of BRAF mRNA
CTD
PMID:28973697
NCBI chr 4:69,329,772...69,476,931
Ensembl chr 4:69,342,813...69,476,931
G
Brap
BRCA1 associated protein
decreases expression
ISO
troglitazone results in decreased expression of BRAP mRNA
CTD
PMID:28973697
NCBI chr12:40,535,232...40,561,726
Ensembl chr12:40,535,232...40,561,726
G
Brca1
BRCA1, DNA repair associated
decreases expression
ISO
troglitazone results in decreased expression of BRCA1 mRNA
CTD
PMID:19140230
NCBI chr10:86,917,693...86,978,012
Ensembl chr10:86,917,693...86,977,763
G
Brd1
bromodomain containing 1
decreases expression
ISO
troglitazone results in decreased expression of BRD1 mRNA
CTD
PMID:28973697
NCBI chr 7:121,653,859...121,701,700
Ensembl chr 7:121,653,859...121,701,700
G
Brd3
bromodomain containing 3
decreases expression
ISO
troglitazone results in decreased expression of BRD3 mRNA
CTD
PMID:28973697
NCBI chr 3:31,173,332...31,227,749
Ensembl chr 3:31,173,332...31,227,629
G
Brd4
bromodomain containing 4
decreases expression
ISO
troglitazone results in decreased expression of BRD4 mRNA
CTD
PMID:28973697
NCBI chr 7:11,866,997...11,946,575
Ensembl chr 7:11,866,997...11,946,923
G
Brd8
bromodomain containing 8
increases response to substance multiple interactions decreases expression
ISO
BRD8 protein results in increased susceptibility to troglitazone RXRA protein inhibits the reaction [BRD8 protein results in increased susceptibility to troglitazone] troglitazone results in decreased expression of BRD8 mRNA
CTD
PMID:15581905 PMID:28973697
NCBI chr18:26,455,824...26,504,106
Ensembl chr18:26,455,512...26,504,006
G
Brpf1
bromodomain and PHD finger containing, 1
decreases expression
ISO
troglitazone results in decreased expression of BRPF1 mRNA
CTD
PMID:28973697
NCBI chr 4:148,011,977...148,028,431
Ensembl chr 4:148,011,931...148,028,424
G
Brwd3
bromodomain and WD repeat domain containing 3
decreases expression
ISO
troglitazone results in decreased expression of BRWD3 mRNA
CTD
PMID:28973697
NCBI chr X:77,843,766...77,937,240
Ensembl chr X:77,848,982...77,937,745
G
Bst1
bone marrow stromal cell antigen 1
decreases expression
ISO
troglitazone results in decreased expression of BST1 mRNA
CTD
PMID:19140230
NCBI chr14:71,466,179...71,482,671
Ensembl chr14:71,466,180...71,482,647
G
Btbd7
BTB domain containing 7
decreases expression
ISO
troglitazone results in decreased expression of BTBD7 mRNA
CTD
PMID:28973697
NCBI chr 6:127,685,185...127,774,947
Ensembl chr 6:127,688,421...127,737,222
G
Btg3
BTG anti-proliferation factor 3
increases expression
ISO
troglitazone results in increased expression of BTG3 mRNA
CTD
PMID:28973697
NCBI chr11:30,517,068...30,532,981
Ensembl chr11:30,517,072...30,533,082
G
Btnl9
butyrophilin-like 9
increases expression
ISO
troglitazone results in increased expression of BTNL9 mRNA
CTD
PMID:28973697
NCBI chr10:33,967,098...33,990,304
Ensembl chr10:33,970,675...33,990,354
G
Bub1
BUB1 mitotic checkpoint serine/threonine kinase
decreases expression
ISO
troglitazone results in decreased expression of BUB1 mRNA
CTD
PMID:19140230
NCBI chr 3:135,473,525...135,504,921
Ensembl chr 3:135,472,582...135,504,921
G
Bub1b
BUB1 mitotic checkpoint serine/threonine kinase B
decreases expression
ISO
troglitazone results in decreased expression of BUB1B mRNA
CTD
PMID:19140230
NCBI chr 3:126,017,019...126,069,470
Ensembl chr 3:126,017,045...126,069,796
G
Bzw1
basic leucine zipper and W2 domains 1
multiple interactions
ISO
troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of BZW1 mRNA]
CTD
PMID:20847119
NCBI chr 9:67,424,860...67,438,656
Ensembl chr 9:67,424,866...67,439,684
G
C10h16orf90
similar to human chromosome 16 open reading frame 90
decreases expression
ISO
troglitazone results in decreased expression of C16ORF90 mRNA
CTD
PMID:28973697
NCBI chr10:12,125,235...12,138,441
Ensembl chr10:12,125,212...12,128,109
G
C19h1orf198
similar to human chromosome 1 open reading frame 198
decreases expression
ISO
troglitazone results in decreased expression of C1ORF198 mRNA
CTD
PMID:28973697
NCBI chr19:69,501,453...69,526,826
Ensembl chr19:69,501,453...69,526,826
G
C1qa
complement C1q A chain
increases expression
ISO
troglitazone results in increased expression of C1QA mRNA
CTD
PMID:28973697
NCBI chr 5:154,417,086...154,419,933
Ensembl chr 5:154,417,087...154,427,732
G
C1qb
complement C1q B chain
increases expression
ISO
troglitazone results in increased expression of C1QB mRNA
CTD
PMID:28973697
NCBI chr 5:154,402,276...154,407,827
Ensembl chr 5:154,402,279...154,407,840
G
C1qc
complement C1q C chain
increases expression
ISO
troglitazone results in increased expression of C1QC mRNA
CTD
PMID:28973697
NCBI chr 5:154,410,845...154,414,208
Ensembl chr 5:154,410,848...154,414,468
G
C1qtnf12
C1q and TNF related 12
increases expression
ISO
troglitazone results in increased expression of C1QTNF12 mRNA
CTD
PMID:28973697
NCBI chr 5:171,833,854...171,838,229
Ensembl chr 5:171,833,854...171,838,800
G
C1r
complement C1r
increases expression
ISO
troglitazone results in increased expression of C1R mRNA
CTD
PMID:28973697
NCBI chr 4:159,099,013...159,109,770
Ensembl chr 4:159,098,918...159,109,714
G
C1s
complement C1s
decreases expression increases expression
EXP ISO
troglitazone results in decreased expression of C1S mRNA Troglitazone results in increased expression of C1S mRNA
CTD
PMID:21515302 PMID:28973697
NCBI chr 4:159,116,549...159,128,736
Ensembl chr 4:159,116,549...159,128,736
G
C2h1orf54
similar to human chromosome 1 open reading frame 54
increases expression decreases expression
ISO
Troglitazone results in increased expression of C1ORF54 mRNA Troglitazone results in decreased expression of C1ORF54 mRNA
CTD
PMID:28973697
NCBI chr 2:186,113,922...186,124,637
Ensembl chr 2:186,113,922...186,124,335
G
C3
complement C3
decreases expression
ISO
troglitazone results in decreased expression of C3 mRNA
CTD
PMID:25572481
NCBI chr 9:2,174,412...2,201,339
Ensembl chr 9:2,174,412...2,201,339
G
C4bpb
complement component 4 binding protein, beta
decreases expression
EXP
troglitazone results in decreased expression of C4BPB mRNA
CTD
PMID:21515302
NCBI chr13:44,673,064...44,683,781
Ensembl chr13:44,673,065...44,683,793
G
C5ar2
complement C5a receptor 2
decreases expression
EXP
troglitazone results in decreased expression of C5AR2 mRNA
CTD
PMID:21515302
NCBI chr 1:86,058,557...86,073,583
Ensembl chr 1:86,057,256...86,061,372
G
C5h1orf210
similar to human chromosome 1 open reading frame 210
decreases expression
ISO
troglitazone results in decreased expression of C1ORF210 mRNA
CTD
PMID:28973697
NCBI chr 5:137,334,142...137,337,300
Ensembl chr 5:137,334,142...137,337,300
G
C5h1orf50
similar to human chromosome 1 open reading frame 50
decreases expression
ISO
troglitazone results in decreased expression of C1ORF50 mRNA
CTD
PMID:28973697
NCBI chr 5:138,122,595...138,126,973
Ensembl chr 5:138,122,236...138,127,240
G
C8a
complement C8 alpha chain
decreases expression
ISO
troglitazone results in decreased expression of C8A mRNA
CTD
PMID:25572481
NCBI chr 5:124,812,131...124,866,631
Ensembl chr 5:124,812,131...124,866,710
G
C8b
complement C8 beta chain
decreases expression
ISO
troglitazone results in decreased expression of C8B mRNA
CTD
PMID:25572481
NCBI chr 5:124,763,974...124,801,522
Ensembl chr 5:124,761,790...124,801,516
G
C8g
complement C8 gamma chain
decreases expression
ISO
troglitazone results in decreased expression of C8G mRNA
CTD
PMID:25572481
NCBI chr 3:28,718,648...28,720,232
G
Ca12
carbonic anhydrase 12
increases expression
ISO
troglitazone results in increased expression of CA12 mRNA
CTD
PMID:25572481
NCBI chr 8:76,169,723...76,225,465
Ensembl chr 8:76,169,815...76,225,465
G
Ca8
carbonic anhydrase 8
decreases expression
ISO
troglitazone results in decreased expression of CA8 mRNA
CTD
PMID:28973697
NCBI chr 5:26,102,767...26,199,819
Ensembl chr 5:26,102,813...26,199,796
G
Cables1
Cdk5 and Abl enzyme substrate 1
decreases expression
ISO
troglitazone results in decreased expression of CABLES1 mRNA
CTD
PMID:28973697
NCBI chr18:3,349,681...3,455,956
Ensembl chr18:3,351,652...3,455,956
G
Cacybp
calcyclin binding protein
increases expression
ISO
troglitazone results in increased expression of CACYBP mRNA
CTD
PMID:28973697
NCBI chr13:74,970,917...74,981,298
Ensembl chr13:74,970,923...74,981,505
G
Cadm1
cell adhesion molecule 1
decreases expression
ISO
troglitazone results in decreased expression of CADM1 mRNA
CTD
PMID:28973697
NCBI chr 8:56,744,374...57,075,264
Ensembl chr 8:56,744,372...57,080,192
G
Calcb
calcitonin-related polypeptide, beta
decreases expression
EXP
troglitazone results in decreased expression of CALCB mRNA
CTD
PMID:21515302
NCBI chr 1:178,399,634...178,404,654
Ensembl chr 1:178,399,785...178,404,654
G
Calcoco1
calcium binding and coiled coil domain 1
decreases expression
ISO
troglitazone results in decreased expression of CALCOCO1 mRNA
CTD
PMID:28973697
NCBI chr 7:135,713,208...135,728,044
Ensembl chr 7:135,713,208...135,727,928
G
Calhm6
calcium homeostasis modulator family member 6
decreases expression
EXP
troglitazone results in decreased expression of CALHM6 mRNA
CTD
PMID:21515302
NCBI chr20:26,638,721...26,640,466
Ensembl chr20:26,638,722...26,640,408
G
Calml4
calmodulin-like 4
decreases expression
ISO
troglitazone results in decreased expression of CALML4 mRNA
CTD
PMID:25572481
NCBI chr 8:72,218,870...72,230,650
Ensembl chr 8:72,218,613...72,230,650
G
Camk1d
calcium/calmodulin-dependent protein kinase ID
decreases expression
ISO
troglitazone results in decreased expression of CAMK1D mRNA
CTD
PMID:28973697
NCBI chr17:77,491,191...77,892,018
Ensembl chr17:77,491,220...77,892,012
G
Cand1
cullin-associated and neddylation-dissociated 1
decreases expression
ISO
troglitazone results in decreased expression of CAND1 mRNA
CTD
PMID:28973697
NCBI chr 7:56,566,765...56,604,653
Ensembl chr 7:56,551,394...56,604,655
G
Capg
capping actin protein, gelsolin like
decreases expression
EXP
troglitazone results in decreased expression of CAPG protein
CTD
PMID:21315101
NCBI chr 4:106,152,912...106,170,010
Ensembl chr 4:106,152,890...106,170,672
G
Caprin2
caprin family member 2
decreases expression
ISO
troglitazone results in decreased expression of CAPRIN2 mRNA
CTD
PMID:28973697
NCBI chr 4:183,537,935...183,592,162
Ensembl chr 4:183,537,430...183,592,809
G
Card6
caspase recruitment domain family, member 6
decreases expression
ISO
troglitazone results in decreased expression of CARD6 mRNA
CTD
PMID:17569031 PMID:28973697
NCBI chr 2:55,921,832...55,934,388
Ensembl chr 2:55,921,832...55,934,363
G
Cars2
cysteinyl-tRNA synthetase 2, mitochondrial
increases expression
ISO
troglitazone results in increased expression of CARS2 mRNA
CTD
PMID:28973697
NCBI chr16:84,649,617...84,689,254
Ensembl chr16:84,645,627...84,690,192
G
Cask
calcium/calmodulin dependent serine protein kinase
decreases expression
ISO
troglitazone results in decreased expression of CASK mRNA
CTD
PMID:28973697
NCBI chr X:11,572,328...11,915,831
Ensembl chr X:11,572,636...11,911,948
G
Casp3
caspase 3
multiple interactions increases activity increases expression increases cleavage
ISO EXP
[N-(4-methoxybenzyl)-N'-(5-nitro-1,3-thiazol-2-yl)urea results in decreased activity of GSK3B protein] results in increased susceptibility to [troglitazone results in increased expression of CASP3 protein]; [troglitazone co-treated with Aspirin] results in increased cleavage of and results in increased activity of CASP3 protein; GSK3B protein affects the susceptibility to [troglitazone results in increased expression of CASP3 protein]; Palmitic Acid promotes the reaction [troglitazone results in increased activity of CASP3 protein] troglitazone inhibits the reaction [Potassium deficiency results in increased activity of CASP3 protein] troglitazone results in increased expression of CASP3; troglitazone results in increased expression of CASP3 protein; troglitazone results in increased expression of CASP3 protein modified form troglitazone results in increased cleavage of CASP3 protein
CTD
PMID:11218074 PMID:11750908 PMID:12680223 PMID:16820965 PMID:17363128 PMID:18407589 PMID:19632256 PMID:19908241 PMID:20540935 PMID:22700542 More...
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732
G
Casp7
caspase 7
multiple interactions increases activity
ISO
Palmitic Acid promotes the reaction [troglitazone results in increased activity of CASP7 protein]
CTD
PMID:22700542
NCBI chr 1:265,442,647...265,481,938
Ensembl chr 1:265,442,676...265,482,512
G
Casp8
caspase 8
increases activity decreases expression increases expression
ISO
troglitazone results in increased activity of CASP8 protein troglitazone results in decreased expression of CASP8 mRNA troglitazone results in increased expression of CASP8; troglitazone results in increased expression of CASP8 mRNA; troglitazone results in increased expression of CASP8 protein modified form
CTD
PMID:12680223 PMID:14508522 PMID:16820965 PMID:19631733 PMID:28973697
NCBI chr 9:67,747,109...67,806,699
Ensembl chr 9:67,758,033...67,806,699
G
Casp9
caspase 9
multiple interactions increases activity increases expression
ISO
[N-(4-methoxybenzyl)-N'-(5-nitro-1,3-thiazol-2-yl)urea results in decreased activity of GSK3B protein] results in increased susceptibility to [troglitazone results in increased expression of CASP9 protein]; GSK3B protein affects the susceptibility to [troglitazone results in increased expression of CASP9 protein] troglitazone results in increased activity of CASP9 protein
CTD
PMID:14508522 PMID:20540935
Ensembl chr 5:159,391,188...159,409,648
G
Casr
calcium-sensing receptor
increases expression
EXP
troglitazone results in increased expression of CASR mRNA
CTD
PMID:21515302
NCBI chr11:77,738,398...77,813,639
Ensembl chr11:77,740,614...77,810,167
G
Cat
catalase
increases expression decreases expression
ISO EXP
troglitazone results in increased expression of CAT mRNA troglitazone results in decreased expression of CAT protein troglitazone results in increased expression of CAT protein
CTD
PMID:18495193 PMID:19631733 PMID:21315101 PMID:21515302
NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:110,297,342...110,329,526
G
Catsperd
cation channel sperm associated auxiliary subunit delta
increases expression
EXP
troglitazone results in increased expression of CATSPERD mRNA
CTD
PMID:21515302
NCBI chr 9:1,546,903...1,585,470
Ensembl chr 9:1,548,205...1,585,467
G
Cav1
caveolin 1
decreases expression
EXP
troglitazone results in decreased expression of CAV1 mRNA
CTD
PMID:21515302
NCBI chr 4:46,606,538...46,639,616
Ensembl chr 4:46,600,738...46,639,740
G
Cbfa2t3
CBFA2/RUNX1 partner transcriptional co-repressor 3
decreases expression
ISO
troglitazone results in decreased expression of CBFA2T3 mRNA
CTD
PMID:28973697
NCBI chr19:67,584,319...67,658,533
Ensembl chr19:67,589,258...67,658,136
G
Cbl
Cbl proto-oncogene
decreases expression
ISO
troglitazone results in decreased expression of CBL mRNA
CTD
PMID:28973697
NCBI chr 8:53,384,656...53,468,067
Ensembl chr 8:53,384,656...53,468,067
G
Cblc
Cbl proto-oncogene C
decreases expression
ISO
troglitazone results in decreased expression of CBLC mRNA
CTD
PMID:28973697
NCBI chr 1:88,567,930...88,584,709
Ensembl chr 1:88,567,932...88,584,709
G
Cbll1
Cbl proto-oncogene like 1
decreases expression
ISO
troglitazone results in decreased expression of CBLL1 mRNA
CTD
PMID:28973697
NCBI chr 6:53,798,712...53,812,890
Ensembl chr 6:53,798,712...53,813,880
G
Cbr2
carbonyl reductase 2
increases expression
ISO
Troglitazone results in increased expression of CBR2 mRNA
CTD
PMID:28973697
NCBI chr10:106,508,964...106,511,614
Ensembl chr10:106,509,136...106,511,180
G
Cbs
cystathionine beta synthase
increases expression increases activity
EXP
troglitazone results in increased expression of CBS mRNA troglitazone increases activity of CBS enzyme protein in Zucker rat liver
CTD RGD
PMID:21515302 PMID:12037736
RGD:40903050
NCBI chr20:9,709,394...9,733,925
Ensembl chr20:9,709,395...9,734,066
G
Cbx1
chromobox 1
decreases expression
ISO
troglitazone results in decreased expression of CBX1 mRNA
CTD
PMID:19140230
NCBI chr10:82,266,746...82,286,431
Ensembl chr10:82,266,759...82,287,242
G
Cbx5
chromobox 5
decreases expression
ISO
troglitazone results in decreased expression of CBX5 mRNA
CTD
PMID:28973697
NCBI chr 7:136,203,827...136,254,575
Ensembl chr 7:136,211,649...136,229,118
G
Cc2d1a
coiled-coil and C2 domain containing 1A
decreases expression
ISO
troglitazone results in decreased expression of CC2D1A mRNA
CTD
PMID:28973697
NCBI chr19:40,916,587...40,931,702
Ensembl chr19:40,916,532...40,931,701
G
Ccar1
cell division cycle and apoptosis regulator 1
decreases expression
ISO
troglitazone results in decreased expression of CCAR1 mRNA
CTD
PMID:28973697
NCBI chr20:31,228,624...31,271,233
Ensembl chr20:31,228,624...31,271,227
G
Ccl11
C-C motif chemokine ligand 11
multiple interactions decreases activity
ISO
PPARA protein affects the reaction [Troglitazone inhibits the reaction [TNF protein results in increased expression of CCL11 protein]]; Troglitazone inhibits the reaction [TNF protein results in increased expression of CCL11 mRNA]; Troglitazone inhibits the reaction [TNF protein results in increased expression of CCL11 protein] troglitazone results in decreased activity of CCL11 protein
CTD
PMID:12644321 PMID:15531761
NCBI chr10:67,525,975...67,530,576
Ensembl chr10:67,525,862...67,530,575
G
Ccl12
C-C motif chemokine ligand 12
decreases expression
ISO
troglitazone results in decreased expression of CCL13 mRNA
CTD
PMID:28934090
NCBI chr10:67,567,876...67,569,426
Ensembl chr10:67,567,876...67,569,426
G
Ccl2
C-C motif chemokine ligand 2
multiple interactions decreases expression
ISO EXP
[troglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of CCL2 mRNA; troglitazone inhibits the reaction [tert-Butylhydroperoxide promotes the reaction [PPARG protein binds to CCL2 promoter]]; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of CCL2 mRNA]; troglitazone inhibits the reaction [TNF protein results in increased expression of CCL2 protein] troglitazone results in decreased expression of CCL2 mRNA [Troglitazone co-treated with Buthionine Sulfoximine] results in increased expression of CCL2 mRNA; Troglitazone promotes the reaction [Capsaicin results in decreased secretion of CCL2 protein]
CTD
PMID:12468449 PMID:15531761 PMID:17719033 PMID:19140230 PMID:20847119 PMID:21515302 PMID:31294483 More...
NCBI chr10:67,503,077...67,504,875
Ensembl chr10:67,503,077...67,504,875
G
Ccl20
C-C motif chemokine ligand 20
increases expression decreases expression
ISO EXP
troglitazone results in increased expression of CCL20 mRNA troglitazone results in decreased expression of CCL20 mRNA
CTD
PMID:19140230 PMID:21515302
NCBI chr 9:91,837,139...91,839,736
Ensembl chr 9:91,836,946...91,839,736
G
Ccl3
C-C motif chemokine ligand 3
increases expression decreases expression
ISO EXP
troglitazone results in increased expression of CCL3 mRNA troglitazone results in decreased expression of CCL3 mRNA
CTD
PMID:19631733 PMID:21515302
NCBI chr10:68,948,889...68,950,439
Ensembl chr10:68,948,889...68,950,439
G
Ccl4
C-C motif chemokine ligand 4
increases expression decreases expression decreases secretion multiple interactions
ISO
troglitazone results in increased expression of CCL4 mRNA troglitazone results in decreased expression of CCL4 mRNA Troglitazone results in decreased secretion of CCL4 protein [mono-(2-ethylhexyl)phthalate co-treated with Troglitazone] results in decreased secretion of CCL4 protein
CTD
PMID:19631733 PMID:20453712 PMID:20846491
NCBI chr10:68,963,893...68,965,728
Ensembl chr10:68,950,289...68,965,722
G
Ccl5
C-C motif chemokine ligand 5
increases expression decreases secretion
ISO
troglitazone results in increased expression of CCL5 mRNA Troglitazone results in decreased secretion of CCL5 protein
CTD
PMID:19140230 PMID:20453712
NCBI chr10:68,820,330...68,824,906
Ensembl chr10:68,738,651...68,824,884
G
Ccl7
C-C motif chemokine ligand 7
decreases expression
EXP
troglitazone results in decreased expression of CCL7 mRNA
CTD
PMID:21515302
NCBI chr10:67,514,095...67,515,945
Ensembl chr10:67,514,091...67,515,947
G
Ccl9
C-C motif chemokine ligand 9
increases expression
ISO
Troglitazone results in increased expression of CCL6 mRNA
CTD
PMID:28973697
NCBI chr10:68,863,994...68,868,928
Ensembl chr10:68,863,995...68,868,877
G
Ccn1
cellular communication network factor 1
decreases expression
ISO
Troglitazone results in decreased expression of CCN1 mRNA
CTD
PMID:19140230 PMID:25572481
NCBI chr 2:237,222,730...237,225,689
Ensembl chr 2:237,222,432...237,225,883
G
Ccn2
cellular communication network factor 2
multiple interactions increases expression decreases expression
ISO
[Troglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of CCN2 mRNA; Troglitazone inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of CCN2 mRNA]; Troglitazone inhibits the reaction [TGFB1 protein results in increased expression of CCN2 mRNA]; Troglitazone inhibits the reaction [TGFB1 protein results in increased expression of CCN2 protein] Troglitazone results in increased expression of CCN2 mRNA Troglitazone results in decreased expression of CCN2 mRNA
CTD
PMID:17056281 PMID:19140230 PMID:19429239 PMID:20847119 PMID:25572481
NCBI chr 1:22,621,498...22,624,614
Ensembl chr 1:22,621,501...22,624,976
G
Ccn4
cellular communication network factor 4
decreases expression
ISO
Troglitazone results in decreased expression of CCN4 mRNA
CTD
PMID:28934090
NCBI chr 7:100,534,578...100,566,287
Ensembl chr 7:100,534,505...100,563,094
G
Ccn5
cellular communication network factor 5
decreases expression
ISO
Troglitazone results in decreased expression of CCN5 mRNA
CTD
PMID:19140230
NCBI chr 3:172,910,670...172,922,064
Ensembl chr 3:172,910,681...172,922,062
G
Ccna2
cyclin A2
decreases expression
ISO
troglitazone results in decreased expression of CCNA2 mRNA; troglitazone results in decreased expression of CCNA2 protein
CTD
PMID:15729575 PMID:19140230
NCBI chr 2:121,355,363...121,361,762
Ensembl chr 2:121,355,363...121,361,701
G
Ccnb1
cyclin B1
multiple interactions decreases expression
ISO
[N-(4-methoxybenzyl)-N'-(5-nitro-1,3-thiazol-2-yl)urea results in decreased activity of GSK3B protein] results in increased susceptibility to [Troglitazone results in decreased expression of CCNB1 protein]; Aspirin inhibits the reaction [Troglitazone results in decreased expression of CCNB1 protein]; GSK3B protein affects the susceptibility to [Troglitazone results in decreased expression of CCNB1 protein] troglitazone results in decreased expression of CCNB1 mRNA; troglitazone results in decreased expression of CCNB1 protein
CTD
PMID:15729575 PMID:19140230 PMID:19908241 PMID:20540935
NCBI chr 2:33,646,252...33,655,225
Ensembl chr 2:33,646,252...33,655,225
G
Ccnb2
cyclin B2
decreases expression
ISO
troglitazone results in decreased expression of CCNB2 mRNA
CTD
PMID:19140230
NCBI chr 8:79,968,459...79,981,717
Ensembl chr 8:79,968,465...79,981,682
G
Ccnd1
cyclin D1
increases expression multiple interactions increases degradation decreases expression
ISO EXP
troglitazone results in increased expression of CCND1 mRNA; troglitazone results in increased expression of CCND1 protein [N-(4-methoxybenzyl)-N'-(5-nitro-1,3-thiazol-2-yl)urea results in decreased activity of GSK3B protein] results in increased susceptibility to [troglitazone results in decreased expression of CCND1 protein]; GSK3B protein affects the susceptibility to [troglitazone results in decreased expression of CCND1 protein] troglitazone results in increased degradation of CCND1 protein troglitazone results in decreased expression of CCND1 mRNA; troglitazone results in decreased expression of CCND1 protein [Urethane co-treated with troglitazone] results in increased expression of CCND1 mRNA
CTD
PMID:11834241 PMID:12595159 PMID:12680223 PMID:15610522 PMID:17143939 PMID:17409431 PMID:17569031 PMID:18162602 PMID:18465119 PMID:19022234 PMID:20540935 PMID:21515302 PMID:22684020 PMID:22750490 More...
NCBI chr 1:209,518,288...209,527,986
Ensembl chr 1:209,518,288...209,527,810
G
Ccnd2
cyclin D2
decreases expression
ISO
troglitazone results in decreased expression of CCND2 mRNA; troglitazone results in decreased expression of CCND2 protein
CTD
PMID:12649303
NCBI chr 4:161,653,048...161,675,422
Ensembl chr 4:161,653,048...161,680,301 Ensembl chr 4:161,653,048...161,680,301
G
Ccnd3
cyclin D3
multiple interactions decreases expression
ISO
Aspirin promotes the reaction [troglitazone results in decreased expression of CCND3 protein]; troglitazone promotes the reaction [Aspirin results in decreased expression of CCND3 protein]
CTD
PMID:15729575 PMID:19908241
NCBI chr 9:20,891,696...20,987,199
Ensembl chr 9:20,891,704...20,987,033
G
Ccne1
cyclin E1
multiple interactions decreases expression
ISO
[N-(4-methoxybenzyl)-N'-(5-nitro-1,3-thiazol-2-yl)urea results in decreased activity of GSK3B protein] results in increased susceptibility to [troglitazone results in decreased expression of CCNE1 protein]; GSK3B protein affects the susceptibility to [troglitazone results in decreased expression of CCNE1 protein]
CTD
PMID:11834241 PMID:15729575 PMID:20540935
NCBI chr 1:99,918,672...99,927,986
Ensembl chr 1:99,918,674...99,927,822
G
Ccnf
cyclin F
decreases expression
ISO
troglitazone results in decreased expression of CCNF mRNA
CTD
PMID:19140230
NCBI chr10:13,757,884...13,783,669
Ensembl chr10:13,758,421...13,783,837
G
Ccng1
cyclin G1
decreases expression
ISO
troglitazone results in decreased expression of CCNG1 mRNA
CTD
PMID:19631733
NCBI chr10:25,678,503...25,684,876
Ensembl chr10:25,677,885...25,683,766
G
Ccnt2
cyclin T2
decreases expression
ISO
troglitazone results in decreased expression of CCNT2 mRNA
CTD
PMID:28973697
NCBI chr13:41,804,007...41,845,641
Ensembl chr13:41,804,046...41,844,488
G
Ccr5
C-C motif chemokine receptor 5
increases expression
ISO
troglitazone results in increased expression of CCR5 mRNA
CTD
PMID:28973697
NCBI chr 8:132,629,097...132,660,980
Ensembl chr 8:132,629,683...132,637,594
G
Cd14
CD14 molecule
decreases expression increases expression
ISO
troglitazone results in decreased expression of CD14 mRNA Troglitazone results in increased expression of CD14 mRNA; Troglitazone results in increased expression of CD14 protein
CTD
PMID:12649303 PMID:19140230 PMID:25572481
NCBI chr18:28,609,558...28,611,409
Ensembl chr18:28,608,883...28,611,292
G
Cd207
CD207 molecule
increases expression
ISO
troglitazone results in increased expression of CD207 mRNA
CTD
PMID:28973697
NCBI chr 4:117,712,879...117,719,191
Ensembl chr 4:117,712,879...117,719,191
G
Cd209d
CD209d molecule
increases expression
ISO
troglitazone results in increased expression of CD209D mRNA
CTD
PMID:28973697
NCBI chr12:6,689,002...6,695,452
Ensembl chr12:6,689,002...6,698,976
G
Cd248
CD248 molecule
increases expression
ISO
troglitazone results in increased expression of CD248 mRNA
CTD
PMID:28973697
NCBI chr 1:211,803,052...211,805,616
Ensembl chr 1:211,801,934...211,805,776
G
Cd27
CD27 molecule
decreases expression
ISO
troglitazone results in decreased expression of CD27 mRNA
CTD
PMID:17569031
NCBI chr 4:159,716,932...159,721,823
Ensembl chr 4:159,716,935...159,721,823
G
Cd36
CD36 molecule
multiple interactions increases expression decreases expression
ISO EXP
afimoxifene inhibits the reaction [Troglitazone results in increased expression of CD36 protein]; T 0070907 inhibits the reaction [Troglitazone results in increased expression of CD36 mRNA]; Tamoxifen inhibits the reaction [Troglitazone results in increased expression of CD36 protein] troglitazone results in increased expression of CD36 mRNA [troglitazone co-treated with Ethanol] results in increased expression of CD36 protein; alpha-Tocopherol inhibits the reaction [[troglitazone co-treated with Ethanol] results in increased expression of CD36 protein] [Troglitazone results in increased activity of PPARG protein] which results in increased expression of CD36 mRNA; tanshinone inhibits the reaction [Troglitazone results in increased expression of CD36 mRNA]; Troglitazone inhibits the reaction [tanshinone results in decreased expression of CD36 mRNA] troglitazone results in increased expression of CD36 mRNA; troglitazone results in increased expression of CD36 protein troglitazone results in decreased expression of CD36 mRNA
CTD
PMID:11089532 PMID:11231916 PMID:14977855 PMID:16407258 PMID:18155510 PMID:20854809 PMID:21515302 PMID:22124178 PMID:25572481 PMID:27358406 PMID:28903485 PMID:28973697 More...
NCBI chr 4:18,209,088...18,302,142
G
Cd37
CD37 molecule
increases expression
EXP ISO
troglitazone results in increased expression of CD37 mRNA
CTD
PMID:21515302 PMID:28973697
NCBI chr 1:104,855,622...104,861,111
Ensembl chr 1:104,849,166...104,861,276
G
Cd47
Cd47 molecule
decreases expression
ISO
troglitazone results in decreased expression of CD47 mRNA
CTD
PMID:28973697
NCBI chr11:64,374,816...64,438,763
Ensembl chr11:64,377,926...64,438,272
G
Cd55
CD55 molecule (Cromer blood group)
increases expression
ISO
troglitazone results in increased expression of CD55 mRNA
CTD
PMID:19140230 PMID:28973697
NCBI chr13:44,409,574...44,438,913
Ensembl chr13:44,409,587...44,438,107
G
Cd5l
Cd5 molecule-like
decreases expression
ISO
troglitazone results in decreased expression of CD5L mRNA
CTD
PMID:17569031
NCBI chr 2:175,088,915...175,099,928
Ensembl chr 2:175,088,884...175,099,926
G
Cd83
CD83 molecule
increases expression
ISO
troglitazone results in increased expression of CD83 mRNA
CTD
PMID:19140230
NCBI chr17:21,093,281...21,113,223
Ensembl chr17:21,093,281...21,113,047
G
Cd86
CD86 molecule
increases expression
ISO
troglitazone results in increased expression of CD86 mRNA
CTD
PMID:28973697
NCBI chr11:77,647,565...77,706,178
Ensembl chr11:77,647,600...77,725,361
G
Cd9
CD9 molecule
decreases expression
EXP
troglitazone results in decreased expression of CD9 mRNA
CTD
PMID:21515302
NCBI chr 4:159,942,553...159,975,463
Ensembl chr 4:159,942,560...159,975,444
G
Cd93
CD93 molecule
decreases expression
ISO
troglitazone results in decreased expression of CD93 mRNA
CTD
PMID:28973697
NCBI chr 3:156,345,019...156,351,537
Ensembl chr 3:156,345,019...156,351,537
G
Cd96
CD96 molecule
increases expression
ISO
troglitazone results in increased expression of CD96 mRNA
CTD
PMID:28934090
NCBI chr11:68,164,926...68,239,266
Ensembl chr11:68,164,872...68,241,937
G
Cdc14b
cell division cycle 14B
decreases expression
ISO
troglitazone results in decreased expression of CDC14B mRNA
CTD
PMID:28973697
NCBI chr17:850,272...938,972
Ensembl chr17:850,390...971,164
G
Cdc20
cell division cycle 20
decreases expression
ISO
troglitazone results in decreased expression of CDC20 mRNA
CTD
PMID:19140230
NCBI chr 5:137,251,596...137,255,799
Ensembl chr 5:137,251,596...137,255,799
G
Cdc20b
cell division cycle 20B
decreases expression
ISO
troglitazone results in decreased expression of CDC20B mRNA
CTD
PMID:25572481
G
Cdc25a
cell division cycle 25A
decreases expression increases expression
ISO EXP
troglitazone results in decreased expression of CDC25A mRNA troglitazone results in increased expression of CDC25A mRNA
CTD
PMID:19140230 PMID:21515302
NCBI chr 8:118,742,824...118,761,190
Ensembl chr 8:118,742,426...118,761,188
G
Cdc25c
cell division cycle 25C
decreases expression
ISO
troglitazone results in decreased expression of CDC25C mRNA
CTD
PMID:19140230
NCBI chr18:26,608,483...26,630,292
Ensembl chr18:26,609,959...26,630,292
G
Cdc42ep4
CDC42 effector protein 4
decreases expression
ISO
troglitazone results in decreased expression of CDC42EP4 mRNA
CTD
PMID:28973697
NCBI chr10:99,271,750...99,298,551
Ensembl chr10:99,267,540...99,300,168
G
Cdc45
cell division cycle 45
decreases expression
ISO
Troglitazone results in decreased expression of CDC45 mRNA
CTD
PMID:19140230
NCBI chr11:95,689,702...95,714,980
Ensembl chr11:95,689,919...95,714,981
G
Cdc5l
cell division cycle 5-like
decreases expression
ISO
troglitazone results in decreased expression of CDC5L mRNA
CTD
PMID:28973697
NCBI chr 9:23,062,397...23,100,901
Ensembl chr 9:23,062,205...23,100,899
G
Cdc6
cell division cycle 6
decreases expression
ISO
troglitazone results in decreased expression of CDC6 mRNA
CTD
PMID:19140230
NCBI chr10:84,360,361...84,374,239
Ensembl chr10:84,360,381...84,374,241
G
Cdc7
cell division cycle 7
decreases expression
ISO
troglitazone results in decreased expression of CDC7 mRNA
CTD
PMID:19140230
NCBI chr14:2,949,538...2,969,656
Ensembl chr14:2,949,539...2,969,656
G
Cdc73
cell division cycle 73
decreases expression
ISO
troglitazone results in decreased expression of CDC73 mRNA
CTD
PMID:28973697
NCBI chr13:57,897,924...58,000,031
Ensembl chr13:57,883,983...57,999,978
G
Cdca5
cell division cycle associated 5
decreases expression
ISO
troglitazone results in decreased expression of CDCA5 mRNA
CTD
PMID:19140230
NCBI chr 1:212,807,863...212,821,313
Ensembl chr 1:212,804,014...212,821,309
G
Cdca7
cell division cycle associated 7
decreases expression
ISO
troglitazone results in decreased expression of CDCA7 mRNA
CTD
PMID:19140230
NCBI chr 3:77,730,315...77,740,950
Ensembl chr 3:77,729,970...77,740,947
G
Cdca7l
cell division cycle associated 7 like
decreases expression
ISO
troglitazone results in decreased expression of CDCA7L mRNA
CTD
PMID:19140230
NCBI chr 6:144,936,885...144,982,844
Ensembl chr 6:144,908,171...144,982,843
G
Cdh1
cadherin 1
decreases expression increases expression
EXP ISO
troglitazone results in decreased expression of CDH1 mRNA troglitazone results in increased expression of CDH1 mRNA; troglitazone results in increased expression of CDH1 protein
CTD
PMID:19022234 PMID:19285010 PMID:21515302 PMID:22684020
NCBI chr19:51,402,178...51,471,572
Ensembl chr19:51,402,034...51,471,565
G
Cdh22
cadherin 22
increases expression
ISO
troglitazone results in increased expression of CDH22 mRNA
CTD
PMID:28934090
NCBI chr 3:174,264,869...174,389,940
Ensembl chr 3:174,264,869...174,390,142
G
Cdip1
cell death-inducing p53 target 1
decreases expression
ISO
troglitazone results in decreased expression of CDIP1 mRNA
CTD
PMID:28973697
NCBI chr10:11,278,213...11,303,415
Ensembl chr10:11,293,827...11,303,415
G
Cdk1
cyclin-dependent kinase 1
decreases expression
ISO
Troglitazone results in decreased expression of CDK1 mRNA; Troglitazone results in decreased expression of CDK1 protein
CTD
PMID:12595159 PMID:19140230
NCBI chr20:19,265,252...19,280,456
Ensembl chr20:19,265,289...19,280,455
G
Cdk12
cyclin-dependent kinase 12
decreases expression
ISO
troglitazone results in decreased expression of CDK12 mRNA
CTD
PMID:28973697
NCBI chr10:83,697,174...83,793,676
Ensembl chr10:83,767,206...83,777,183 Ensembl chr10:83,767,206...83,777,183
G
Cdk13
cyclin-dependent kinase 13
decreases expression
ISO
troglitazone results in decreased expression of CDK13 mRNA
CTD
PMID:28973697
NCBI chr17:51,945,975...52,040,218
Ensembl chr17:51,946,701...52,037,257
G
Cdk19
cyclin-dependent kinase 19
decreases expression
ISO
troglitazone results in decreased expression of CDK19 mRNA
CTD
PMID:28973697
NCBI chr20:45,324,911...45,465,121
Ensembl chr20:45,324,862...45,465,121
G
Cdk2
cyclin dependent kinase 2
multiple interactions decreases expression increases activity decreases activity
ISO
[N-(4-methoxybenzyl)-N'-(5-nitro-1,3-thiazol-2-yl)urea results in decreased activity of GSK3B protein] results in increased susceptibility to [troglitazone results in decreased expression of CDK2 protein]; GSK3B protein affects the susceptibility to [troglitazone results in decreased expression of CDK2 protein]; troglitazone promotes the reaction [Aspirin results in decreased expression of CDK2 protein]; troglitazone promotes the reaction [CDKN1A protein binds to CDK2 protein]; troglitazone promotes the reaction [CDKN1B protein binds to CDK2 protein] troglitazone results in decreased expression of CDK2 mRNA; troglitazone results in decreased expression of CDK2 protein troglitazone results in increased activity of CDK2 protein troglitazone results in decreased activity of CDK2 protein benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [troglitazone results in decreased expression of CDK2 protein]; troglitazone results in increased degradation of and results in increased ubiquitination of CDK2 protein
CTD
PMID:11343236 PMID:11741176 PMID:12595159 PMID:12717389 PMID:15610522 PMID:15729575 PMID:19140230 PMID:19908241 PMID:20540935 More...
NCBI chr 7:1,714,392...1,721,964
Ensembl chr 7:1,714,392...1,721,878
G
Cdk4
cyclin-dependent kinase 4
multiple interactions decreases expression
ISO
[N-(4-methoxybenzyl)-N'-(5-nitro-1,3-thiazol-2-yl)urea results in decreased activity of GSK3B protein] results in increased susceptibility to [troglitazone results in decreased expression of CDK4 protein]; GSK3B protein affects the susceptibility to [troglitazone results in decreased expression of CDK4 protein] troglitazone results in decreased expression of CDK4 mRNA; troglitazone results in decreased expression of CDK4 protein
CTD
PMID:15610522 PMID:19140230 PMID:20540935
NCBI chr 7:64,771,453...64,774,891
Ensembl chr 7:64,771,147...64,775,163
G
Cdk5
cyclin-dependent kinase 5
multiple interactions
EXP
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Troglitazone results in increased phosphorylation of CDK5 protein]; pyrazolanthrone inhibits the reaction [Troglitazone results in increased phosphorylation of CDK5 protein]; Troglitazone promotes the reaction [CDK5 protein results in increased phosphorylation of PPARG protein]; Troglitazone results in increased phosphorylation of and results in increased activity of CDK5 protein
CTD
PMID:24481447
NCBI chr 4:11,647,098...11,651,606
Ensembl chr 4:11,647,141...11,652,777
G
Cdk5rap3
CDK5 regulatory subunit associated protein 3
decreases expression
ISO
troglitazone results in decreased expression of CDK5RAP3 mRNA
CTD
PMID:19140230
NCBI chr10:82,390,845...82,402,814
Ensembl chr10:82,390,845...82,400,001
G
Cdk6
cyclin-dependent kinase 6
decreases expression
ISO
troglitazone results in decreased expression of CDK6 mRNA
CTD
PMID:19140230
NCBI chr 4:31,592,384...31,784,732
Ensembl chr 4:31,601,192...31,781,701
G
Cdkn1a
cyclin-dependent kinase inhibitor 1A
multiple interactions decreases expression increases expression increases metabolic processing
ISO EXP
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [troglitazone affects the localization of and results in increased expression of CDKN1A protein]; [troglitazone co-treated with IFNG protein] results in increased expression of CDKN1A mRNA; Cycloheximide inhibits the reaction [troglitazone results in increased expression of CDKN1A protein]; troglitazone affects the localization of and results in increased expression of CDKN1A protein; troglitazone promotes the reaction [[IFNG protein co-treated with TNF protein] results in increased expression of CDKN1A mRNA]; troglitazone promotes the reaction [CDKN1A protein binds to CDK2 protein]; troglitazone results in increased expression of and affects the localization of CDKN1A protein; troglitazone results in increased expression of and results in increased stability of CDKN1A mRNA troglitazone results in decreased expression of CDKN1A mRNA; troglitazone results in decreased expression of CDKN1A protein troglitazone results in increased expression of CDKN1A mRNA troglitazone results in increased metabolism of CDKN1A protein troglitazone results in increased expression of CDKN1A mRNA; troglitazone results in increased expression of CDKN1A protein
CTD
PMID:10441511 PMID:11318962 PMID:11343236 PMID:11741176 PMID:11888673 PMID:12149143 PMID:12595159 PMID:12717389 PMID:15064713 PMID:15729575 PMID:16597547 PMID:17143939 PMID:17569031 PMID:19140230 PMID:19631733 PMID:19908241 PMID:25596134 PMID:25669987 PMID:28973697 More...
NCBI chr20:7,150,820...7,161,373
Ensembl chr20:7,153,958...7,164,969
G
Cdkn1b
cyclin-dependent kinase inhibitor 1B
multiple interactions decreases expression affects response to substance increases expression
ISO EXP
[troglitazone binds to and results in increased activity of PPARG protein] which results in decreased degradation of CDKN1B protein; [troglitazone binds to and results in increased activity of PPARG protein] which results in increased expression of and results in increased ubiquitination of CDKN1B protein; [troglitazone binds to and results in increased activity of PPARG protein] which results in increased expression of CDKN1B protein; [troglitazone co-treated with Aspirin] results in increased expression of CDKN1B protein; troglitazone promotes the reaction [CDKN1B protein binds to CDK2 protein] troglitazone results in decreased expression of CDKN1B mRNA; troglitazone results in decreased expression of CDKN1B protein [troglitazone co-treated with [Hydrochlorothiazide co-treated with Hydralazine co-treated with Reserpine]] results in decreased expression of CDKN1B protein CDKN1B protein affects the susceptibility to troglitazone troglitazone results in increased expression of CDKN1B mRNA; troglitazone results in increased expression of CDKN1B protein
CTD
PMID:11034103 PMID:11318962 PMID:11343236 PMID:12149143 PMID:12595159 PMID:12680223 PMID:12717389 PMID:12824901 PMID:14618613 PMID:16374840 PMID:17143939 PMID:19908241 PMID:25669987 More...
NCBI chr 4:169,491,273...169,496,500
Ensembl chr 4:169,490,876...169,496,498
G
Cdkn1c
cyclin-dependent kinase inhibitor 1C
multiple interactions
ISO
[troglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of CDKN1C mRNA; troglitazone inhibits the reaction [tert-Butylhydroperoxide promotes the reaction [PPARG protein binds to CDKN1C promoter]]; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of CDKN1C mRNA]
CTD
PMID:20847119
NCBI chr 1:208,084,801...208,087,680
Ensembl chr 1:208,084,787...208,087,498
G
Cdkn2c
cyclin-dependent kinase inhibitor 2C
decreases expression increases expression
ISO
troglitazone results in decreased expression of CDKN2C mRNA troglitazone results in increased expression of CDKN2C protein
CTD
PMID:11343236 PMID:12732648 PMID:19140230
NCBI chr 5:129,639,736...129,645,564
Ensembl chr 5:129,639,736...129,644,891
G
Cdkn3
cyclin-dependent kinase inhibitor 3
decreases expression
ISO
troglitazone results in decreased expression of CDKN3 mRNA
CTD
PMID:19140230
NCBI chr15:22,502,299...22,513,725
Ensembl chr15:22,502,382...22,513,722
G
Cds2
CDP-diacylglycerol synthase 2
decreases expression
ISO
troglitazone results in decreased expression of CDS2 mRNA
CTD
PMID:28973697
NCBI chr 3:139,967,870...140,006,459
Ensembl chr 3:139,967,742...140,009,201
G
Cdt1
chromatin licensing and DNA replication factor 1
decreases expression
ISO
troglitazone results in decreased expression of CDT1 mRNA
CTD
PMID:19140230
NCBI chr19:67,529,249...67,534,195
Ensembl chr19:67,529,201...67,534,194
G
Ceacam1
CEA cell adhesion molecule 1
decreases expression
ISO
troglitazone results in decreased expression of CEACAM1 mRNA
CTD
PMID:28973697
NCBI chr 1:90,171,401...90,187,810
Ensembl chr 1:90,171,401...90,187,798
G
Cebpa
CCAAT/enhancer binding protein alpha
increases expression decreases expression multiple interactions
ISO EXP
troglitazone results in increased expression of CEBPA mRNA troglitazone results in decreased expression of CEBPA mRNA [1-Methyl-3-isobutylxanthine co-treated with Troglitazone co-treated with INS protein] results in increased expression of CEBPA mRNA; Troglitazone inhibits the reaction [TNF protein inhibits the reaction [INS protein results in increased expression of CEBPA mRNA]] (+)-JQ1 compound inhibits the reaction [[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Troglitazone] results in increased expression of CEBPA protein]; [INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Troglitazone] results in increased expression of CEBPA protein; JMJD6 mutant form inhibits the reaction [[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Troglitazone] results in increased expression of CEBPA protein]
CTD
PMID:7956951 PMID:8895337 PMID:12732648 PMID:19022234 PMID:19682441 PMID:24559133 PMID:26117538 PMID:27003841 More...
NCBI chr 1:96,896,584...96,899,256
Ensembl chr 1:96,896,171...96,899,309
G
Cebpb
CCAAT/enhancer binding protein beta
increases expression
ISO EXP
troglitazone results in increased expression of CEBPB mRNA
CTD
PMID:12732648 PMID:19140230 PMID:21515302 PMID:21877759
NCBI chr 3:176,817,005...176,818,436
Ensembl chr 3:176,816,859...176,838,072
G
Cebpg
CCAAT/enhancer binding protein gamma
increases expression
ISO
troglitazone results in increased expression of CEBPG mRNA
CTD
PMID:24559133
NCBI chr 1:96,820,981...96,829,736
Ensembl chr 1:96,810,214...96,830,283
G
Celf1
CUGBP, Elav-like family member 1
decreases expression
ISO
troglitazone results in decreased expression of CELF1 mRNA
CTD
PMID:28973697
NCBI chr 3:97,380,407...97,455,253
Ensembl chr 3:97,380,424...97,452,791
G
Cemip2
cell migration inducing hyaluronidase 2
decreases expression
ISO
Troglitazone results in decreased expression of CEMIP2 mRNA
CTD
PMID:28973697
NCBI chr 1:228,756,826...228,834,313
Ensembl chr 1:228,757,466...228,832,906
G
Cenpa
centromere protein A
decreases expression
ISO
troglitazone results in decreased expression of CENPA mRNA
CTD
PMID:19140230
NCBI chr 6:31,420,062...31,431,703
G
Cenpe
centromere protein E
decreases expression
ISO
troglitazone results in decreased expression of CENPE mRNA
CTD
PMID:19140230
NCBI chr 2:226,310,970...226,369,636
Ensembl chr 2:226,300,798...226,369,636
G
Cenpf
centromere protein F
decreases expression
ISO
troglitazone results in decreased expression of CENPF mRNA
CTD
PMID:19140230
NCBI chr13:103,715,344...103,760,931
Ensembl chr13:103,715,344...103,760,886
G
Cenps
centromere protein S
decreases expression
ISO
troglitazone results in decreased expression of CENPS mRNA
CTD
PMID:19140230
NCBI chr 5:164,847,009...164,856,705
G
Cenpu
centromere protein U
decreases expression
EXP
troglitazone results in decreased expression of CENPU mRNA
CTD
PMID:21515302
NCBI chr16:52,448,446...52,471,662
Ensembl chr16:52,425,096...52,471,662
G
Cep104
centrosomal protein 104
decreases expression
ISO
troglitazone results in decreased expression of CEP104 mRNA
CTD
PMID:28973697
NCBI chr 5:169,817,383...169,849,681
Ensembl chr 5:169,817,182...169,852,695
G
Cep120
centrosomal protein 120
decreases expression
ISO
troglitazone results in decreased expression of CEP120 mRNA
CTD
PMID:28973697
NCBI chr18:49,326,266...49,388,380
Ensembl chr18:49,326,266...49,388,243
G
Cep170b
centrosomal protein 170B
decreases expression
ISO
troglitazone results in decreased expression of CEP170B mRNA
CTD
PMID:28973697
NCBI chr 6:137,602,707...137,627,750
Ensembl chr 6:137,602,707...137,627,750
G
Cep68
centrosomal protein 68
decreases expression
ISO
troglitazone results in decreased expression of CEP68 mRNA
CTD
PMID:28973697
NCBI chr14:98,649,993...98,671,892
Ensembl chr14:98,649,993...98,671,868
G
Ces1d
carboxylesterase 1D
increases expression
EXP
troglitazone results in increased expression of CES1D protein
CTD
PMID:21315101
NCBI chr19:30,046,494...30,085,039
Ensembl chr19:30,046,449...30,085,449
G
Cesl1
carboxylesterase-like 1
increases expression
EXP
troglitazone results in increased expression of CESL1 mRNA
CTD
PMID:21515302
NCBI chr19:38,554,365...38,612,663
G
Cfb
complement factor B
increases expression
ISO
troglitazone results in increased expression of CFB mRNA
CTD
PMID:19140230
NCBI chr20:3,975,271...3,981,138
Ensembl chr20:3,955,776...3,981,740
G
Cfd
complement factor D
decreases secretion increases expression
ISO EXP
troglitazone results in decreased secretion of CFD protein troglitazone results in increased expression of CFD mRNA
CTD
PMID:10097144 PMID:17452443 PMID:19122273 PMID:21515302 PMID:21877759
NCBI chr 7:10,463,773...10,465,496
Ensembl chr 7:10,463,775...10,465,572
G
Cfh
complement factor H
decreases expression
ISO
troglitazone results in decreased expression of CFH mRNA
CTD
PMID:19140230
NCBI chr13:54,063,079...54,164,523
Ensembl chr13:54,062,531...54,164,532
G
Cflar
CASP8 and FADD-like apoptosis regulator
decreases expression increases expression
ISO
troglitazone results in decreased expression of CFLAR protein troglitazone results in increased expression of CFLAR mRNA
CTD
PMID:16820965 PMID:28973697
NCBI chr 9:67,679,502...67,747,226
Ensembl chr 9:67,679,559...67,726,434
G
Cfp
complement factor properdin
increases expression
ISO
troglitazone results in increased expression of CFP mRNA
CTD
PMID:28973697
NCBI chr X:3,715,551...3,721,113
Ensembl chr X:3,710,425...3,721,112
G
Ch25h
cholesterol 25-hydroxylase
decreases expression
EXP
troglitazone results in decreased expression of CH25H mRNA
CTD
PMID:21515302
NCBI chr 1:241,428,048...241,429,366
Ensembl chr 1:241,331,619...241,431,190
G
Chaf1a
chromatin assembly factor 1 subunit A
decreases expression
ISO
troglitazone results in decreased expression of CHAF1A mRNA
CTD
PMID:19140230
NCBI chr 9:961,225...987,825
Ensembl chr 9:961,084...987,868
G
Chaf1b
chromatin assembly factor 1 subunit B
decreases expression
ISO
troglitazone results in decreased expression of CHAF1B mRNA
CTD
PMID:19140230
NCBI chr11:46,670,560...46,690,739
Ensembl chr11:46,670,630...46,690,733
G
Chchd10
coiled-coil-helix-coiled-coil-helix domain containing 10
increases expression
EXP
troglitazone results in increased expression of CHCHD10 mRNA
CTD
PMID:21515302
NCBI chr20:12,725,274...12,730,295
Ensembl chr20:12,725,277...12,745,677
G
Chchd6
coiled-coil-helix-coiled-coil-helix domain containing 6
increases expression
ISO
troglitazone results in increased expression of CHCHD6 mRNA
CTD
PMID:28973697
NCBI chr 4:123,360,729...123,581,429
Ensembl chr 4:123,349,187...123,581,421
G
Chd1
chromodomain helicase DNA binding protein 1
decreases expression
ISO
troglitazone results in decreased expression of CHD1 mRNA
CTD
PMID:28973697
NCBI chr 1:65,334,905...65,402,270
Ensembl chr 1:65,335,218...65,401,280
G
Chd2
chromodomain helicase DNA binding protein 2
decreases expression
ISO
troglitazone results in decreased expression of CHD2 mRNA
CTD
PMID:28973697
NCBI chr 1:136,597,993...136,726,874
Ensembl chr 1:136,599,900...136,710,335
G
Chd3
chromodomain helicase DNA binding protein 3
decreases expression
ISO
troglitazone results in decreased expression of CHD3 mRNA
CTD
PMID:28973697
NCBI chr10:54,562,437...54,588,842
Ensembl chr10:54,562,437...54,588,810
G
Chd7
chromodomain helicase DNA binding protein 7
decreases expression
ISO
troglitazone results in decreased expression of CHD7 mRNA
CTD
PMID:28973697
NCBI chr 5:26,609,245...26,792,736
Ensembl chr 5:26,609,407...26,792,734
G
Chd8
chromodomain helicase DNA binding protein 8
decreases expression
ISO
troglitazone results in decreased expression of CHD8 mRNA
CTD
PMID:28973697
NCBI chr15:27,379,285...27,438,959
Ensembl chr15:27,379,285...27,417,851
G
Chd9
chromodomain helicase DNA binding protein 9
decreases expression
ISO
troglitazone results in decreased expression of CHD9 mRNA
CTD
PMID:28973697
NCBI chr19:32,114,379...32,337,488
Ensembl chr19:32,115,920...32,319,042
G
Chdh
choline dehydrogenase
decreases expression
ISO
troglitazone results in decreased expression of CHDH protein
CTD
PMID:18495193
NCBI chr16:5,199,738...5,232,067
Ensembl chr16:5,200,763...5,232,997
G
Chek1
checkpoint kinase 1
decreases expression
ISO
troglitazone results in decreased expression of CHEK1 mRNA
CTD
PMID:19140230
NCBI chr 8:44,609,417...44,629,867
Ensembl chr 8:44,609,417...44,629,359
G
Chgb
chromogranin B
increases expression
EXP
troglitazone results in increased expression of CHGB mRNA
CTD
PMID:21515302
NCBI chr 3:140,496,712...140,510,057
Ensembl chr 3:140,495,951...140,510,054
G
Chkb
choline kinase beta
increases expression
EXP
troglitazone results in increased expression of CHKB mRNA
CTD
PMID:21515302
NCBI chr 7:122,380,592...122,385,102
Ensembl chr 7:122,380,594...122,383,949
G
Chl1
cell adhesion molecule L1-like
decreases expression
EXP
troglitazone results in decreased expression of CHL1 mRNA
CTD
PMID:21515302
NCBI chr 4:137,847,648...138,062,077
Ensembl chr 4:137,847,895...138,062,077
G
Chp1
calcineurin-like EF-hand protein 1
increases expression
ISO
troglitazone results in increased expression of CHP1 mRNA
CTD
PMID:28973697
NCBI chr 3:126,989,800...127,025,071
Ensembl chr 3:126,989,579...127,042,443
G
Chpt1
choline phosphotransferase 1
increases expression
ISO
troglitazone results in increased expression of CHPT1 mRNA
CTD
PMID:28973697
NCBI chr 7:24,753,880...24,802,529
Ensembl chr 7:24,750,343...24,802,521
G
Chrna2
cholinergic receptor nicotinic alpha 2 subunit
increases expression
EXP ISO
troglitazone results in increased expression of CHRNA2 mRNA
CTD
PMID:21515302 PMID:28973697
NCBI chr15:44,517,862...44,534,144
Ensembl chr15:44,517,862...44,534,144
G
Chrna6
cholinergic receptor nicotinic alpha 6 subunit
decreases expression
EXP
troglitazone results in decreased expression of CHRNA6 mRNA
CTD
PMID:21515302
NCBI chr16:71,400,615...71,407,315
Ensembl chr16:71,400,615...71,407,315
G
Chrng
cholinergic receptor nicotinic gamma subunit
decreases expression
EXP
troglitazone results in decreased expression of CHRNG mRNA
CTD
PMID:21515302
NCBI chr 9:95,325,984...95,332,092
Ensembl chr 9:95,325,984...95,332,092
G
Chst11
carbohydrate sulfotransferase 11
increases expression
ISO
troglitazone results in increased expression of CHST11 mRNA
CTD
PMID:28973697
NCBI chr 7:22,412,121...22,630,577
Ensembl chr 7:22,415,686...22,630,441
G
Chst15
carbohydrate sulfotransferase 15
increases expression
ISO
troglitazone results in increased expression of CHST15 mRNA
CTD
PMID:28973697
NCBI chr 1:196,458,978...196,540,088
Ensembl chr 1:196,460,425...196,491,444
G
Chtf18
chromosome transmission fidelity factor 18
decreases expression
ISO
troglitazone results in decreased expression of CHTF18 mRNA
CTD
PMID:19140230
NCBI chr10:15,247,525...15,255,573
Ensembl chr10:15,246,362...15,255,685
G
Ciart
circadian associated repressor of transcription
decreases expression
ISO
troglitazone results in decreased expression of CIART mRNA
CTD
PMID:28973697
NCBI chr 2:186,108,744...186,113,778
Ensembl chr 2:186,108,752...186,112,246
G
Cideb
cell death-inducing DFFA-like effector b
decreases expression
ISO
troglitazone results in decreased expression of CIDEB mRNA
CTD
PMID:25572481
NCBI chr15:33,222,135...33,226,407
Ensembl chr15:33,221,824...33,226,688
G
Cidec
cell death-inducing DFFA-like effector c
increases expression
ISO
troglitazone results in increased expression of CIDEC mRNA
CTD
PMID:12732648 PMID:25572481 PMID:25669987
NCBI chr 4:148,124,924...148,137,806
Ensembl chr 4:148,124,925...148,137,806
G
Cipc
CLOCK-interacting pacemaker
decreases expression
ISO
troglitazone results in decreased expression of CIPC mRNA
CTD
PMID:28973697
NCBI chr 6:112,325,980...112,344,692
Ensembl chr 6:112,325,671...112,344,692
G
Cirbp
cold inducible RNA binding protein
decreases expression
ISO
troglitazone results in decreased expression of CIRBP mRNA
CTD
PMID:28973697
NCBI chr 7:10,184,515...10,189,623
G
Cit
citron rho-interacting serine/threonine kinase
decreases expression
ISO
troglitazone results in decreased expression of CIT mRNA
CTD
PMID:19140230
NCBI chr12:46,263,881...46,425,642
Ensembl chr12:46,266,369...46,424,656
G
Cited1
Cbp/p300-interacting transactivator with Glu/Asp-rich carboxy-terminal domain 1
decreases expression
EXP
troglitazone results in decreased expression of CITED1 mRNA
CTD
PMID:21515302
NCBI chr X:71,390,328...71,395,023
Ensembl chr X:71,390,331...71,393,649
G
Cited2
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2
decreases expression
EXP
troglitazone results in decreased expression of CITED2 mRNA
CTD
PMID:21515302
NCBI chr 1:14,132,303...14,134,746
Ensembl chr 1:14,103,457...14,134,782
G
Cited4
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 4
decreases expression
ISO
troglitazone results in decreased expression of CITED4 mRNA
CTD
PMID:19140230
NCBI chr 5:139,532,165...139,533,056
Ensembl chr 5:139,531,584...139,533,361
G
Ciz1
CDKN1A interacting zinc finger protein 1
decreases expression
ISO
troglitazone results in decreased expression of CIZ1 mRNA
CTD
PMID:28973697
NCBI chr 3:36,055,753...36,071,510
Ensembl chr 3:36,056,370...36,075,192
G
Cklf
chemokine-like factor
increases expression
ISO
troglitazone results in increased expression of CKLF mRNA
CTD
PMID:28973697
NCBI chr19:704,528...712,998
Ensembl chr19:697,451...712,998
G
Cks1b
CDC28 protein kinase regulatory subunit 1B
decreases expression
ISO
troglitazone results in decreased expression of CKS1B mRNA
CTD
PMID:19140230
NCBI chr 2:177,130,751...177,135,333
Ensembl chr 2:177,130,777...177,135,365
G
Cks2
CDC28 protein kinase regulatory subunit 2
decreases expression increases expression
ISO
troglitazone results in decreased expression of CKS2 mRNA troglitazone results in increased expression of CKS2 mRNA
CTD
PMID:19140230 PMID:28973697
NCBI chr17:13,722,360...13,727,519
Ensembl chr17:13,722,361...13,727,519
G
Clasp1
cytoplasmic linker associated protein 1
decreases expression
ISO
troglitazone results in decreased expression of CLASP1 mRNA
CTD
PMID:28973697
NCBI chr13:32,046,362...32,267,954
Ensembl chr13:32,046,444...32,267,924
G
Clasp2
cytoplasmic linker associated protein 2
decreases expression
ISO
troglitazone results in decreased expression of CLASP2 mRNA
CTD
PMID:28973697
NCBI chr 8:122,555,532...122,736,934
Ensembl chr 8:122,555,524...122,737,587
G
Clcc1
chloride channel CLIC-like 1
decreases expression
ISO
troglitazone results in decreased expression of CLCC1 mRNA
CTD
PMID:28973697
NCBI chr 2:198,984,455...199,015,015
Ensembl chr 2:198,984,495...199,015,014
G
Cldn1
claudin 1
increases expression decreases expression
ISO EXP
troglitazone results in increased expression of CLDN1 mRNA troglitazone results in decreased expression of CLDN1 mRNA
CTD
PMID:19140230 PMID:21515302 PMID:28973697
NCBI chr11:87,926,376...87,941,533
Ensembl chr11:87,926,337...87,941,529
G
Cldn12
claudin 12
increases expression
ISO
troglitazone results in increased expression of CLDN12 mRNA
CTD
PMID:19140230
NCBI chr 4:29,477,468...29,488,465
Ensembl chr 4:29,477,342...29,493,776
G
Cldn4
claudin 4
increases expression
ISO
troglitazone results in increased expression of CLDN4 mRNA; troglitazone results in increased expression of CLDN4 protein
CTD
PMID:19285010
NCBI chr12:27,388,160...27,389,958
Ensembl chr12:27,387,981...27,389,958
G
Cldn5
claudin 5
increases expression
ISO
troglitazone results in increased expression of CLDN5 mRNA
CTD
PMID:28973697
NCBI chr11:95,717,172...95,718,598
Ensembl chr11:95,717,176...95,719,322
G
Clec10a
C-type lectin domain containing 10A
increases expression
ISO
troglitazone results in increased expression of CLEC10A mRNA
CTD
PMID:28973697
NCBI chr10:55,374,914...55,379,110
Ensembl chr10:55,374,887...55,379,108
G
Clec14a
C-type lectin domain containing 14A
increases expression
EXP
troglitazone results in increased expression of CLEC14A mRNA
CTD
PMID:21515302
NCBI chr 6:81,616,414...81,619,556
Ensembl chr 6:81,612,953...81,619,614
G
Clec2d
C-type lectin domain family 2, member D
decreases expression
ISO
troglitazone results in decreased expression of CLEC2D mRNA
CTD
PMID:19140230
NCBI chr 4:163,902,124...163,925,587
Ensembl chr 4:163,902,547...163,925,587
G
Clec3b
C-type lectin domain family 3, member B
increases expression
ISO
troglitazone results in increased expression of CLEC3B mRNA
CTD
PMID:28973697
NCBI chr 8:131,687,575...131,693,292
G
Clec4m
C-type lectin domain family 4 member M
increases expression
ISO
troglitazone results in increased expression of CD209B mRNA; troglitazone results in increased expression of CLEC4M mRNA
CTD
PMID:28973697
NCBI chr12:6,713,795...6,722,414
Ensembl chr12:6,713,812...6,722,410
G
Clmn
calmin
decreases expression
ISO
troglitazone results in decreased expression of CLMN mRNA
CTD
PMID:28973697
NCBI chr 6:129,470,613...129,572,079
Ensembl chr 6:129,478,149...129,572,027
G
Clpp
caseinolytic mitochondrial matrix peptidase proteolytic subunit
increases expression
ISO
troglitazone results in increased expression of CLPP protein
CTD
PMID:18495193
NCBI chr 9:1,917,305...1,924,706
Ensembl chr 9:1,918,682...1,924,705
G
Clpx
caseinolytic mitochondrial matrix peptidase chaperone subunit X
increases expression
EXP
troglitazone results in increased expression of CLPX mRNA
CTD
PMID:21515302
NCBI chr 8:74,700,602...74,740,244
Ensembl chr 8:74,700,662...74,744,762
G
Clstn2
calsyntenin 2
decreases expression
EXP
troglitazone results in decreased expression of CLSTN2 mRNA
CTD
PMID:21515302
NCBI chr 8:106,899,894...107,516,402
Ensembl chr 8:106,899,894...107,040,053
G
Clstn3
calsyntenin 3
increases expression
ISO
troglitazone results in increased expression of CLSTN3 mRNA
CTD
PMID:28973697
NCBI chr 4:159,017,795...159,051,069
Ensembl chr 4:159,017,795...159,051,069
G
Clu
clusterin
increases expression
EXP
troglitazone results in increased expression of CLU mRNA
CTD
PMID:11854617
NCBI chr15:44,336,619...44,375,861
Ensembl chr15:44,359,914...44,375,860
G
Clxn
calaxin
decreases expression
EXP
Troglitazone results in decreased expression of CLXN mRNA
CTD
PMID:21515302
NCBI chr11:99,410,925...99,500,713
Ensembl chr11:99,487,448...99,500,760
G
Cma1
chymase 1
increases expression
ISO
troglitazone results in increased expression of CMA1 mRNA
CTD
PMID:28973697
NCBI chr15:33,387,351...33,390,133
Ensembl chr15:33,387,351...33,390,133
G
Cmbl
carboxymethylenebutenolidase homolog
increases expression
EXP ISO
troglitazone results in increased expression of CMBL mRNA
CTD
PMID:21515302 PMID:25596134 PMID:28973697
NCBI chr 2:84,280,128...84,301,878
Ensembl chr 2:84,242,512...84,301,880
G
Cmip
c-Maf-inducing protein
decreases expression
ISO
troglitazone results in decreased expression of CMIP mRNA
CTD
PMID:28973697
NCBI chr19:62,213,402...62,419,443
Ensembl chr19:62,213,365...62,417,500
G
Cmklr2
chemerin chemokine-like receptor 2
decreases expression
EXP
Troglitazone results in decreased expression of CMKLR2 mRNA
CTD
PMID:21515302
NCBI chr 9:72,077,164...72,111,979
Ensembl chr 9:72,078,608...72,116,257
G
Cnn1
calponin 1
decreases expression
EXP
troglitazone results in decreased expression of CNN1 mRNA
CTD
PMID:21515302
NCBI chr 8:28,908,437...28,917,099
Ensembl chr 8:28,908,330...28,919,482
G
Cnnm3
cyclin and CBS domain divalent metal cation transport mediator 3
decreases expression
ISO
troglitazone results in decreased expression of CNNM3 mRNA
CTD
PMID:28973697
NCBI chr 9:46,251,252...46,266,613
Ensembl chr 9:46,251,265...46,266,613
G
Cnot1
CCR4-NOT transcription complex, subunit 1
decreases expression
ISO
troglitazone results in decreased expression of CNOT1 mRNA
CTD
PMID:28973697
NCBI chr19:9,261,290...9,352,636
Ensembl chr19:9,261,294...9,352,636
G
Cnot2
CCR4-NOT transcription complex, subunit 2
decreases expression
ISO
troglitazone results in decreased expression of CNOT2 mRNA
CTD
PMID:28973697
NCBI chr 7:54,016,447...54,117,511
Ensembl chr 7:54,016,447...54,107,960
G
Cnot3
CCR4-NOT transcription complex, subunit 3
decreases expression
ISO
troglitazone results in decreased expression of CNOT3 mRNA
CTD
PMID:28973697
NCBI chr 1:74,471,284...74,487,527
Ensembl chr 1:74,470,566...74,487,527
G
Cnot4
CCR4-NOT transcription complex, subunit 4
decreases expression
ISO
troglitazone results in decreased expression of CNOT4 mRNA
CTD
PMID:28973697
NCBI chr 4:64,679,903...64,781,432
Ensembl chr 4:64,679,904...64,738,083
G
Cnot6l
CCR4-NOT transcription complex, subunit 6-like
decreases expression
ISO
troglitazone results in decreased expression of CNOT6L mRNA
CTD
PMID:28973697
NCBI chr14:13,714,475...13,806,481
Ensembl chr14:13,714,475...13,806,481
G
Cnppd1
cyclin Pas1/PHO80 domain containing 1
decreases expression
ISO
troglitazone results in decreased expression of CNPPD1 mRNA
CTD
PMID:28973697
NCBI chr 9:84,082,148...84,088,888
Ensembl chr 9:84,082,149...84,089,788
G
Coa7
cytochrome c oxidase assembly factor 7
decreases expression
ISO
troglitazone results in decreased expression of COA7 mRNA
CTD
PMID:28973697
NCBI chr 5:128,298,084...128,308,935
Ensembl chr 5:128,298,093...128,309,664
G
Coa8
cytochrome c oxidase assembly factor 8
decreases expression
ISO
Troglitazone results in decreased expression of COA8 mRNA
CTD
PMID:28973697
NCBI chr 6:136,593,399...136,618,237
Ensembl chr 6:136,592,787...136,619,602
G
Cog8
component of oligomeric golgi complex 8
multiple interactions
ISO
troglitazone inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of COG8 mRNA]
CTD
PMID:20847119
NCBI chr19:51,861,376...51,872,126
Ensembl chr19:51,861,376...51,872,129
G
Col10a1
collagen type X alpha 1 chain
multiple interactions
EXP
troglitazone inhibits the reaction [Triiodothyronine results in increased expression of COL10A1 mRNA]
CTD
PMID:16023420
NCBI chr20:39,737,536...39,744,518
Ensembl chr20:39,716,822...39,751,440
G
Col14a1
collagen type XIV alpha 1 chain
decreases expression
ISO
troglitazone results in decreased expression of COL14A1 mRNA
CTD
PMID:28973697
NCBI chr 7:88,611,827...88,826,939
Ensembl chr 7:88,611,828...88,826,938
G
Col18a1
collagen type XVIII alpha 1 chain
increases expression decreases expression
ISO
troglitazone results in increased expression of COL18A1 mRNA troglitazone results in decreased expression of COL18A1 mRNA
CTD
PMID:17569031 PMID:28973697
NCBI chr20:11,473,645...11,582,111
Ensembl chr20:11,473,645...11,582,112
G
Col1a1
collagen type I alpha 1 chain
decreases expression multiple interactions affects expression increases expression
ISO EXP
troglitazone results in decreased expression of COL1A1 mRNA troglitazone inhibits the reaction [TGFB2 protein results in increased expression of COL1A1 mRNA] troglitazone affects the expression of COL1A1 mRNA troglitazone results in increased expression of COL1A1 mRNA
CTD
PMID:15211114 PMID:16813520 PMID:18253093 PMID:28973697
NCBI chr10:80,380,458...80,397,461
Ensembl chr10:80,380,453...80,397,460
G
Col1a2
collagen type I alpha 2 chain
decreases expression multiple interactions increases expression
ISO EXP
troglitazone results in decreased expression of COL1A2 mRNA troglitazone inhibits the reaction [Glucose results in increased expression of COL1A2 mRNA] troglitazone results in increased expression of COL1A2 mRNA
CTD
PMID:17199790 PMID:19122273 PMID:21515302 PMID:28973697
NCBI chr 4:33,518,557...33,553,484
Ensembl chr 4:33,518,420...33,553,995
G
Col27a1
collagen type XXVII alpha 1 chain
decreases expression
ISO
troglitazone results in decreased expression of COL27A1 mRNA
CTD
PMID:28973697
NCBI chr 5:81,662,822...81,781,502
Ensembl chr 5:81,661,685...81,781,502
G
Col4a2
collagen type IV alpha 2 chain
decreases expression
ISO
troglitazone results in decreased expression of COL4A2 mRNA
CTD
PMID:28973697
NCBI chr16:84,749,672...84,885,520
Ensembl chr16:84,749,672...84,885,520
G
Col5a1
collagen type V alpha 1 chain
increases expression
ISO
troglitazone results in increased expression of COL5A1 mRNA
CTD
PMID:28973697
NCBI chr 3:31,606,475...31,755,097
Ensembl chr 3:31,606,486...31,753,020
G
Col5a2
collagen type V alpha 2 chain
increases expression
ISO
troglitazone results in increased expression of COL5A2 mRNA
CTD
PMID:28973697
NCBI chr 9:54,940,768...55,090,151
Ensembl chr 9:54,940,764...55,090,150
G
Col7a1
collagen type VII alpha 1 chain
increases expression
ISO
troglitazone results in increased expression of COL7A1 mRNA
CTD
PMID:19140230
NCBI chr 8:118,483,364...118,515,736
Ensembl chr 8:118,483,364...118,517,439
G
Col8a1
collagen type VIII alpha 1 chain
decreases expression
ISO
troglitazone results in decreased expression of COL8A1 mRNA
CTD
PMID:25572481
NCBI chr11:56,245,998...56,378,586
Ensembl chr11:56,369,868...56,376,229
G
Colq
collagen like tail subunit of asymmetric acetylcholinesterase
increases expression
EXP
troglitazone results in increased expression of COLQ mRNA
CTD
PMID:21515302
NCBI chr16:6,738,251...6,830,492
Ensembl chr16:6,738,251...6,793,501
G
Coro1c
coronin 1C
decreases expression
ISO
troglitazone results in decreased expression of CORO1C mRNA
CTD
PMID:28973697
NCBI chr12:48,373,573...48,445,718
Ensembl chr12:48,373,597...48,445,716
G
Cox6b2
cytochrome c oxidase subunit 6B2
increases expression
ISO
troglitazone results in increased expression of COX6B2 mRNA
CTD
PMID:28973697
NCBI chr 1:78,122,871...78,124,096
Ensembl chr 1:78,122,453...78,124,094
G
Cox6c-ps1
cytochrome c oxidase subunit VIc, pseudogene
decreases expression
EXP
troglitazone results in decreased expression of COX6C-PS1 mRNA
CTD
PMID:21515302
NCBI chr19:69,090,047...69,090,905
Ensembl chr19:69,090,047...69,090,905
G
Cpa3
carboxypeptidase A3
increases expression
ISO
troglitazone results in increased expression of CPA3 mRNA
CTD
PMID:28973697
NCBI chr 2:104,641,619...104,673,253
Ensembl chr 2:104,641,621...104,673,237
G
Cpd
carboxypeptidase D
decreases expression
ISO
troglitazone results in decreased expression of CPD mRNA
CTD
PMID:28973697
NCBI chr10:62,121,681...62,185,638
Ensembl chr10:62,121,679...62,185,638
G
Cpeb1
cytoplasmic polyadenylation element binding protein 1
decreases expression
ISO
troglitazone results in decreased expression of CPEB1 mRNA
CTD
PMID:28973697
NCBI chr 1:144,709,278...144,817,388
Ensembl chr 1:144,709,691...144,815,880
G
Cpeb2
cytoplasmic polyadenylation element binding protein 2
decreases expression
ISO
troglitazone results in decreased expression of CPEB2 mRNA
CTD
PMID:28973697
NCBI chr14:71,999,958...72,056,012
Ensembl chr14:72,002,072...72,052,263
G
Cpeb3
cytoplasmic polyadenylation element binding protein 3
decreases expression
ISO
troglitazone results in decreased expression of CPEB3 mRNA
CTD
PMID:28973697
NCBI chr 1:244,161,690...244,343,765
Ensembl chr 1:244,161,690...244,343,561
G
Cpn1
carboxypeptidase N subunit 1
decreases expression
ISO
troglitazone results in decreased expression of CPN1 mRNA
CTD
PMID:25572481
NCBI chr 1:252,793,786...252,822,675
Ensembl chr 1:252,793,423...252,822,664
G
Cps1
carbamoyl-phosphate synthase 1
decreases expression increases expression
ISO EXP
troglitazone results in decreased expression of CPS1 protein troglitazone results in increased expression of CPS1 protein
CTD
PMID:18495193 PMID:21315101
NCBI chr 9:76,063,863...76,186,739
Ensembl chr 9:76,000,754...76,186,734
G
Cpsf1
cleavage and polyadenylation specific factor 1
decreases expression
ISO
troglitazone results in decreased expression of CPSF1 mRNA
CTD
PMID:28973697
NCBI chr 7:110,200,078...110,210,644
Ensembl chr 7:110,199,066...110,210,644
G
Cpsf4l
cleavage and polyadenylation specific factor 4-like
decreases expression
ISO
troglitazone results in decreased expression of CPSF4L mRNA
CTD
PMID:28973697
NCBI chr10:99,241,187...99,255,207
Ensembl chr10:99,242,794...99,257,172
G
Cpt1a
carnitine palmitoyltransferase 1A
increases expression decreases expression
EXP ISO
troglitazone results in increased expression of CPT1A mRNA troglitazone results in decreased expression of CPT1A mRNA
CTD
PMID:19022234 PMID:21515302 PMID:25572481 PMID:28973697
NCBI chr 1:209,993,881...210,056,329
Ensembl chr 1:209,993,875...210,056,326
G
Cpt1b
carnitine palmitoyltransferase 1B
increases expression
ISO EXP
troglitazone results in increased expression of CPT1B mRNA
CTD
PMID:12759900 PMID:12920214 PMID:21515302
NCBI chr 7:122,370,974...122,380,473
Ensembl chr 7:122,370,444...122,380,036
G
Cpt2
carnitine palmitoyltransferase 2
increases expression
ISO EXP
troglitazone results in increased expression of CPT2 mRNA troglitazone results in increased expression of CPT2 mRNA; troglitazone results in increased expression of CPT2 protein
CTD
PMID:12732648 PMID:21315101 PMID:21515302 PMID:27551952
NCBI chr 5:127,893,450...127,911,347
Ensembl chr 5:127,893,207...127,910,818
G
Cramp1
cramped chromatin regulator homolog 1
decreases expression
ISO
troglitazone results in decreased expression of CRAMP1 mRNA
CTD
PMID:28973697
NCBI chr10:14,488,292...14,536,844
Ensembl chr10:14,467,661...14,535,664
G
Crat
carnitine O-acetyltransferase
increases expression
EXP
troglitazone results in increased expression of CRAT mRNA
CTD
PMID:21515302
NCBI chr 3:34,073,504...34,087,099
Ensembl chr 3:34,073,506...34,087,099
G
Creb1
cAMP responsive element binding protein 1
decreases phosphorylation decreases expression
ISO
troglitazone results in decreased phosphorylation of CREB1 protein troglitazone results in decreased expression of CREB1 mRNA
CTD
PMID:15908479 PMID:28973697
NCBI chr 9:73,397,333...73,466,339
Ensembl chr 9:73,397,306...73,466,339
G
Creb3l3
cAMP responsive element binding protein 3-like 3
increases expression
EXP
troglitazone results in increased expression of CREB3L3 mRNA
CTD
PMID:21515302
NCBI chr 7:9,273,320...9,281,755
Ensembl chr 7:9,273,338...9,281,778
G
Crebbp
CREB binding protein
multiple interactions increases response to substance decreases expression
ISO EXP
RXRA protein inhibits the reaction [CREBBP protein results in increased susceptibility to troglitazone] troglitazone results in decreased expression of CREBBP mRNA
CTD
PMID:15581905 PMID:28973697
NCBI chr10:11,842,307...11,968,266
Ensembl chr10:11,822,620...11,968,266
G
Crebrf
CREB3 regulatory factor
decreases expression
ISO
troglitazone results in decreased expression of CREBRF mRNA
CTD
PMID:28973697
NCBI chr10:16,903,607...16,967,450
Ensembl chr10:16,903,547...16,966,430
G
Crebzf
CREB/ATF bZIP transcription factor
decreases expression
ISO
troglitazone results in decreased expression of CREBZF mRNA
CTD
PMID:28973697
NCBI chr 1:153,829,544...153,836,073
Ensembl chr 1:153,829,448...153,845,122
G
Creld2
cysteine-rich with EGF-like domains 2
increases expression
ISO
troglitazone results in increased expression of CRELD2 mRNA
CTD
PMID:28973697
NCBI chr 7:121,788,754...121,796,230
Ensembl chr 7:121,788,745...121,796,228
G
Crot
carnitine O-octanoyltransferase
increases expression
EXP
troglitazone results in increased expression of CROT mRNA
CTD
PMID:21515302
NCBI chr 4:26,031,729...26,088,057
Ensembl chr 4:26,052,516...26,088,064
G
Crtc2
CREB regulated transcription coactivator 2
decreases expression
ISO
troglitazone results in decreased expression of CRTC2 mRNA
CTD
PMID:28973697
NCBI chr 2:178,007,233...178,017,397
Ensembl chr 2:178,007,240...178,017,389
G
Crtc3
CREB regulated transcription coactivator 3
decreases expression
ISO
troglitazone results in decreased expression of CRTC3 mRNA
CTD
PMID:28973697
NCBI chr 1:143,962,038...144,064,324
Ensembl chr 1:143,962,038...144,064,288
G
Cry1
cryptochrome circadian regulator 1
increases expression
ISO
troglitazone results in increased expression of CRY1 mRNA
CTD
PMID:28973697
NCBI chr 7:20,417,526...20,481,791
Ensembl chr 7:20,417,107...20,481,822
G
Cryab
crystallin, alpha B
multiple interactions increases expression
ISO
[troglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of CRYAB mRNA; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of CRYAB mRNA] troglitazone results in increased expression of CRYAB mRNA
CTD
PMID:19631733 PMID:20847119
NCBI chr 8:59,989,885...59,995,532
Ensembl chr 8:59,989,814...59,995,528
G
Crybg1
crystallin beta-gamma domain containing 1
decreases expression
ISO
troglitazone results in decreased expression of CRYBG1 mRNA
CTD
PMID:28973697
NCBI chr20:49,007,673...49,204,040
Ensembl chr20:49,007,929...49,204,047
G
Csf1
colony stimulating factor 1
decreases expression
EXP
troglitazone results in decreased expression of CSF1 mRNA
CTD
PMID:21515302
NCBI chr 2:198,065,400...198,084,774
Ensembl chr 2:198,065,405...198,084,468
G
Csf1r
colony stimulating factor 1 receptor
increases expression
ISO
troglitazone results in increased expression of CSF1R mRNA
CTD
PMID:28973697
NCBI chr18:56,834,152...56,860,804
Ensembl chr18:56,817,049...56,860,806
G
Csf2
colony stimulating factor 2
increases expression
ISO
troglitazone results in increased expression of CSF2 mRNA
CTD
PMID:19631733
NCBI chr10:38,887,692...38,889,673
Ensembl chr10:38,887,692...38,890,031
G
Csf2rb
colony stimulating factor 2 receptor subunit beta
decreases expression
EXP
troglitazone results in decreased expression of CSF2RB mRNA
CTD
PMID:21515302
NCBI chr 7:111,756,950...111,782,089
Ensembl chr 7:111,757,405...111,784,654
G
Csf3
colony stimulating factor 3
decreases expression
ISO
troglitazone results in decreased expression of CSF3 mRNA
CTD
PMID:28934090
NCBI chr10:84,157,485...84,159,860
Ensembl chr10:84,157,211...84,159,860
G
Csnk1e
casein kinase 1, epsilon
decreases expression
ISO
troglitazone results in decreased expression of CSNK1E mRNA
CTD
PMID:28973697
NCBI chr 7:112,863,726...112,887,338
Ensembl chr 7:112,863,731...112,884,101
G
Csnk1g3
casein kinase 1, gamma 3
decreases expression
ISO
troglitazone results in decreased expression of CSNK1G3 mRNA
CTD
PMID:28973697
NCBI chr18:49,497,839...49,584,828
Ensembl chr18:49,497,839...49,584,828
G
Csnk2a2
casein kinase 2 alpha 2
decreases expression
ISO
troglitazone results in decreased expression of CSNK2A2 mRNA
CTD
PMID:28973697
NCBI chr19:9,562,340...9,602,136
Ensembl chr19:9,562,321...9,602,136
G
Csrnp1
cysteine and serine rich nuclear protein 1
decreases expression
ISO
troglitazone results in decreased expression of CSRNP1 mRNA
CTD
PMID:28973697
NCBI chr 8:128,582,364...128,594,163
Ensembl chr 8:128,582,365...128,588,469
G
Csrp3
cysteine and glycine rich protein 3
increases expression
EXP
troglitazone results in increased expression of CSRP3 mRNA
CTD
PMID:21515302
NCBI chr 1:107,664,338...107,682,916
Ensembl chr 1:107,664,338...107,682,916
G
Cstf2t
cleavage stimulation factor subunit 2, tau variant
decreases expression
ISO
troglitazone results in decreased expression of CSTF2T mRNA
CTD
PMID:28973697
NCBI chr 1:238,366,042...238,369,608
Ensembl chr 1:238,365,912...238,369,749
G
Cstf3
cleavage stimulation factor subunit 3
decreases expression
ISO
troglitazone results in decreased expression of CSTF3 mRNA
CTD
PMID:19140230
NCBI chr 3:111,421,291...111,492,539
Ensembl chr 3:111,421,234...111,497,046
G
Ctbp2
C-terminal binding protein 2
increases expression
EXP
troglitazone results in increased expression of CTBP2 mRNA
CTD
PMID:21515302
NCBI chr 1:197,208,536...197,348,802
Ensembl chr 1:197,212,133...197,254,261
G
Ctdp1
CTD phosphatase subunit 1
decreases expression
ISO
troglitazone results in decreased expression of CTDP1 mRNA
CTD
PMID:28973697
NCBI chr18:76,129,243...76,193,404
Ensembl chr18:76,129,243...76,190,578
G
Ctdsp1
CTD small phosphatase 1
decreases expression
ISO
troglitazone results in decreased expression of CTDSP1 mRNA
CTD
PMID:28973697
NCBI chr 9:83,422,755...83,428,411
Ensembl chr 9:83,423,051...83,428,412
G
Ctdsp2
CTD small phosphatase 2
decreases expression
ISO
troglitazone results in decreased expression of CTDSP2 mRNA
CTD
PMID:28973697
NCBI chr 7:64,690,737...64,710,639
Ensembl chr 7:64,690,490...64,710,639
G
Ctnnb1
catenin beta 1
multiple interactions decreases expression
ISO
[troglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of CTNNB1 mRNA; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of CTNNB1 mRNA] troglitazone results in decreased expression of CTNNB1
CTD
PMID:15892897 PMID:20847119
NCBI chr 8:129,517,576...129,544,661
Ensembl chr 8:129,517,545...129,544,662
G
Ctnnd1
catenin delta 1
decreases expression
ISO
troglitazone results in decreased expression of CTNND1 mRNA
CTD
PMID:28973697
NCBI chr 3:90,090,025...90,141,247
Ensembl chr 3:90,090,564...90,141,189
G
Ctrl
chymotrypsin-like
increases expression
EXP
troglitazone results in increased expression of CTRL mRNA
CTD
PMID:21515302
NCBI chr19:50,737,078...50,740,659
Ensembl chr19:50,737,079...50,738,979
G
Ctsb
cathepsin B
decreases expression
ISO
troglitazone results in decreased expression of CTSB protein
CTD
PMID:18495193
NCBI chr15:41,565,607...41,586,479
Ensembl chr15:41,565,611...41,586,478
G
Ctsc
cathepsin C
increases expression
ISO
troglitazone results in increased expression of CTSC mRNA
CTD
PMID:28973697
NCBI chr 1:151,440,860...151,472,430
Ensembl chr 1:151,441,032...151,474,082
G
Ctsh
cathepsin H
increases expression
ISO
troglitazone results in increased expression of CTSH mRNA
CTD
PMID:28973697
NCBI chr 8:99,488,756...99,507,639
Ensembl chr 8:99,488,874...99,509,181
G
Ctsk
cathepsin K
increases expression
ISO
troglitazone results in increased expression of CTSK mRNA
CTD
PMID:28973697
NCBI chr 2:185,747,548...185,758,512
Ensembl chr 2:185,747,165...185,765,582
G
Cuedc1
CUE domain containing 1
decreases expression
ISO
troglitazone results in decreased expression of CUEDC1 mRNA
CTD
PMID:28973697
NCBI chr10:73,389,798...73,484,914
Ensembl chr10:73,389,841...73,483,749
G
Cul3
cullin 3
decreases expression
ISO
troglitazone results in decreased expression of CUL3 mRNA
CTD
PMID:28973697
NCBI chr 9:89,040,987...89,118,775
Ensembl chr 9:89,040,987...89,118,427
G
Cux1
cut-like homeobox 1
decreases expression
ISO
troglitazone results in decreased expression of CUX1 mRNA
CTD
PMID:28973697
NCBI chr12:25,728,393...26,062,497
Ensembl chr12:25,743,733...26,062,497
G
Cwc22
CWC22 spliceosome associated protein
decreases expression
ISO
troglitazone results in decreased expression of CWC22 mRNA
CTD
PMID:28973697
NCBI chr 3:83,222,400...83,271,427
Ensembl chr 3:83,209,194...83,271,513
G
Cwc27
CWC27 spliceosome associated cyclophilin
decreases expression
ISO
troglitazone results in decreased expression of CWC27 mRNA
CTD
PMID:28973697
NCBI chr 2:37,498,462...37,709,691
Ensembl chr 2:37,498,468...37,709,355
G
Cwf19l1
CWF19 like cell cycle control factor 1
decreases expression
ISO
troglitazone results in decreased expression of CWF19L1 mRNA
CTD
PMID:28973697
NCBI chr 1:252,946,934...252,970,194
Ensembl chr 1:252,946,934...252,970,168
G
Cxcl1
C-X-C motif chemokine ligand 1
increases expression
ISO
troglitazone results in increased expression of CXCL1 mRNA
CTD
PMID:19140230
NCBI chr14:17,477,542...17,479,321
Ensembl chr14:17,477,549...17,479,811
G
Cxcl10
C-X-C motif chemokine ligand 10
increases expression
ISO
troglitazone results in increased expression of CXCL10 mRNA
CTD
PMID:19631733
NCBI chr14:15,989,066...15,991,263
Ensembl chr14:15,989,018...15,991,261
G
Cxcl12
C-X-C motif chemokine ligand 12
decreases expression
EXP
troglitazone results in decreased expression of CXCL12 mRNA
CTD
PMID:21515302
NCBI chr 4:152,060,781...152,073,628
Ensembl chr 4:152,060,780...152,073,627
G
Cxcl2
C-X-C motif chemokine ligand 2
increases expression decreases expression multiple interactions
ISO EXP
troglitazone results in increased expression of CXCL2 mRNA troglitazone results in decreased expression of CXCL2 mRNA Troglitazone results in increased expression of CXCL2 mRNA [Troglitazone co-treated with Buthionine Sulfoximine] results in increased expression of CXCL2 mRNA
CTD
PMID:12468449 PMID:19140230 PMID:19631733 PMID:21515302 PMID:31294483
NCBI chr14:17,465,210...17,467,255
Ensembl chr14:17,465,242...17,467,255
G
Cxcl3
C-X-C motif chemokine ligand 3
increases expression multiple interactions
ISO
troglitazone results in increased expression of CXCL1 mRNA [Troglitazone co-treated with Buthionine Sulfoximine] results in increased expression of CXCL1 mRNA Troglitazone results in increased expression of CXCL1 mRNA
CTD
PMID:19140230 PMID:31294483
NCBI chr14:17,571,900...17,573,624
Ensembl chr14:17,571,900...17,573,624
G
Cxcr4
C-X-C motif chemokine receptor 4
multiple interactions
ISO
[Troglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of CXCR4 mRNA; Troglitazone inhibits the reaction [tert-Butylhydroperoxide promotes the reaction [PPARG protein binds to CXCR4 promoter]]; Troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of CXCR4 mRNA]
CTD
PMID:20847119
NCBI chr13:42,630,383...42,634,288
Ensembl chr13:42,630,104...42,634,459
G
Cyb561a3
cytochrome b561 family, member A3
decreases expression
ISO
troglitazone results in decreased expression of CYBASC3 mRNA
CTD
PMID:25572481
NCBI chr 1:216,641,108...216,662,495
Ensembl chr 1:216,651,128...216,662,492
G
Cyba
cytochrome b-245 alpha chain
multiple interactions decreases expression
ISO
troglitazone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of CYBA mRNA] troglitazone results in decreased expression of CYBA mRNA
CTD
PMID:11172467
NCBI chr19:67,396,143...67,404,214
Ensembl chr19:67,396,143...67,404,214
G
Cycs
cytochrome c, somatic
increases expression decreases expression multiple interactions affects localization
ISO
troglitazone results in increased expression of CYCS troglitazone results in decreased expression of CYCS mRNA [2-chloro-5-nitrobenzanilide binds to and results in decreased activity of PPARG protein] inhibits the reaction [troglitazone affects the localization of CYCS protein]
CTD
PMID:12680223 PMID:20860658 PMID:22108328
NCBI chr 4:80,982,667...80,984,767
Ensembl chr 4:80,982,668...80,984,816 Ensembl chr18:80,982,668...80,984,816
G
Cyp17a1
cytochrome P450, family 17, subfamily a, polypeptide 1
decreases activity increases expression
ISO EXP
troglitazone results in decreased activity of CYP17A1 protein troglitazone results in increased expression of CYP17A1 mRNA
CTD
PMID:15072549 PMID:21515302
NCBI chr 1:255,476,861...255,484,547
Ensembl chr 1:255,476,861...255,482,974
G
Cyp19a1
cytochrome P450, family 19, subfamily a, polypeptide 1
multiple interactions decreases activity decreases expression
ISO EXP
LG 100268 promotes the reaction [troglitazone results in decreased activity of CYP19A1 mRNA]; LG 100268 promotes the reaction [troglitazone results in decreased activity of CYP19A1 protein]; troglitazone promotes the reaction [LG 100268 results in decreased activity of CYP19A1 mRNA]; troglitazone promotes the reaction [LG 100268 results in decreased activity of CYP19A1 protein] troglitazone results in decreased expression of CYP19A1 mRNA
CTD
PMID:10814527 PMID:12706301
NCBI chr 8:63,449,148...63,476,534
Ensembl chr 8:63,449,148...63,476,917
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
increases expression multiple interactions increases activity decreases expression decreases activity
ISO EXP
troglitazone results in increased expression of CYP1A1 mRNA 2-chloro-5-nitrobenzanilide inhibits the reaction [troglitazone results in increased activity of CYP1A1 protein]; [troglitazone binds to and results in increased activity of PPARG protein] promotes the reaction [[PPARG protein binds to CYP1A1 promoter] which results in increased expression of CYP1A1 mRNA]; [troglitazone binds to and results in increased activity of PPARG protein] promotes the reaction [PPARG protein binds to CYP1A1 promoter]; ellipticine inhibits the reaction [troglitazone results in increased activity of CYP1A1 protein]; PPARG protein affects the reaction [troglitazone results in increased activity of CYP1A1 protein]; PPARG protein affects the reaction [troglitazone results in increased expression of CYP1A1 mRNA] troglitazone results in decreased expression of CYP1A1 mRNA Troglitazone results in decreased activity of CYP1A1 protein
CTD
PMID:18308446 PMID:19631733 PMID:21515302 PMID:33814510
NCBI chr 8:66,991,940...66,998,014
Ensembl chr 8:66,991,970...66,998,012
G
Cyp1a2
cytochrome P450, family 1, subfamily a, polypeptide 2
multiple interactions
ISO
[CYP1A2 protein co-treated with CYP2C9 protein co-treated with CYP3A4 protein co-treated with CYP2D6 protein co-treated with CYP2C19 protein] affects the susceptibility to troglitazone
CTD
PMID:23397584
NCBI chr 8:66,971,261...66,978,149
Ensembl chr 8:66,971,261...66,978,149
G
Cyp1b1
cytochrome P450, family 1, subfamily b, polypeptide 1
increases expression decreases activity
ISO
troglitazone results in increased expression of CYP1B1 mRNA Troglitazone results in decreased activity of CYP1B1 protein
CTD
PMID:19140230 PMID:28973697 PMID:33814510
NCBI chr 6:21,093,927...21,103,091
Ensembl chr 6:21,078,146...21,103,142
G
Cyp26a1
cytochrome P450, family 26, subfamily a, polypeptide 1
increases expression
EXP
troglitazone results in increased expression of CYP26A1 mRNA
CTD
PMID:21515302
NCBI chr 1:244,883,822...244,887,657
Ensembl chr 1:244,883,752...244,887,657
G
Cyp2a3
cytochrome P450, family 2, subfamily a, polypeptide 3
decreases expression
ISO
troglitazone results in decreased expression of CYP2A7 mRNA
CTD
PMID:25572481
NCBI chr 1:91,299,584...91,307,650
Ensembl chr 1:91,299,561...91,307,649
G
Cyp2b1
cytochrome P450, family 2, subfamily b, polypeptide 1
increases expression
EXP
troglitazone results in increased expression of CYP2B1 mRNA
CTD
PMID:16597547
NCBI chr 1:90,646,098...90,669,762
G
Cyp2b2
cytochrome P450, family 2, subfamily b, polypeptide 2
increases expression
EXP
troglitazone results in increased expression of CYP2B2 mRNA
CTD
PMID:21515302
NCBI chr 1:90,722,243...90,736,272
G
Cyp2b3
cytochrome P450, family 2, subfamily b, polypeptide 3
multiple interactions increases expression
ISO
[Oleic Acid co-treated with Troglitazone] results in increased expression of CYP2B6 mRNA; [Troglitazone results in increased activity of NR1I3 protein alternative form] which results in increased expression of CYP2B6 mRNA troglitazone results in increased expression of CYP2B6 mRNA; troglitazone results in increased expression of CYP2B6 protein Troglitazone results in increased expression of CYP2B6 mRNA
CTD
PMID:10752642 PMID:12642470 PMID:17041008 PMID:17954527 PMID:24534255 PMID:27551952 PMID:28973697 More...
NCBI chr 1:90,780,468...90,859,852
G
Cyp2c6
cytochrome P450, family 2, subfamily C, polypeptide 6
multiple interactions increases response to substance decreases activity increases metabolic processing increases expression
ISO
[CYP1A2 protein co-treated with CYP2C9 protein co-treated with CYP3A4 protein co-treated with CYP2D6 protein co-treated with CYP2C19 protein] affects the susceptibility to troglitazone CYP2C19 gene polymorphism results in increased susceptibility to troglitazone Troglitazone results in decreased activity of CYP2C19 protein CYP2C19 protein results in increased metabolism of troglitazone troglitazone results in increased expression of CYP2C19 mRNA Troglitazone results in increased expression of CYP2C8 mRNA
CTD
PMID:12642470 PMID:12963435 PMID:19356091 PMID:23397584 PMID:25572481 PMID:28973697 PMID:33438235 More...
NCBI chr 1:247,879,058...247,916,804
Ensembl chr 1:247,879,078...247,916,798
G
Cyp2c79
cytochrome P450, family 2, subfamily c, polypeptide 79
decreases activity increases metabolic processing increases expression
ISO
troglitazone results in decreased activity of CYP2C8 protein CYP2C8 protein results in increased metabolism of troglitazone troglitazone results in increased expression of CYP2C8 mRNA
CTD
PMID:12642470 PMID:19356091 PMID:25572481
G
Cyp2d4
cytochrome P450, family 2, subfamily d, polypeptide 4
multiple interactions
ISO
[CYP1A2 protein co-treated with CYP2C9 protein co-treated with CYP3A4 protein co-treated with CYP2D6 protein co-treated with CYP2C19 protein] affects the susceptibility to troglitazone
CTD
PMID:23397584
NCBI chr 7:115,762,662...115,771,832
Ensembl chr 7:115,761,696...115,771,837
G
Cyp2e1
cytochrome P450, family 2, subfamily e, polypeptide 1
increases expression
EXP ISO
troglitazone results in increased expression of CYP2E1 mRNA
CTD
PMID:21515302 PMID:28973697
NCBI chr 1:205,269,967...205,280,365
Ensembl chr 1:205,267,505...205,293,495
G
Cyp2j4
cytochrome P450, family 2, subfamily j, polypeptide 4
decreases activity increases expression
ISO EXP
troglitazone results in decreased activity of CYP2J2 protein troglitazone results in increased expression of CYP2J4 mRNA
CTD
PMID:12851038 PMID:21515302
NCBI chr 5:116,295,691...116,323,219
Ensembl chr 5:116,295,694...116,323,042
G
Cyp2u1
cytochrome P450, family 2, subfamily u, polypeptide 1
decreases expression
ISO
troglitazone results in decreased expression of CYP2U1 mRNA
CTD
PMID:28973697
NCBI chr 2:222,523,516...222,541,055
Ensembl chr 2:222,523,518...222,541,124
G
Cyp3a18
cytochrome P450, family 3, subfamily a, polypeptide 18
increases expression
ISO
Troglitazone results in increased expression of CYP3A43 mRNA
CTD
PMID:25572481
NCBI chr12:13,994,312...14,044,185
Ensembl chr12:13,994,311...14,045,788
G
Cyp3a2
cytochrome P450, family 3, subfamily a, polypeptide 2
multiple interactions increases expression increases activity increases metabolic processing increases response to substance decreases activity
EXP ISO
[SOD2 co-treated with CYP3A4] affects the susceptibility to Troglitazone Troglitazone results in increased expression of CYP3A4 mRNA; Troglitazone results in increased expression of CYP3A4 protein Troglitazone results in increased activity of CYP3A4 protein CYP3A4 protein results in increased metabolism of Troglitazone CYP3A4 protein results in increased susceptibility to Troglitazone [CYP1A2 protein co-treated with CYP2C9 protein co-treated with CYP3A4 protein co-treated with CYP2D6 protein co-treated with CYP2C19 protein] affects the susceptibility to Troglitazone; [Troglitazone results in increased activity of NR1I2 protein] which results in increased expression of CYP3A4 mRNA; [Troglitazone results in increased expression of CYP3A4 protein] which results in decreased abundance of Ethinyl Estradiol; Troglitazone results in increased expression of and results in increased activity of CYP3A4 protein Troglitazone results in decreased activity of CYP3A4 protein
CTD
PMID:10752642 PMID:12505310 PMID:12642470 PMID:15466163 PMID:15860655 PMID:16837568 PMID:17041008 PMID:17954527 PMID:19022234 PMID:19356091 PMID:19501153 PMID:22524704 PMID:23397584 PMID:25572481 PMID:26706816 PMID:27551952 PMID:28762043 More...
NCBI chr12:14,321,771...14,343,886
Ensembl chr12:14,321,771...14,343,857
G
Cyp3a23-3a1
cytochrome P450, family 3, subfamily a, polypeptide 23-polypeptide 1
increases expression
EXP
Troglitazone results in increased expression of CYP3A23-3A1 mRNA
CTD
PMID:16597547 PMID:19022234 PMID:21515302
NCBI chr12:14,369,950...14,398,803
Ensembl chr12:14,368,266...14,398,813
G
Cyp3a62
cytochrome P450, family 3, subfamily a, polypeptide 62
decreases expression
EXP
troglitazone results in decreased expression of CYP3A62 mRNA
CTD
PMID:21515302
NCBI chr12:21,511,763...21,547,598
Ensembl chr12:21,471,542...21,547,598
G
Cyp3a9
cytochrome P450, family 3, subfamily a, polypeptide 9
decreases expression increases metabolic processing
ISO
troglitazone results in decreased expression of CYP3A5 CYP3A5 protein results in increased metabolism of troglitazone
CTD
PMID:15618651 PMID:19356091
NCBI chr12:21,919,955...21,960,160
Ensembl chr12:21,919,940...21,960,154
G
Cyp4a1
cytochrome P450, family 4, subfamily a, polypeptide 1
increases expression
EXP
troglitazone results in increased expression of CYP4A1 mRNA
CTD
PMID:21515302
NCBI chr 5:134,360,096...134,374,233
Ensembl chr 5:134,360,111...134,374,231
G
Cyp4a2
cytochrome P450, family 4, subfamily a, polypeptide 2
increases expression
EXP
troglitazone results in increased expression of CYP4A2 mRNA
CTD
PMID:21515302
NCBI chr 5:134,160,356...134,170,908
Ensembl chr 5:134,160,358...134,176,156
G
Cyp4a3
cytochrome P450, family 4, subfamily a, polypeptide 3
increases expression
EXP
troglitazone results in increased expression of CYP4A3 mRNA
CTD
PMID:21515302
NCBI chr 5:134,334,396...134,352,268
Ensembl chr 5:134,334,701...134,352,236
G
Cyp4a8
cytochrome P450, family 4, subfamily a, polypeptide 8
increases expression
EXP
troglitazone results in increased expression of CYP4A8 mRNA
CTD
PMID:21515302
NCBI chr 5:133,938,882...133,970,226
Ensembl chr 5:133,938,883...133,970,226
G
Cyp4b1
cytochrome P450, family 4, subfamily b, polypeptide 1
increases expression
EXP
troglitazone results in increased expression of CYP4B1 mRNA
CTD
PMID:21515302
NCBI chr 5:134,375,807...134,413,635
Ensembl chr 5:134,375,807...134,393,116
G
Cyp4v3
cytochrome P450, family 4, subfamily v, polypeptide 3
increases expression
ISO
troglitazone results in increased expression of CYP4V2 mRNA
CTD
PMID:28973697
NCBI chr16:53,650,978...53,675,916
Ensembl chr16:53,650,569...53,676,746
G
Cyp7a1
cytochrome P450 family 7 subfamily A member 1
decreases expression increases expression
ISO EXP
troglitazone results in decreased expression of CYP7A1 mRNA troglitazone results in increased expression of CYP7A1 mRNA
CTD
PMID:19631733 PMID:21515302
NCBI chr 5:24,174,505...24,184,202
Ensembl chr 5:24,174,505...24,184,202
G
Cyp8b1
cytochrome P450 family 8 subfamily B member 1
increases expression
EXP
troglitazone results in increased expression of CYP8B1 mRNA
CTD
PMID:21515302
NCBI chr 8:130,455,622...130,457,592
Ensembl chr 8:130,442,503...130,457,689
G
Daam1
dishevelled associated activator of morphogenesis 1
decreases expression
ISO
troglitazone results in decreased expression of DAAM1 mRNA
CTD
PMID:28973697
NCBI chr 6:96,125,521...96,286,049
Ensembl chr 6:96,125,621...96,286,049
G
Dab1
DAB adaptor protein 1
decreases expression
EXP
troglitazone results in decreased expression of DAB1 mRNA
CTD
PMID:21515302
NCBI chr 5:123,621,510...124,742,585
Ensembl chr 5:124,369,415...124,742,584
G
Daglb
diacylglycerol lipase, beta
decreases expression
ISO
troglitazone results in decreased expression of DAGLB mRNA
CTD
PMID:28973697
NCBI chr12:16,173,345...16,215,777
Ensembl chr12:16,173,345...16,215,758
G
Dapk1
death associated protein kinase 1
decreases expression
ISO
troglitazone results in decreased expression of DAPK1 mRNA
CTD
PMID:28973697
NCBI chr17:3,935,826...4,096,858
Ensembl chr17:3,935,625...4,096,581
G
Dbi
diazepam binding inhibitor
increases expression
ISO
troglitazone results in increased expression of DBI mRNA
CTD
PMID:12732648
NCBI chr13:33,794,231...33,802,632
Ensembl chr13:33,759,845...33,821,450
G
Dcaf5
DDB1 and CUL4 associated factor 5
decreases expression
ISO
troglitazone results in decreased expression of DCAF5 mRNA
CTD
PMID:28973697
NCBI chr 6:104,904,423...104,993,150
Ensembl chr 6:104,904,423...104,993,103
G
Dcaf6
DDB1 and CUL4 associated factor 6
decreases expression
ISO
troglitazone results in decreased expression of DCAF6 mRNA
CTD
PMID:28973697
NCBI chr13:80,159,282...80,260,510
Ensembl chr13:80,159,321...80,260,510
G
Dcaf7
DDB1 and CUL4 associated factor 7
decreases expression
ISO
troglitazone results in decreased expression of DCAF7 mRNA
CTD
PMID:28973697
NCBI chr10:91,473,900...91,496,080
Ensembl chr10:91,473,900...91,496,080
G
Dcbld1
discoidin, CUB and LCCL domain containing 1
decreases expression
ISO
troglitazone results in decreased expression of DCBLD1 mRNA
CTD
PMID:28973697
NCBI chr20:32,161,241...32,254,391
Ensembl chr20:32,161,254...32,281,176
G
Dclk1
doublecortin-like kinase 1
decreases expression
EXP
troglitazone results in decreased expression of DCLK1 mRNA
CTD
PMID:21515302
NCBI chr 2:141,567,215...141,861,088
Ensembl chr 2:141,571,983...141,861,090
G
Dcn
decorin
increases expression
ISO
troglitazone results in increased expression of DCN mRNA
CTD
PMID:19140230 PMID:28973697
NCBI chr 7:34,167,973...34,208,004
Ensembl chr 7:34,163,011...34,218,926
G
Dcp2
decapping mRNA 2
decreases expression
ISO
troglitazone results in decreased expression of DCP2 mRNA
CTD
PMID:28973697
NCBI chr18:37,001,615...37,037,949
Ensembl chr18:37,001,615...37,049,939
G
Dcst2
DC-STAMP domain containing 2
increases expression
ISO
troglitazone results in increased expression of DCST2 mRNA
CTD
PMID:28973697
NCBI chr 2:177,079,574...177,093,566
Ensembl chr 2:177,079,480...177,093,567
G
Dct
dopachrome tautomerase
increases expression
ISO
troglitazone results in increased expression of DCT mRNA
CTD
PMID:28973697
NCBI chr15:101,469,159...101,508,029
Ensembl chr15:101,469,159...101,508,029
G
Dcun1d1
defective in cullin neddylation 1 domain containing 1
decreases expression
ISO
troglitazone results in decreased expression of DCUN1D1 mRNA
CTD
PMID:28973697
NCBI chr 2:120,649,445...120,700,879
Ensembl chr 2:120,649,445...120,700,870
G
Ddi2
DNA damage inducible 1 homolog 2
decreases expression
ISO
troglitazone results in decreased expression of DDI2 mRNA
CTD
PMID:28973697
NCBI chr 5:159,272,625...159,318,365
Ensembl chr 5:159,272,625...159,318,310
G
Ddit3
DNA-damage inducible transcript 3
increases expression decreases expression
EXP ISO
troglitazone results in increased expression of DDIT3 mRNA Troglitazone results in increased expression of DDIT3 mRNA troglitazone results in decreased expression of DDIT3 mRNA
CTD
PMID:16597547 PMID:19140230 PMID:19631733 PMID:28973697 PMID:32535746
NCBI chr 7:65,001,695...65,006,517
Ensembl chr 7:65,005,501...65,006,509
G
Ddit4
DNA-damage-inducible transcript 4
increases expression
ISO EXP
troglitazone results in increased expression of DDIT4 mRNA
CTD
PMID:20846491 PMID:21515302
NCBI chr20:28,434,938...28,437,037
Ensembl chr20:28,434,944...28,437,037
G
Ddx1
DEAD-box helicase 1
decreases expression
ISO
troglitazone results in decreased expression of DDX1 mRNA
CTD
PMID:28973697
NCBI chr 6:41,725,365...41,756,236
Ensembl chr 6:41,725,367...41,758,302
G
Ddx17
DEAD-box helicase 17
decreases expression
ISO
troglitazone results in decreased expression of DDX17 mRNA
CTD
PMID:28973697
NCBI chr 7:112,971,522...112,989,747
Ensembl chr 7:112,971,523...112,989,747
G
Ddx46
DEAD-box helicase 46
decreases expression
ISO
troglitazone results in decreased expression of DDX46 mRNA
CTD
PMID:28973697
NCBI chr17:8,947,237...8,993,705
Ensembl chr17:8,947,237...8,990,247
G
Ddx49
DEAD-box helicase 49
decreases expression
ISO
troglitazone results in decreased expression of DDX49 mRNA
CTD
PMID:28973697
NCBI chr16:19,159,353...19,167,003
Ensembl chr16:19,159,087...19,167,580
G
Ddx6
DEAD-box helicase 6
decreases expression
ISO
troglitazone results in decreased expression of DDX6 mRNA
CTD
PMID:28973697
NCBI chr 8:53,827,661...53,864,538
Ensembl chr 8:53,827,835...53,860,977
G
Decr1
2,4-dienoyl-CoA reductase 1
increases expression
EXP
troglitazone results in increased expression of DECR1 mRNA
CTD
PMID:21515302
NCBI chr 5:34,208,195...34,236,074
Ensembl chr 5:34,208,195...34,236,033
G
Decr2
2,4-dienoyl-CoA reductase 2
increases expression
EXP ISO
troglitazone results in increased expression of DECR2 mRNA
CTD
PMID:21515302 PMID:28973697
NCBI chr10:15,609,389...15,617,779
Ensembl chr10:15,611,092...15,617,397
G
Def6
DEF6 guanine nucleotide exchange factor
increases expression
ISO
troglitazone results in increased expression of DEF6 mRNA
CTD
PMID:28973697
NCBI chr20:6,270,323...6,291,724
Ensembl chr20:6,269,357...6,291,771
G
Defb1
defensin beta 1
increases expression decreases expression
ISO EXP
troglitazone results in increased expression of DEFB1 mRNA troglitazone results in decreased expression of DEFB1 mRNA
CTD
PMID:19140230 PMID:21515302 PMID:25572481
NCBI chr16:77,001,326...77,016,068
Ensembl chr16:77,001,326...77,016,068
G
Dennd1b
DENN domain containing 1B
decreases expression
ISO
troglitazone results in decreased expression of DENND1B mRNA
CTD
PMID:28973697
NCBI chr13:53,096,717...53,324,372
Ensembl chr13:53,092,261...53,324,369
G
Dennd5b
DENN domain containing 5B
decreases expression
ISO
troglitazone results in decreased expression of DENND5B mRNA
CTD
PMID:28973697
NCBI chr 4:183,688,039...183,821,012
Ensembl chr 4:183,692,227...183,820,508
G
Depp1
DEPP autophagy regulator 1
multiple interactions decreases expression
ISO
[troglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of DEPP1 mRNA; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of DEPP1 mRNA] troglitazone results in decreased expression of DEPP1 mRNA
CTD
PMID:20847119 PMID:28973697
NCBI chr 4:151,583,105...151,585,455
Ensembl chr 4:151,581,502...151,586,233
G
Deptor
DEP domain containing MTOR-interacting protein
decreases expression
ISO
troglitazone results in decreased expression of DEPTOR mRNA
CTD
PMID:28973697
NCBI chr 7:88,404,745...88,574,065
Ensembl chr 7:88,404,620...88,574,041
G
Dgat1
diacylglycerol O-acyltransferase 1
increases expression
ISO
troglitazone results in increased expression of DGAT1 mRNA
CTD
PMID:12732648
NCBI chr 7:110,104,514...110,119,091
Ensembl chr 7:110,098,906...110,115,016
G
Dhrs3
dehydrogenase/reductase 3
increases expression
ISO EXP
troglitazone results in increased expression of DHRS3 mRNA
CTD
PMID:12732648 PMID:21515302
NCBI chr 5:162,031,853...162,065,655
Ensembl chr 5:162,031,386...162,065,653
G
Dhrs9
dehydrogenase/reductase 9
increases expression
ISO
troglitazone results in increased expression of DHRS9 mRNA
CTD
PMID:19140230 PMID:25572481
NCBI chr 3:74,553,357...74,579,535
Ensembl chr 3:74,555,606...74,581,376
G
Dhx16
DEAH-box helicase 16
decreases expression
ISO
troglitazone results in decreased expression of DHX16 mRNA
CTD
PMID:28973697
NCBI chr20:2,866,804...2,879,790
Ensembl chr20:2,866,804...2,879,751
G
Dhx35
DEAH-box helicase 35
decreases expression
ISO
troglitazone results in decreased expression of DHX35 mRNA
CTD
PMID:28973697
NCBI chr 3:167,869,971...167,927,300
Ensembl chr 3:167,870,055...167,927,300
G
Dhx36
DEAH-box helicase 36
decreases expression
ISO
troglitazone results in decreased expression of DHX36 mRNA
CTD
PMID:28973697
NCBI chr 2:149,006,089...149,044,192
Ensembl chr 2:149,006,089...149,044,191
G
Dhx9
DExH-box helicase 9
decreases expression
ISO
troglitazone results in decreased expression of DHX9 mRNA
CTD
PMID:28973697
NCBI chr13:68,152,813...68,189,580
Ensembl chr13:68,152,813...68,189,546
G
Diaph2
diaphanous-related formin 2
decreases expression
ISO
troglitazone results in decreased expression of DIAPH2 mRNA
CTD
PMID:28973697
NCBI chr X:96,700,535...97,528,080
Ensembl chr X:96,700,726...97,528,080
G
Diaph3
diaphanous-related formin 3
decreases expression
ISO
troglitazone results in decreased expression of DIAPH3 mRNA
CTD
PMID:19140230
NCBI chr15:68,951,992...69,421,623
Ensembl chr15:68,951,989...69,421,552
G
Dido1
death inducer-obliterator 1
increases expression
ISO
Troglitazone results in increased expression of DIDO1 mRNA
CTD
PMID:28973697
NCBI chr 3:188,150,100...188,203,445
Ensembl chr 3:188,150,100...188,194,823
G
Dio2
iodothyronine deiodinase 2
multiple interactions increases activity decreases expression
ISO
PPARG protein promotes the reaction [troglitazone results in increased activity of DIO2 protein] troglitazone results in decreased expression of DIO2 mRNA
CTD
PMID:19036883 PMID:28973697
NCBI chr 6:115,396,308...115,410,594
Ensembl chr 6:115,396,308...115,410,594
G
Dipk2a
divergent protein kinase domain 2A
increases expression
EXP
Troglitazone results in increased expression of DIPK2A mRNA
CTD
PMID:21515302
NCBI chr 8:103,950,345...103,969,461
Ensembl chr 8:103,909,931...103,969,461
G
Dixdc1
DIX domain containing 1
decreases expression
ISO
troglitazone results in decreased expression of DIXDC1 mRNA
CTD
PMID:28973697
NCBI chr 8:59,904,218...59,977,595
Ensembl chr 8:59,904,218...59,978,447
G
Dlc1
DLC1 Rho GTPase activating protein
decreases expression
ISO
troglitazone results in decreased expression of DLC1 mRNA
CTD
PMID:28973697
NCBI chr16:61,954,177...62,374,819
Ensembl chr16:61,995,001...62,374,819
G
Dlg1
discs large MAGUK scaffold protein 1
multiple interactions
ISO
[troglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of DLG1 mRNA; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of DLG1 mRNA]
CTD
PMID:20847119
NCBI chr11:82,416,853...82,607,797
Ensembl chr11:82,416,853...82,607,797
G
Dlgap2
DLG associated protein 2
decreases expression
EXP
troglitazone results in decreased expression of DLGAP2 mRNA
CTD
PMID:21515302
NCBI chr16:81,489,059...82,198,693
Ensembl chr16:81,494,649...82,198,684
G
Dlgap5
DLG associated protein 5
decreases expression
ISO
troglitazone results in decreased expression of DLGAP5 mRNA
CTD
PMID:19140230
NCBI chr15:23,113,678...23,144,281
Ensembl chr15:23,113,678...23,144,176
G
Dll4
delta like canonical Notch ligand 4
increases expression
ISO
troglitazone results in increased expression of DLL4 mRNA
CTD
PMID:17569031
NCBI chr 3:126,770,945...126,780,769
Ensembl chr 3:126,770,794...126,780,763
G
Dlx4
distal-less homeobox 4
increases expression
ISO
troglitazone results in increased expression of DLX4 mRNA
CTD
PMID:28973697
NCBI chr10:80,581,878...80,587,272
Ensembl chr10:80,582,303...80,587,294
G
Dmap1
DNA methyltransferase 1-associated protein 1
decreases expression
ISO
troglitazone results in decreased expression of DMAP1 mRNA
CTD
PMID:28973697
NCBI chr 5:136,380,211...136,388,229
Ensembl chr 5:136,380,216...136,388,219
G
Dmbx1
diencephalon/mesencephalon homeobox 1
decreases expression
ISO
troglitazone results in decreased expression of DMBX1 mRNA
CTD
PMID:19140230
NCBI chr 5:134,630,968...134,639,781
Ensembl chr 5:134,630,968...134,639,781
G
Dmgdh
dimethylglycine dehydrogenase
decreases expression
ISO
troglitazone results in decreased expression of DMGDH protein troglitazone results in decreased expression of DMGDH mRNA
CTD
PMID:18495193 PMID:25572481
NCBI chr 2:26,647,540...26,722,496
Ensembl chr 2:26,647,565...26,723,071
G
Dmtf1
cyclin D binding myb-like transcription factor 1
decreases expression
ISO
troglitazone results in decreased expression of DMTF1 mRNA
CTD
PMID:28973697
NCBI chr 4:25,864,891...25,905,916
Ensembl chr 4:25,865,447...25,905,943
G
Dnaaf2
dynein, axonemal, assembly factor 2
multiple interactions
ISO
[troglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of DNAAF2 mRNA; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of DNAAF2 mRNA]
CTD
PMID:20847119
NCBI chr 6:93,397,157...93,406,323
Ensembl chr 6:93,397,164...93,406,323
G
Dnai1
dynein, axonemal, intermediate chain 1
decreases expression
EXP ISO
troglitazone results in decreased expression of DNAI1 mRNA
CTD
PMID:21515302 PMID:28973697
NCBI chr 5:61,526,079...61,596,806
Ensembl chr 5:61,525,999...61,596,810
G
Dnaja1
DnaJ heat shock protein family (Hsp40) member A1
decreases expression
ISO
troglitazone results in decreased expression of DNAJA1 mRNA
CTD
PMID:19631733
NCBI chr 5:60,638,404...60,649,315
Ensembl chr 5:60,638,410...60,650,160
G
Dnajb1
DnaJ heat shock protein family (Hsp40) member B1
increases expression
ISO
troglitazone results in increased expression of DNAJB1 mRNA
CTD
PMID:28973697
NCBI chr19:41,427,453...41,431,141
Ensembl chr19:41,427,453...41,431,416
G
Dnajb2
DnaJ heat shock protein family (Hsp40) member B2
increases expression
ISO
troglitazone results in increased expression of DNAJB2 mRNA
CTD
PMID:19140230
NCBI chr 9:84,179,702...84,187,942
Ensembl chr 9:84,179,695...84,187,942
G
Dnajb4
DnaJ heat shock protein family (Hsp40) member B4
decreases expression increases expression
ISO
troglitazone results in decreased expression of DNAJB4 mRNA troglitazone results in increased expression of DNAJB4 mRNA
CTD
PMID:19631733
NCBI chr 2:243,790,296...243,819,042
Ensembl chr 2:243,790,297...243,819,042
G
Dnajb7
DnaJ heat shock protein family (Hsp40) member B7
decreases expression
EXP
troglitazone results in decreased expression of DNAJB7 mRNA
CTD
PMID:21515302
NCBI chr 7:114,812,886...114,814,200
Ensembl chr 7:114,810,853...114,814,405
G
Dnajb9
DnaJ heat shock protein family (Hsp40) member B9
decreases expression
EXP
troglitazone results in decreased expression of DNAJB9 mRNA
CTD
PMID:25596134
NCBI chr 6:66,997,842...67,007,371
Ensembl chr 6:66,997,842...67,009,344
G
Dnajc12
DnaJ heat shock protein family (Hsp40) member C12
increases expression
ISO
troglitazone results in increased expression of DNAJC12 mRNA
CTD
PMID:19140230
NCBI chr20:25,245,475...25,266,238
Ensembl chr20:25,222,298...25,266,251
G
Dnajc14
DnaJ heat shock protein family (Hsp40) member C14
decreases expression
ISO
troglitazone results in decreased expression of DNAJC14 mRNA
CTD
PMID:28973697
NCBI chr 7:1,818,360...1,831,642
Ensembl chr 7:1,820,247...1,831,658
G
Dnajc22
DnaJ heat shock protein family (Hsp40) member C22
increases expression
ISO
troglitazone results in increased expression of DNAJC22 mRNA
CTD
PMID:28973697
NCBI chr 7:132,136,516...132,141,802
Ensembl chr 7:132,136,545...132,142,758
G
Dnajc28
DnaJ heat shock protein family (Hsp40) member C28
decreases expression
ISO
troglitazone results in decreased expression of DNAJC28 mRNA
CTD
PMID:28973697
NCBI chr11:44,341,528...44,344,348
Ensembl chr11:44,338,646...44,344,482
G
Dnajc5g
DnaJ heat shock protein family (Hsp40) member C5 gamma
decreases expression
EXP
troglitazone results in decreased expression of DNAJC5G mRNA
CTD
PMID:21515302
NCBI chr 6:30,980,051...30,984,218
Ensembl chr 6:30,979,869...30,984,115
G
Dnase1l3
deoxyribonuclease 1L3
affects expression
EXP
troglitazone affects the expression of DNASE1L3 mRNA
CTD
PMID:21515302
NCBI chr15:19,351,683...19,378,536
Ensembl chr15:19,352,493...19,378,531
G
Dner
delta/notch-like EGF repeat containing
increases expression
ISO
troglitazone results in increased expression of DNER mRNA
CTD
PMID:19140230
NCBI chr 9:93,035,108...93,350,568
Ensembl chr 9:93,035,108...93,350,568
G
Dnmbp
dynamin binding protein
decreases expression
ISO
troglitazone results in decreased expression of DNMBP mRNA
CTD
PMID:28973697
NCBI chr 1:252,685,406...252,778,642
Ensembl chr 1:252,685,406...252,778,688
G
Dnmt1
DNA methyltransferase 1
decreases expression
ISO
troglitazone results in decreased expression of DNMT1 mRNA
CTD
PMID:19140230 PMID:28973697
NCBI chr 8:27,716,797...27,763,405
Ensembl chr 8:27,716,797...27,763,119
G
Dnmt3a
DNA methyltransferase 3 alpha
decreases expression
ISO
troglitazone results in decreased expression of DNMT3A mRNA
CTD
PMID:28973697
NCBI chr 6:32,507,316...32,621,678
Ensembl chr 6:32,512,070...32,614,970
G
Dnmt3l
DNA methyltransferase 3 like
decreases expression
ISO
troglitazone results in decreased expression of DNMT3L mRNA
CTD
PMID:25572481
NCBI chr20:10,614,591...10,628,989
Ensembl chr20:10,614,591...10,629,168
G
Dpp9
dipeptidyl peptidase 9
increases expression
EXP
troglitazone results in increased expression of DPP9 mRNA
CTD
PMID:25596134
NCBI chr 9:1,098,505...1,133,500
Ensembl chr 9:1,095,929...1,177,715
G
Dpys
dihydropyrimidinase
decreases expression
ISO
troglitazone results in decreased expression of DPYS mRNA
CTD
PMID:25572481
NCBI chr 7:72,707,566...72,814,183
Ensembl chr 7:72,721,048...72,814,142
G
Dpysl2
dihydropyrimidinase-like 2
decreases expression
ISO
troglitazone results in decreased expression of DPYSL2 mRNA
CTD
PMID:28973697
NCBI chr15:45,181,041...45,287,065
Ensembl chr15:45,181,041...45,287,065
G
Drc12
dynein regulatory complex subunit 12 homolog
increases expression
EXP
Troglitazone results in increased expression of CCDC153 mRNA
CTD
PMID:21515302
NCBI chr 8:53,468,344...53,481,168
Ensembl chr 8:53,472,849...53,486,567
G
Drosha
drosha ribonuclease III
decreases expression
ISO
troglitazone results in decreased expression of DROSHA mRNA
CTD
PMID:28973697
NCBI chr 2:63,591,885...63,703,688
Ensembl chr 2:63,591,968...63,703,687
G
Dsc2
desmocollin 2
decreases expression
ISO
troglitazone results in decreased expression of DSC2 mRNA
CTD
PMID:28973697
NCBI chr18:11,725,466...11,757,591
Ensembl chr18:11,725,466...11,757,466
G
Dsg2
desmoglein 2
decreases expression
ISO
troglitazone results in decreased expression of DSG2 mRNA
CTD
PMID:28973697
NCBI chr18:12,121,287...12,179,590
Ensembl chr18:12,121,181...12,179,590
G
Dtx2
deltex E3 ubiquitin ligase 2
increases expression
ISO
troglitazone results in increased expression of DTX2 mRNA
CTD
PMID:28973697
NCBI chr12:26,279,899...26,319,541
Ensembl chr12:26,279,899...26,319,507
G
Dtymk
deoxythymidylate kinase
decreases expression increases expression
ISO
troglitazone results in decreased expression of DTYMK mRNA troglitazone results in increased expression of DTYMK mRNA
CTD
PMID:19140230 PMID:28973697
NCBI chr 9:101,762,899...101,771,733
Ensembl chr 9:101,762,899...101,774,504
G
Duoxa1
dual oxidase maturation factor 1
increases expression
ISO
troglitazone results in increased expression of DUOXA1 mRNA
CTD
PMID:28973697
NCBI chr 3:129,703,416...129,714,110
Ensembl chr 3:129,703,416...129,706,829
G
Dus2
dihydrouridine synthase 2
increases expression
ISO
troglitazone results in increased expression of DUS2 mRNA
CTD
PMID:28973697
NCBI chr19:50,816,306...50,864,559
Ensembl chr19:50,816,310...50,864,559
G
Dusp10
dual specificity phosphatase 10
multiple interactions
ISO
[troglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of DUSP10 mRNA; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of DUSP10 mRNA]
CTD
PMID:20847119
NCBI chr13:98,145,317...98,183,304
Ensembl chr13:98,145,893...98,183,304
G
Dusp16
dual specificity phosphatase 16
increases expression
ISO
troglitazone results in increased expression of DUSP16 mRNA
CTD
PMID:19140230
NCBI chr 4:169,278,118...169,361,508
Ensembl chr 4:169,278,118...169,361,508
G
Dusp6
dual specificity phosphatase 6
decreases expression
EXP
troglitazone results in decreased expression of DUSP6 mRNA
CTD
PMID:21515302
NCBI chr 7:35,979,502...35,983,834
Ensembl chr 7:35,977,921...35,983,833
G
Dusp7
dual specificity phosphatase 7
decreases expression
ISO
troglitazone results in decreased expression of DUSP7 mRNA
CTD
PMID:28973697
NCBI chr 8:115,888,091...115,895,126
Ensembl chr 8:115,887,892...115,895,126
G
Dynll1
dynein light chain LC8-type 1
increases expression
ISO
troglitazone results in increased expression of DYNLL1 mRNA
CTD
PMID:28973697
NCBI chr12:46,945,291...46,976,867
Ensembl chr12:46,973,050...46,976,861
G
Dyrk1a
dual specificity tyrosine phosphorylation regulated kinase 1A
decreases expression
ISO
troglitazone results in decreased expression of DYRK1A mRNA
CTD
PMID:28973697
NCBI chr11:47,360,824...47,479,033
Ensembl chr11:47,360,850...47,479,033
G
Dyrk2
dual specificity tyrosine phosphorylation regulated kinase 2
decreases expression
ISO
troglitazone results in decreased expression of DYRK2 mRNA
CTD
PMID:28973697
NCBI chr 7:56,235,276...56,265,741
Ensembl chr 7:56,235,276...56,265,942
G
Dyrk3
dual specificity tyrosine phosphorylation regulated kinase 3
decreases expression
ISO
troglitazone results in decreased expression of DYRK3 mRNA
CTD
PMID:28973697
NCBI chr13:45,146,383...45,157,082
Ensembl chr13:45,146,384...45,157,249
G
E2f1
E2F transcription factor 1
multiple interactions decreases expression
ISO
[troglitazone co-treated with Aspirin] results in decreased expression of E2F1 protein troglitazone results in decreased expression of E2F1 mRNA
CTD
PMID:19140230 PMID:19631733 PMID:19908241
NCBI chr 3:163,524,739...163,535,563
Ensembl chr 3:163,524,739...163,535,563
G
E2f2
E2F transcription factor 2
decreases expression
ISO
troglitazone results in decreased expression of E2F2 mRNA
CTD
PMID:19140230
NCBI chr 5:153,682,789...153,706,087
Ensembl chr 5:153,682,789...153,706,087
G
Ebf1
EBF transcription factor 1
decreases expression
ISO
troglitazone results in decreased expression of EBF1 mRNA
CTD
PMID:28973697
NCBI chr10:29,597,221...29,990,571
Ensembl chr10:29,601,351...29,988,702
G
Ece1
endothelin converting enzyme 1
decreases expression
ISO
troglitazone results in decreased expression of ECE1 mRNA
CTD
PMID:28973697
NCBI chr 5:155,361,031...155,462,723
Ensembl chr 5:155,360,639...155,462,719
G
Ech1
enoyl-CoA hydratase 1
increases expression multiple interactions
EXP ISO
troglitazone results in increased expression of ECH1 mRNA; troglitazone results in increased expression of ECH1 protein [Oleic Acid co-treated with troglitazone] results in increased expression of ECH1 mRNA
CTD
PMID:21315101 PMID:21515302 PMID:24534255
NCBI chr 1:93,241,076...93,248,314
Ensembl chr 1:93,241,734...93,248,440
G
Echdc2
enoyl CoA hydratase domain containing 2
increases expression
EXP
troglitazone results in increased expression of ECHDC2 protein
CTD
PMID:21315101
NCBI chr 5:128,144,241...128,163,611
Ensembl chr 5:128,144,425...128,163,610
G
Eci1
enoyl-CoA delta isomerase 1
increases expression
EXP
troglitazone results in increased expression of ECI1 mRNA
CTD
PMID:21515302
NCBI chr10:13,961,250...13,974,595
Ensembl chr10:13,961,218...13,974,773
G
Eci2
enoyl-CoA delta isomerase 2
increases expression
EXP
Troglitazone results in increased expression of ECI2 mRNA
CTD
PMID:21515302
NCBI chr17:30,056,274...30,092,169
Ensembl chr17:30,076,524...30,092,161
G
Ecm1
extracellular matrix protein 1
increases expression
ISO
troglitazone results in increased expression of ECM1 mRNA
CTD
PMID:28973697
NCBI chr 2:185,976,439...185,981,656
Ensembl chr 2:185,976,440...185,981,606
G
Edar
ectodysplasin-A receptor
increases expression
ISO
troglitazone results in increased expression of EDAR mRNA
CTD
PMID:28973697
NCBI chr20:27,130,934...27,209,672
Ensembl chr20:27,130,934...27,209,630
G
Edn1
endothelin 1
multiple interactions
ISO
troglitazone inhibits the reaction [AGT protein modified form results in increased expression of EDN1 protein]
CTD
PMID:17666345
NCBI chr17:22,660,799...22,666,687
Ensembl chr17:22,660,799...22,666,687
G
Ednrb
endothelin receptor type B
decreases expression
ISO
troglitazone results in decreased expression of EDNRB mRNA
CTD
PMID:28973697
NCBI chr15:87,055,490...87,086,765
Ensembl chr15:87,057,691...87,086,765
G
Efna1
ephrin A1
increases expression
ISO
troglitazone results in increased expression of EFNA1 mRNA
CTD
PMID:19140230
NCBI chr 2:176,979,434...176,988,675
Ensembl chr 2:176,979,434...176,988,726
G
Efna5
ephrin A5
decreases expression
ISO
troglitazone results in decreased expression of EFNA5 mRNA
CTD
PMID:28973697
NCBI chr 9:109,763,786...110,042,396
Ensembl chr 9:109,767,252...110,042,348
G
Efnb2
ephrin B2
increases expression
ISO
troglitazone results in increased expression of EFNB2 mRNA
CTD
PMID:17569031
NCBI chr16:87,485,215...87,529,224
Ensembl chr16:87,485,198...87,529,208
G
Egfr
epidermal growth factor receptor
decreases expression multiple interactions affects expression
ISO
Troglitazone results in decreased expression of EGFR protein [Troglitazone co-treated with 4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline] results in decreased expression of EGFR protein Troglitazone affects the expression of EGFR mRNA
CTD
PMID:32822399
NCBI chr14:95,378,626...95,551,358
Ensembl chr14:95,378,626...95,551,358
G
Egln3
egl-9 family hypoxia-inducible factor 3
decreases expression
EXP
troglitazone results in decreased expression of EGLN3 mRNA
CTD
PMID:21515302
NCBI chr 6:77,385,549...77,411,015
Ensembl chr 6:77,385,549...77,411,015
G
Egr1
early growth response 1
multiple interactions increases expression increases activity decreases expression
ISO EXP
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [troglitazone results in increased expression of EGR1 mRNA]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [troglitazone results in increased expression of EGR1 protein]; [EGR1 protein binds to GDF15 promoter] affects the reaction [troglitazone results in increased expression of GDF15]; EGR1 protein promotes the reaction [troglitazone results in increased expression of ATF3 mRNA]; troglitazone results in increased expression of and results in increased stability of EGR1 mRNA Troglitazone results in increased expression of EGR1 mRNA; Troglitazone results in increased expression of EGR1 protein troglitazone results in increased activity of EGR1 protein troglitazone results in decreased expression of EGR1 mRNA; troglitazone results in decreased expression of EGR1 protein troglitazone inhibits the reaction [Oxygen deficiency results in increased expression of and results in increased activity of EGR1 protein]; troglitazone inhibits the reaction [Oxygen deficiency results in increased expression of EGR1 mRNA]
CTD
PMID:12468449 PMID:12475986 PMID:14662774 PMID:15064713 PMID:16079301 PMID:19631733 PMID:21461570 PMID:25572481 PMID:28973697 More...
NCBI chr18:26,737,078...26,740,877
Ensembl chr18:26,736,838...26,740,843
G
Ehbp1
EH domain binding protein 1
decreases expression
ISO
troglitazone results in decreased expression of EHBP1 mRNA
CTD
PMID:28973697
NCBI chr14:100,294,585...100,581,764
Ensembl chr14:100,294,585...100,546,579
G
Ehbp1l1
EH domain binding protein 1-like 1
decreases expression
ISO
troglitazone results in decreased expression of EHBP1L1 mRNA
CTD
PMID:28973697
NCBI chr 1:212,423,444...212,444,357
Ensembl chr 1:212,423,447...212,443,598
G
Ehf
ets homologous factor
increases expression
ISO
troglitazone results in increased expression of EHF mRNA
CTD
PMID:28973697
NCBI chr 3:110,094,770...110,134,991
Ensembl chr 3:110,096,756...110,134,928
G
Ehhadh
enoyl-CoA hydratase and 3-hydroxyacyl CoA dehydrogenase
increases expression
EXP
troglitazone results in increased expression of EHHADH mRNA
CTD
PMID:21515302
NCBI chr11:92,746,409...92,779,647
Ensembl chr11:92,746,420...92,779,662
G
Eif2ak3
eukaryotic translation initiation factor 2 alpha kinase 3
increases expression
ISO
Troglitazone results in increased expression of EIF2AK3 mRNA
CTD
PMID:32535746
NCBI chr 4:104,363,838...104,425,271
Ensembl chr 4:104,363,833...104,425,268
G
Eif2s1
eukaryotic translation initiation factor 2 subunit alpha
decreases phosphorylation
ISO
troglitazone results in decreased phosphorylation of EIF2S1 protein
CTD
PMID:11834241
NCBI chr 6:103,405,880...103,430,549
Ensembl chr 6:103,405,788...103,431,649
G
Eif3a
eukaryotic translation initiation factor 3, subunit A
decreases expression
ISO
troglitazone results in decreased expression of EIF3A mRNA
CTD
PMID:28973697
NCBI chr 1:269,888,730...269,925,785
Ensembl chr 1:269,888,615...269,919,025
G
Eif3c
eukaryotic translation initiation factor 3, subunit C
decreases expression
EXP
troglitazone results in decreased expression of EIF3C mRNA
CTD
PMID:25596134
NCBI chr 1:190,565,183...190,583,067
Ensembl chr 1:190,565,184...190,583,067
G
Eif4ebp2
eukaryotic translation initiation factor 4E binding protein 2
decreases expression
ISO
troglitazone results in decreased expression of EIF4EBP2 mRNA
CTD
PMID:28973697
NCBI chr20:29,922,260...29,942,922
Ensembl chr20:29,922,260...29,942,922
G
Elf1
E74 like ETS transcription factor 1
decreases expression
ISO
troglitazone results in decreased expression of ELF1 mRNA
CTD
PMID:28973697
NCBI chr15:61,354,026...61,395,762
Ensembl chr15:61,330,877...61,395,758
G
Elk1
ETS transcription factor ELK1
increases activity
ISO
troglitazone results in increased activity of ELK1 protein
CTD
PMID:11888673
NCBI chr X:3,692,367...3,709,252
Ensembl chr X:3,693,293...3,709,249
G
Elk4
ETS transcription factor ELK4
decreases expression
ISO
troglitazone results in decreased expression of ELK4 mRNA
CTD
PMID:28973697
NCBI chr13:46,004,145...46,027,206
Ensembl chr13:46,004,182...46,027,199
G
Elovl6
ELOVL fatty acid elongase 6
decreases expression increases expression
ISO EXP
troglitazone results in decreased expression of ELOVL6 mRNA troglitazone results in increased expression of ELOVL6 mRNA
CTD
PMID:21515302 PMID:25572481 PMID:28973697
NCBI chr 2:220,738,095...220,845,528
Ensembl chr 2:220,738,064...220,845,549
G
Eme1
essential meiotic structure-specific endonuclease 1
decreases expression
ISO
troglitazone results in decreased expression of EME1 mRNA
CTD
PMID:19140230
NCBI chr10:80,083,585...80,092,450
Ensembl chr10:80,083,585...80,092,301
G
Emilin2
elastin microfibril interfacer 2
increases expression
ISO
troglitazone results in increased expression of EMILIN2 mRNA
CTD
PMID:28973697
NCBI chr 9:118,607,312...118,667,087
Ensembl chr 9:118,606,891...118,666,957
G
Emsy
EMSY transcriptional repressor, BRCA2 interacting
decreases expression
ISO
troglitazone results in decreased expression of EMSY mRNA
CTD
PMID:28973697
NCBI chr 1:162,295,167...162,364,742
Ensembl chr 1:162,295,169...162,364,707
G
Enc1
ectodermal-neural cortex 1
increases expression
ISO
troglitazone results in increased expression of ENC1 mRNA
CTD
PMID:28973697
NCBI chr 2:30,285,274...30,297,194
Ensembl chr 2:30,283,736...30,315,721
G
Eng
endoglin
increases expression
EXP
troglitazone results in increased expression of ENG mRNA
CTD
PMID:21515302
NCBI chr 3:36,332,190...36,370,324
Ensembl chr 3:36,326,202...36,370,933
G
Enho
energy homeostasis associated
decreases expression
ISO
troglitazone results in decreased expression of ENHO mRNA
CTD
PMID:28973697
NCBI chr 5:61,596,860...61,598,657
Ensembl chr 5:61,596,860...61,598,657
G
Eno1
enolase 1
decreases expression
EXP
troglitazone results in decreased expression of ENO1 protein
CTD
PMID:21315101
NCBI chr 5:166,002,867...166,014,252
Ensembl chr 3:77,946,261...77,986,003 Ensembl chr 5:77,946,261...77,986,003
G
Enpp1
ectonucleotide pyrophosphatase/phosphodiesterase 1
decreases expression
ISO
troglitazone results in decreased expression of ENPP1 mRNA
CTD
PMID:28973697
NCBI chr 1:22,518,051...22,583,044
Ensembl chr 1:22,518,069...22,583,044
G
Enpp3
ectonucleotide pyrophosphatase/phosphodiesterase 3
decreases expression
ISO
troglitazone results in decreased expression of ENPP3 mRNA
CTD
PMID:28973697
NCBI chr 1:22,382,717...22,454,324
Ensembl chr 1:22,382,964...22,454,314
G
Entpd5
ectonucleoside triphosphate diphosphohydrolase 5
increases expression
ISO
troglitazone results in increased expression of ENTPD5 mRNA
CTD
PMID:28973697
NCBI chr 6:109,750,210...109,786,376
Ensembl chr 6:109,753,204...109,786,495
G
Ep400
E1A binding protein p400
decreases expression
ISO
troglitazone results in decreased expression of EP400 mRNA
CTD
PMID:28973697
NCBI chr12:51,551,665...51,658,635
Ensembl chr12:51,551,695...51,658,634
G
Epas1
endothelial PAS domain protein 1
decreases expression
ISO
troglitazone results in decreased expression of EPAS1 mRNA
CTD
PMID:28973697
NCBI chr 6:13,543,252...13,626,147
Ensembl chr 6:13,544,389...13,624,729
G
Epb41
erythrocyte membrane protein band 4.1
decreases expression
ISO
troglitazone results in decreased expression of EPB41 mRNA
CTD
PMID:28973697
NCBI chr 5:149,394,080...149,548,178
Ensembl chr 5:149,394,096...149,543,540
G
Epc1
enhancer of polycomb homolog 1
increases expression decreases expression
ISO
troglitazone results in increased expression of EPC1 mRNA troglitazone results in decreased expression of EPC1 mRNA
CTD
PMID:19140230 PMID:28973697
NCBI chr17:59,198,513...59,289,535
Ensembl chr17:59,197,677...59,289,519
G
Ephx2
epoxide hydrolase 2
increases expression
ISO EXP
troglitazone results in increased expression of EPHX2 mRNA troglitazone results in increased expression of EPHX2 mRNA; troglitazone results in increased expression of EPHX2 protein
CTD
PMID:19631733 PMID:21315101 PMID:21515302 PMID:28973697
NCBI chr15:44,465,447...44,503,157
Ensembl chr15:44,465,448...44,503,160
G
Epn2
epsin 2
decreases expression
ISO
troglitazone results in decreased expression of EPN2 mRNA
CTD
PMID:28973697
NCBI chr10:46,697,238...46,759,128
Ensembl chr10:46,697,238...46,759,092
G
Epn3
epsin 3
increases expression
EXP
troglitazone results in increased expression of EPN3 mRNA
CTD
PMID:21515302
NCBI chr10:79,935,857...79,946,121
Ensembl chr10:79,935,857...79,944,235
G
Epor
erythropoietin receptor
increases expression
ISO
troglitazone results in increased expression of EPOR mRNA
CTD
PMID:28973697
NCBI chr 8:28,765,738...28,770,371
Ensembl chr 8:28,765,746...28,770,322
G
Erbb3
erb-b2 receptor tyrosine kinase 3
decreases expression
ISO
troglitazone results in decreased expression of ERBB3 mRNA
CTD
PMID:28973697
NCBI chr 7:1,579,079...1,600,379
Ensembl chr 7:1,579,816...1,601,120
G
Erbin
erbb2 interacting protein
multiple interactions
ISO
[troglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of ERBIN mRNA; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ERBIN mRNA]
CTD
PMID:20847119
NCBI chr 2:36,660,399...36,762,584
Ensembl chr 2:36,660,399...36,762,153
G
Ereg
epiregulin
increases expression
ISO
Troglitazone results in increased expression of EREG mRNA
CTD
PMID:19140230 PMID:32816093
NCBI chr14:17,311,485...17,325,260
Ensembl chr14:17,311,485...17,325,260
G
Erich6
glutamate-rich 6
decreases expression
EXP
troglitazone results in decreased expression of ERICH6 mRNA
CTD
PMID:21515302
NCBI chr 2:145,001,833...145,027,935
Ensembl chr 2:145,001,833...145,028,223
G
Erlec1
endoplasmic reticulum lectin 1
decreases expression
ISO
troglitazone results in decreased expression of ERLEC1 mRNA
CTD
PMID:28973697
NCBI chr14:108,856,661...108,894,511
Ensembl chr14:108,856,661...108,894,297
G
Ermp1
endoplasmic reticulum metallopeptidase 1
increases expression
ISO
troglitazone results in increased expression of ERMP1 mRNA
CTD
PMID:28973697
NCBI chr 1:236,801,459...236,835,656
Ensembl chr 1:236,801,466...236,839,197
G
Ern1
endoplasmic reticulum to nucleus signaling 1
decreases expression increases expression
ISO
troglitazone results in decreased expression of ERN1 mRNA Troglitazone results in increased expression of ERN1 mRNA
CTD
PMID:28973697 PMID:32535746
NCBI chr10:91,826,663...91,920,976
Ensembl chr10:91,830,428...91,920,791
G
Ero1a
endoplasmic reticulum oxidoreductase 1 alpha
multiple interactions
ISO
[Troglitazone results in increased activity of PPARG protein] which results in increased expression of ERO1A mRNA
CTD
PMID:17452443
NCBI chr15:20,974,771...21,010,170
Ensembl chr15:20,972,679...21,018,039
G
Erp27
endoplasmic reticulum protein 27
decreases expression
ISO
troglitazone results in decreased expression of ERP27 mRNA
CTD
PMID:25572481
NCBI chr 4:171,535,845...171,552,848
Ensembl chr 4:171,535,847...171,553,072
G
Erp29
endoplasmic reticulum protein 29
increases expression
EXP
troglitazone results in increased expression of ERP29 protein
CTD
PMID:21315101
NCBI chr12:40,750,177...40,756,607
Ensembl chr12:40,750,314...40,757,010
G
Errfi1
ERBB receptor feedback inhibitor 1
increases expression decreases expression
ISO
troglitazone results in increased expression of ERRFI1 mRNA troglitazone results in decreased expression of ERRFI1 mRNA
CTD
PMID:19140230 PMID:28973697
NCBI chr 5:166,606,841...166,620,124
Ensembl chr 5:166,606,834...166,620,432
G
Esf1
ESF1 nucleolar pre-rRNA processing protein homolog
decreases expression
ISO
troglitazone results in decreased expression of ESF1 mRNA
CTD
PMID:28973697
NCBI chr 3:147,908,405...147,961,567
Ensembl chr 3:147,908,405...147,961,485
G
Espl1
extra spindle pole bodies like 1, separase
decreases expression
ISO
troglitazone results in decreased expression of ESPL1 mRNA
CTD
PMID:19140230
NCBI chr 7:135,302,460...135,329,570
Ensembl chr 7:135,302,716...135,329,570
G
Esrp2
epithelial splicing regulatory protein 2
decreases expression
ISO
troglitazone results in decreased expression of ESRP2 mRNA
CTD
PMID:28973697
NCBI chr19:50,944,401...50,951,919
Ensembl chr19:50,944,401...50,951,568
G
Esrra
estrogen related receptor, alpha
increases expression
ISO
troglitazone results in increased expression of ESRRA mRNA
CTD
PMID:20860658
NCBI chr 1:213,533,309...213,543,432
Ensembl chr 1:213,533,310...213,543,811
G
Esrrb
estrogen-related receptor beta
increases expression
ISO
troglitazone results in increased expression of ESRRB mRNA
CTD
PMID:20860658
NCBI chr 6:111,738,662...111,894,087
Ensembl chr 6:111,738,662...111,894,087
G
Etfdh
electron transfer flavoprotein dehydrogenase
increases expression
EXP
troglitazone results in increased expression of ETFDH protein
CTD
PMID:21315101
NCBI chr 2:167,038,707...167,060,758
Ensembl chr 2:167,025,823...167,060,770
G
Ethe1
ETHE1, persulfide dioxygenase
decreases expression
ISO
troglitazone results in decreased expression of ETHE1 protein
CTD
PMID:18495193
NCBI chr 1:89,311,948...89,327,000
Ensembl chr 1:89,311,934...89,326,998
G
Etnk2
ethanolamine kinase 2
decreases expression
ISO
troglitazone results in decreased expression of ETNK2 mRNA
CTD
PMID:25572481
NCBI chr13:47,362,964...47,381,100
Ensembl chr13:47,363,060...47,381,100
G
Etnppl
ethanolamine-phosphate phospho-lyase
decreases expression
ISO
troglitazone results in decreased expression of ETNPPL mRNA
CTD
PMID:28973697
NCBI chr 2:221,847,210...221,868,827
Ensembl chr 2:221,847,250...221,866,357
G
Etv6
ETS variant transcription factor 6
decreases expression
ISO
troglitazone results in decreased expression of ETV6 mRNA
CTD
PMID:28973697
NCBI chr 4:168,580,405...168,819,817
Ensembl chr 4:168,580,138...168,819,802
G
Ewsr1
EWS RNA-binding protein 1
decreases expression
ISO
troglitazone results in decreased expression of EWSR1 mRNA
CTD
PMID:28973697
NCBI chr14:84,179,413...84,208,149
Ensembl chr14:84,179,618...84,208,095
G
Exo1
exonuclease 1
decreases expression
ISO
troglitazone results in decreased expression of EXO1 mRNA
CTD
PMID:19140230
NCBI chr13:90,341,947...90,366,861
Ensembl chr13:90,342,018...90,366,861
G
Exoc4
exocyst complex component 4
decreases expression
ISO
troglitazone results in decreased expression of EXOC4 mRNA
CTD
PMID:28973697
NCBI chr 4:62,774,896...63,551,541
Ensembl chr 4:62,774,935...63,552,943
G
Exosc2
exosome component 2
decreases expression
ISO
troglitazone results in decreased expression of EXOSC2 mRNA
CTD
PMID:19140230
NCBI chr 3:35,360,652...35,370,948
Ensembl chr 3:35,360,666...35,371,373
G
Ezh2
enhancer of zeste 2 polycomb repressive complex 2 subunit
decreases expression
ISO
troglitazone results in decreased expression of EZH2 mRNA
CTD
PMID:19140230
NCBI chr 4:77,624,223...77,698,598
Ensembl chr 4:77,624,223...77,687,183
G
F13a1
coagulation factor XIII A1 chain
increases expression
ISO
troglitazone results in increased expression of F13A1 mRNA
CTD
PMID:28973697
NCBI chr17:28,021,197...28,197,960
Ensembl chr17:28,020,845...28,197,948
G
F2r
coagulation factor II (thrombin) receptor
decreases expression
ISO
troglitazone results in decreased expression of F2R mRNA
CTD
PMID:28973697
NCBI chr 2:28,604,066...28,620,579
Ensembl chr 2:28,604,066...28,620,579
G
Fabp1
fatty acid binding protein 1
increases expression
ISO EXP
troglitazone results in increased expression of FABP1 mRNA
CTD
PMID:19022234 PMID:21515302
NCBI chr 4:104,744,302...104,753,119
Ensembl chr 4:104,744,309...104,753,113
G
Fabp2
fatty acid binding protein 2
increases expression
EXP
troglitazone results in increased expression of FABP2 mRNA
CTD
PMID:19022234
NCBI chr 2:213,724,629...213,728,686
Ensembl chr 2:213,724,629...213,728,686
G
Fabp3
fatty acid binding protein 3
decreases expression increases expression
ISO
troglitazone results in decreased expression of FABP3 mRNA troglitazone results in increased expression of FABP3 protein
CTD
PMID:9709955 PMID:11162573
NCBI chr 5:147,936,027...147,942,870
Ensembl chr 5:147,936,119...147,942,881
G
Fabp4
fatty acid binding protein 4
increases expression multiple interactions
ISO EXP
troglitazone results in increased expression of FABP4 mRNA; troglitazone results in increased expression of FABP4 protein [troglitazone results in increased activity of PPARG protein] which results in increased expression of FABP4 mRNA; troglitazone promotes the reaction [PPARG protein results in increased expression of FABP4 mRNA] Troglitazone results in increased expression of FABP4 mRNA 2-chloro-5-nitrobenzanilide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with INS protein co-treated with Troglitazone] results in increased expression of FABP4 mRNA]; [1-Methyl-3-isobutylxanthine co-treated with INS protein co-treated with Troglitazone] results in increased expression of FABP4 mRNA; [1-Methyl-3-isobutylxanthine co-treated with INS protein co-treated with Troglitazone] results in increased expression of FABP4 protein; [1-Methyl-3-isobutylxanthine co-treated with Troglitazone co-treated with INS protein] results in increased expression of FABP4 mRNA
CTD
PMID:9709955 PMID:10097144 PMID:10871190 PMID:11089532 PMID:11162573 PMID:12759900 PMID:16813520 PMID:19682441 PMID:21515302 PMID:21877759 PMID:22710028 PMID:22953781 PMID:23277027 PMID:24559133 PMID:25572481 PMID:27003841 PMID:28437481 More...
NCBI chr 2:93,488,251...93,492,961
Ensembl chr 2:93,488,271...93,492,972
G
Fabp5
fatty acid binding protein 5
increases expression
ISO
troglitazone results in increased expression of FABP5 mRNA
CTD
PMID:12732648 PMID:28973697
NCBI chr 2:93,672,451...93,676,186
Ensembl chr 2:93,672,458...93,676,127
G
Fads1
fatty acid desaturase 1
multiple interactions
EXP
troglitazone inhibits the reaction [Dietary Sucrose results in increased expression of FADS1 mRNA]
CTD
PMID:15763435
NCBI chr 1:216,252,605...216,267,618
Ensembl chr 1:216,252,602...216,267,615
G
Fads2
fatty acid desaturase 2
decreases expression multiple interactions
ISO EXP
troglitazone results in decreased expression of FADS2 mRNA [troglitazone results in decreased expression of FADS2 mRNA] which affects the abundance of Cholesterol Esters; [troglitazone results in decreased expression of FADS2 mRNA] which affects the abundance of Phospholipids; [troglitazone results in decreased expression of FADS2 mRNA] which affects the abundance of Triglycerides troglitazone inhibits the reaction [Dietary Sucrose results in increased activity of FADS2 protein]; troglitazone inhibits the reaction [Dietary Sucrose results in increased expression of FADS2 mRNA]
CTD
PMID:11916926 PMID:15763435 PMID:28973697
NCBI chr 1:216,132,277...216,172,190
Ensembl chr 1:216,133,676...216,172,066
G
Fah
fumarylacetoacetate hydrolase
increases expression
EXP
troglitazone results in increased expression of FAH protein
CTD
PMID:21315101
NCBI chr 1:147,957,931...147,980,708
Ensembl chr 1:147,957,935...147,981,046
G
Fam13a
family with sequence similarity 13, member A
increases expression
EXP
troglitazone results in increased expression of FAM13A mRNA
CTD
PMID:21515302
NCBI chr 4:89,386,685...89,485,940
Ensembl chr 4:89,388,569...89,485,988
G
Fam149a
family with sequence similarity 149, member A
decreases expression
EXP
troglitazone results in decreased expression of FAM149A mRNA
CTD
PMID:21515302
NCBI chr16:53,587,841...53,647,072
Ensembl chr16:53,587,841...53,647,072
G
Fam149b1
family with sequence similarity 149, member B1
decreases expression
ISO
troglitazone results in decreased expression of FAM149B1 mRNA
CTD
PMID:28973697
NCBI chr15:3,978,377...4,016,323
Ensembl chr15:3,978,377...4,016,317
G
Fam168a
family with sequence similarity 168, member A
decreases expression
ISO
troglitazone results in decreased expression of FAM168A mRNA
CTD
PMID:28973697
NCBI chr 1:164,469,447...164,615,542
Ensembl chr 1:164,469,471...164,615,506
G
Fam193a
family with sequence similarity 193, member A
decreases expression
ISO
troglitazone results in decreased expression of FAM193A mRNA
CTD
PMID:28973697
NCBI chr14:80,480,742...80,607,086
Ensembl chr14:80,480,742...80,607,024
G
Fam20a
FAM20A, golgi associated secretory pathway pseudokinase
decreases expression
ISO
troglitazone results in decreased expression of FAM20A mRNA
CTD
PMID:28973697
NCBI chr10:95,136,799...95,197,176
Ensembl chr10:95,142,458...95,197,053
G
Fam210a
family with sequence similarity 210, member A
multiple interactions
ISO
[troglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of FAM210A mRNA; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of FAM210A mRNA]
CTD
PMID:20847119
NCBI chr18:64,116,274...64,155,971
Ensembl chr18:64,116,274...64,155,949
G
Fam76a
family with sequence similarity 76, member A
decreases expression
ISO
troglitazone results in decreased expression of FAM76A mRNA
CTD
PMID:28973697
NCBI chr 5:150,391,460...150,419,526
Ensembl chr 5:150,391,463...150,419,807
G
Fam83d
family with sequence similarity 83, member D
decreases expression
ISO
troglitazone results in decreased expression of FAM83D mRNA
CTD
PMID:19140230
NCBI chr 3:167,841,748...167,861,062
Ensembl chr 3:167,841,791...167,861,061
G
Fancb
FA complementation group B
decreases expression
ISO
troglitazone results in decreased expression of FANCB mRNA
CTD
PMID:19140230
NCBI chr X:33,035,387...33,051,993
Ensembl chr X:33,035,387...33,051,808
G
Fancd2
FA complementation group D2
decreases expression
ISO
troglitazone results in decreased expression of FANCD2 mRNA
CTD
PMID:19140230
NCBI chr 4:148,234,633...148,299,035
Ensembl chr 4:148,234,708...148,299,035
G
Fancg
FA complementation group G
decreases expression
ISO
troglitazone results in decreased expression of FANCG mRNA
CTD
PMID:19140230
NCBI chr 5:62,027,494...62,037,202
Ensembl chr 5:62,027,500...62,035,787
G
Fancl
FA complementation group L
decreases expression
ISO
troglitazone results in decreased expression of FANCL mRNA
CTD
PMID:19140230
NCBI chr14:104,449,403...104,515,297
Ensembl chr14:104,394,590...104,515,297
G
Fas
Fas cell surface death receptor
multiple interactions increases expression decreases expression
ISO EXP
[troglitazone co-treated with Diethylstilbestrol] results in increased expression of FAS protein troglitazone results in increased expression of FAS mRNA troglitazone results in decreased expression of FAS mRNA
CTD
PMID:22684020 PMID:22710028 PMID:25596134
NCBI chr 1:241,212,155...241,245,774
Ensembl chr 1:241,205,935...241,246,104
G
Faslg
Fas ligand
increases expression
ISO
troglitazone results in increased expression of FASLG mRNA
CTD
PMID:19631733
NCBI chr13:76,680,885...76,706,042
Ensembl chr13:76,688,243...76,695,503
G
Fasn
fatty acid synthase
increases expression decreases expression multiple interactions
ISO EXP
troglitazone results in increased expression of FASN mRNA troglitazone results in decreased expression of FASN mRNA [[[troglitazone binds to and results in increased activity of PPARG protein] which results in decreased localization of and results in decreased activity of SREBF1 protein] which results in decreased expression of FASN mRNA] which results in decreased abundance of Triglycerides Troglitazone results in increased expression of FASN mRNA
CTD
PMID:19022234 PMID:19248225 PMID:22953781 PMID:23277027
NCBI chr10:106,570,415...106,588,581
Ensembl chr10:106,570,413...106,588,583
G
Fblim1
filamin binding LIM protein 1
increases expression
ISO
troglitazone results in increased expression of FBLIM1 mRNA
CTD
PMID:28973697
NCBI chr 5:159,167,004...159,198,578
Ensembl chr 5:159,167,004...159,196,853
G
Fbln5
fibulin 5
decreases expression increases expression
ISO
troglitazone results in decreased expression of FBLN5 mRNA troglitazone results in increased expression of FBLN5 mRNA
CTD
PMID:28973697
NCBI chr 6:126,664,100...126,742,847
Ensembl chr 6:126,664,100...126,746,296
G
Fbn1
fibrillin 1
increases expression
ISO
troglitazone results in increased expression of FBN1 mRNA
CTD
PMID:19140230 PMID:28973697
NCBI chr 3:133,007,693...133,204,277
Ensembl chr 3:133,008,361...133,204,283
G
Fbp1
fructose-bisphosphatase 1
increases expression
EXP
troglitazone results in increased expression of FBP1 mRNA
CTD
PMID:21515302
NCBI chr17:2,212,941...2,235,749
Ensembl chr17:2,213,492...2,235,746
G
Fbp2
fructose-bisphosphatase 2
increases expression
EXP
troglitazone results in increased expression of FBP2 mRNA
CTD
PMID:21515302
NCBI chr17:2,241,767...2,259,371
Ensembl chr17:2,241,975...2,259,366
G
Fbrs
fibrosin
decreases expression
ISO
troglitazone results in decreased expression of FBRS mRNA
CTD
PMID:28973697
NCBI chr 1:191,520,148...191,534,510
Ensembl chr 1:191,522,036...191,534,500
G
Fbrsl1
fibrosin-like 1
decreases expression
ISO
troglitazone results in decreased expression of FBRSL1 mRNA
CTD
PMID:28973697
NCBI chr12:51,891,211...51,979,715
Ensembl chr12:51,960,790...51,979,361
G
Fbxl20
F-box and leucine-rich repeat protein 20
decreases expression
ISO
troglitazone results in decreased expression of FBXL20 mRNA
CTD
PMID:28973697
NCBI chr10:83,577,038...83,640,022
Ensembl chr10:83,577,038...83,639,977
G
Fbxl7
F-box and leucine-rich repeat protein 7
decreases expression
ISO
troglitazone results in decreased expression of FBXL7 mRNA
CTD
PMID:28973697
NCBI chr 2:78,870,236...79,239,697
Ensembl chr 2:78,871,287...79,239,697
G
Fbxo21
F-box protein 21
decreases expression
ISO
troglitazone results in decreased expression of FBXO21 mRNA
CTD
PMID:28973697
NCBI chr12:44,231,918...44,266,035
Ensembl chr12:44,231,923...44,266,035
G
Fbxo22
F-box protein 22
decreases expression
EXP
troglitazone results in decreased expression of FBXO22 mRNA
CTD
PMID:25596134
NCBI chr 8:64,476,034...64,492,063
Ensembl chr 8:64,475,957...64,492,062
G
Fbxo30
F-box protein 30
decreases expression
ISO
troglitazone results in decreased expression of FBXO30 mRNA
CTD
PMID:28973697
NCBI chr 1:7,475,636...7,491,719
Ensembl chr 1:7,475,575...7,493,199
G
Fbxo32
F-box protein 32
decreases expression
EXP
troglitazone results in decreased expression of FBXO32 mRNA
CTD
PMID:21515302
NCBI chr 7:91,620,925...91,654,491
Ensembl chr 7:91,620,925...91,654,491
G
Fbxo42
F-box protein 42
decreases expression
ISO
troglitazone results in decreased expression of FBXO42 mRNA
CTD
PMID:28973697
NCBI chr 5:158,734,165...158,792,560
Ensembl chr 5:158,734,175...158,792,565
G
Fbxw7
F-box and WD repeat domain containing 7
decreases expression
ISO
troglitazone results in decreased expression of FBXW7 mRNA
CTD
PMID:28973697
NCBI chr 2:172,447,738...172,609,591
Ensembl chr 2:172,447,738...172,609,591
G
Fcer1g
Fc epsilon receptor Ig
increases expression
ISO
troglitazone results in increased expression of FCER1G mRNA
CTD
PMID:28973697
NCBI chr13:86,181,908...86,186,766
Ensembl chr13:86,181,908...86,186,859
G
Fcgr2a
Fc gamma receptor 2A
increases expression
ISO
Troglitazone results in increased expression of FCGR2A mRNA
CTD
PMID:28973697
NCBI chr13:85,813,516...85,830,269
Ensembl chr13:85,855,437...85,864,394 Ensembl chr13:85,855,437...85,864,394
G
Fcgr2b
Fc gamma receptor 2B
increases expression
ISO
Troglitazone results in increased expression of FCGR2B mRNA
CTD
PMID:28973697
NCBI chr13:85,725,897...85,740,517
Ensembl chr13:85,725,897...85,740,517
G
Fcmr
Fc mu receptor
increases expression
ISO
troglitazone results in increased expression of FCMR mRNA
CTD
PMID:19140230
NCBI chr13:44,889,628...44,903,926
Ensembl chr13:44,889,697...44,906,314
G
Fcrl2
Fc receptor-like 2
increases expression
ISO
Troglitazone results in increased expression of FCRL2 mRNA
CTD
PMID:28973697
NCBI chr 2:174,992,226...175,005,177
Ensembl chr 2:174,992,226...175,004,967
G
Fen1
flap structure-specific endonuclease 1
decreases expression
ISO
troglitazone results in decreased expression of FEN1 mRNA
CTD
PMID:19140230
NCBI chr 1:216,270,016...216,274,873
Ensembl chr 1:216,269,163...216,275,016
G
Fer
FER tyrosine kinase
decreases expression
ISO
troglitazone results in decreased expression of FER mRNA
CTD
PMID:28973697
NCBI chr 9:110,967,317...111,274,315
Ensembl chr 9:110,967,390...111,274,315
G
Fermt3
FERM domain containing kindlin 3
decreases expression
ISO
troglitazone results in decreased expression of FERMT3 mRNA
CTD
PMID:17569031
NCBI chr 1:213,618,691...213,636,889
Ensembl chr 1:213,618,208...213,636,273
G
Ffar2
free fatty acid receptor 2
increases expression
ISO
troglitazone results in increased expression of FFAR2 mRNA
CTD
PMID:28973697
NCBI chr 1:95,199,277...95,202,599
Ensembl chr 1:95,199,271...95,202,623
G
Fgd5
FYVE, RhoGEF and PH domain containing 5
decreases expression
ISO
troglitazone results in decreased expression of FGD5 mRNA
CTD
PMID:28973697
NCBI chr 4:126,054,201...126,151,698
Ensembl chr 4:126,054,210...126,151,697
G
Fgd6
FYVE, RhoGEF and PH domain containing 6
decreases expression
ISO
troglitazone results in decreased expression of FGD6 mRNA
CTD
PMID:28973697
NCBI chr 7:30,484,600...30,599,898
Ensembl chr 7:30,484,600...30,595,806
G
Fgf21
fibroblast growth factor 21
increases expression decreases expression
EXP ISO
troglitazone results in increased expression of FGF21 mRNA troglitazone results in decreased expression of FGF21 mRNA
CTD
PMID:21515302 PMID:28973697
NCBI chr 1:105,219,825...105,221,376
Ensembl chr 1:105,219,825...105,232,056
G
Fgfr2
fibroblast growth factor receptor 2
decreases expression
ISO
troglitazone results in decreased expression of FGFR2 mRNA
CTD
PMID:28973697
NCBI chr 1:194,175,703...194,280,914
Ensembl chr 1:194,175,705...194,280,914
G
Fgr
FGR proto-oncogene, Src family tyrosine kinase
increases expression
ISO
troglitazone results in increased expression of FGR mRNA
CTD
PMID:28973697
NCBI chr 5:150,473,767...150,503,524
Ensembl chr 5:150,473,792...150,503,169
G
Fhdc1
FH2 domain containing 1
decreases expression
ISO
troglitazone results in decreased expression of FHDC1 mRNA
CTD
PMID:28973697
NCBI chr 2:172,088,987...172,127,838
Ensembl chr 2:172,089,010...172,125,956
G
Fhip2a
FHF complex subunit HOOK interacting protein 2A
decreases expression
ISO
Troglitazone results in decreased expression of FHIP2A mRNA
CTD
PMID:28973697
NCBI chr 1:266,422,617...266,449,206
Ensembl chr 1:266,422,723...266,449,206
G
Fhip2b
FHF complex subunit HOOK interacting protein 2B
decreases expression
ISO
Troglitazone results in decreased expression of FHIP2B mRNA
CTD
PMID:28973697
NCBI chr15:52,066,341...52,084,296
Ensembl chr15:52,066,341...52,083,798
G
Fibin
fin bud initiation factor homolog
increases expression
EXP
troglitazone results in increased expression of FIBIN mRNA
CTD
PMID:21515302
NCBI chr 3:117,396,973...117,399,244
Ensembl chr 3:117,391,724...117,399,479
G
Filip1l
filamin A interacting protein 1-like
decreases expression
ISO
troglitazone results in decreased expression of FILIP1L mRNA
CTD
PMID:20846491
NCBI chr11:56,403,467...56,646,422
Ensembl chr11:56,410,582...56,646,402
G
Fip1l1
factor interacting with PAPOLA and CPSF1
decreases expression
ISO
troglitazone results in decreased expression of FIP1L1 mRNA
CTD
PMID:28973697
NCBI chr14:33,969,341...34,030,871
Ensembl chr14:33,971,914...34,029,753
G
Fjx1
four-jointed box kinase 1
multiple interactions
ISO
[troglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of FJX1 mRNA; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of FJX1 mRNA]
CTD
PMID:20847119
NCBI chr 3:109,229,223...109,231,324
Ensembl chr 3:109,227,170...109,232,479
G
Fktn
fukutin
decreases expression
ISO
troglitazone results in decreased expression of FKTN mRNA
CTD
PMID:28973697
NCBI chr 5:73,134,746...73,191,772
Ensembl chr 5:73,135,361...73,189,181
G
Flacc1
flagellum associated containing coiled-coil domains 1
increases expression
ISO
Troglitazone results in increased expression of FLACC1 mRNA
CTD
PMID:28973697
NCBI chr 9:67,809,731...67,837,793
Ensembl chr 9:67,809,739...67,837,793
G
Flcn
folliculin
decreases expression
ISO
troglitazone results in decreased expression of FLCN mRNA
CTD
PMID:28973697
NCBI chr10:45,088,164...45,107,581
Ensembl chr10:45,088,167...45,107,309
G
Flt1
Fms related receptor tyrosine kinase 1
increases expression multiple interactions decreases expression
ISO
troglitazone results in increased expression of FLT1 mRNA [Urethane co-treated with troglitazone] results in increased expression of FLT1 mRNA troglitazone results in decreased expression of FLT1 mRNA
CTD
PMID:17569031 PMID:18465119 PMID:28973697
NCBI chr12:12,333,050...12,504,750
Ensembl chr12:12,333,430...12,504,750
G
Flt4
Fms related receptor tyrosine kinase 4
decreases expression
ISO
troglitazone results in decreased expression of FLT4 mRNA
CTD
PMID:28973697
NCBI chr10:34,414,834...34,455,878
Ensembl chr10:34,414,733...34,456,645
G
Fmnl2
formin-like 2
increases expression
ISO
troglitazone results in increased expression of FMNL2 mRNA
CTD
PMID:19140230
NCBI chr 3:57,758,236...58,033,832
Ensembl chr 3:57,758,191...58,033,831
G
Fmo1
flavin containing dimethylaniline monoxygenase 1
decreases expression increases expression
ISO EXP
troglitazone results in decreased expression of FMO1 mRNA troglitazone results in increased expression of FMO1 mRNA
CTD
PMID:19631733 PMID:21515302
NCBI chr13:77,715,405...77,747,666
Ensembl chr13:77,715,402...77,747,874
G
Fmo5
flavin containing dimethylaniline monoxygenase 5
decreases expression
ISO
troglitazone results in decreased expression of FMO5 mRNA
CTD
PMID:19631733 PMID:25572481
NCBI chr 2:187,885,741...187,938,468
Ensembl chr 2:187,910,964...187,938,464
G
Fn1
fibronectin 1
multiple interactions decreases expression decreases secretion increases expression
ISO
2-chloro-5-nitrobenzanilide inhibits the reaction [troglitazone results in decreased expression of FN1 protein]; PPARG protein promotes the reaction [troglitazone results in decreased expression of FN1 protein]; troglitazone inhibits the reaction [Glucose results in increased expression of FN1 mRNA]; troglitazone inhibits the reaction [TGFB1 protein results in increased expression of FN1 mRNA]; troglitazone inhibits the reaction [TGFB1 protein results in increased expression of FN1 protein]; troglitazone inhibits the reaction [TGFB2 protein results in increased expression of FN1 mRNA]; troglitazone inhibits the reaction [TGFB2 protein results in increased expression of FN1 protein] troglitazone results in decreased expression of FN1 mRNA; troglitazone results in decreased expression of FN1 protein troglitazone results in decreased secretion of FN1 protein troglitazone results in increased expression of FN1 mRNA
CTD
PMID:15908479 PMID:17056281 PMID:17199790 PMID:18253093 PMID:28973697
NCBI chr 9:80,645,507...80,714,200
Ensembl chr 9:80,645,507...80,714,137
G
Fnbp1
formin binding protein 1
increases expression
ISO
troglitazone results in increased expression of FNBP1 mRNA
CTD
PMID:28973697
NCBI chr 3:34,706,814...34,826,770
Ensembl chr 3:34,706,814...34,822,117
G
Fndc1
fibronectin type III domain containing 1
increases expression
ISO
troglitazone results in increased expression of FNDC1 mRNA
CTD
PMID:28973697
NCBI chr 1:49,686,856...49,769,263
Ensembl chr 1:49,686,856...49,769,263
G
Folr2
folate receptor beta
increases expression
ISO
troglitazone results in increased expression of FOLR2 mRNA
CTD
PMID:28973697
NCBI chr 1:165,612,047...165,630,382
Ensembl chr 1:165,612,063...165,617,731
G
Fos
Fos proto-oncogene, AP-1 transcription factor subunit
increases expression decreases expression multiple interactions
ISO EXP
troglitazone results in increased expression of FOS mRNA troglitazone results in decreased expression of FOS mRNA [Urethane co-treated with troglitazone] results in increased expression of FOS mRNA troglitazone inhibits the reaction [Phenylephrine results in increased expression of FOS protein]
CTD
PMID:10422649 PMID:11401521 PMID:11687581 PMID:17569031 PMID:18465119 PMID:19140230 PMID:19631733 More...
NCBI chr 6:110,852,188...110,855,054
Ensembl chr 6:110,852,190...110,855,598
G
Fosl1
FOS like 1, AP-1 transcription factor subunit
increases expression
ISO
troglitazone results in increased expression of FOSL1 mRNA
CTD
PMID:12732648
NCBI chr 1:212,183,885...212,192,391
Ensembl chr 1:212,183,833...212,192,391
G
Foxa1
forkhead box A1
multiple interactions decreases expression
ISO
[Troglitazone co-treated with 4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline] results in decreased expression of FOXA1 mRNA; [Troglitazone co-treated with 4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline] results in decreased expression of FOXA1 protein Troglitazone results in decreased expression of FOXA1 mRNA; Troglitazone results in decreased expression of FOXA1 protein
CTD
PMID:32822399
NCBI chr 6:80,838,380...80,871,195
Ensembl chr 6:80,800,960...80,871,191
G
Foxf1
forkhead box F1
increases expression
ISO
troglitazone results in increased expression of FOXF1 mRNA
CTD
PMID:19140230
NCBI chr19:66,062,635...66,066,427
Ensembl chr19:66,062,369...66,066,428
G
Foxi2
forkhead box I2
increases expression
EXP
troglitazone results in increased expression of FOXI2 mRNA
CTD
PMID:21515302
NCBI chr 1:199,652,703...199,656,503
Ensembl chr 1:199,652,703...199,656,498
G
Foxj1
forkhead box J1
decreases expression
EXP
troglitazone results in decreased expression of FOXJ1 mRNA
CTD
PMID:21515302
NCBI chr10:102,065,163...102,069,945
Ensembl chr10:102,065,170...102,069,241
G
Foxj3
forkhead box J3
decreases expression
ISO
troglitazone results in decreased expression of FOXJ3 mRNA
CTD
PMID:28973697
NCBI chr 5:138,425,623...138,513,760
Ensembl chr 5:138,424,923...138,513,760
G
Foxk1
forkhead box K1
decreases expression
ISO
troglitazone results in decreased expression of FOXK1 mRNA
CTD
PMID:28973697
NCBI chr12:17,223,599...17,288,564
Ensembl chr12:17,229,430...17,288,564
G
Foxm1
forkhead box M1
decreases expression
ISO
troglitazone results in decreased expression of FOXM1 mRNA
CTD
PMID:19140230
NCBI chr 4:163,325,628...163,338,100
Ensembl chr 4:163,325,614...163,337,172
G
Foxn2
forkhead box N2
decreases expression
ISO
troglitazone results in decreased expression of FOXN2 mRNA
CTD
PMID:28973697
NCBI chr 6:11,772,180...11,818,751
Ensembl chr 6:11,772,180...11,818,751
G
Foxn3
forkhead box N3
decreases expression
ISO
troglitazone results in decreased expression of FOXN3 mRNA
CTD
PMID:28973697
NCBI chr 6:124,191,695...124,572,070
Ensembl chr 6:124,195,701...124,572,040
G
Foxo1
forkhead box O1
decreases expression
ISO
troglitazone results in decreased expression of FOXO1 mRNA
CTD
PMID:28973697
NCBI chr 2:138,462,974...138,541,420
Ensembl chr 2:138,462,697...138,541,419
G
Foxo3
forkhead box O3
decreases expression
ISO
troglitazone results in decreased expression of FOXO3 mRNA
CTD
PMID:28973697
NCBI chr20:47,251,968...47,348,254
Ensembl chr20:47,255,878...47,346,845
G
Foxp1
forkhead box P1
decreases expression
ISO
troglitazone results in decreased expression of FOXP1 mRNA
CTD
PMID:28973697
NCBI chr 4:133,117,346...133,808,647
Ensembl chr 4:133,122,055...133,500,272
G
Foxp3
forkhead box P3
increases expression
ISO
Troglitazone results in increased expression of FOXP3 mRNA
CTD
PMID:31294483
NCBI chr X:17,580,380...17,601,181
Ensembl chr X:17,580,380...17,595,894
G
Foxp4
forkhead box P4
decreases expression
ISO
troglitazone results in decreased expression of FOXP4 mRNA
CTD
PMID:28973697
NCBI chr 9:20,556,270...20,612,967
Ensembl chr 9:20,556,270...20,612,967
G
Frk
fyn-related Src family tyrosine kinase
increases expression
ISO
troglitazone results in increased expression of FRK mRNA
CTD
PMID:17569031
NCBI chr20:39,820,441...39,926,065
Ensembl chr20:39,820,295...39,926,362
G
Frmd4b
FERM domain containing 4B
decreases expression
EXP ISO
troglitazone results in decreased expression of FRMD4B mRNA
CTD
PMID:21515302 PMID:28973697
NCBI chr 4:131,452,361...131,778,734
Ensembl chr 4:131,452,365...131,640,287
G
Frmd6
FERM domain containing 6
decreases expression
EXP
troglitazone results in decreased expression of FRMD6 mRNA
CTD
PMID:21515302
NCBI chr 6:95,081,958...95,155,561
Ensembl chr 6:95,081,985...95,155,560
G
Frmpd4
FERM and PDZ domain containing 4
decreases expression
ISO
troglitazone results in decreased expression of FRMPD4 mRNA
CTD
PMID:28934090
NCBI chr X:29,739,834...30,386,917
Ensembl chr X:29,368,849...30,384,621
G
Fscn1
fascin actin-bundling protein 1
increases expression
ISO
troglitazone results in increased expression of FSCN1 mRNA
CTD
PMID:19140230
NCBI chr12:16,710,601...16,723,734
Ensembl chr12:16,710,601...16,723,734
G
Fst
follistatin
increases expression
ISO
troglitazone results in increased expression of FST mRNA
CTD
PMID:19140230 PMID:28973697
NCBI chr 2:47,856,345...47,863,670
Ensembl chr 2:47,856,345...47,863,491
G
Fstl1
follistatin-like 1
increases expression
ISO
troglitazone results in increased expression of FSTL1 mRNA
CTD
PMID:28973697
NCBI chr11:76,400,870...76,454,053
Ensembl chr11:76,391,315...76,455,126
G
Fth1
ferritin heavy chain 1
increases expression
ISO
troglitazone results in increased expression of FTH1 mRNA
CTD
PMID:19140230
NCBI chr 1:216,052,037...216,054,325
Ensembl chr 1:216,051,998...216,055,214
G
Fubp1
far upstream element binding protein 1
decreases expression
ISO
troglitazone results in decreased expression of FUBP1 mRNA
CTD
PMID:28973697
NCBI chr 2:243,819,529...243,846,544
Ensembl chr 2:243,819,218...243,846,428
G
Fundc2
FUN14 domain containing 2
decreases expression
ISO
troglitazone results in decreased expression of FUNDC2 mRNA
CTD
PMID:28973697
NCBI chr18:142,829...155,123
Ensembl chr18:142,640...155,674
G
Furin
furin (paired basic amino acid cleaving enzyme)
decreases expression
ISO
troglitazone results in decreased expression of FURIN mRNA
CTD
PMID:28973697
NCBI chr 1:143,757,389...143,770,430
Ensembl chr 1:143,757,391...143,773,497
G
Fus
Fus RNA binding protein
decreases expression
ISO
troglitazone results in decreased expression of FUS mRNA
CTD
PMID:28973697
NCBI chr 1:192,007,011...192,020,887
Ensembl chr 1:192,007,006...192,020,884
G
Fut1
fucosyltransferase 1
increases expression
EXP
troglitazone results in increased expression of FUT1 mRNA
CTD
PMID:21515302
NCBI chr 1:105,223,399...105,226,817
Ensembl chr 1:105,223,390...105,227,513
G
Fxr1
FMR1 autosomal homolog 1
decreases expression
ISO
troglitazone results in decreased expression of FXR1 mRNA
CTD
PMID:28973697
NCBI chr 2:118,812,287...118,865,813
Ensembl chr 2:118,811,980...118,867,027
G
Fxyd5
FXYD domain-containing ion transport regulator 5
decreases expression increases expression
EXP ISO
troglitazone results in decreased expression of FXYD5 mRNA troglitazone results in increased expression of FXYD5 mRNA
CTD
PMID:21515302 PMID:25572481
NCBI chr 1:95,395,327...95,404,722
Ensembl chr 1:95,395,146...95,405,364
G
Fyco1
FYVE and coiled-coil domain autophagy adaptor 1
decreases expression
ISO
troglitazone results in decreased expression of FYCO1 mRNA
CTD
PMID:28973697
NCBI chr 8:132,289,538...132,356,810
Ensembl chr 8:132,289,539...132,356,451
G
Fzd7
frizzled class receptor 7
decreases expression
ISO
troglitazone results in decreased expression of FZD7 mRNA
CTD
PMID:28973697
NCBI chr 9:68,425,538...68,428,357
Ensembl chr 9:68,411,259...68,432,585
G
Fzd8
frizzled class receptor 8
decreases expression
ISO
troglitazone results in decreased expression of FZD8 mRNA
CTD
PMID:28973697
NCBI chr17:62,007,849...62,015,485
Ensembl chr17:62,007,627...62,015,961
G
G0s2
G0/G1switch 2
increases expression decreases expression
EXP ISO
troglitazone results in increased expression of G0S2 mRNA troglitazone results in decreased expression of G0S2 mRNA
CTD
PMID:21515302 PMID:25572481
NCBI chr13:107,335,036...107,335,948
Ensembl chr13:107,335,036...107,336,293
G
G6pc1
glucose-6-phosphatase catalytic subunit 1
decreases expression
EXP ISO
Troglitazone results in decreased expression of G6PC1 mRNA
CTD
PMID:10446394 PMID:11228057 PMID:25572481
NCBI chr10:86,807,659...86,819,023
Ensembl chr10:86,757,899...86,818,033
G
G6pd
glucose-6-phosphate dehydrogenase
increases expression
ISO
troglitazone results in increased expression of G6PD mRNA
CTD
PMID:28973697
NCBI chr X:157,352,364...157,372,144
Ensembl chr X:157,352,373...157,372,144
G
Gab1
GRB2-associated binding protein 1
decreases expression
ISO
troglitazone results in decreased expression of GAB1 mRNA
CTD
PMID:28973697
NCBI chr19:44,035,693...44,143,617
Ensembl chr19:44,035,063...44,143,617
G
Gabarapl1
GABA type A receptor associated protein like 1
increases expression decreases expression
ISO
troglitazone results in increased expression of GABARAPL1 mRNA troglitazone results in decreased expression of GABARAPL1 mRNA
CTD
PMID:19140230 PMID:28973697
NCBI chr 4:164,666,332...164,675,474
Ensembl chr 4:164,666,246...164,674,578
G
Gabbr2
gamma-aminobutyric acid type B receptor subunit 2
decreases expression
ISO
troglitazone results in decreased expression of GABBR2 mRNA
CTD
PMID:19140230
NCBI chr 5:65,743,073...66,083,695
Ensembl chr 5:65,743,073...66,083,695
G
Gabpb1
GA binding protein transcription factor subunit beta 1
decreases expression
ISO
troglitazone results in decreased expression of GABPB1 mRNA
CTD
PMID:28973697
NCBI chr 3:134,333,339...134,380,239
Ensembl chr 3:134,333,339...134,361,344
G
Gabrg3
gamma-aminobutyric acid type A receptor subunit gamma 3
increases expression
EXP
troglitazone results in increased expression of GABRG3 mRNA
CTD
PMID:21515302
NCBI chr 1:116,763,332...117,386,770
Ensembl chr 1:116,763,129...117,382,536
G
Gadd45a
growth arrest and DNA-damage-inducible, alpha
increases expression affects response to substance multiple interactions
EXP ISO
troglitazone results in increased expression of GADD45A mRNA; troglitazone results in increased expression of GADD45A protein GADD45A protein affects the susceptibility to troglitazone troglitazone inhibits the reaction [pyrazolanthrone results in increased expression of GADD45A mRNA]; troglitazone inhibits the reaction [pyrazolanthrone results in increased expression of GADD45A protein]; troglitazone promotes the reaction [2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one results in increased expression of GADD45A mRNA]; troglitazone promotes the reaction [SB 203580 results in increased expression of GADD45A mRNA]
CTD
PMID:11068018 PMID:15064713 PMID:19022234 PMID:19631733
NCBI chr 4:97,484,497...97,486,799
Ensembl chr 4:97,484,502...97,486,807
G
Gal3st1
galactose-3-O-sulfotransferase 1
increases expression
ISO
troglitazone results in increased expression of GAL3ST1 mRNA
CTD
PMID:28973697
NCBI chr14:83,094,265...83,109,992
Ensembl chr14:83,094,385...83,109,978
G
Gale
UDP-galactose-4-epimerase
increases expression
ISO
troglitazone results in increased expression of GALE mRNA
CTD
PMID:28973697
NCBI chr 5:153,477,420...153,481,926
Ensembl chr 5:153,478,325...153,481,922
G
Galnt16
polypeptide N-acetylgalactosaminyltransferase 16
decreases expression
EXP
troglitazone results in decreased expression of GALNT16 mRNA
CTD
PMID:21515302
NCBI chr 6:105,900,987...105,982,039
Ensembl chr 6:105,901,153...105,991,350
G
Galnt18
polypeptide N-acetylgalactosaminyltransferase 18
increases expression
ISO
troglitazone results in increased expression of GALNT18 mRNA
CTD
PMID:28973697
NCBI chr 1:175,027,832...175,338,883
Ensembl chr 1:175,027,839...175,338,883
G
Gas1
growth arrest-specific 1
decreases expression
ISO
troglitazone results in decreased expression of GAS1 mRNA
CTD
PMID:28973697
NCBI chr17:4,487,716...4,490,701
Ensembl chr17:4,484,283...4,497,657
G
Gas7
growth arrest specific 7
increases expression
ISO
troglitazone results in increased expression of GAS7 mRNA
CTD
PMID:28973697
NCBI chr10:52,651,690...52,882,244
Ensembl chr10:52,651,690...52,882,244
G
Gata2
GATA binding protein 2
decreases expression
ISO
troglitazone results in decreased expression of GATA2 mRNA
CTD
PMID:19140230
NCBI chr 4:122,211,501...122,225,058
Ensembl chr 4:122,211,829...122,225,055
G
Gata3
GATA binding protein 3
multiple interactions increases expression decreases expression
ISO
[Troglitazone co-treated with 4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline] results in decreased expression of GATA3 mRNA; [Troglitazone co-treated with 4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline] results in increased expression of GATA3 protein Troglitazone results in increased expression of GATA3 protein Troglitazone results in decreased expression of GATA3 mRNA
CTD
PMID:32822399
NCBI chr17:73,544,234...73,575,670
Ensembl chr17:73,553,548...73,575,670
G
Gatad2a
GATA zinc finger domain containing 2A
decreases expression
ISO
troglitazone results in decreased expression of GATAD2A mRNA
CTD
PMID:28973697
NCBI chr16:19,463,500...19,553,497
Ensembl chr16:19,463,500...19,553,497
G
Gatad2b
GATA zinc finger domain containing 2B
decreases expression
ISO
troglitazone results in decreased expression of GATAD2B mRNA
CTD
PMID:28973697
NCBI chr 2:178,046,192...178,127,633
Ensembl chr 2:178,046,085...178,147,315
G
Gba3
glucosylceramidase beta 3
decreases expression
ISO
troglitazone results in decreased expression of GBA3 mRNA
CTD
PMID:25572481
NCBI chr14:64,787,601...64,934,043
Ensembl chr14:64,787,601...64,934,043
G
Gcg
glucagon
multiple interactions
EXP
troglitazone inhibits the reaction [Glucose results in decreased secretion of GCG protein]
CTD
PMID:12914525
NCBI chr 3:67,522,489...67,531,533
Ensembl chr 3:67,522,489...67,531,533
G
Gcgr
glucagon receptor
decreases expression
EXP
troglitazone results in decreased expression of GCGR mRNA
CTD
PMID:21515302
NCBI chr10:106,306,803...106,314,970
Ensembl chr10:106,306,559...106,314,969
G
Gckr
glucokinase regulator
decreases expression increases expression
EXP
troglitazone results in decreased expression of GCKR mRNA troglitazone results in increased expression of GCKR protein
CTD
PMID:21315101 PMID:21515302
NCBI chr 6:30,765,071...30,795,627
Ensembl chr 6:30,765,075...30,795,627
G
Gclc
glutamate-cysteine ligase, catalytic subunit
increases expression
ISO
troglitazone results in increased expression of GCLC mRNA
CTD
PMID:19140230
NCBI chr 8:87,510,251...87,548,896
Ensembl chr 8:87,510,463...87,548,893
G
Gcn1
GCN1 activator of EIF2AK4
decreases expression
ISO
troglitazone results in decreased expression of GCN1 mRNA
CTD
PMID:28973697
NCBI chr12:46,652,273...46,715,119
Ensembl chr12:46,652,273...46,713,488
G
Gde1
glycerophosphodiester phosphodiesterase 1
increases expression
ISO
troglitazone results in increased expression of GDE1 mRNA
CTD
PMID:28973697
NCBI chr 1:182,451,182...182,466,569
Ensembl chr 1:182,451,184...182,466,772
G
Gdf10
growth differentiation factor 10
increases expression
ISO
troglitazone results in increased expression of GDF10 mRNA
CTD
PMID:28973697
NCBI chr16:9,243,434...9,256,788
Ensembl chr16:9,243,317...9,256,794
G
Gdf15
growth differentiation factor 15
multiple interactions increases expression
ISO
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [troglitazone results in increased expression of GDF15 protein]; [EGR1 protein binds to GDF15 promoter] affects the reaction [troglitazone results in increased expression of GDF15]; Cycloheximide inhibits the reaction [troglitazone results in increased expression of GDF15 mRNA] troglitazone results in increased expression of GDF15 mRNA; troglitazone results in increased expression of GDF15 protein
CTD
PMID:14662774 PMID:19140230 PMID:19631733 PMID:21461570 PMID:22750490
NCBI chr16:18,838,436...18,842,022
Ensembl chr16:18,838,436...18,842,022
G
Gdf5
growth differentiation factor 5
increases expression
ISO
troglitazone results in increased expression of GDF5 mRNA
CTD
PMID:28973697
NCBI chr 3:164,914,401...164,918,593
Ensembl chr 3:164,914,401...164,918,593
G
Gem
GTP binding protein overexpressed in skeletal muscle
multiple interactions
ISO
[troglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of GEM mRNA; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of GEM mRNA]
CTD
PMID:20847119
NCBI chr 5:30,011,641...30,022,554
Ensembl chr 5:30,011,592...30,022,542
G
Gemin4
gem (nuclear organelle) associated protein 4
multiple interactions
ISO
Troglitazone inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of GEMIN4 mRNA]
CTD
PMID:20847119
NCBI chr10:61,560,172...61,571,765
Ensembl chr10:61,564,657...61,596,532
G
Gfap
glial fibrillary acidic protein
multiple interactions decreases expression
EXP
[Troglitazone results in increased phosphorylation of and results in increased activity of PPARG protein] which results in decreased expression of GFAP protein; CR8 compound inhibits the reaction [Troglitazone results in decreased expression of GFAP protein]; Troglitazone inhibits the reaction [Lipopolysaccharides results in increased expression of GFAP protein]; Troglitazone promotes the reaction [PPARG protein binds to GFAP promoter] troglitazone results in decreased expression of GFAP mRNA; troglitazone results in decreased expression of GFAP protein
CTD
PMID:24481447
NCBI chr10:88,352,987...88,361,661
Ensembl chr10:88,352,986...88,361,685
G
Gfpt2
glutamine-fructose-6-phosphate transaminase 2
increases expression
ISO
troglitazone results in increased expression of GFPT2 mRNA
CTD
PMID:19140230
NCBI chr10:34,616,146...34,662,420
Ensembl chr10:34,615,370...34,662,419
G
Gfra1
GDNF family receptor alpha 1
decreases expression
EXP
troglitazone results in decreased expression of GFRA1 mRNA
CTD
PMID:21515302
NCBI chr 1:267,325,297...267,557,037
Ensembl chr 1:267,326,817...267,556,501
G
Gga3
golgi associated, gamma adaptin ear containing, ARF binding protein 3
decreases expression
ISO
troglitazone results in decreased expression of GGA3 mRNA
CTD
PMID:28973697
NCBI chr10:101,324,378...101,342,373
Ensembl chr10:101,324,378...101,342,373
G
Ggt5
gamma-glutamyltransferase 5
decreases expression
ISO
troglitazone results in decreased expression of GGT5 mRNA
CTD
PMID:25572481
NCBI chr20:13,042,694...13,070,960
Ensembl chr20:13,042,696...13,070,892
G
Ggta1
glycoprotein alpha-galactosyltransferase 1
increases expression
ISO
Troglitazone results in increased expression of GGTA1 mRNA
CTD
PMID:28973697
NCBI chr 3:39,130,466...39,208,652
Ensembl chr 3:39,130,467...39,206,870
G
Ghrhr
growth hormone releasing hormone receptor
increases expression
EXP
troglitazone results in increased expression of GHRHR mRNA
CTD
PMID:21515302
NCBI chr 4:85,830,345...85,863,127
Ensembl chr 4:85,830,486...85,863,127
G
Gigyf2
GRB10 interacting GYF protein 2
decreases expression
ISO
troglitazone results in decreased expression of GIGYF2 mRNA
CTD
PMID:28973697
NCBI chr 9:95,449,143...95,574,927
Ensembl chr 9:95,449,167...95,574,927
G
Gins2
GINS complex subunit 2
decreases expression
ISO
troglitazone results in decreased expression of GINS2 mRNA
CTD
PMID:19140230
NCBI chr19:65,535,492...65,548,270
Ensembl chr19:65,535,492...65,548,052
G
Gja4
gap junction protein, alpha 4
increases expression
ISO
troglitazone results in increased expression of GJA4 mRNA
CTD
PMID:17569031
NCBI chr 5:144,917,791...144,920,324
Ensembl chr 5:144,914,147...144,921,216
G
Gjb1
gap junction protein, beta 1
multiple interactions decreases expression
ISO
Troglitazone results in increased expression of and affects the localization of GJB1 protein Troglitazone results in decreased expression of GJB1 mRNA
CTD
PMID:40024757
NCBI chr X:70,541,845...70,549,776
Ensembl chr X:70,541,862...70,549,843
G
Gjb3
gap junction protein, beta 3
decreases expression
EXP
troglitazone results in decreased expression of GJB3 mRNA
CTD
PMID:21515302
NCBI chr 5:144,933,692...144,939,435
Ensembl chr 5:144,933,696...144,940,280
G
Gk
glycerol kinase
increases expression
EXP
troglitazone results in increased expression of GK mRNA
CTD
PMID:21515302
NCBI chr X:54,106,708...54,189,940
Ensembl chr X:54,112,214...54,196,701
G
Glb1l2
galactosidase, beta 1-like 2
increases expression
ISO
troglitazone results in increased expression of GLB1L2 mRNA
CTD
PMID:28973697
NCBI chr 8:33,391,201...33,442,587
Ensembl chr 8:33,390,678...33,442,695
G
Glce
glucuronic acid epimerase
decreases expression
ISO
troglitazone results in decreased expression of GLCE mRNA
CTD
PMID:28973697
NCBI chr 8:71,441,607...71,507,639
Ensembl chr 8:71,441,616...71,507,587
G
Glg1
golgi glycoprotein 1
decreases expression
ISO
troglitazone results in decreased expression of GLG1 mRNA
CTD
PMID:28973697
NCBI chr19:56,034,248...56,133,538
Ensembl chr19:56,006,459...56,133,528
G
Glo1
glyoxalase 1
multiple interactions decreases expression decreases activity
ISO EXP
[troglitazone results in decreased expression of GLO1 mRNA] which results in increased susceptibility to Doxorubicin; troglitazone inhibits the reaction [GLO1 mRNA results in decreased susceptibility to Doxorubicin] troglitazone results in decreased activity of GLO1 mRNA; troglitazone results in decreased activity of GLO1 protein
CTD
PMID:11719831 PMID:12572858 PMID:16085563
NCBI chr20:8,665,061...8,683,095
Ensembl chr20:8,665,061...8,683,191
G
Glrx
glutaredoxin
increases expression
EXP
troglitazone results in increased expression of GLRX mRNA
CTD
PMID:21515302
NCBI chr 2:7,073,737...7,083,548
Ensembl chr 2:7,073,759...7,083,543
G
Gls
glutaminase
increases expression
ISO
troglitazone results in increased expression of GLS mRNA
CTD
PMID:19140230
NCBI chr 9:56,836,584...56,908,861
Ensembl chr 9:56,836,584...56,908,861
G
Glul
glutamate-ammonia ligase
increases expression
EXP
troglitazone results in increased expression of GLUL protein
CTD
PMID:21315101
NCBI chr13:68,519,500...68,585,554
Ensembl chr13:68,576,067...68,585,520
G
Gmnn
geminin, DNA replication inhibitor
decreases expression
ISO
troglitazone results in decreased expression of GMNN mRNA
CTD
PMID:19140230
NCBI chr17:40,729,760...40,738,077
Ensembl chr17:40,729,824...40,738,068
G
Gmps
guanine monophosphate synthase
decreases expression
ISO
troglitazone results in decreased expression of GMPS mRNA
CTD
PMID:28973697
NCBI chr 2:150,587,824...150,641,564
Ensembl chr 2:150,587,854...150,648,986
G
Gna12
G protein subunit alpha 12
decreases expression
ISO
troglitazone results in decreased expression of GNA12 mRNA
CTD
PMID:28973697
NCBI chr12:18,919,629...19,000,185
Ensembl chr12:18,919,629...19,000,185
G
Gna13
G protein subunit alpha 13
decreases expression
ISO
troglitazone results in decreased expression of GNA13 mRNA
CTD
PMID:28973697
NCBI chr10:94,837,271...94,870,290
Ensembl chr10:94,836,444...94,874,968
G
Gnai1
G protein subunit alpha i1
increases expression
ISO
troglitazone results in increased expression of GNAI1 mRNA
CTD
PMID:28973697
NCBI chr 4:17,706,061...17,790,176
Ensembl chr 4:17,706,025...17,789,198
G
Gnaq
G protein subunit alpha q
decreases expression
ISO
troglitazone results in decreased expression of GNAQ mRNA
CTD
PMID:28973697
NCBI chr 1:222,852,453...223,098,754
Ensembl chr 1:222,852,097...223,126,742
G
Gnat3
G protein subunit alpha transducin 3
increases expression
EXP
troglitazone results in increased expression of GNAT3 mRNA
CTD
PMID:21515302
NCBI chr 4:18,054,551...18,104,332
Ensembl chr 4:18,054,541...18,104,332
G
Gne
glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase
decreases expression
ISO
troglitazone results in decreased expression of GNE mRNA
CTD
PMID:19140230
NCBI chr 5:63,062,953...63,103,320
Ensembl chr 5:63,062,850...63,103,251
G
Gng2
G protein subunit gamma 2
increases expression
ISO
troglitazone results in increased expression of GNG2 mRNA
CTD
PMID:28973697
NCBI chr15:4,365,222...4,466,060
Ensembl chr15:4,365,135...4,466,059
G
Gnmt
glycine N-methyltransferase
decreases expression
ISO
troglitazone results in decreased expression of GNMT mRNA
CTD
PMID:25572481
NCBI chr 9:21,752,235...21,756,368
Ensembl chr 9:21,752,266...21,755,692
G
Gns
glucosamine (N-acetyl)-6-sulfatase
decreases expression
ISO
troglitazone results in decreased expression of GNS mRNA
CTD
PMID:28973697
NCBI chr 7:58,774,625...58,808,650
Ensembl chr 7:58,774,625...58,808,650
G
Golga3
golgin A3
decreases expression
ISO
troglitazone results in decreased expression of GOLGA3 mRNA
CTD
PMID:28973697
NCBI chr12:52,112,129...52,160,311
Ensembl chr12:52,114,590...52,160,226
G
Golga4
golgin A4
decreases expression
ISO
troglitazone results in decreased expression of GOLGA4 mRNA
CTD
PMID:28973697
NCBI chr 8:127,085,830...127,163,227
Ensembl chr 8:127,085,848...127,163,603
G
Golm1
golgi membrane protein 1
increases expression
ISO
troglitazone results in increased expression of GOLM1 mRNA
CTD
PMID:28973697
NCBI chr17:4,996,978...5,049,278
Ensembl chr17:4,996,223...5,047,414
G
Golm2
golgi membrane protein 2
increases expression
ISO
Troglitazone results in increased expression of GOLM2 mRNA
CTD
PMID:28973697
NCBI chr 3:129,280,623...129,349,895
Ensembl chr 3:129,280,701...129,349,895
G
Golt1b
golgi transport 1B
increases expression
ISO
troglitazone results in increased expression of GOLT1B mRNA
CTD
PMID:28973697
NCBI chr 4:177,064,071...177,077,165
Ensembl chr 4:177,064,073...177,077,164
G
Got1
glutamic-oxaloacetic transaminase 1
increases expression
EXP
troglitazone results in increased expression of GOT1 protein
CTD
PMID:21315101
NCBI chr 1:252,306,541...252,337,622
Ensembl chr 1:252,284,434...252,329,871
G
Got1l1
glutamic-oxaloacetic transaminase 1-like 1
increases expression
EXP
troglitazone results in increased expression of GOT1L1 mRNA
CTD
PMID:21515302
NCBI chr16:71,563,562...71,576,446
Ensembl chr16:71,563,534...71,570,468
G
Gp1bb
glycoprotein Ib platelet subunit beta
decreases expression
ISO
troglitazone results in decreased expression of GP1BB mRNA
CTD
PMID:19140230
NCBI chr11:95,882,561...95,883,738
G
Gpam
glycerol-3-phosphate acyltransferase, mitochondrial
decreases expression
EXP ISO
troglitazone results in decreased expression of GPAM mRNA
CTD
PMID:9452481 PMID:25572481
NCBI chr 1:264,111,599...264,176,112
Ensembl chr 1:264,113,813...264,175,911
G
Gpat3
glycerol-3-phosphate acyltransferase 3
increases expression
ISO
troglitazone results in increased expression of GPAT3 mRNA
CTD
PMID:28973697
NCBI chr14:9,018,762...9,072,552
G
Gpatch8
G patch domain containing 8
decreases expression
ISO
troglitazone results in decreased expression of GPATCH8 mRNA
CTD
PMID:28973697
NCBI chr10:87,932,174...88,012,523
Ensembl chr10:87,932,174...88,012,523
G
Gpc4
glypican 4
decreases expression
ISO
troglitazone results in decreased expression of GPC4 mRNA
CTD
PMID:28973697
NCBI chr X:136,565,536...136,676,142
Ensembl chr X:136,565,591...136,676,057
G
Gpd1
glycerol-3-phosphate dehydrogenase 1
increases expression
EXP
troglitazone results in increased expression of GPD1 protein
CTD
PMID:21315101
NCBI chr 7:132,722,982...132,730,373
Ensembl chr 7:132,721,915...132,730,368
G
Gpd2
glycerol-3-phosphate dehydrogenase 2
increases expression
ISO
troglitazone results in increased expression of GPD2 mRNA
CTD
PMID:11162573
NCBI chr 3:62,209,432...62,346,590
Ensembl chr 3:62,210,814...62,346,593
G
Gphn
gephyrin
decreases expression
ISO
troglitazone results in decreased expression of GPHN mRNA
CTD
PMID:28973697
NCBI chr 6:102,687,405...103,216,679
Ensembl chr 6:102,687,423...103,216,674
G
Gpi
glucose-6-phosphate isomerase
decreases expression
ISO
troglitazone results in decreased expression of GPI mRNA
CTD
PMID:28973697
NCBI chr 1:95,965,389...95,996,932
Ensembl chr 1:95,965,396...95,993,261
G
Gpnmb
glycoprotein nmb
increases expression
ISO EXP
troglitazone results in increased expression of GPNMB mRNA
CTD
PMID:19140230 PMID:25596134
NCBI chr 4:79,341,128...79,362,366
Ensembl chr 4:79,341,021...79,380,240
G
Gpr135
G protein-coupled receptor 135
increases expression
ISO
troglitazone results in increased expression of GPR135 mRNA
CTD
PMID:28973697
NCBI chr 6:96,363,466...96,366,594
Ensembl chr 6:96,362,867...96,382,988
G
Gpr146
G protein-coupled receptor 146
decreases expression
ISO
troglitazone results in decreased expression of GPR146 mRNA
CTD
PMID:28973697
NCBI chr12:20,365,790...20,381,122
Ensembl chr12:20,364,269...20,381,345
G
Gpr160
G protein-coupled receptor 160
increases expression
ISO
troglitazone results in increased expression of GPR160 mRNA
CTD
PMID:28973697
NCBI chr 2:114,414,084...114,491,590
Ensembl chr 2:114,410,261...114,474,790
G
Gpr18
G protein-coupled receptor 18
decreases expression
EXP
troglitazone results in decreased expression of GPR18 mRNA
CTD
PMID:21515302
NCBI chr15:105,404,062...105,407,812
Ensembl chr15:105,404,077...105,408,836
G
Gpr182
G protein-coupled receptor 182
increases expression
ISO
Troglitazone results in increased expression of GPR182 mRNA
CTD
PMID:28973697
NCBI chr 7:65,471,254...65,474,110
Ensembl chr 7:65,452,965...65,474,998
G
Gpr183
G protein-coupled receptor 183
decreases expression
EXP
troglitazone results in decreased expression of GPR183 mRNA
CTD
PMID:21515302
NCBI chr15:105,445,129...105,457,192
Ensembl chr15:105,437,561...105,466,977
G
Gprasp3
G protein-coupled receptor associated sorting protein family member 3
increases expression
ISO
Troglitazone results in increased expression of BHLHB9 mRNA
CTD
PMID:28973697
NCBI chr X:103,639,366...103,644,561
Ensembl chr X:103,609,243...103,650,463
G
Gprc5c
G protein-coupled receptor, class C, group 5, member C
decreases expression
ISO
troglitazone results in decreased expression of GPRC5C mRNA
CTD
PMID:28973697
NCBI chr10:100,385,682...100,407,953
Ensembl chr10:100,383,631...100,426,962
G
Gpt
glutamic--pyruvic transaminase
increases expression
EXP
troglitazone results in increased expression of GPT mRNA
CTD
PMID:21515302
NCBI chr 7:110,295,599...110,300,134
Ensembl chr 7:110,296,206...110,300,160
G
Gpx1
glutathione peroxidase 1
increases expression decreases expression
ISO EXP
troglitazone results in increased expression of GPX1 mRNA troglitazone results in decreased expression of GPX1 protein troglitazone results in increased expression of GPX1 protein
CTD
PMID:11328671 PMID:19631733 PMID:21315101
NCBI chr 8:117,905,462...117,906,588
Ensembl chr 8:117,905,280...117,906,581
G
Gpx2
glutathione peroxidase 2
increases expression
ISO
troglitazone results in increased expression of GPX2 mRNA
CTD
PMID:25572481
NCBI chr 6:101,226,745...101,230,033
Ensembl chr 6:101,226,745...101,230,862
G
Gpx3
glutathione peroxidase 3
decreases expression
EXP
troglitazone results in decreased expression of GPX3 protein
CTD
PMID:11328671
NCBI chr10:39,529,335...39,537,406
Ensembl chr10:39,529,448...39,537,405
G
Gpx7
glutathione peroxidase 7
increases expression
ISO
troglitazone results in increased expression of GPX7 mRNA
CTD
PMID:28973697
NCBI chr 5:128,373,881...128,381,866
Ensembl chr 5:128,372,875...128,381,725
G
Gramd1b
GRAM domain containing 1B
increases expression
ISO
troglitazone results in increased expression of GRAMD1B mRNA
CTD
PMID:28973697
NCBI chr 8:49,551,642...49,790,965
Ensembl chr 8:49,556,332...49,791,052
G
Grb10
growth factor receptor bound protein 10
increases expression
ISO
troglitazone results in increased expression of GRB10 mRNA
CTD
PMID:19140230
NCBI chr14:90,708,653...90,816,399
Ensembl chr14:90,708,653...90,816,387
G
Grb7
growth factor receptor bound protein 7
decreases expression increases expression
ISO
troglitazone results in decreased expression of GRB7 mRNA troglitazone results in increased expression of GRB7 mRNA
CTD
PMID:28973697
NCBI chr10:83,936,538...83,949,344
Ensembl chr10:83,939,299...83,949,382
G
Grm3
glutamate metabotropic receptor 3
increases expression
ISO
troglitazone results in increased expression of GRM3 mRNA
CTD
PMID:25572481
NCBI chr 4:25,319,218...25,600,721
Ensembl chr 4:25,319,942...25,564,764
G
Grp
gastrin releasing peptide
increases expression
EXP
troglitazone results in increased expression of GRP mRNA
CTD
PMID:21515302
NCBI chr18:61,658,655...61,672,037
Ensembl chr18:61,658,250...61,672,037
G
Gsk3b
glycogen synthase kinase 3 beta
multiple interactions affects response to substance decreases activity
ISO
[N-(4-methoxybenzyl)-N'-(5-nitro-1,3-thiazol-2-yl)urea results in decreased activity of GSK3B protein] results in increased susceptibility to [Troglitazone results in decreased expression of CCNB1 protein]; [N-(4-methoxybenzyl)-N'-(5-nitro-1,3-thiazol-2-yl)urea results in decreased activity of GSK3B protein] results in increased susceptibility to [Troglitazone results in decreased expression of CCND1 protein]; [N-(4-methoxybenzyl)-N'-(5-nitro-1,3-thiazol-2-yl)urea results in decreased activity of GSK3B protein] results in increased susceptibility to [Troglitazone results in decreased expression of CCNE1 protein]; [N-(4-methoxybenzyl)-N'-(5-nitro-1,3-thiazol-2-yl)urea results in decreased activity of GSK3B protein] results in increased susceptibility to [Troglitazone results in decreased expression of CDK2 protein]; [N-(4-methoxybenzyl)-N'-(5-nitro-1,3-thiazol-2-yl)urea results in decreased activity of GSK3B protein] results in increased susceptibility to [Troglitazone results in decreased expression of CDK4 protein]; [N-(4-methoxybenzyl)-N'-(5-nitro-1,3-thiazol-2-yl)urea results in decreased activity of GSK3B protein] results in increased susceptibility to [Troglitazone results in increased expression of BAX protein]; [N-(4-methoxybenzyl)-N'-(5-nitro-1,3-thiazol-2-yl)urea results in decreased activity of GSK3B protein] results in increased susceptibility to [Troglitazone results in increased expression of CASP3 protein]; [N-(4-methoxybenzyl)-N'-(5-nitro-1,3-thiazol-2-yl)urea results in decreased activity of GSK3B protein] results in increased susceptibility to [Troglitazone results in increased expression of CASP9 protein]; [N-(4-methoxybenzyl)-N'-(5-nitro-1,3-thiazol-2-yl)urea results in decreased activity of GSK3B protein] which results in increased susceptibility to Troglitazone; GSK3B protein affects the susceptibility to [Troglitazone results in decreased expression of CCNB1 protein]; GSK3B protein affects the susceptibility to [Troglitazone results in decreased expression of CCND1 protein]; GSK3B protein affects the susceptibility to [Troglitazone results in decreased expression of CCNE1 protein]; GSK3B protein affects the susceptibility to [Troglitazone results in decreased expression of CDK2 protein]; GSK3B protein affects the susceptibility to [Troglitazone results in decreased expression of CDK4 protein]; GSK3B protein affects the susceptibility to [Troglitazone results in increased expression of BAX protein]; GSK3B protein affects the susceptibility to [Troglitazone results in increased expression of CASP3 protein]; GSK3B protein affects the susceptibility to [Troglitazone results in increased expression of CASP9 protein] GSK3B protein affects the susceptibility to troglitazone troglitazone results in decreased activity of GSK3B protein
CTD
PMID:20540935
NCBI chr11:76,004,502...76,154,665
Ensembl chr11:76,009,507...76,153,249
G
Gsn
gelsolin
decreases expression increases expression
EXP ISO
troglitazone results in decreased expression of GSN mRNA troglitazone results in increased expression of GSN mRNA
CTD
PMID:19022234 PMID:22684020 PMID:28973697
NCBI chr 3:38,982,605...39,035,849
Ensembl chr 3:38,982,671...39,035,850
G
Gspt1
G1 to S phase transition 1
decreases expression
ISO
troglitazone results in decreased expression of GSPT1 mRNA
CTD
PMID:28973697
NCBI chr10:4,867,687...4,904,186
Ensembl chr10:4,869,465...4,908,040
G
Gsr
glutathione-disulfide reductase
increases expression
EXP
troglitazone results in increased expression of GSR mRNA
CTD
PMID:25596134
NCBI chr16:65,185,574...65,228,742
Ensembl chr16:65,185,574...65,228,394
G
Gsta2
glutathione S-transferase alpha 2
multiple interactions
EXP
[troglitazone co-treated with alitretinoin] results in increased expression of GSTA2 protein
CTD
PMID:15150131
NCBI chr 8:88,064,829...88,077,168
Ensembl chr 8:88,064,616...88,077,092
G
Gstm1
glutathione S-transferase mu 1
affects response to substance
ISO
GSTM1 gene polymorphism affects the susceptibility to troglitazone
CTD
PMID:12732844
NCBI chr 2:198,338,005...198,346,007
Ensembl chr 2:198,338,008...198,343,569
G
Gstm5
glutathione S-transferase, mu 5
increases expression decreases expression
ISO
troglitazone results in increased expression of GSTM3 mRNA troglitazone results in decreased expression of GSTM3 mRNA
CTD
PMID:19631733
NCBI chr 2:198,219,769...198,222,732
Ensembl chr 2:198,219,647...198,222,731
G
Gstp1
glutathione S-transferase pi 1
multiple interactions decreases activity affects binding increases expression
EXP ISO
troglitazone inhibits the reaction [Diethylnitrosamine results in increased expression of GSTP1 protein] troglitazone metabolite results in decreased activity of GSTP1 protein troglitazone metabolite binds to GSTP1 protein troglitazone results in increased expression of GSTP1 mRNA
CTD
PMID:15526359 PMID:21515302 PMID:21639118
NCBI chr 1:210,767,237...210,770,242
Ensembl chr 1:210,767,237...210,769,705
G
Gstt1
glutathione S-transferase theta 1
affects response to substance
ISO
GSTT1 gene polymorphism affects the susceptibility to troglitazone
CTD
PMID:12732844
NCBI chr20:12,856,068...12,873,020
Ensembl chr20:12,856,083...12,873,019
G
Gtf2a1
general transcription factor 2A subunit 1
decreases expression
ISO
troglitazone results in decreased expression of GTF2A1 mRNA
CTD
PMID:28973697
NCBI chr 6:116,219,614...116,252,220
Ensembl chr 6:116,219,614...116,252,220
G
Gtf2ird1
GTF2I repeat domain containing 1
increases expression
ISO
troglitazone results in increased expression of GTF2IRD1 mRNA
CTD
PMID:28973697
NCBI chr12:27,890,594...27,997,506
Ensembl chr12:27,890,675...27,997,494
G
Gtf3c2
general transcription factor IIIC subunit 2
decreases expression
ISO
troglitazone results in decreased expression of GTF3C2 mRNA
CTD
PMID:28973697
NCBI chr 6:30,913,263...30,941,305
Ensembl chr 6:30,923,106...30,940,465
G
Gtse1
G-2 and S-phase expressed 1
decreases expression
ISO
troglitazone results in decreased expression of GTSE1 mRNA
CTD
PMID:19140230
NCBI chr 7:118,829,793...118,846,662
Ensembl chr 7:118,829,903...118,846,661
G
Gxylt1
glucoside xylosyltransferase 1
decreases expression
ISO
troglitazone results in decreased expression of GXYLT1 mRNA
CTD
PMID:28973697
NCBI chr 7:126,280,349...126,320,803
Ensembl chr 7:126,280,349...126,314,237
G
Gys2
glycogen synthase 2
increases expression
EXP
troglitazone results in increased expression of GYS2 mRNA
CTD
PMID:21515302
NCBI chr 4:177,096,063...177,137,236
Ensembl chr 4:177,096,063...177,137,236
G
Gzma
granzyme A
decreases expression
ISO
troglitazone results in decreased expression of GZMA mRNA
CTD
PMID:17569031
NCBI chr 2:46,473,763...46,485,696
Ensembl chr 2:46,473,763...46,485,696
G
H1f2
H1.2 linker histone, cluster member
increases expression
ISO
Troglitazone results in increased expression of H1-2 mRNA
CTD
PMID:19140230
NCBI chr17:41,818,962...41,820,453
Ensembl chr17:41,779,051...41,822,317
G
H2ac18
H2A clustered histone 18
increases expression
ISO
Troglitazone results in increased expression of H2AC18 mRNA
CTD
PMID:19140230
NCBI chr 2:186,497,271...186,497,865
G
H2ac25
H2A clustered histone 25
decreases expression
ISO
Troglitazone results in decreased expression of H2AC25 mRNA
CTD
PMID:28973697
NCBI chr10:44,233,283...44,234,835
Ensembl chr10:44,233,181...44,241,197
G
H2ax
H2A.X variant histone
decreases expression
ISO
Troglitazone results in decreased expression of H2AX mRNA
CTD
PMID:19140230
NCBI chr 8:53,568,718...53,570,072
Ensembl chr 8:53,568,281...53,573,079
G
H2bc12
H2B clustered histone 12
increases expression
ISO
Troglitazone results in increased expression of H2BC12 mRNA
CTD
PMID:19140230
NCBI chr17:47,181,477...47,181,940
Ensembl chr17:47,121,467...47,182,816
G
H2bc14
H2B clustered histone 14
increases expression
ISO
Troglitazone results in increased expression of H2BC5 mRNA
CTD
PMID:19140230
NCBI chr17:47,488,627...47,489,008
G
H2bc9
H2B clustered histone 9
decreases expression
ISO
Troglitazone results in decreased expression of H2BC9 mRNA
CTD
PMID:19140230
NCBI chr17:47,166,372...47,174,369
G
H4c8
H4 clustered histone 8
increases expression
ISO
Troglitazone results in increased expression of H4C9 mRNA
CTD
PMID:28973697
NCBI chr17:47,176,246...47,180,690
Ensembl chr17:41,797,152...41,806,539 Ensembl chr17:41,797,152...41,806,539 Ensembl chr17:41,797,152...41,806,539 Ensembl chr 4:41,797,152...41,806,539
G
H6pd
hexose-6-phosphate dehydrogenase (glucose 1-dehydrogenase)
decreases expression
ISO
troglitazone results in decreased expression of H6PD mRNA
CTD
PMID:28973697
NCBI chr 5:165,717,456...165,753,158
Ensembl chr 5:165,721,654...165,753,125
G
Habp2
hyaluronan binding protein 2
decreases expression
ISO
troglitazone results in decreased expression of HABP2 mRNA
CTD
PMID:28973697
NCBI chr 1:265,321,084...265,355,375
Ensembl chr 1:265,303,172...265,355,374
G
Hacl1
2-hydroxyacyl-CoA lyase 1
decreases expression increases expression
ISO EXP
troglitazone results in decreased expression of HACL1 protein troglitazone results in increased expression of HACL1 protein troglitazone results in increased expression of HACL1 mRNA
CTD
PMID:18495193 PMID:21515302
NCBI chr16:6,831,293...6,869,410
Ensembl chr16:6,833,268...6,869,410
G
Hadh
hydroxyacyl-CoA dehydrogenase
increases expression
ISO EXP
troglitazone results in increased expression of HADH protein troglitazone results in increased expression of HADH mRNA
CTD
PMID:18495193 PMID:21515302
NCBI chr 2:222,462,049...222,504,446
Ensembl chr 2:222,462,049...222,504,446
G
Hadha
hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha
increases expression
EXP
troglitazone results in increased expression of HADHA mRNA
CTD
PMID:21515302
NCBI chr 6:31,907,801...31,947,434
Ensembl chr 6:31,907,291...31,947,698
G
Hadhb
hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit beta
increases expression
EXP
troglitazone results in increased expression of HADHB mRNA
CTD
PMID:21515302
NCBI chr 6:31,873,404...31,907,557
Ensembl chr 6:31,873,404...31,907,835
G
Hagh
hydroxyacyl glutathione hydrolase
decreases activity
ISO
troglitazone results in decreased activity of HAGH protein
CTD
PMID:11719831 PMID:12572858
NCBI chr10:14,379,400...14,394,046
Ensembl chr10:14,382,410...14,394,043
G
Hal
histidine ammonia lyase
increases expression
EXP ISO
troglitazone results in increased expression of HAL protein troglitazone results in increased expression of HAL mRNA
CTD
PMID:21315101 PMID:28973697
NCBI chr 7:29,894,495...29,924,744
Ensembl chr 7:29,893,855...29,924,744
G
Hand2
heart and neural crest derivatives expressed 2
decreases expression
ISO
troglitazone results in decreased expression of HAND2 mRNA
CTD
PMID:28973697
NCBI chr16:37,928,145...37,931,488
Ensembl chr16:37,928,145...37,931,488
G
Hapln2
hyaluronan and proteoglycan link protein 2
increases expression
EXP
troglitazone results in increased expression of HAPLN2 mRNA
CTD
PMID:21515302
NCBI chr 2:175,786,767...175,794,515
Ensembl chr 2:175,789,009...175,794,438
G
Hapstr1
HUWE1 associated protein modifying stress responses
decreases expression
ISO
Troglitazone results in decreased expression of HAPSTR1 mRNA
CTD
PMID:28973697
NCBI chr10:7,252,737...7,281,678
Ensembl chr10:7,252,737...7,281,678
G
Haspin
histone H3 associated protein kinase
decreases expression
ISO
troglitazone results in decreased expression of HASPIN mRNA
CTD
PMID:19140230
NCBI chr10:58,246,244...58,249,031
Ensembl chr10:58,240,447...58,249,249
G
Hat1
histone acetyltransferase 1
decreases expression
ISO
troglitazone results in decreased expression of HAT1 mRNA
CTD
PMID:19140230
NCBI chr 3:76,624,442...76,672,701
Ensembl chr 3:76,624,869...76,672,696
G
Haus6
HAUS augmin like complex subunit 6
decreases expression
ISO
Troglitazone results in decreased expression of HAUS6 mRNA
CTD
PMID:28973697
NCBI chr 5:106,162,526...106,201,503
Ensembl chr 5:106,162,526...106,199,072
G
Haus7
HAUS augmin-like complex, subunit 7
decreases expression
ISO
troglitazone results in decreased expression of HAUS7 mRNA
CTD
PMID:19140230
NCBI chr X:156,306,320...156,331,940
Ensembl chr X:156,306,320...156,352,158
G
Hbegf
heparin-binding EGF-like growth factor
decreases expression
EXP
troglitazone results in decreased expression of HBEGF mRNA
CTD
PMID:21515302
NCBI chr18:28,380,337...28,390,220
Ensembl chr18:28,380,337...28,390,220
G
Hcar1
hydroxycarboxylic acid receptor 1
increases expression
ISO
troglitazone results in increased expression of HCAR1 mRNA
CTD
PMID:28973697
NCBI chr12:38,371,593...38,374,847
Ensembl chr12:38,371,374...38,407,284
G
Hcar2
hydroxycarboxylic acid receptor 2
decreases expression
EXP
troglitazone results in decreased expression of HCAR2 mRNA
CTD
PMID:21515302
NCBI chr12:38,387,163...38,389,149
Ensembl chr12:38,387,230...38,389,391
G
Hcfc1
host cell factor C1
decreases expression
ISO
troglitazone results in decreased expression of HCFC1 mRNA
CTD
PMID:28973697
NCBI chr X:156,839,100...156,864,132
Ensembl chr X:156,839,100...156,863,813
G
Hdac5
histone deacetylase 5
decreases expression
ISO
troglitazone results in decreased expression of HDAC5 mRNA
CTD
PMID:28973697
NCBI chr10:87,653,139...87,688,078
Ensembl chr10:87,652,656...87,694,244
G
Hdc
histidine decarboxylase
decreases expression multiple interactions
ISO
troglitazone results in decreased expression of HDC mRNA [troglitazone results in decreased expression of HDC mRNA] which results in decreased secretion of Histamine
CTD
PMID:11834241
NCBI chr 3:134,300,628...134,318,704
Ensembl chr 3:134,300,632...134,318,711
G
Hdgf
heparin binding growth factor
decreases expression
ISO
troglitazone results in decreased expression of HDGF mRNA
CTD
PMID:19140230
NCBI chr 2:175,668,290...175,677,614
Ensembl chr 2:175,668,324...175,677,225
G
Hdlbp
high density lipoprotein binding protein
decreases expression
ISO
troglitazone results in decreased expression of HDLBP mRNA
CTD
PMID:28973697
NCBI chr 9:101,395,491...101,465,446
Ensembl chr 9:101,397,305...101,465,379
G
Heca
hdc homolog, cell cycle regulator
decreases expression
ISO
troglitazone results in decreased expression of HECA mRNA
CTD
PMID:28973697
NCBI chr 1:14,345,306...14,395,226
Ensembl chr 1:14,345,306...14,395,191
G
Hectd1
HECT domain E3 ubiquitin protein ligase 1
decreases expression
ISO
troglitazone results in decreased expression of HECTD1 mRNA
CTD
PMID:28973697
NCBI chr 6:74,916,803...75,003,408
Ensembl chr 6:74,916,803...75,003,408
G
Helz
helicase with zinc finger
decreases expression
ISO
troglitazone results in decreased expression of HELZ mRNA
CTD
PMID:28973697
NCBI chr10:92,979,039...93,144,868
Ensembl chr10:92,999,733...93,138,075
G
Herc1
HECT and RLD domain containing E3 ubiquitin protein ligase family member 1
decreases expression
ISO
troglitazone results in decreased expression of HERC1 mRNA
CTD
PMID:28973697
NCBI chr 8:75,796,347...75,965,347
Ensembl chr 8:75,796,357...75,965,347
G
Herpud1
homocysteine inducible ER protein with ubiquitin like domain 1
decreases expression
ISO
troglitazone results in decreased expression of HERPUD1 mRNA
CTD
PMID:28973697
NCBI chr19:10,604,360...10,624,168
Ensembl chr19:10,604,362...10,624,081
G
Hes1
hes family bHLH transcription factor 1
decreases expression
ISO
troglitazone results in decreased expression of HES1 mRNA
CTD
PMID:28973697
NCBI chr11:84,210,632...84,213,045
Ensembl chr11:84,210,633...84,213,061
G
Hexd
hexosaminidase D
decreases expression
ISO
Troglitazone results in decreased expression of HEXD mRNA
CTD
PMID:28973697
NCBI chr10:106,978,426...107,002,252
Ensembl chr10:106,978,165...106,997,083
G
Hibch
3-hydroxyisobutyryl-CoA hydrolase
increases expression
ISO EXP
troglitazone results in increased expression of HIBCH protein troglitazone results in increased expression of HIBCH mRNA
CTD
PMID:18495193 PMID:21515302
NCBI chr 9:56,082,082...56,161,796
Ensembl chr 9:56,082,091...56,161,886
G
Hif1a
hypoxia inducible factor 1 subunit alpha
multiple interactions
ISO
troglitazone affects the localization of and results in increased expression of HIF1A protein
CTD
PMID:20846491
NCBI chr 6:98,357,788...98,405,068
Ensembl chr 6:98,359,910...98,405,323
G
Hif1an
hypoxia inducible factor 1 subunit alpha inhibitor
decreases expression
ISO
troglitazone results in decreased expression of HIF1AN mRNA
CTD
PMID:28973697
NCBI chr 1:253,368,400...253,385,495
Ensembl chr 1:253,367,683...253,385,491
G
Hilpda
hypoxia inducible lipid droplet-associated
multiple interactions
ISO
[Troglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of HILPDA mRNA; Troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of HILPDA mRNA]
CTD
PMID:20847119
NCBI chr 4:58,836,463...58,839,423
Ensembl chr 4:58,836,463...58,839,423
G
Hip1r
huntingtin interacting protein 1 related
increases expression
ISO
troglitazone results in increased expression of HIP1R mRNA
CTD
PMID:28973697
NCBI chr12:38,251,085...38,279,756
Ensembl chr12:38,251,086...38,279,654
G
Hipk2
homeodomain interacting protein kinase 2
increases expression decreases expression
ISO
troglitazone results in increased expression of HIPK2 mRNA troglitazone results in decreased expression of HIPK2 mRNA
CTD
PMID:12732648 PMID:19140230 PMID:28973697
NCBI chr 4:68,399,358...68,586,404
Ensembl chr 4:68,369,099...68,586,108
G
Hipk3
homeodomain interacting protein kinase 3
increases expression
ISO
troglitazone results in increased expression of HIPK3 mRNA
CTD
PMID:12732648
NCBI chr 3:111,251,863...111,322,815
Ensembl chr 3:111,251,863...111,322,772
G
Hira
histone cell cycle regulator
decreases expression
ISO
troglitazone results in decreased expression of HIRA mRNA
CTD
PMID:28973697
NCBI chr11:95,528,831...95,637,565
Ensembl chr11:95,528,831...95,638,549
G
Hivep3
HIVEP zinc finger 3
decreases expression
ISO
troglitazone results in decreased expression of HIVEP3 mRNA
CTD
PMID:28973697
NCBI chr 5:138,610,592...139,013,058
Ensembl chr 5:138,943,312...139,010,430
G
Hk2
hexokinase 2
decreases expression
ISO
troglitazone results in decreased expression of HK2 mRNA
CTD
PMID:12732648
NCBI chr 4:116,792,258...116,841,275
Ensembl chr 4:116,792,258...116,841,275
G
Hmgb1
high mobility group box 1
multiple interactions increases secretion
ISO
[troglitazone results in increased activity of PPARG protein] inhibits the reaction [Lipopolysaccharides results in increased expression of HMGB1 mRNA]; [troglitazone results in increased activity of PPARG protein] inhibits the reaction [Lipopolysaccharides results in increased expression of HMGB1 protein]; [troglitazone results in increased activity of PPARG protein] which results in decreased expression of HMGB1 mRNA; [troglitazone results in increased activity of PPARG protein] which results in decreased expression of HMGB1 protein Troglitazone results in increased secretion of HMGB1 protein
CTD
PMID:21617575 PMID:31294483
NCBI chr12:11,009,236...11,015,941
Ensembl chr16:39,039,050...39,041,327 Ensembl chr12:39,039,050...39,041,327
G
Hmgb2
high mobility group box 2
decreases expression
ISO
troglitazone results in decreased expression of HMGB2 mRNA
CTD
PMID:19140230
NCBI chr16:37,721,374...37,723,950
Ensembl chr16:37,721,379...37,723,860
G
Hmgcr
3-hydroxy-3-methylglutaryl-CoA reductase
multiple interactions increases activity increases expression
ISO
[[troglitazone binds to and results in increased activity of PPARG protein] which results in decreased expression of SREBF2 protein] which results in decreased expression of HMGCR mRNA; [troglitazone binds to and results in increased activity of PPARG protein] which results in increased expression of HMGCR mRNA troglitazone results in increased activity of HMGCR protein troglitazone results in increased expression of HMGCR mRNA
CTD
PMID:12044893 PMID:16946405
NCBI chr 2:29,732,163...29,754,276
Ensembl chr 2:29,720,553...29,754,533
G
Hmgcs1
3-hydroxy-3-methylglutaryl-CoA synthase 1
increases expression multiple interactions decreases expression
ISO
troglitazone results in increased expression of HMGCS1 mRNA [troglitazone binds to and results in increased activity of PPARG protein] which results in increased expression of HMGCS1 mRNA troglitazone results in decreased expression of HMGCS1 mRNA
CTD
PMID:12044893 PMID:25572481 PMID:28973697
NCBI chr 2:53,379,457...53,399,807
Ensembl chr 2:53,382,643...53,399,802
G
Hmgcs2
3-hydroxy-3-methylglutaryl-CoA synthase 2
increases expression decreases expression
ISO EXP
troglitazone results in increased expression of HMGCS2 protein troglitazone results in increased expression of HMGCS2 mRNA troglitazone results in decreased expression of HMGCS2 mRNA
CTD
PMID:18495193 PMID:21515302 PMID:28973697
NCBI chr 2:188,564,348...188,590,872
Ensembl chr 2:188,547,767...188,592,242
G
Hmox1
heme oxygenase 1
increases expression multiple interactions
ISO EXP
troglitazone results in increased expression of HMOX1 mRNA Troglitazone results in increased expression of HMOX1 mRNA [Troglitazone co-treated with Buthionine Sulfoximine] results in increased expression of HMOX1 mRNA
CTD
PMID:16597547 PMID:19631733 PMID:25596134 PMID:31294483
NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,472,884...13,479,818
G
Hnf1b
HNF1 homeobox B
decreases expression
ISO
troglitazone results in decreased expression of HNF1B mRNA
CTD
PMID:28973697
NCBI chr10:69,233,377...69,287,360
Ensembl chr10:69,233,131...69,287,361
G
Hnf4a
hepatocyte nuclear factor 4, alpha
decreases expression
EXP
troglitazone results in decreased expression of HNF4A mRNA
CTD
PMID:19022234
NCBI chr 3:172,606,220...172,667,758
Ensembl chr 3:172,606,220...172,667,758
G
Hnrnpa0
heterogeneous nuclear ribonucleoprotein A0
decreases expression
ISO
troglitazone results in decreased expression of HNRNPA0 mRNA
CTD
PMID:28973697
NCBI chr17:6,513,129...6,515,786
Ensembl chr17:6,512,629...6,516,127
G
Hnrnpa1
heterogeneous nuclear ribonucleoprotein A1
decreases expression
ISO
troglitazone results in decreased expression of HNRNPA1 mRNA
CTD
PMID:19140230 PMID:28973697
NCBI chr 7:136,253,633...136,260,085
Ensembl chr 7:136,253,278...136,260,085
G
Hnrnpd
heterogeneous nuclear ribonucleoprotein D
decreases expression
ISO
troglitazone results in decreased expression of HNRNPD mRNA
CTD
PMID:28973697
NCBI chr14:9,918,630...9,938,072
Ensembl chr14:9,919,739...9,938,066
G
Hnrnpdl
heterogeneous nuclear ribonucleoprotein D-like
multiple interactions decreases expression
ISO
[troglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of HNRNPDL mRNA; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of HNRNPDL mRNA] troglitazone results in decreased expression of HNRNPDL mRNA
CTD
PMID:20847119 PMID:28973697
NCBI chr14:9,861,716...9,867,945
Ensembl chr14:9,861,716...9,867,945
G
Hnrnpul1
heterogeneous nuclear ribonucleoprotein U-like 1
decreases expression
ISO
troglitazone results in decreased expression of HNRNPUL1 mRNA
CTD
PMID:28973697
NCBI chr 1:90,356,182...90,391,923
Ensembl chr 1:90,356,182...90,390,370
G
Hnrnpul2
heterogeneous nuclear ribonucleoprotein U-like 2
decreases expression
ISO
troglitazone results in decreased expression of HNRNPUL2 mRNA
CTD
PMID:28973697
NCBI chr 1:215,142,750...215,154,668
Ensembl chr 1:215,142,644...215,155,161
G
Hoga1
4-hydroxy-2-oxoglutarate aldolase 1
decreases expression
ISO
troglitazone results in decreased expression of HOGA1 mRNA
CTD
PMID:25572481 PMID:28973697
NCBI chr 1:250,806,430...250,833,544
Ensembl chr 1:250,806,255...250,833,869
G
Hook3
hook microtubule-tethering protein 3
decreases expression
ISO
troglitazone results in decreased expression of HOOK3 mRNA
CTD
PMID:28973697
NCBI chr16:72,656,929...72,751,696
Ensembl chr16:72,657,019...72,764,071
G
Hoxa2
homeobox A2
decreases expression
ISO
troglitazone results in decreased expression of HOXA2 mRNA
CTD
PMID:19140230
NCBI chr 4:82,593,389...82,597,589
Ensembl chr 4:82,593,389...82,595,692
G
Hoxc8
homeobox C8
decreases expression
ISO
troglitazone results in decreased expression of HOXC8 mRNA
CTD
PMID:28973697
NCBI chr 7:136,006,407...136,008,973
Ensembl chr 7:136,006,162...136,009,849
G
Hprt1
hypoxanthine phosphoribosyltransferase 1
decreases expression
ISO
troglitazone results in decreased expression of HPRT1 mRNA
CTD
PMID:19631733
NCBI chr X:137,655,744...137,687,718
Ensembl chr X:137,655,680...137,687,712
G
Hps4
HPS4, biogenesis of lysosomal organelles complex 3 subunit 2
decreases expression
ISO
troglitazone results in decreased expression of HPS4 mRNA
CTD
PMID:28973697
NCBI chr12:49,924,444...49,955,201
Ensembl chr12:49,924,444...49,953,613
G
Hpx
hemopexin
decreases expression
ISO
troglitazone results in decreased expression of HPX mRNA
CTD
PMID:25572481
NCBI chr 1:169,344,647...169,352,155
Ensembl chr 1:169,344,583...169,352,156
G
Hras
HRas proto-oncogene, GTPase
increases expression multiple interactions
ISO
troglitazone results in increased expression of HRAS mRNA troglitazone promotes the reaction [HRAS protein results in increased susceptibility to Urethane]
CTD
PMID:17569031 PMID:26558449
NCBI chr 1:205,712,625...205,729,406
Ensembl chr 1:205,725,975...205,729,590
G
Hrg
histidine-rich glycoprotein
decreases expression
ISO
troglitazone results in decreased expression of HRG mRNA
CTD
PMID:25572481
NCBI chr11:91,559,087...91,573,982
Ensembl chr11:91,559,091...91,573,982
G
Hs6st1
heparan sulfate 6-O-sulfotransferase 1
decreases expression
ISO
troglitazone results in decreased expression of HS6ST1 mRNA
CTD
PMID:28973697
NCBI chr 9:45,779,402...45,818,583
Ensembl chr 9:45,779,019...45,818,582
G
Hsd11b1
hydroxysteroid 11-beta dehydrogenase 1
decreases expression increases expression
EXP ISO
troglitazone results in decreased expression of HSD11B1 mRNA troglitazone results in increased expression of HSD11B1 mRNA
CTD
PMID:14697232 PMID:25572481
NCBI chr13:107,277,526...107,327,462
Ensembl chr13:107,257,239...107,327,432
G
Hsd17b13
hydroxysteroid (17-beta) dehydrogenase 13
decreases expression
ISO
troglitazone results in decreased expression of HSD17B13 mRNA
CTD
PMID:25572481
NCBI chr14:6,056,708...6,071,463
Ensembl chr14:6,056,774...6,072,823
G
Hsd17b2
hydroxysteroid (17-beta) dehydrogenase 2
decreases expression
EXP
troglitazone results in decreased expression of HSD17B2 mRNA
CTD
PMID:21515302
NCBI chr19:62,662,320...62,733,944
Ensembl chr19:62,662,098...62,733,943
G
Hsd17b4
hydroxysteroid (17-beta) dehydrogenase 4
increases expression
ISO EXP
troglitazone results in increased expression of HSD17B4 mRNA
CTD
PMID:12732648 PMID:21515302
NCBI chr18:45,515,427...45,604,467
Ensembl chr18:45,515,373...45,604,467
G
Hsd17b6
hydroxysteroid (17-beta) dehydrogenase 6
decreases expression
ISO
troglitazone results in decreased expression of HSD17B6 mRNA
CTD
PMID:25572481 PMID:28973697
NCBI chr 7:831,407...850,950
Ensembl chr 7:831,421...850,873
G
Hsd3b1
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1
decreases expression
EXP
troglitazone results in decreased expression of HSD3B1 mRNA
CTD
PMID:21515302
NCBI chr 2:188,858,574...188,864,694
G
Hsd3b2
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2
decreases activity decreases expression
ISO EXP
troglitazone results in decreased activity of HSD3B2 protein Troglitazone results in decreased expression of HSD3B6 mRNA
CTD
PMID:15072549 PMID:21515302
NCBI chr 2:188,784,614...188,812,535
Ensembl chr 2:188,784,614...188,790,569
G
Hsdl2
hydroxysteroid dehydrogenase like 2
increases expression
EXP
troglitazone results in increased expression of HSDL2 mRNA; troglitazone results in increased expression of HSDL2 protein
CTD
PMID:21315101 PMID:21515302
NCBI chr 5:79,238,881...79,274,051
Ensembl chr 5:79,212,525...79,274,798
G
Hsp90ab1
heat shock protein 90 alpha family class B member 1
increases expression
ISO
troglitazone results in increased expression of HSP90AB1 mRNA
CTD
PMID:19631733
NCBI chr 9:22,930,249...22,935,929
Ensembl chr 9:22,931,070...22,935,926
G
Hspa1a
heat shock protein family A (Hsp70) member 1A
increases expression
ISO
troglitazone results in increased expression of HSPA1A mRNA
CTD
PMID:19631733
NCBI chr20:3,875,411...3,877,866
Ensembl chr20:3,855,780...3,877,979
G
Hspa1l
heat shock protein family A (Hsp70) member 1 like
multiple interactions decreases expression
ISO
[troglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of HSPA1L mRNA; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of HSPA1L mRNA] troglitazone results in decreased expression of HSPA1L mRNA
CTD
PMID:19631733 PMID:20847119
NCBI chr20:3,853,496...3,860,223
Ensembl chr20:3,853,331...3,876,877
G
Hspa2
heat shock protein family A (Hsp70) member 2
decreases expression increases expression
ISO
troglitazone results in decreased expression of HSPA2 mRNA troglitazone results in increased expression of HSPA2 mRNA
CTD
PMID:19140230 PMID:19631733
NCBI chr 6:100,864,172...100,866,946
Ensembl chr 6:100,864,553...100,867,133
G
Hspa4
heat shock protein family A (Hsp70) member 4
increases expression
ISO
troglitazone results in increased expression of HSPA4 mRNA
CTD
PMID:19631733
NCBI chr10:37,908,866...37,951,994
Ensembl chr10:37,908,866...37,949,835
G
Hspa4l
heat shock protein family A (Hsp70) member 4 like
increases expression
ISO
troglitazone results in increased expression of HSPA4L mRNA
CTD
PMID:28973697
NCBI chr 2:125,668,346...125,726,404
Ensembl chr 2:125,668,236...125,720,986
G
Hspa5
heat shock protein family A (Hsp70) member 5
affects response to substance increases expression decreases expression
ISO EXP
HSPA5 protein affects the susceptibility to troglitazone Troglitazone results in increased expression of HSPA5 mRNA; Troglitazone results in increased expression of HSPA5 protein troglitazone results in decreased expression of HSPA5 mRNA
CTD
PMID:15525695 PMID:19631733 PMID:25596134 PMID:32535746
NCBI chr 3:38,453,016...38,457,475
Ensembl chr 3:38,453,041...38,458,790
G
Hspa6l-ps1
heat shock protein family A (Hsp70) member 6 like, pseudogene 1
increases expression
ISO
Troglitazone results in increased expression of HSPA6 mRNA
CTD
PMID:19140230 PMID:19631733
NCBI chr13:85,805,911...85,807,052
G
Hspa8
heat shock protein family A (Hsp70) member 8
increases expression
ISO
troglitazone results in increased expression of HSPA8 protein
CTD
PMID:18495193
NCBI chr 8:50,080,514...50,084,376
Ensembl chr 8:50,080,199...50,084,372
G
Hspa9
heat shock protein family A (Hsp70) member 9
increases expression
ISO
troglitazone results in increased expression of HSPA9 protein
CTD
PMID:18495193
NCBI chr18:26,810,004...26,832,958
Ensembl chr18:26,804,774...26,828,398
G
Hspb1
heat shock protein family B (small) member 1
increases expression
ISO
troglitazone results in increased expression of HSPB1 mRNA
CTD
PMID:28973697
NCBI chr12:26,430,640...26,432,301
Ensembl chr12:26,430,640...26,432,301
G
Hspb8
heat shock protein family B (small) member 8
increases expression
ISO
troglitazone results in increased expression of HSPB8 mRNA
CTD
PMID:28973697
NCBI chr12:45,835,899...45,866,449
Ensembl chr12:45,837,066...45,851,937
G
Hspd1
heat shock protein family D (Hsp60) member 1
increases expression
ISO
troglitazone results in increased expression of HSPD1 mRNA
CTD
PMID:19631733
NCBI chr 9:64,073,610...64,084,332
Ensembl chr 9:64,073,611...64,084,037
G
Hspe1
heat shock protein family E (Hsp10) member 1
increases expression
ISO
troglitazone results in increased expression of HSPE1 mRNA
CTD
PMID:28973697
NCBI chr 9:64,084,327...64,087,415
Ensembl chr 9:64,085,068...64,087,502
G
Hsph1
heat shock protein family H (Hsp110) member 1
increases expression
ISO
troglitazone results in increased expression of HSPH1 mRNA
CTD
PMID:19631733
NCBI chr12:10,427,368...10,446,602
Ensembl chr12:10,427,297...10,446,891
G
Htr5a
5-hydroxytryptamine receptor 5A
increases expression
ISO
troglitazone results in increased expression of HTR5A mRNA
CTD
PMID:28973697
NCBI chr 4:8,178,802...8,188,485
Ensembl chr 4:8,178,802...8,200,482
G
Huwe1
HECT, UBA and WWE domain containing E3 ubiquitin protein ligase 1
decreases expression
ISO
troglitazone results in decreased expression of HUWE1 mRNA
CTD
PMID:28973697
NCBI chr X:24,350,708...24,480,798
Ensembl chr X:24,353,217...24,480,798
G
Hyal2
hyaluronidase 2
increases expression
ISO
troglitazone results in increased expression of HYAL2 mRNA
CTD
PMID:28973697
NCBI chr 8:117,121,802...117,125,494
Ensembl chr 8:117,121,787...117,125,493
G
Hykk
hydroxylysine kinase
decreases expression
ISO
troglitazone results in decreased expression of HYKK mRNA
CTD
PMID:28973697
NCBI chr 8:64,212,043...64,235,809
Ensembl chr 8:64,212,071...64,235,818
G
Ibtk
inhibitor of Bruton tyrosine kinase
decreases expression
ISO
troglitazone results in decreased expression of IBTK mRNA
CTD
PMID:28973697
NCBI chr 8:95,505,630...95,579,435
Ensembl chr 8:95,505,630...95,578,301
G
Icam1
intercellular adhesion molecule 1
multiple interactions increases expression decreases expression
ISO EXP
PPARG protein affects the reaction [troglitazone results in increased expression of ICAM1 mRNA] troglitazone results in increased expression of ICAM1 mRNA; troglitazone results in increased expression of ICAM1 protein troglitazone results in decreased expression of ICAM1 mRNA; troglitazone results in decreased expression of ICAM1 protein
CTD
PMID:11401521 PMID:17425601 PMID:21515302
NCBI chr 8:27,829,688...27,841,618
Ensembl chr 8:27,829,161...27,841,617
G
Id1
inhibitor of DNA binding 1
increases expression
EXP
troglitazone results in increased expression of ID1 mRNA
CTD
PMID:21515302
NCBI chr 3:161,671,525...161,672,691
Ensembl chr 3:161,671,538...161,672,685
G
Id2
inhibitor of DNA binding 2
multiple interactions
ISO
[troglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of ID2 mRNA; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ID2 mRNA]
CTD
PMID:20847119
NCBI chr 6:47,469,162...47,470,995
Ensembl chr 6:47,457,554...47,472,961
G
Id3
inhibitor of DNA binding 3
decreases expression
ISO
troglitazone results in decreased expression of ID3 mRNA
CTD
PMID:19140230
NCBI chr 5:153,656,253...153,657,860
Ensembl chr 5:153,630,498...153,657,856
G
Id4
inhibitor of DNA binding 4
decreases expression
EXP
troglitazone results in decreased expression of ID4 mRNA
CTD
PMID:21515302
NCBI chr17:16,595,724...16,598,293
Ensembl chr17:16,595,724...16,598,492
G
Idh1
isocitrate dehydrogenase (NADP(+)) 1
increases expression
EXP
troglitazone results in increased expression of IDH1 protein
CTD
PMID:21315101
NCBI chr 9:74,027,887...74,057,442
Ensembl chr 9:74,027,892...74,049,555
G
Idh3g
isocitrate dehydrogenase (NAD(+)) 3 non-catalytic subunit gamma
decreases expression
ISO
troglitazone results in decreased expression of IDH3G mRNA
CTD
PMID:12732648
NCBI chr X:156,666,573...156,675,482
Ensembl chr X:156,666,577...156,675,799
G
Ido2
indoleamine 2,3-dioxygenase 2
decreases expression
ISO
troglitazone results in decreased expression of IDO2 mRNA
CTD
PMID:28973697
NCBI chr16:74,161,761...74,200,651
Ensembl chr16:74,161,774...74,200,650
G
Ier3
immediate early response 3
increases expression
ISO
troglitazone results in increased expression of IER3 mRNA
CTD
PMID:19140230
NCBI chr20:2,933,173...2,934,377
Ensembl chr20:2,933,174...2,934,377
G
Ifitm1
interferon induced transmembrane protein 1
decreases expression
ISO
Troglitazone results in decreased expression of IFITM1 mRNA
CTD
PMID:19140230
NCBI chr 1:205,496,757...205,498,796
Ensembl chr 1:205,496,807...205,498,776
G
Ifng
interferon gamma
multiple interactions
ISO
[troglitazone co-treated with IFNG protein] results in increased expression of CDKN1A mRNA; troglitazone promotes the reaction [[IFNG protein co-treated with TNF protein] results in increased expression of CDKN1A mRNA]
CTD
PMID:10441511
NCBI chr 7:55,789,180...55,793,216
Ensembl chr 7:55,761,736...55,793,216
G
Ifrd1
interferon-related developmental regulator 1
increases expression
ISO
troglitazone results in increased expression of IFRD1 mRNA
CTD
PMID:19140230
NCBI chr 6:62,996,560...63,044,996
Ensembl chr 6:62,996,562...63,016,131
G
Ift70b
intraflagellar transport 70B
decreases expression
ISO
Troglitazone results in decreased expression of IFT70B mRNA
CTD
PMID:28973697
NCBI chr 3:81,263,074...81,265,645
G
Ift81
intraflagellar transport 81
decreases expression
ISO
troglitazone results in decreased expression of IFT81 mRNA
CTD
PMID:28973697
NCBI chr12:39,618,559...39,697,971
Ensembl chr12:39,618,651...39,697,962
G
Igf1
insulin-like growth factor 1
increases expression
ISO
troglitazone results in increased expression of IGF1
CTD
PMID:21937740
NCBI chr 7:24,169,608...24,249,446
Ensembl chr 7:24,130,137...24,246,764
G
Igf2bp3
insulin-like growth factor 2 mRNA binding protein 3
increases expression
ISO
troglitazone results in increased expression of IGF2BP3 mRNA
CTD
PMID:19140230
NCBI chr 4:79,391,367...79,525,923
Ensembl chr 4:79,393,067...79,525,730
G
Igfbp1
insulin-like growth factor binding protein 1
increases expression increases secretion decreases expression
ISO
troglitazone results in increased expression of IGFBP1 mRNA troglitazone results in increased secretion of IGFBP1 protein troglitazone results in decreased expression of IGFBP1 mRNA
CTD
PMID:12659874 PMID:25572481
NCBI chr14:86,261,277...86,266,344
Ensembl chr14:86,261,277...86,266,344
G
Igfbp2
insulin-like growth factor binding protein 2
decreases expression
ISO
troglitazone results in decreased expression of IGFBP2 mRNA
CTD
PMID:25572481
NCBI chr 9:81,864,811...81,892,179
Ensembl chr 9:81,864,783...81,892,171
G
Igfbp3
insulin-like growth factor binding protein 3
decreases expression
ISO
troglitazone results in decreased expression of IGFBP3 mRNA
CTD
PMID:19140230
NCBI chr14:86,270,208...86,277,944
Ensembl chr14:86,270,208...86,277,944
G
Igfbp4
insulin-like growth factor binding protein 4
increases expression
ISO
troglitazone results in increased expression of IGFBP4 mRNA
CTD
PMID:28973697
NCBI chr10:84,491,471...84,503,487
Ensembl chr10:84,485,775...84,503,473
G
Igfbp5
insulin-like growth factor binding protein 5
increases expression decreases expression
ISO
troglitazone results in increased expression of IGFBP5 mRNA troglitazone results in decreased expression of IGFBP5 mRNA
CTD
PMID:19140230 PMID:28973697
NCBI chr 9:81,901,605...81,914,187
Ensembl chr 9:81,897,616...81,914,390
G
Igfbp6
insulin-like growth factor binding protein 6
decreases expression increases expression
ISO
troglitazone results in decreased expression of IGFBP6 mRNA troglitazone results in increased expression of IGFBP6 mRNA
CTD
PMID:19631733 PMID:28973697
NCBI chr 7:135,154,919...135,159,550
Ensembl chr 7:135,154,685...135,159,795
G
Ighg1
immunoglobulin heavy constant gamma 1
increases expression
ISO
troglitazone results in increased expression of IGHG1 mRNA
CTD
PMID:28973697
G
Il10
interleukin 10
increases expression
ISO
Troglitazone results in increased expression of IL10 mRNA
CTD
PMID:31294483
NCBI chr13:45,024,921...45,029,586
Ensembl chr13:45,025,087...45,029,580
G
Il11
interleukin 11
increases expression
ISO
troglitazone results in increased expression of IL11 mRNA
CTD
PMID:19140230
NCBI chr 1:78,098,622...78,104,915
Ensembl chr 1:78,096,930...78,104,915
G
Il17rb
interleukin 17 receptor B
decreases expression
ISO EXP
troglitazone results in decreased expression of IL17RB mRNA
CTD
PMID:19140230 PMID:25596134
NCBI chr16:5,186,961...5,200,657
Ensembl chr16:5,186,961...5,200,694
G
Il18rap
interleukin 18 receptor accessory protein
decreases expression
EXP
troglitazone results in decreased expression of IL18RAP mRNA
CTD
PMID:21515302
NCBI chr 9:50,263,723...50,296,583
Ensembl chr 9:50,263,733...50,296,583
G
Il1a
interleukin 1 alpha
decreases expression increases expression
ISO
troglitazone results in decreased expression of IL1A mRNA Troglitazone results in increased expression of IL1A mRNA
CTD
PMID:19631733 PMID:32816093
NCBI chr 3:136,979,804...136,990,236
Ensembl chr 3:136,979,805...136,998,013
G
Il1b
interleukin 1 beta
increases expression multiple interactions decreases expression decreases response to substance
EXP ISO
troglitazone results in increased expression of IL1B mRNA [mono-(2-ethylhexyl)phthalate co-treated with Troglitazone] results in increased secretion of IL1B protein; Troglitazone inhibits the reaction [IL1B protein results in increased abundance of Nitric Oxide]; Troglitazone inhibits the reaction [IL1B protein results in increased chemical synthesis of Nitric Oxide]; Troglitazone inhibits the reaction [IL1B protein results in increased expression of NOS2 mRNA] Troglitazone results in increased expression of IL1B mRNA troglitazone results in decreased expression of IL1B mRNA troglitazone results in decreased susceptibility to IL1B protein
CTD
PMID:7956951 PMID:9312173 PMID:11457450 PMID:12468449 PMID:15135310 PMID:19631733 PMID:20453712 PMID:21515302 PMID:28138970 PMID:32816093 More...
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:137,030,205...137,036,601
G
Il1r2
interleukin 1 receptor type 2
decreases expression increases expression
EXP ISO
troglitazone results in decreased expression of IL1R2 mRNA troglitazone results in increased expression of IL1R2 mRNA
CTD
PMID:21515302 PMID:25572481 PMID:28973697
NCBI chr 9:49,879,928...49,920,374
Ensembl chr 9:49,877,266...49,920,374
G
Il1rap
interleukin 1 receptor accessory protein
decreases expression
ISO
troglitazone results in decreased expression of IL1RAP mRNA
CTD
PMID:28973697
NCBI chr11:87,567,813...87,704,346
Ensembl chr11:87,575,116...87,704,342
G
Il1rl1
interleukin 1 receptor-like 1
increases expression
EXP ISO
troglitazone results in increased expression of IL1RL1 mRNA
CTD
PMID:21515302 PMID:28973697
NCBI chr 9:50,157,326...50,222,888
Ensembl chr 9:50,204,551...50,222,891
G
Il24
interleukin 24
increases expression
ISO
Troglitazone results in increased expression of IL24 mRNA
CTD
PMID:19140230 PMID:32816093
NCBI chr13:44,905,362...44,910,760
Ensembl chr13:44,905,363...44,910,760
G
Il33
interleukin 33
increases expression
EXP
troglitazone results in increased expression of IL33 mRNA
CTD
PMID:21515302
NCBI chr 1:237,115,478...237,149,897
Ensembl chr 1:237,115,572...237,150,901
G
Il5
interleukin 5
decreases activity
ISO
troglitazone results in decreased activity of IL5 protein
CTD
PMID:12644321
NCBI chr10:38,375,132...38,378,003
Ensembl chr10:38,375,132...38,378,003
G
Il6
interleukin 6
multiple interactions decreases expression increases expression decreases response to substance
ISO
[Troglitazone co-treated with Buthionine Sulfoximine] results in increased expression of IL6 mRNA; Troglitazone inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 mRNA]; Troglitazone promotes the reaction [Capsaicin results in decreased secretion of IL6 protein] troglitazone results in decreased expression of IL6 mRNA troglitazone results in increased expression of IL6 mRNA troglitazone results in decreased susceptibility to IL6 protein Troglitazone results in increased expression of IL6 mRNA
CTD
PMID:7956951 PMID:10807946 PMID:16813520 PMID:17719033 PMID:19140230 PMID:19631733 PMID:31294483 More...
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,889,999...5,894,610
G
Ilf3
interleukin enhancer binding factor 3
decreases expression
ISO
troglitazone results in decreased expression of ILF3 mRNA
CTD
PMID:19140230
NCBI chr 8:28,198,454...28,236,634
Ensembl chr 8:28,198,543...28,236,612
G
Immt
inner membrane mitochondrial protein
increases expression
ISO
troglitazone results in increased expression of IMMT mRNA
CTD
PMID:28973697
NCBI chr 4:105,438,657...105,477,370
Ensembl chr 4:105,438,712...105,477,368
G
Impa2
inositol monophosphatase 2
increases expression
EXP
troglitazone results in increased expression of IMPA2 mRNA
CTD
PMID:21515302
NCBI chr18:63,104,113...63,135,232
Ensembl chr18:63,104,083...63,137,543
G
Impact
impact RWD domain protein
decreases expression increases expression
ISO
troglitazone results in decreased expression of IMPACT mRNA troglitazone results in increased expression of IMPACT mRNA
CTD
PMID:28973697
NCBI chr18:4,383,546...4,422,280
Ensembl chr18:4,383,575...4,422,278
G
Inafm1
InaF-motif containing 1
decreases expression
ISO
troglitazone results in decreased expression of INAFM1 mRNA
CTD
PMID:28973697
NCBI chr 1:86,104,970...86,106,454
G
Inha
inhibin subunit alpha
decreases expression
ISO
troglitazone results in decreased expression of INHA mRNA
CTD
PMID:19140230
NCBI chr 9:84,443,109...84,446,010
Ensembl chr 9:84,443,109...84,446,009
G
Inhbc
inhibin subunit beta C
increases expression
EXP
troglitazone results in increased expression of INHBC mRNA
CTD
PMID:21515302
NCBI chr 7:65,069,450...65,082,919
Ensembl chr 7:65,069,451...65,082,919
G
Inhbe
inhibin subunit beta E
decreases expression
ISO
troglitazone results in decreased expression of INHBE mRNA
CTD
PMID:25572481
NCBI chr 7:65,061,531...65,064,519
Ensembl chr 7:65,061,531...65,064,519
G
Ino80d
INO80 complex subunit D
decreases expression
ISO
troglitazone results in decreased expression of INO80D mRNA
CTD
PMID:28973697
NCBI chr 9:71,940,941...72,007,879
Ensembl chr 9:71,951,031...72,040,232
G
Ins1
insulin 1
multiple interactions
ISO
(+)-JQ1 compound inhibits the reaction [[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Troglitazone] results in increased expression of CEBPA protein]; (+)-JQ1 compound inhibits the reaction [[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Troglitazone] results in increased expression of PPARG protein]; [INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Troglitazone] results in increased expression of CEBPA protein; [INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Troglitazone] results in increased expression of JMJD6 mRNA; [INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Troglitazone] results in increased expression of JMJD6 protein; [INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Troglitazone] results in increased expression of PPARG protein; JMJD6 mutant form inhibits the reaction [[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Troglitazone] results in increased expression of CEBPA protein]; JMJD6 mutant form inhibits the reaction [[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Troglitazone] results in increased expression of PPARG protein]
CTD
PMID:26117538
NCBI chr 1:261,186,119...261,186,686
Ensembl chr 1:261,186,119...261,186,682
G
Ins2
insulin 2
multiple interactions increases response to substance decreases expression
ISO EXP
2-chloro-5-nitrobenzanilide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with INS protein co-treated with Troglitazone] results in increased expression of FABP4 mRNA]; [1-Methyl-3-isobutylxanthine co-treated with INS protein co-treated with Troglitazone] results in increased expression of FABP4 mRNA; [1-Methyl-3-isobutylxanthine co-treated with INS protein co-treated with Troglitazone] results in increased expression of FABP4 protein; [1-Methyl-3-isobutylxanthine co-treated with INS protein co-treated with Troglitazone] results in increased expression of LPL protein; [1-Methyl-3-isobutylxanthine co-treated with INS protein co-treated with Troglitazone] results in increased expression of PLIN1 protein; [1-Methyl-3-isobutylxanthine co-treated with Troglitazone co-treated with INS protein] results in increased expression of CEBPA mRNA; [1-Methyl-3-isobutylxanthine co-treated with Troglitazone co-treated with INS protein] results in increased expression of FABP4 mRNA; [1-Methyl-3-isobutylxanthine co-treated with Troglitazone co-treated with INS protein] results in increased expression of LPL mRNA; [1-Methyl-3-isobutylxanthine co-treated with Troglitazone co-treated with INS protein] results in increased expression of PLIN1 mRNA; [1-Methyl-3-isobutylxanthine co-treated with Troglitazone co-treated with INS protein] results in increased expression of PPARG mRNA; [1-Methyl-3-isobutylxanthine co-treated with Troglitazone co-treated with INS protein] results in increased expression of SREBF1 mRNA; Troglitazone inhibits the reaction [TNF protein inhibits the reaction [INS protein results in increased expression of CEBPA mRNA]]; Troglitazone inhibits the reaction [TNF protein inhibits the reaction [INS protein results in increased uptake of Deoxyglucose]]; Troglitazone inhibits the reaction [TNF protein inhibits the reaction [INS protein results in increased uptake of Glucose]]; Troglitazone promotes the reaction [[Oleic Acid co-treated with INS protein] results in increased expression of SERPINE1 mRNA]; Troglitazone promotes the reaction [[Oleic Acid co-treated with INS protein] results in increased expression of SERPINE1 protein] troglitazone results in increased susceptibility to INS protein troglitazone results in decreased expression of INS protein troglitazone results in decreased expression of INS2 mRNA
CTD
PMID:7956951 PMID:8772734 PMID:9727893 PMID:10406828 PMID:11292061 PMID:12914525 PMID:16483873 PMID:21779873 PMID:27003841 PMID:28437481 More...
NCBI chr 1:207,272,738...207,421,998
Ensembl chr 1:207,272,742...207,273,805
G
Insc
INSC, spindle orientation adaptor protein
increases expression
ISO
troglitazone results in increased expression of INSC mRNA
CTD
PMID:28973697
NCBI chr 1:178,427,360...178,534,827
Ensembl chr 1:178,427,423...178,535,047
G
Insig1
insulin induced gene 1
multiple interactions decreases expression
EXP ISO
[troglitazone binds to and results in increased activity of PPARG protein] which results in increased expression of INSIG1 protein troglitazone results in decreased expression of INSIG1 mRNA
CTD
PMID:19248225 PMID:25572481
NCBI chr 4:8,049,339...8,057,812
Ensembl chr 4:8,049,556...8,057,778
G
Insig2
insulin induced gene 2
multiple interactions decreases expression
EXP
[troglitazone binds to and results in increased activity of PPARG protein] which results in increased expression of INSIG2 protein troglitazone results in decreased expression of INSIG2 mRNA
CTD
PMID:19248225 PMID:25596134
NCBI chr13:35,025,160...35,052,937
Ensembl chr13:35,025,164...35,047,658
G
Insr
insulin receptor
decreases expression
ISO
troglitazone results in decreased expression of INSR mRNA
CTD
PMID:28973697
NCBI chr12:5,991,135...6,129,275
Ensembl chr12:5,981,835...6,128,803
G
Ip6k2
inositol hexakisphosphate kinase 2
decreases expression
ISO
troglitazone results in decreased expression of IP6K2 mRNA
CTD
PMID:28973697
NCBI chr 8:118,362,154...118,388,668
Ensembl chr 8:118,362,795...118,388,667
G
Ipmk
inositol polyphosphate multikinase
decreases expression
ISO
troglitazone results in decreased expression of IPMK mRNA
CTD
PMID:28973697
NCBI chr20:17,216,151...17,250,826
Ensembl chr20:17,216,151...17,250,757
G
Iqgap3
IQ motif containing GTPase activating protein 3
decreases expression
ISO
troglitazone results in decreased expression of IQGAP3 mRNA
CTD
PMID:19140230
NCBI chr 2:175,840,001...175,881,799
Ensembl chr 2:175,839,949...175,881,797
G
Irak2
interleukin-1 receptor-associated kinase 2
increases expression
ISO
troglitazone results in increased expression of IRAK2 mRNA
CTD
PMID:19140230
NCBI chr 4:148,341,704...148,398,211
Ensembl chr 4:148,341,719...148,398,210
G
Irf1
interferon regulatory factor 1
increases expression
ISO
troglitazone results in increased expression of IRF1 mRNA
CTD
PMID:19140230
NCBI chr10:38,417,935...38,424,946
Ensembl chr10:38,417,148...38,424,947
G
Irf2bp2
interferon regulatory factor 2 binding protein 2
decreases expression
ISO
troglitazone results in decreased expression of IRF2BP2 mRNA
CTD
PMID:28973697
NCBI chr19:71,456,689...71,462,368
Ensembl chr19:71,456,689...71,462,368
G
Irf7
interferon regulatory factor 7
increases expression
ISO
troglitazone results in increased expression of IRF7 mRNA
CTD
PMID:25572481
NCBI chr 1:205,796,956...205,800,543
Ensembl chr 1:205,796,959...205,800,023
G
Irs1
insulin receptor substrate 1
decreases expression
EXP
troglitazone results in decreased expression of IRS1 mRNA
CTD
PMID:21515302
NCBI chr 9:91,001,137...91,053,959
Ensembl chr 9:90,993,519...91,054,538
G
Irs2
insulin receptor substrate 2
increases expression
ISO
troglitazone results in increased expression of IRS2 mRNA
CTD
PMID:19140230
NCBI chr16:85,190,310...85,214,543
Ensembl chr16:85,190,111...85,214,543
G
Irx3
iroquois homeobox 3
decreases expression
ISO
troglitazone results in decreased expression of IRX3 mRNA
CTD
PMID:12732648
NCBI chr19:31,384,803...31,388,241
Ensembl chr19:31,384,833...31,388,238
G
Isl1
ISL LIM homeobox 1
decreases expression
EXP
troglitazone results in decreased expression of ISL1 mRNA
CTD
PMID:21515302
NCBI chr 2:49,813,618...49,823,442
Ensembl chr 2:49,813,618...49,823,442
G
Islr
immunoglobulin superfamily containing leucine-rich repeat
increases expression
ISO
troglitazone results in increased expression of ISLR mRNA
CTD
PMID:28973697
NCBI chr 8:67,467,013...67,469,989
Ensembl chr 8:67,444,536...67,487,493
G
Isoc1
isochorismatase domain containing 1
increases expression
ISO
troglitazone results in increased expression of ISOC1 mRNA
CTD
PMID:28973697
NCBI chr18:54,356,757...54,377,170
Ensembl chr18:54,356,734...54,377,170
G
Itga2
integrin subunit alpha 2
increases expression decreases expression
ISO EXP
troglitazone results in increased expression of ITGA2 mRNA troglitazone results in decreased expression of ITGA2 mRNA
CTD
PMID:19140230 PMID:21515302
NCBI chr 2:48,253,412...48,354,509
Ensembl chr 2:48,253,412...48,354,509
G
Itga3
integrin subunit alpha 3
increases expression
ISO
troglitazone results in increased expression of ITGA3 mRNA
CTD
PMID:19140230 PMID:25572481
NCBI chr10:80,486,998...80,522,548
Ensembl chr10:80,486,999...80,518,901
G
Itga5
integrin subunit alpha 5
increases expression
ISO
troglitazone results in increased expression of ITGA5 mRNA
CTD
PMID:19140230
NCBI chr 7:136,358,097...136,381,305
Ensembl chr 7:136,358,097...136,381,305
G
Itgav
integrin subunit alpha V
multiple interactions decreases expression
ISO
troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ITGAV mRNA] troglitazone results in decreased expression of ITGAV mRNA
CTD
PMID:20847119 PMID:28973697
NCBI chr 3:89,245,382...89,333,512
Ensembl chr 3:89,245,095...89,333,511
G
Itgb1bp1
integrin subunit beta 1 binding protein 1
increases expression
ISO
troglitazone results in increased expression of ITGB1BP1 mRNA
CTD
PMID:28973697
NCBI chr 6:46,549,994...46,564,735
Ensembl chr 6:46,549,999...46,564,398
G
Itgb3bp
integrin subunit beta 3 binding protein
decreases expression
ISO
troglitazone results in decreased expression of ITGB3BP mRNA
CTD
PMID:19140230
NCBI chr 5:119,575,657...119,640,974
Ensembl chr 5:119,575,248...119,640,997
G
Itih5
inter-alpha-trypsin inhibitor heavy chain 5
decreases expression
ISO
Troglitazone results in decreased expression of ITIH5 mRNA
CTD
PMID:28973697
NCBI chr17:73,161,886...73,261,930
Ensembl chr17:73,161,611...73,262,496
G
Iyd
iodotyrosine deiodinase
multiple interactions
ISO
Troglitazone inhibits the reaction [IYD protein results in increased metabolism of Monoiodotyrosine]
CTD
PMID:33352258
NCBI chr 1:42,410,099...42,425,414
Ensembl chr 1:42,410,130...42,426,386
G
Jade1
jade family PHD finger 1
decreases expression
ISO
troglitazone results in decreased expression of JADE1 mRNA
CTD
PMID:28973697
NCBI chr 2:126,471,124...126,524,252
Ensembl chr 2:126,471,124...126,524,252
G
Jak2
Janus kinase 2
increases expression
ISO
Troglitazone results in increased expression of JAK2 mRNA
CTD
PMID:31294483
NCBI chr 1:236,408,905...236,468,769
Ensembl chr 1:236,408,662...236,468,762
G
Jazf1
JAZF zinc finger 1
increases expression
ISO
troglitazone results in increased expression of JAZF1 mRNA
CTD
PMID:19140230
NCBI chr 4:83,210,054...83,513,790
Ensembl chr 4:83,210,058...83,513,644
G
Jmjd6
jumonji domain containing 6, arginine demethylase and lysine hydroxylase
multiple interactions
ISO
[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with troglitazone] results in increased expression of JMJD6 mRNA; [INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with troglitazone] results in increased expression of JMJD6 protein; JMJD6 mutant form inhibits the reaction [[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with troglitazone] results in increased expression of CEBPA protein]; JMJD6 mutant form inhibits the reaction [[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with troglitazone] results in increased expression of PPARG protein]
CTD
PMID:26117538
NCBI chr10:102,539,935...102,545,986
Ensembl chr10:102,539,894...102,545,986
G
Jmy
junction mediating and regulatory protein, p53 cofactor
decreases expression
ISO
troglitazone results in decreased expression of JMY mRNA
CTD
PMID:28973697
NCBI chr 2:26,401,047...26,465,959
Ensembl chr 2:26,409,969...26,465,649
G
Jun
Jun proto-oncogene, AP-1 transcription factor subunit
increases expression
ISO
troglitazone results in increased expression of JUN protein; troglitazone results in increased expression of JUN protein modified form troglitazone results in increased expression of JUN mRNA
CTD
PMID:11401521 PMID:17569031
NCBI chr 5:115,009,900...115,012,993
Ensembl chr 5:114,973,151...115,013,285
G
Junb
JunB proto-oncogene, AP-1 transcription factor subunit
decreases expression
EXP
troglitazone results in decreased expression of JUNB mRNA
CTD
PMID:21515302
NCBI chr19:40,081,126...40,082,910
Ensembl chr19:40,073,541...40,085,218
G
Kank1
KN motif and ankyrin repeat domains 1
decreases expression
ISO
troglitazone results in decreased expression of KANK1 mRNA
CTD
PMID:28973697
NCBI chr 1:232,381,720...232,500,834
Ensembl chr 1:232,445,658...232,500,839
G
Kansl3
KAT8 regulatory NSL complex subunit 3
decreases expression
ISO
troglitazone results in decreased expression of KANSL3 mRNA
CTD
PMID:28973697
NCBI chr 9:46,058,070...46,101,643
Ensembl chr 9:46,058,071...46,101,521
G
Kat6a
lysine acetyltransferase 6A
decreases expression
ISO
troglitazone results in decreased expression of KAT6A mRNA
CTD
PMID:28973697
NCBI chr16:75,787,411...75,868,584
Ensembl chr16:75,787,411...75,866,099
G
Kat7
lysine acetyltransferase 7
decreases expression
ISO
troglitazone results in decreased expression of KAT7 mRNA
CTD
PMID:28973697
NCBI chr10:80,718,335...80,752,387
Ensembl chr10:80,718,335...80,752,387
G
Kazald1
Kazal-type serine peptidase inhibitor domain 1
decreases expression
ISO
troglitazone results in decreased expression of KAZALD1 mRNA
CTD
PMID:19140230
NCBI chr 1:253,888,639...253,892,211
Ensembl chr 1:253,888,783...253,892,305
G
Kbtbd7
kelch repeat and BTB domain containing 7
decreases expression
ISO
troglitazone results in decreased expression of KBTBD7 mRNA
CTD
PMID:28973697
NCBI chr15:61,215,957...61,220,536
Ensembl chr15:61,215,396...61,223,671
G
Kcna5
potassium voltage-gated channel subfamily A member 5
decreases expression
ISO
troglitazone results in decreased expression of KCNA5 mRNA
CTD
PMID:28973697
NCBI chr 4:161,040,853...161,044,311
Ensembl chr 4:160,996,950...161,044,408
G
Kcng1
potassium voltage-gated channel modifier subfamily G member 1
decreases expression
EXP
troglitazone results in decreased expression of KCNG1 mRNA
CTD
PMID:21515302
NCBI chr 3:177,379,593...177,412,986
Ensembl chr 3:177,392,031...177,411,507
G
Kcng3
potassium voltage-gated channel modifier subfamily G member 3
decreases expression
EXP
troglitazone results in decreased expression of KCNG3 mRNA
CTD
PMID:21515302
NCBI chr 6:16,803,842...16,851,791
Ensembl chr 6:16,803,665...16,851,791
G
Kcnj8
potassium inwardly-rectifying channel, subfamily J, member 8
increases expression decreases expression
EXP ISO
troglitazone results in increased expression of KCNJ8 mRNA troglitazone results in decreased expression of KCNJ8 mRNA
CTD
PMID:21515302 PMID:28973697
NCBI chr 4:177,240,692...177,246,548
Ensembl chr 4:177,239,908...177,246,531
G
Kcnmb2
potassium calcium-activated channel subfamily M regulatory beta subunit 2
decreases expression
EXP
troglitazone results in decreased expression of KCNMB2 mRNA
CTD
PMID:21515302
NCBI chr 2:116,598,511...116,903,886
Ensembl chr 2:116,599,387...116,903,854
G
Kcns3
potassium voltage-gated channel, modifier subfamily S, member 3
decreases expression
EXP
troglitazone results in decreased expression of KCNS3 mRNA
CTD
PMID:21515302
NCBI chr 6:39,527,410...39,584,105
Ensembl chr 6:39,523,777...39,618,848
G
Kctd12
potassium channel tetramerization domain containing 12
increases expression
ISO
troglitazone results in increased expression of KCTD12 mRNA
CTD
PMID:28973697
NCBI chr15:86,214,786...86,220,725
Ensembl chr15:86,214,840...86,224,539
G
Kctd20
potassium channel tetramerization domain containing 20
decreases expression
ISO
troglitazone results in decreased expression of KCTD20 mRNA
CTD
PMID:28973697
NCBI chr20:7,017,480...7,034,440
Ensembl chr20:7,017,502...7,034,441
G
Kctd6
potassium channel tetramerization domain containing 6
decreases expression
ISO
troglitazone results in decreased expression of KCTD6 mRNA
CTD
PMID:28973697
NCBI chr15:19,125,529...19,142,038
Ensembl chr15:19,124,932...19,134,583
G
Kdm2a
lysine demethylase 2A
decreases expression
ISO
troglitazone results in decreased expression of KDM2A mRNA
CTD
PMID:28973697
NCBI chr 1:211,041,859...211,125,749
Ensembl chr 1:211,041,885...211,084,479
G
Kdm3a
lysine demethylase 3A
decreases expression
ISO
troglitazone results in decreased expression of KDM3A mRNA
CTD
PMID:28973697
NCBI chr 4:105,189,208...105,233,526
Ensembl chr 4:105,189,208...105,233,370
G
Kdm5a
lysine demethylase 5A
decreases expression
ISO
troglitazone results in decreased expression of KDM5A mRNA
CTD
PMID:28973697
NCBI chr 4:155,238,124...155,316,121
Ensembl chr 4:155,238,044...155,316,121
G
Kdm5b
lysine demethylase 5B
increases expression
ISO
troglitazone results in increased expression of KDM5B mRNA
CTD
PMID:19140230
NCBI chr13:48,554,367...48,625,721
Ensembl chr13:48,554,420...48,626,423
G
Kdm5c
lysine demethylase 5C
decreases expression
ISO
troglitazone results in decreased expression of KDM5C mRNA
CTD
PMID:28973697
NCBI chr X:24,821,568...24,866,423
Ensembl chr X:24,824,859...24,866,423
G
Kdm7a
lysine demethylase 7A
decreases expression
ISO
troglitazone results in decreased expression of KDM7A mRNA
CTD
PMID:28973697
NCBI chr 4:68,866,263...68,992,979
Ensembl chr 4:68,871,677...68,931,506
G
Kdr
kinase insert domain receptor
multiple interactions increases expression decreases expression
ISO
[Urethane co-treated with troglitazone] results in increased expression of KDR mRNA troglitazone results in increased expression of KDR mRNA troglitazone results in decreased expression of KDR mRNA
CTD
PMID:17569031 PMID:18465119 PMID:28973697
NCBI chr14:32,572,031...32,615,204
Ensembl chr14:32,572,049...32,615,192
G
Keap1
Kelch-like ECH-associated protein 1
multiple interactions
ISO
KEAP1 protein promotes the reaction [troglitazone results in increased susceptibility to arsenic trioxide]
CTD
PMID:22684020
NCBI chr 8:28,044,555...28,054,042
Ensembl chr 8:28,044,555...28,054,042
G
Khdrbs1
KH RNA binding domain containing, signal transduction associated 1
decreases expression
ISO
troglitazone results in decreased expression of KHDRBS1 mRNA
CTD
PMID:28973697
NCBI chr 5:147,337,048...147,374,604
Ensembl chr 5:147,347,904...147,373,448
G
Khsrp
KH-type splicing regulatory protein
decreases expression
ISO
troglitazone results in decreased expression of KHSRP mRNA
CTD
PMID:28973697
NCBI chr 9:1,949,557...1,959,400
Ensembl chr 9:1,949,557...1,959,497
G
Kiaa0040
KIAA0040 ortholog
increases expression
ISO
troglitazone results in increased expression of KIAA0040 mRNA
CTD
PMID:28973697
NCBI chr13:74,807,959...74,845,530
Ensembl chr13:74,807,982...74,845,530
G
Kiaa0319
KIAA0319 homolog
increases expression
ISO
troglitazone results in increased expression of KIAA0319 mRNA
CTD
PMID:19140230
NCBI chr17:40,587,001...40,654,525
Ensembl chr17:40,590,546...40,653,679
G
Kif11
kinesin family member 11
decreases expression
ISO
troglitazone results in decreased expression of KIF11 mRNA
CTD
PMID:19140230
NCBI chr 1:244,494,916...244,589,250
Ensembl chr 1:244,494,875...244,589,250
G
Kif12
kinesin family member 12
decreases expression
EXP
troglitazone results in decreased expression of KIF12 mRNA
CTD
PMID:21515302
NCBI chr 5:81,611,730...81,620,977
Ensembl chr 5:81,611,734...81,618,369
G
Kif13a
kinesin family member 13A
decreases expression
ISO
troglitazone results in decreased expression of KIF13A mRNA
CTD
PMID:28973697
NCBI chr17:17,972,227...18,154,763
Ensembl chr17:17,972,325...18,154,760
G
Kif13b
kinesin family member 13B
decreases expression
ISO
troglitazone results in decreased expression of KIF13B mRNA
CTD
PMID:28973697
NCBI chr15:43,084,059...43,241,719
Ensembl chr15:43,080,910...43,241,719
G
Kif14
kinesin family member 14
decreases expression
ISO
troglitazone results in decreased expression of KIF14 mRNA
CTD
PMID:19140230
NCBI chr13:50,478,646...50,542,256
Ensembl chr13:50,478,721...50,542,248
G
Kif15
kinesin family member 15
decreases expression
ISO
troglitazone results in decreased expression of KIF15 mRNA
CTD
PMID:19140230
NCBI chr 8:131,479,340...131,550,209
Ensembl chr 8:131,479,337...131,550,202
G
Kif1a
kinesin family member 1A
increases expression
ISO
troglitazone results in increased expression of KIF1A mRNA
CTD
PMID:19140230
NCBI chr 9:101,010,447...101,094,891
Ensembl chr 9:101,010,447...101,094,777
G
Kif1b
kinesin family member 1B
decreases expression
ISO
troglitazone results in decreased expression of KIF1B mRNA
CTD
PMID:28973697
NCBI chr 5:164,890,778...165,025,848
Ensembl chr 5:164,894,763...165,008,841
G
Kif20a
kinesin family member 20A
decreases expression
ISO
troglitazone results in decreased expression of KIF20A mRNA
CTD
PMID:19140230
NCBI chr18:26,504,422...26,512,908
Ensembl chr18:26,504,072...26,512,909
G
Kif20b
kinesin family member 20B
decreases expression
ISO
troglitazone results in decreased expression of KIF20B mRNA
CTD
PMID:19140230
NCBI chr 1:241,840,898...241,896,451
Ensembl chr 1:241,840,987...241,896,451
G
Kif23
kinesin family member 23
decreases expression
ISO
troglitazone results in decreased expression of KIF23 mRNA
CTD
PMID:19140230
NCBI chr 8:71,293,439...71,321,911
Ensembl chr 8:71,293,482...71,320,856
G
Kif24
kinesin family member 24
decreases expression
ISO
troglitazone results in decreased expression of KIF24 mRNA
CTD
PMID:19140230
NCBI chr 5:61,357,078...61,423,882
Ensembl chr 5:61,357,940...61,399,379
G
Kif2c
kinesin family member 2C
decreases expression
ISO
troglitazone results in decreased expression of KIF2C mRNA
CTD
PMID:19140230
NCBI chr 5:135,873,925...135,899,267
Ensembl chr 5:135,873,925...135,899,212
G
Kif4a
kinesin family member 4A
decreases expression
ISO
troglitazone results in decreased expression of KIF4A mRNA
CTD
PMID:19140230
NCBI chr X:69,761,803...69,864,335
Ensembl chr X:69,761,883...69,864,335
G
Kl
Klotho
increases expression
EXP
troglitazone results in increased expression of KL mRNA
CTD
PMID:11768731
NCBI chr12:5,326,003...5,367,016
Ensembl chr12:5,325,959...5,367,015
G
Klb
klotho beta
decreases expression
ISO
troglitazone results in decreased expression of KLB mRNA
CTD
PMID:28973697
NCBI chr14:43,253,963...43,304,532
Ensembl chr14:43,253,255...43,304,515
G
Klf11
KLF transcription factor 11
decreases expression
ISO
troglitazone results in decreased expression of KLF11 mRNA
CTD
PMID:28973697
NCBI chr 6:47,014,312...47,026,152
Ensembl chr 6:47,014,326...47,037,044
G
Klf12
KLF transcription factor 12
decreases expression
ISO
troglitazone results in decreased expression of KLF12 mRNA
CTD
PMID:28973697
NCBI chr15:83,037,548...83,469,998
Ensembl chr15:83,045,463...83,670,640
G
Klf15
KLF transcription factor 15
increases expression
EXP
troglitazone results in increased expression of KLF15 mRNA
CTD
PMID:21515302
NCBI chr 4:124,522,652...124,535,613
Ensembl chr 4:124,522,909...124,542,373
G
Klf2
KLF transcription factor 2
multiple interactions decreases expression
ISO
troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of KLF2 mRNA] troglitazone results in decreased expression of KLF2 mRNA
CTD
PMID:20847119 PMID:28973697
NCBI chr16:17,555,136...17,557,768
Ensembl chr16:17,555,136...17,557,768
G
Klf3
KLF transcription factor 3
increases expression
ISO
troglitazone results in increased expression of KLF3 mRNA
CTD
PMID:28973697
NCBI chr14:43,828,387...43,859,418
Ensembl chr14:43,828,387...43,850,826
G
Klf6
KLF transcription factor 6
increases expression
ISO
troglitazone results in increased expression of KLF6 mRNA
CTD
PMID:19140230
NCBI chr17:69,449,483...69,458,478
Ensembl chr17:69,441,493...69,498,601
G
Klf7
KLF transcription factor 7
decreases expression
ISO
troglitazone results in decreased expression of KLF7 mRNA
CTD
PMID:28973697
NCBI chr 9:72,927,485...73,020,167
Ensembl chr 9:72,933,136...73,020,056
G
Klf9
KLF transcription factor 9
decreases expression
ISO
troglitazone results in decreased expression of KLF9 mRNA
CTD
PMID:28973697
NCBI chr 1:230,126,646...230,151,641
Ensembl chr 1:230,126,646...230,151,641
G
Klhl21
kelch-like family member 21
decreases expression
ISO
troglitazone results in decreased expression of KLHL21 mRNA
CTD
PMID:28973697
NCBI chr 5:167,797,621...167,806,276
Ensembl chr 5:167,797,591...167,806,276
G
Klhl24
kelch-like family member 24
decreases expression
ISO
troglitazone results in decreased expression of KLHL24 mRNA
CTD
PMID:28973697
NCBI chr11:94,348,024...94,382,085
Ensembl chr11:94,351,157...94,382,050
G
Klhl5
kelch-like family member 5
increases expression
ISO
troglitazone results in increased expression of KLHL5 mRNA
CTD
PMID:19140230
NCBI chr14:43,497,915...43,565,833
Ensembl chr14:43,497,918...43,537,894
G
Klk1
kallikrein 1
increases expression
ISO
Troglitazone results in increased expression of KLK3 mRNA
CTD
PMID:28973697
NCBI chr 1:103,779,152...103,783,270
Ensembl chr 1:103,779,164...103,783,270
G
Klk1c10
kallikrein 1-related peptidase C10
decreases expression
ISO
Troglitazone results in decreased expression of KLK3 mRNA; Troglitazone results in decreased expression of KLK3 protein
CTD
PMID:17409431 PMID:25669987
NCBI chr 1:103,539,527...103,543,586
Ensembl chr 1:103,539,527...103,543,586
G
Klk1c6
kallikrein 1-related peptidase C6
affects expression
EXP
troglitazone affects the expression of KLK1C6 mRNA
CTD
PMID:21515302
NCBI chr 1:103,604,150...103,612,366
Ensembl chr 1:103,604,150...103,612,366
G
Klk1c9
kallikrein 1-related peptidase C9
increases expression
EXP
troglitazone results in increased expression of KLK1C9 mRNA
CTD
PMID:21515302
NCBI chr 1:103,733,870...103,737,756
Ensembl chr 1:103,727,746...103,737,756
G
Klkb1
kallikrein B1
decreases expression
ISO
troglitazone results in decreased expression of KLKB1 mRNA
CTD
PMID:25572481
NCBI chr16:53,690,180...53,714,570
Ensembl chr16:53,691,220...53,716,339
G
Klrb1a
killer cell lectin like receptor B1A
decreases expression
EXP
troglitazone results in decreased expression of KLRB1A mRNA
CTD
PMID:21515302
NCBI chr 4:163,576,672...163,590,201
Ensembl chr 4:163,576,672...163,619,374
G
Kmt2a
lysine methyltransferase 2A
decreases expression
ISO
troglitazone results in decreased expression of KMT2A mRNA
CTD
PMID:28973697
NCBI chr 8:54,013,547...54,089,219
Ensembl chr 8:54,013,547...54,089,317
G
Kmt2b
lysine methyltransferase 2B
decreases expression
ISO
troglitazone results in decreased expression of KMT2B mRNA
CTD
PMID:28973697
NCBI chr 1:94,949,144...94,969,239
Ensembl chr 1:94,949,144...94,968,441
G
Kmt2c
lysine methyltransferase 2C
decreases expression
ISO
troglitazone results in decreased expression of KMT2C mRNA
CTD
PMID:28973697
NCBI chr 4:10,353,698...10,755,965
Ensembl chr 4:10,353,735...10,568,620
G
Kmt2d
lysine methyltransferase 2D
decreases expression
ISO
troglitazone results in decreased expression of KMT2D mRNA
CTD
PMID:28973697
NCBI chr 7:131,859,696...131,901,032
Ensembl chr 7:131,859,696...131,900,072
G
Kmt2e
lysine methyltransferase 2E
decreases expression
ISO
troglitazone results in decreased expression of KMT2E mRNA
CTD
PMID:28973697
NCBI chr 4:12,550,570...12,655,329
Ensembl chr 4:12,550,570...12,619,721
G
Kmt5b
lysine methyltransferase 5B
decreases expression
ISO
troglitazone results in decreased expression of KMT5B mRNA
CTD
PMID:28973697
NCBI chr 1:210,429,672...210,479,042
Ensembl chr 1:210,430,127...210,479,035
G
Kntc1
kinetochore associated 1
decreases expression
ISO
troglitazone results in decreased expression of KNTC1 mRNA
CTD
PMID:19140230
NCBI chr12:38,429,925...38,500,564
Ensembl chr12:38,429,925...38,500,457
G
Kpna4
karyopherin subunit alpha 4
decreases expression
ISO
troglitazone results in decreased expression of KPNA4 mRNA
CTD
PMID:28973697
NCBI chr 2:155,635,679...155,691,056
Ensembl chr 2:155,634,247...155,691,053
G
Kpna6
karyopherin subunit alpha 6
decreases expression
ISO
troglitazone results in decreased expression of KPNA6 mRNA
CTD
PMID:28973697
NCBI chr 5:147,272,466...147,307,523
Ensembl chr 5:147,275,918...147,305,851
G
Krt1
keratin 1
decreases expression multiple interactions
ISO
Troglitazone results in decreased expression of KRT1 mRNA [Troglitazone co-treated with 4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline] results in decreased expression of KRT1 mRNA
CTD
PMID:32822399
NCBI chr 7:134,855,311...134,860,537
Ensembl chr 7:134,855,313...134,860,537
G
Krt13
keratin 13
multiple interactions decreases expression
ISO
[Troglitazone co-treated with 4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline] results in decreased expression of KRT13 mRNA; [Troglitazone co-treated with 4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline] results in decreased expression of KRT13 protein Troglitazone results in decreased expression of KRT13 mRNA; Troglitazone results in decreased expression of KRT13 protein
CTD
PMID:32822399
NCBI chr10:85,552,287...85,556,499
Ensembl chr10:85,552,287...85,556,499
G
Krt14
keratin 14
decreases expression multiple interactions
ISO
Troglitazone results in decreased expression of KRT14 mRNA; Troglitazone results in decreased expression of KRT14 protein [Troglitazone co-treated with 4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline] results in decreased expression of KRT14 mRNA; [Troglitazone co-treated with 4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline] results in decreased expression of KRT14 protein
CTD
PMID:32822399
NCBI chr10:85,638,182...85,642,450
G
Krt16
keratin 16
increases expression multiple interactions
ISO
Troglitazone results in increased expression of KRT16 mRNA; Troglitazone results in increased expression of KRT16 protein [Troglitazone co-treated with 4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline] affects the expression of KRT16 mRNA; [Troglitazone co-treated with 4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline] affects the expression of KRT16 protein
CTD
PMID:32822399
NCBI chr10:85,669,276...85,672,211
Ensembl chr10:85,669,276...85,672,211
G
Krt36
keratin 36
increases expression
ISO
troglitazone results in increased expression of KRT36 mRNA
CTD
PMID:28973697
NCBI chr10:85,536,779...85,540,403
Ensembl chr10:85,536,779...85,540,403
G
Krt5
keratin 5
multiple interactions decreases expression
ISO
[Troglitazone co-treated with 4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline] results in decreased expression of KRT5 mRNA; [Troglitazone co-treated with 4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline] results in decreased expression of KRT5 protein Troglitazone results in decreased expression of KRT5 mRNA; Troglitazone results in decreased expression of KRT5 protein
CTD
PMID:32822399
NCBI chr 7:134,724,840...134,730,569
Ensembl chr 7:134,724,840...134,730,569
G
Krt6c
keratin 6c
increases expression multiple interactions
ISO
Troglitazone results in increased expression of KRT6C mRNA [Troglitazone co-treated with 4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline] results in decreased expression of KRT6C mRNA
CTD
PMID:32822399
NCBI chr 7:134,678,316...134,682,753
Ensembl chr 7:134,678,324...134,682,753
G
Krt8
keratin 8
decreases expression
ISO
troglitazone results in decreased expression of KRT8 mRNA
CTD
PMID:19140230
NCBI chr 7:135,002,886...135,010,339
Ensembl chr 7:135,002,894...135,010,403
G
Ksr1
kinase suppressor of ras 1
decreases expression
ISO
troglitazone results in decreased expression of KSR1 mRNA
CTD
PMID:28973697
NCBI chr10:64,459,786...64,596,083
Ensembl chr10:64,459,786...64,596,082
G
Ktn1
kinectin 1
decreases expression
ISO
troglitazone results in decreased expression of KTN1 mRNA
CTD
PMID:28973697
NCBI chr15:23,392,570...23,485,061
Ensembl chr15:23,394,315...23,482,263
G
Kynu
kynureninase
decreases expression
ISO
troglitazone results in decreased expression of KYNU mRNA
CTD
PMID:28973697
NCBI chr 3:48,188,286...48,338,996
Ensembl chr 3:48,188,182...48,339,014
G
Lactb2
lactamase, beta 2
increases expression decreases expression
EXP ISO
troglitazone results in increased expression of LACTB2 protein troglitazone results in decreased expression of LACTB2 mRNA
CTD
PMID:21315101 PMID:28973697
NCBI chr 5:10,352,165...10,374,928
Ensembl chr 5:10,352,154...10,379,255
G
Lama1
laminin subunit alpha 1
decreases expression
ISO
troglitazone results in decreased expression of LAMA1 mRNA
CTD
PMID:28973697
NCBI chr 9:115,139,548...115,263,620
Ensembl chr 9:115,139,548...115,264,251
G
Lama3
laminin subunit alpha 3
decreases expression
ISO
troglitazone results in decreased expression of LAMA3 mRNA
CTD
PMID:28973697
NCBI chr18:3,797,898...4,033,021
Ensembl chr18:3,797,939...4,026,449
G
Lama4
laminin subunit alpha 4
increases expression
ISO
troglitazone results in increased expression of LAMA4 mRNA
CTD
PMID:12732648 PMID:19140230 PMID:25572481 PMID:28973697
NCBI chr20:43,946,898...44,087,972
Ensembl chr20:43,946,898...44,087,972
G
Lamp2
lysosomal-associated membrane protein 2
decreases expression
ISO
troglitazone results in decreased expression of LAMP2 mRNA
CTD
PMID:28973697
NCBI chr X:122,038,734...122,087,745
Ensembl chr X:121,922,187...122,087,675
G
Larp1
La ribonucleoprotein 1, translational regulator
decreases expression
ISO
troglitazone results in decreased expression of LARP1 mRNA
CTD
PMID:28973697
NCBI chr10:42,691,833...42,746,816
Ensembl chr10:42,691,600...42,746,816
G
Larp4b
La ribonucleoprotein 4B
decreases expression
ISO
troglitazone results in decreased expression of LARP4B mRNA
CTD
PMID:28973697
NCBI chr17:65,813,125...65,908,920
Ensembl chr17:65,830,022...65,908,676
G
Larp6
La ribonucleoprotein 6, translational regulator
increases expression
ISO
troglitazone results in increased expression of LARP6 mRNA
CTD
PMID:19140230
NCBI chr 8:70,079,753...70,101,175
Ensembl chr 8:70,079,647...70,101,198
G
Larp7
La ribonucleoprotein 7, transcriptional regulator
decreases expression
ISO
troglitazone results in decreased expression of LARP7 mRNA
CTD
PMID:28973697
NCBI chr 2:218,672,145...218,687,332
Ensembl chr 2:218,672,208...218,687,308
G
Lats2
large tumor suppressor kinase 2
increases expression
ISO
troglitazone results in increased expression of LATS2 mRNA
CTD
PMID:28973697
NCBI chr15:35,940,632...35,992,225
Ensembl chr15:35,940,632...35,980,842
G
Lcn2
lipocalin 2
increases expression
EXP
troglitazone results in increased expression of LCN2 mRNA
CTD
PMID:21515302
NCBI chr 3:36,078,432...36,081,851
Ensembl chr 3:36,078,436...36,081,842
G
Ldhb
lactate dehydrogenase B
increases expression
EXP ISO
troglitazone results in increased expression of LDHB mRNA
CTD
PMID:21515302 PMID:25572481
NCBI chr 4:177,159,389...177,177,408
Ensembl chr 4:177,159,392...177,177,408
G
Ldlr
low density lipoprotein receptor
multiple interactions increases expression increases activity decreases expression
ISO
[[troglitazone binds to and results in increased activity of PPARG protein] which results in decreased expression of SREBF2 protein] which results in decreased expression of LDLR mRNA troglitazone results in increased expression of LDLR mRNA troglitazone results in increased activity of LDLR protein troglitazone results in decreased expression of LDLR mRNA
CTD
PMID:9703316 PMID:16946405 PMID:25572481
NCBI chr 8:28,546,191...28,569,075
Ensembl chr 8:28,546,146...28,570,675
G
Ldlrad4
low density lipoprotein receptor class A domain containing 4
decreases expression
ISO
troglitazone results in decreased expression of LDLRAD4 mRNA
CTD
PMID:28973697
NCBI chr18:63,789,089...64,118,166
Ensembl chr18:63,790,440...64,113,064
G
Leap2
liver enriched antimicrobial peptide 2
decreases expression
EXP
Troglitazone results in decreased expression of LEAP2 mRNA
CTD
PMID:21515302
NCBI chr10:38,081,001...38,082,073
Ensembl chr10:38,081,001...38,082,073
G
Lemd3
LEM domain containing 3
decreases expression
ISO
troglitazone results in decreased expression of LEMD3 mRNA
CTD
PMID:28973697
NCBI chr 7:58,300,556...58,389,485
Ensembl chr 7:58,316,851...58,384,707
G
Lep
leptin
decreases expression multiple interactions increases secretion
EXP ISO
troglitazone results in decreased expression of LEP mRNA; troglitazone results in decreased expression of LEP protein [Dexamethasone co-treated with troglitazone] results in decreased secretion of LEP protein; troglitazone inhibits the reaction [Dexamethasone results in increased expression of LEP mRNA]; troglitazone inhibits the reaction [Dexamethasone results in increased secretion of LEP protein] troglitazone results in increased secretion of LEP protein
CTD
PMID:9502777 PMID:9727893 PMID:10753628 PMID:10946865 PMID:11092516 PMID:11909685 PMID:15824971 More...
NCBI chr 4:58,626,529...58,640,663
Ensembl chr 4:58,626,523...58,640,661
G
Lepr
leptin receptor
increases response to substance
EXP
LEPR gene mutant form results in increased susceptibility to Troglitazone
CTD
PMID:29743445
NCBI chr 5:121,409,735...121,593,201
Ensembl chr 5:121,474,099...121,591,215
G
Lgals1
galectin 1
increases expression
ISO
troglitazone results in increased expression of LGALS1 mRNA
CTD
PMID:28973697
NCBI chr 7:112,365,695...112,368,801
Ensembl chr 7:112,361,850...112,368,800
G
Lgr4
leucine-rich repeat-containing G protein-coupled receptor 4
decreases expression
ISO
troglitazone results in decreased expression of LGR4 mRNA
CTD
PMID:28973697
NCBI chr 3:116,901,968...117,004,584
Ensembl chr 3:116,901,968...117,004,153
G
Lhfpl2
LHFPL tetraspan subfamily member 2
increases expression
ISO
troglitazone results in increased expression of LHFPL2 mRNA
CTD
PMID:28973697
NCBI chr 2:27,016,404...27,169,830
Ensembl chr 2:27,016,700...27,162,859
G
Lhpp
phospholysine phosphohistidine inorganic pyrophosphate phosphatase
increases expression
ISO
troglitazone results in increased expression of LHPP mRNA
CTD
PMID:28973697
NCBI chr 1:196,833,516...196,924,687
Ensembl chr 1:196,833,523...196,924,871
G
Lif
LIF, interleukin 6 family cytokine
increases expression decreases response to substance
ISO
troglitazone results in increased expression of LIF mRNA troglitazone results in decreased susceptibility to LIF protein
CTD
PMID:7956951 PMID:19140230
NCBI chr14:83,354,602...83,364,053
Ensembl chr14:83,358,164...83,364,053
G
Lifr
LIF receptor subunit alpha
increases expression
EXP
troglitazone results in increased expression of LIFR mRNA
CTD
PMID:21515302
NCBI chr 2:57,951,787...58,020,357
Ensembl chr 2:57,952,975...58,020,364
G
Lig1
DNA ligase 1
decreases expression
ISO
troglitazone results in decreased expression of LIG1 mRNA
CTD
PMID:19140230
NCBI chr 1:83,243,043...83,281,707
Ensembl chr 1:83,219,545...83,281,708
G
Lin54
lin-54 DREAM MuvB core complex component
decreases expression
ISO
troglitazone results in decreased expression of LIN54 mRNA
CTD
PMID:28973697
NCBI chr14:9,434,093...9,514,091
Ensembl chr14:9,434,112...9,492,106
G
Lipe
lipase E, hormone sensitive type
increases expression
ISO EXP
troglitazone results in increased expression of LIPE mRNA
CTD
PMID:12732648 PMID:21515302
NCBI chr 1:90,093,433...90,112,117
Ensembl chr 1:90,093,433...90,112,117
G
Liph
lipase H
decreases expression
EXP
troglitazone results in decreased expression of LIPH mRNA
CTD
PMID:21515302
NCBI chr11:92,536,724...92,586,117
Ensembl chr11:92,537,860...92,586,120
G
Litaf
lipopolysaccharide-induced TNF factor
multiple interactions
ISO
troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of LITAF mRNA]
CTD
PMID:20847119
NCBI chr10:5,163,258...5,199,930
Ensembl chr10:5,163,242...5,199,930
G
Lix1l
limb and CNS expressed 1 like
decreases expression
ISO
troglitazone results in decreased expression of LIX1L mRNA
CTD
PMID:28973697
NCBI chr 2:186,824,864...186,850,761
Ensembl chr 2:186,824,884...186,850,759
G
Lmcd1
LIM and cysteine-rich domains 1
increases expression
EXP
troglitazone results in increased expression of LMCD1 mRNA
CTD
PMID:25596134
NCBI chr 4:146,948,993...147,007,878
Ensembl chr 4:146,948,958...147,007,875
G
Lnpep
leucyl and cystinyl aminopeptidase
decreases expression
ISO
troglitazone results in decreased expression of LNPEP mRNA
CTD
PMID:28973697
NCBI chr 1:66,931,712...67,027,610
Ensembl chr 1:66,931,712...67,027,610
G
Lonp1
lon peptidase 1, mitochondrial
increases expression
ISO
troglitazone results in increased expression of LONP1 protein
CTD
PMID:18495193
NCBI chr 9:1,534,581...1,546,908
Ensembl chr 9:1,534,584...1,547,427
G
Lonp2
lon peptidase 2, peroxisomal
increases expression
EXP
troglitazone results in increased expression of LONP2 mRNA
CTD
PMID:21515302
NCBI chr19:36,580,736...36,672,242
Ensembl chr19:36,580,736...36,672,242
G
Lox
lysyl oxidase
increases expression
ISO
troglitazone results in increased expression of LOX mRNA
CTD
PMID:28973697
NCBI chr18:48,162,889...48,175,640
Ensembl chr18:48,165,688...48,239,810
G
Lpcat3
lysophosphatidylcholine acyltransferase 3
increases expression decreases expression
EXP ISO
troglitazone results in increased expression of LPCAT3 mRNA troglitazone results in decreased expression of LPCAT3 mRNA
CTD
PMID:21515302 PMID:28973697
NCBI chr 4:159,154,690...159,196,176
Ensembl chr 4:159,154,158...159,196,358
G
Lpin1
lipin 1
decreases expression
ISO
troglitazone results in decreased expression of LPIN1 mRNA
CTD
PMID:25572481
NCBI chr 6:45,039,110...45,145,845
Ensembl chr 6:45,041,522...45,145,991
G
Lpin2
lipin 2
decreases expression
ISO
troglitazone results in decreased expression of LPIN2 mRNA
CTD
PMID:28973697
NCBI chr 9:118,529,988...118,604,796
Ensembl chr 9:118,529,943...118,604,796
G
Lpl
lipoprotein lipase
multiple interactions increases expression decreases expression
ISO EXP
[troglitazone co-treated with Diethylstilbestrol] results in increased expression of LPL protein; troglitazone inhibits the reaction [Calcitriol results in decreased expression of LPL mRNA]; troglitazone inhibits the reaction [Tretinoin results in decreased expression of LPL mRNA] troglitazone results in increased expression of LPL protein [1-Methyl-3-isobutylxanthine co-treated with INS protein co-treated with Troglitazone] results in increased expression of LPL protein; [1-Methyl-3-isobutylxanthine co-treated with Troglitazone co-treated with INS protein] results in increased expression of LPL mRNA; [Troglitazone results in increased expression of LPL protein] which results in increased metabolism of Lipids troglitazone results in decreased expression of LPL mRNA Troglitazone results in increased expression of LPL mRNA; Troglitazone results in increased expression of LPL protein
CTD
PMID:10233209 PMID:16368784 PMID:19122273 PMID:21515302 PMID:22710028 PMID:22953781 PMID:23277027 PMID:24559133 PMID:27003841 PMID:28437481 PMID:28973697 More...
NCBI chr16:25,596,205...25,621,928
Ensembl chr16:25,596,211...25,622,107
G
Lpp
LIM domain containing preferred translocation partner in lipoma
increases expression decreases expression
ISO
troglitazone results in increased expression of LPP mRNA troglitazone results in decreased expression of LPP mRNA
CTD
PMID:19140230 PMID:28973697
NCBI chr11:89,292,060...89,933,973
Ensembl chr11:89,305,187...89,805,264
G
Lrat
lecithin retinol acyltransferase
increases expression
EXP
troglitazone results in increased expression of LRAT mRNA
CTD
PMID:21515302
NCBI chr 2:170,562,148...170,571,212
Ensembl chr 2:170,565,543...170,571,148
G
Lrit1
leucine-rich repeat, Ig-like and transmembrane domains 1
decreases expression
ISO
troglitazone results in decreased expression of LRIT1 mRNA
CTD
PMID:28973697
NCBI chr16:12,842,339...12,850,266
Ensembl chr16:12,842,339...12,852,035
G
Lrp2
LDL receptor related protein 2
decreases expression
EXP
troglitazone results in decreased expression of LRP2 mRNA
CTD
PMID:21515302
NCBI chr 3:74,597,148...74,754,535
Ensembl chr 3:74,597,148...74,754,535
G
Lrp6
LDL receptor related protein 6
decreases expression
ISO
troglitazone results in decreased expression of LRP6 mRNA
CTD
PMID:28973697
NCBI chr 4:168,997,937...169,131,716
Ensembl chr 4:169,000,968...169,131,716
G
Lrpap1
LDL receptor related protein associated protein 1
increases expression
EXP
troglitazone results in increased expression of LRPAP1 protein
CTD
PMID:21315101
NCBI chr14:79,876,002...79,888,011
Ensembl chr14:79,875,708...79,890,034
G
Lrrc24
leucine rich repeat containing 24
increases expression
ISO
troglitazone results in increased expression of LRRC24 mRNA
CTD
PMID:28973697
NCBI chr 7:110,317,935...110,325,201
Ensembl chr 7:110,317,020...110,325,074
G
Lrrc28
leucine rich repeat containing 28
increases expression
ISO
troglitazone results in increased expression of LRRC28 mRNA
CTD
PMID:28973697
NCBI chr 1:130,526,757...130,655,991
Ensembl chr 1:130,537,930...130,655,949
G
Lrrc39
leucine rich repeat containing 39
increases expression
ISO
troglitazone results in increased expression of LRRC39 mRNA
CTD
PMID:28973697
NCBI chr 2:207,201,039...207,220,375
Ensembl chr 2:207,201,042...207,220,371
G
Lrrc8c
leucine rich repeat containing 8 VRAC subunit C
decreases expression
ISO
troglitazone results in decreased expression of LRRC8C mRNA
CTD
PMID:28973697
NCBI chr14:4,528,721...4,621,259
Ensembl chr14:4,531,823...4,620,049
G
Lrwd1
leucine-rich repeats and WD repeat domain containing 1
decreases expression
ISO
troglitazone results in decreased expression of LRWD1 mRNA
CTD
PMID:28973697
NCBI chr12:26,166,648...26,179,689
Ensembl chr12:26,166,648...26,185,200
G
Lss
lanosterol synthase
increases expression decreases expression
EXP ISO
troglitazone results in increased expression of LSS protein troglitazone results in decreased expression of LSS mRNA
CTD
PMID:21315101 PMID:25572481
NCBI chr20:12,090,641...12,118,230
Ensembl chr20:12,073,543...12,118,253
G
Lta
lymphotoxin alpha
decreases expression increases expression
ISO
troglitazone results in decreased expression of LTA mRNA troglitazone results in increased expression of LTA mRNA
CTD
PMID:17569031 PMID:19631733
NCBI chr20:3,622,291...3,625,852
Ensembl chr20:3,623,527...3,625,533
G
Ltbp4
latent transforming growth factor beta binding protein 4
increases expression
ISO
troglitazone results in increased expression of LTBP4 mRNA
CTD
PMID:19140230
NCBI chr 1:91,727,769...91,759,822
Ensembl chr 1:91,727,769...91,760,006
G
Ltc4s
leukotriene C4 synthase
increases expression
ISO
troglitazone results in increased expression of LTC4S mRNA
CTD
PMID:28973697
NCBI chr10:35,060,002...35,066,466
Ensembl chr10:35,061,437...35,063,768
G
Luc7l2
LUC7 pre-mRNA splicing factor like 2
decreases expression
ISO
troglitazone results in decreased expression of LUC7L2 mRNA
CTD
PMID:28973697
NCBI chr 4:68,251,435...68,314,861
Ensembl chr 4:68,271,414...68,314,837
G
Lum
lumican
increases expression
ISO
troglitazone results in increased expression of LUM mRNA
CTD
PMID:28973697
NCBI chr 7:34,245,323...34,252,510
Ensembl chr 7:34,245,360...34,252,508
G
Luzp1
leucine zipper protein 1
decreases expression
ISO
troglitazone results in decreased expression of LUZP1 mRNA
CTD
PMID:28973697
NCBI chr 5:153,989,570...154,065,071
Ensembl chr 5:153,987,683...154,070,438
G
Lxn
latexin
decreases expression
EXP
troglitazone results in decreased expression of LXN mRNA
CTD
PMID:21515302
NCBI chr 2:154,037,604...154,043,473
Ensembl chr 2:154,037,292...154,043,488
G
Ly49i4
Ly49 inhibitory receptor 4
decreases expression
EXP
troglitazone results in decreased expression of LY49I4 mRNA
CTD
PMID:21515302
NCBI chr 4:165,852,010...165,873,606
Ensembl chr 4:165,852,010...165,873,606
G
Ly6i
lymphocyte antigen 6 complex, locus I
increases expression
EXP
Troglitazone results in increased expression of LY6B mRNA
CTD
PMID:21515302
NCBI chr 7:108,943,081...108,948,499
Ensembl chr 7:108,943,081...108,945,889
G
Ly86
lymphocyte antigen 86
decreases expression
ISO
troglitazone results in decreased expression of LY86 mRNA
CTD
PMID:17569031
NCBI chr17:27,621,313...27,705,336
Ensembl chr17:27,621,313...27,692,743
G
Ly96
lymphocyte antigen 96
increases expression
ISO
troglitazone results in increased expression of LY96 mRNA
CTD
PMID:25572481
NCBI chr 5:7,365,536...7,397,864
Ensembl chr 5:7,365,557...7,395,816
G
Lyc2
lysozyme C type 2
decreases expression
EXP
troglitazone results in decreased expression of LYC2 mRNA
CTD
PMID:21515302
NCBI chr 7:54,773,009...54,780,352
Ensembl chr 7:54,772,934...54,780,676
G
Lyz2
lysozyme 2
decreases expression increases expression
EXP ISO
troglitazone results in decreased expression of LYZ mRNA troglitazone results in increased expression of LYZ mRNA
CTD
PMID:21515302 PMID:28973697
NCBI chr 7:54,792,715...54,798,060
Ensembl chr 7:54,792,716...54,798,011
G
Lzts1
leucine zipper tumor suppressor 1
increases expression
ISO
troglitazone results in increased expression of LZTS1 mRNA
CTD
PMID:28973697
NCBI chr16:25,309,502...25,364,942
Ensembl chr16:25,309,507...25,364,940
G
Mab21l2
mab-21 like 2
increases expression
ISO
troglitazone results in increased expression of MAB21L2 mRNA
CTD
PMID:28973697
NCBI chr 2:174,244,538...174,247,620
Ensembl chr 2:174,238,828...174,252,064
G
Macroh2a1
macroH2A.1 histone
decreases expression
ISO
Troglitazone results in decreased expression of MACROH2A1 mRNA
CTD
PMID:28973697
NCBI chr17:8,484,340...8,547,268
Ensembl chr17:8,484,246...8,547,257
G
Mad2l1
mitotic arrest deficient 2 like 1
decreases expression
ISO
troglitazone results in decreased expression of MAD2L1 mRNA
CTD
PMID:19140230
NCBI chr 4:97,236,419...97,247,603
Ensembl chr 4:97,236,503...97,243,222
G
Maff
MAF bZIP transcription factor F
increases expression
ISO
troglitazone results in increased expression of MAFF mRNA
CTD
PMID:19140230
NCBI chr 7:112,792,787...112,804,139
Ensembl chr 7:112,791,416...112,804,147
G
Mafg
MAF bZIP transcription factor G
decreases expression
EXP
troglitazone results in decreased expression of MAFG mRNA
CTD
PMID:25596134
NCBI chr10:106,401,633...106,410,159
G
Magi1
membrane associated guanylate kinase, WW and PDZ domain containing 1
decreases expression
ISO
troglitazone results in decreased expression of MAGI1 mRNA
CTD
PMID:28973697
NCBI chr 4:127,762,590...128,368,228
Ensembl chr 4:127,762,590...128,367,833
G
Magi3
membrane associated guanylate kinase, WW and PDZ domain containing 3
decreases expression
ISO
troglitazone results in decreased expression of MAGI3 mRNA
CTD
PMID:28973697
NCBI chr 2:194,206,587...194,405,468
Ensembl chr 2:194,206,934...194,405,157
G
Maml1
mastermind-like transcriptional coactivator 1
decreases expression
ISO
troglitazone results in decreased expression of MAML1 mRNA
CTD
PMID:28973697
NCBI chr10:35,089,715...35,124,100
Ensembl chr10:35,089,715...35,124,100
G
Man1a2
mannosidase, alpha, class 1A, member 2
decreases expression
EXP
troglitazone results in decreased expression of MAN1A2 mRNA
CTD
PMID:25596134
NCBI chr 2:190,636,134...190,784,975
Ensembl chr 2:190,615,094...190,784,975
G
Man2b1
mannosidase, alpha, class 2B, member 1
increases expression
ISO
troglitazone results in increased expression of MAN2B1 mRNA
CTD
PMID:28973697
NCBI chr19:39,959,964...39,979,299
Ensembl chr19:39,959,965...39,979,246
G
Manf
mesencephalic astrocyte-derived neurotrophic factor
increases expression
ISO
troglitazone results in increased expression of MANF mRNA
CTD
PMID:28973697
NCBI chr 8:116,427,053...116,430,259
Ensembl chr 8:116,427,048...116,429,910
G
Maoa
monoamine oxidase A
increases expression decreases activity
ISO
troglitazone results in increased expression of MAOA mRNA troglitazone results in decreased activity of MAOA protein
CTD
PMID:19140230 PMID:22282722
NCBI chr X:8,615,239...8,681,372
Ensembl chr X:8,615,239...8,682,631
G
Maob
monoamine oxidase B
decreases activity
ISO
troglitazone results in decreased activity of MAOB protein
CTD
PMID:22282722
NCBI chr X:8,490,405...8,594,065
Ensembl chr X:8,490,344...8,594,375
G
Map2k1
mitogen activated protein kinase kinase 1
multiple interactions
ISO
MAP2K1 protein promotes the reaction [troglitazone results in increased expression of ATF3 mRNA]
CTD
PMID:16079301
NCBI chr 8:73,578,747...73,650,184
Ensembl chr 8:73,578,752...73,650,184
G
Map2k5
mitogen activated protein kinase kinase 5
decreases expression
ISO
troglitazone results in decreased expression of MAP2K5 mRNA
CTD
PMID:28973697
NCBI chr 8:72,520,616...72,748,395
Ensembl chr 8:72,520,617...72,747,373
G
Map2k6
mitogen-activated protein kinase kinase 6
decreases expression
ISO
troglitazone results in decreased expression of MAP2K6 mRNA
CTD
PMID:19140230
NCBI chr10:95,872,747...95,987,747
Ensembl chr10:95,872,546...95,987,721
G
Map3k2
mitogen activated protein kinase kinase kinase 2
decreases expression
ISO
troglitazone results in decreased expression of MAP3K2 mRNA
CTD
PMID:28973697
NCBI chr18:24,081,444...24,153,940
Ensembl chr18:24,081,444...24,147,323
G
Map3k20
mitogen-activated protein kinase kinase kinase 20
decreases expression
ISO
troglitazone results in decreased expression of MAP3K20 mRNA
CTD
PMID:28973697
NCBI chr 3:77,538,146...77,697,540
Ensembl chr 3:77,537,956...77,697,538
G
Map3k4
mitogen activated protein kinase kinase kinase 4
decreases expression
ISO
troglitazone results in decreased expression of MAP3K4 mRNA
CTD
PMID:28973697
NCBI chr 1:50,977,870...51,067,117
Ensembl chr 1:50,979,586...51,067,117
G
Map3k5
mitogen-activated protein kinase kinase kinase 5
increases activity multiple interactions
ISO
troglitazone results in increased activity of MAP3K5 protein mito-carboxy proxyl inhibits the reaction [troglitazone results in increased activity of MAP3K5 protein]
CTD
PMID:17975114
NCBI chr 1:16,505,387...16,723,899
Ensembl chr 1:16,505,596...16,723,898
G
Map4
microtubule-associated protein 4
increases expression
ISO
troglitazone results in increased expression of MAP4 mRNA
CTD
PMID:19140230
NCBI chr 8:118,800,393...118,942,805
Ensembl chr 8:118,804,022...118,942,805
G
Map4k4
mitogen-activated protein kinase kinase kinase kinase 4
increases expression
ISO
troglitazone results in increased expression of MAP4K4 mRNA
CTD
PMID:17569031
NCBI chr 9:49,696,573...49,822,353
Ensembl chr 9:49,696,700...49,822,353
G
Map4k5
mitogen-activated protein kinase kinase kinase kinase 5
decreases expression
ISO
troglitazone results in decreased expression of MAP4K5 mRNA
CTD
PMID:28973697
NCBI chr 6:94,020,079...94,112,943
Ensembl chr 6:94,020,079...94,112,943
G
Mapk1
mitogen activated protein kinase 1
multiple interactions increases phosphorylation increases activity decreases phosphorylation increases expression
ISO EXP
[troglitazone results in increased phosphorylation of MAPK1 protein] which results in increased expression of ATF3 protein; troglitazone results in increased activity of and results in increased phosphorylation of MAPK1 protein; troglitazone results in increased phosphorylation of and results in increased activity of MAPK1 protein troglitazone results in increased activity of MAPK1 protein troglitazone results in decreased phosphorylation of MAPK1 protein troglitazone results in increased expression of MAPK1 protein modified form
CTD
PMID:11218074 PMID:11687581 PMID:11854617 PMID:12475986 PMID:15064713 PMID:16079301 PMID:16149072 PMID:16446079 PMID:18599600 PMID:19140230 PMID:20427483 PMID:24481447 More...
NCBI chr11:97,462,025...97,529,193
Ensembl chr11:97,462,025...97,527,825
G
Mapk3
mitogen activated protein kinase 3
increases phosphorylation multiple interactions increases activity decreases phosphorylation increases expression
ISO EXP
troglitazone results in increased phosphorylation of MAPK3 protein [troglitazone results in increased phosphorylation of MAPK3 protein] which results in increased expression of ATF3 protein; troglitazone results in increased activity of and results in increased phosphorylation of MAPK3 protein; troglitazone results in increased phosphorylation of and results in increased activity of MAPK3 protein troglitazone results in increased activity of MAPK3 protein troglitazone results in decreased phosphorylation of MAPK3 protein troglitazone results in increased expression of MAPK3 protein modified form
CTD
PMID:11218074 PMID:11687581 PMID:11854617 PMID:12475986 PMID:15064713 PMID:16079301 PMID:16149072 PMID:16446079 PMID:18599600 PMID:19140230 PMID:20427483 PMID:24481447 More...
NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:190,797,185...190,803,411
G
Mapk8
mitogen-activated protein kinase 8
multiple interactions decreases expression
ISO
troglitazone results in increased phosphorylation of and results in increased activity of MAPK8 protein troglitazone results in decreased expression of MAPK8 mRNA
CTD
PMID:15064713 PMID:28973697
NCBI chr16:8,645,171...8,728,225
Ensembl chr16:8,645,198...8,728,427
G
Mapre2
microtubule-associated protein, RP/EB family, member 2
decreases expression
ISO
troglitazone results in decreased expression of MAPRE2 mRNA
CTD
PMID:28973697
NCBI chr18:15,303,502...15,444,306
Ensembl chr18:15,303,533...15,442,796
G
Mapt
microtubule-associated protein tau
decreases expression
ISO
troglitazone results in decreased expression of MAPT mRNA
CTD
PMID:28973697
NCBI chr10:89,638,618...89,736,108
Ensembl chr10:89,638,599...89,736,108
G
Marchf7
membrane associated ring-CH-type finger 7
decreases expression
ISO
Troglitazone results in decreased expression of MARCHF7 mRNA
CTD
PMID:28973697
NCBI chr 3:65,090,640...65,128,768
Ensembl chr 3:65,090,310...65,128,864
G
Mark2
microtubule affinity regulating kinase 2
decreases expression
ISO
troglitazone results in decreased expression of MARK2 mRNA
CTD
PMID:28973697
NCBI chr 1:213,890,213...213,955,417
Ensembl chr 1:213,890,213...213,955,149
G
Marveld2
MARVEL domain containing 2
decreases expression
ISO
troglitazone results in decreased expression of MARVELD2 mRNA
CTD
PMID:28973697
NCBI chr 2:33,474,750...33,498,225
Ensembl chr 2:33,462,950...33,498,077
G
Masp1
MBL associated serine protease 1
decreases expression
ISO
troglitazone results in decreased expression of MASP1 mRNA
CTD
PMID:28973697
NCBI chr11:90,839,081...90,909,922
Ensembl chr11:90,839,061...90,917,470
G
Mastl
microtubule associated serine/threonine kinase-like
decreases expression
ISO
troglitazone results in decreased expression of MASTL mRNA
CTD
PMID:19140230
NCBI chr17:90,158,592...90,195,550
Ensembl chr17:90,160,068...90,195,564
G
Mat1a
methionine adenosyltransferase 1A
increases expression
EXP
troglitazone results in increased expression of MAT1A mRNA
CTD
PMID:21515302
NCBI chr16:17,017,168...17,035,368
Ensembl chr16:17,016,030...17,035,367
G
Mat2a
methionine adenosyltransferase 2A
decreases expression
ISO
troglitazone results in decreased expression of MAT2A mRNA
CTD
PMID:28973697
NCBI chr 4:106,048,043...106,053,612
Ensembl chr 4:106,038,254...106,053,645
G
Mb21d2
Mab-21 domain containing 2
multiple interactions
ISO
[troglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of MB21D2 mRNA; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of MB21D2 mRNA]
CTD
PMID:20847119
NCBI chr11:85,330,526...85,429,543
Ensembl chr11:85,330,503...85,476,241
G
Mbl2
mannose binding lectin 2
increases expression decreases expression
ISO EXP
troglitazone results in increased expression of MBL2 mRNA troglitazone results in decreased expression of MBL2 mRNA
CTD
PMID:21515302 PMID:25572481
NCBI chr 1:237,429,873...237,465,567
Ensembl chr 1:237,429,973...237,437,546
G
Mbnl2
muscleblind-like splicing regulator 2
increases expression
ISO
troglitazone results in increased expression of MBNL2 mRNA
CTD
PMID:28973697
NCBI chr15:103,792,134...103,949,827
Ensembl chr15:103,792,152...103,949,827
G
Mbp
myelin basic protein
increases expression
ISO
troglitazone results in increased expression of MBP mRNA
CTD
PMID:28973697
NCBI chr18:78,130,652...78,241,174
Ensembl chr18:78,130,325...78,241,174
G
Mbtps1
membrane-bound transcription factor peptidase, site 1
increases expression
ISO
troglitazone results in increased expression of MBTPS1 mRNA
CTD
PMID:28973697
NCBI chr19:64,470,245...64,521,438
Ensembl chr19:64,470,545...64,521,342
G
Mccc1
methylcrotonyl-CoA carboxylase subunit 1
decreases expression
ISO
troglitazone results in decreased expression of MCCC1 mRNA
CTD
PMID:28973697
NCBI chr 2:120,727,313...120,779,334
Ensembl chr 2:120,727,316...120,779,554
G
Mccc2
methylcrotonyl-CoA carboxylase subunit 2
increases expression
ISO
troglitazone results in increased expression of MCCC2 mRNA
CTD
PMID:28973697
NCBI chr 2:33,039,044...33,110,092
Ensembl chr 2:33,039,045...33,110,299
G
Mcf2
MCF.2 cell line derived transforming sequence
decreases expression
ISO
troglitazone results in decreased expression of MCF2 mRNA
CTD
PMID:25572481
NCBI chr X:143,444,510...143,550,839
Ensembl chr X:143,444,038...143,567,714
G
Mchr1
melanin-concentrating hormone receptor 1
increases expression
ISO
troglitazone results in increased expression of MCHR1 mRNA
CTD
PMID:28973697
NCBI chr 7:114,641,721...114,644,913
Ensembl chr 7:114,641,580...114,644,919
G
Mcl1
MCL1 apoptosis regulator, BCL2 family member
increases expression
ISO
Troglitazone results in increased expression of MCL1 mRNA
CTD
PMID:31294483
NCBI chr 2:185,884,840...185,912,532
Ensembl chr 2:185,908,168...185,938,782
G
Mcm2
minichromosome maintenance complex component 2
decreases expression
ISO
troglitazone results in decreased expression of MCM2 mRNA
CTD
PMID:19140230
NCBI chr 4:122,903,679...122,918,205
Ensembl chr 4:122,903,682...122,918,094
G
Mcm3
minichromosome maintenance complex component 3
decreases expression
ISO
troglitazone results in decreased expression of MCM3 mRNA
CTD
PMID:19140230
NCBI chr 9:30,715,602...30,733,746
Ensembl chr 9:30,715,602...30,733,746
G
Mcm4
minichromosome maintenance complex component 4
decreases expression
ISO
troglitazone results in decreased expression of MCM4 mRNA
CTD
PMID:19140230
NCBI chr11:98,762,599...98,776,300
Ensembl chr11:98,762,634...98,776,536
G
Mcm5
minichromosome maintenance complex component 5
decreases expression
ISO
troglitazone results in decreased expression of MCM5 mRNA
CTD
PMID:19140230
NCBI chr19:13,488,813...13,510,131
Ensembl chr19:13,488,813...13,517,758
G
Mcm6
minichromosome maintenance complex component 6
decreases expression
ISO
troglitazone results in decreased expression of MCM6 mRNA
CTD
PMID:19140230
NCBI chr13:42,379,161...42,404,352
Ensembl chr13:42,379,162...42,465,467
G
Mcm7
minichromosome maintenance complex component 7
decreases expression
ISO
troglitazone results in decreased expression of MCM7 mRNA
CTD
PMID:19140230 PMID:28973697
NCBI chr12:22,155,921...22,163,320
Ensembl chr12:22,155,921...22,163,771
G
Mcpt9
mast cell protease 9
decreases expression
EXP
Troglitazone results in decreased expression of MCPT9 mRNA
CTD
PMID:21515302
NCBI chr15:33,827,348...33,830,396
Ensembl chr15:33,827,378...33,830,396
G
Mcu
mitochondrial calcium uniporter
decreases expression
ISO
troglitazone results in decreased expression of MCU mRNA
CTD
PMID:28973697
NCBI chr20:27,960,520...28,123,103
Ensembl chr20:27,961,327...28,123,103
G
Mdc1
mediator of DNA damage checkpoint 1
decreases expression
ISO
troglitazone results in decreased expression of MDC1 mRNA
CTD
PMID:19140230
NCBI chr20:2,898,496...2,914,960
Ensembl chr20:2,900,308...2,914,960
G
Mdk
midkine
decreases expression
ISO
troglitazone results in decreased expression of MDK mRNA
CTD
PMID:19140230
NCBI chr 3:98,356,789...98,358,960
Ensembl chr 3:98,356,789...98,358,743
G
Me1
malic enzyme 1
increases expression
EXP
troglitazone results in increased expression of ME1 mRNA; troglitazone results in increased expression of ME1 protein
CTD
PMID:21315101 PMID:25596134
NCBI chr 8:96,429,057...96,540,244
Ensembl chr 8:96,429,057...96,540,275
G
Mecr
mitochondrial trans-2-enoyl-CoA reductase
increases expression
ISO
troglitazone results in increased expression of MECR mRNA
CTD
PMID:28973697
NCBI chr 5:149,313,765...149,339,964
Ensembl chr 5:149,313,774...149,342,825
G
Med12
mediator complex subunit 12
decreases expression
ISO
troglitazone results in decreased expression of MED12 mRNA
CTD
PMID:28973697
NCBI chr X:70,444,615...70,467,780
Ensembl chr X:70,444,705...70,467,708
G
Med13
mediator complex subunit 13
decreases expression
ISO
troglitazone results in decreased expression of MED13 mRNA
CTD
PMID:28973697
NCBI chr10:71,584,354...71,674,614
Ensembl chr10:71,584,354...71,673,901
G
Med13l
mediator complex subunit 13L
decreases expression increases expression
ISO
troglitazone results in decreased expression of MED13L mRNA troglitazone results in increased expression of MED13L mRNA
CTD
PMID:28973697
NCBI chr12:43,468,556...43,665,819
Ensembl chr12:43,468,556...43,665,819
G
Med21
mediator complex subunit 21
increases expression
ISO
troglitazone results in increased expression of MED21 mRNA
CTD
PMID:28973697
NCBI chr 4:181,291,191...181,314,504
Ensembl chr 4:181,291,271...181,298,234
G
Mef2d
myocyte enhancer factor 2D
decreases expression
ISO
troglitazone results in decreased expression of MEF2D mRNA
CTD
PMID:28973697
NCBI chr 2:175,904,332...175,933,451
Ensembl chr 2:175,903,959...175,930,760
G
Meis2
Meis homeobox 2
decreases expression
ISO
troglitazone results in decreased expression of MEIS2 mRNA
CTD
PMID:28973697
NCBI chr 3:123,197,066...123,399,002
Ensembl chr 3:123,197,066...123,397,751
G
Melk
maternal embryonic leucine zipper kinase
decreases expression
ISO
troglitazone results in decreased expression of MELK mRNA
CTD
PMID:19140230
NCBI chr 5:63,336,151...63,396,254
Ensembl chr 5:63,336,106...63,396,247
G
Meox2
mesenchyme homeobox 2
decreases expression
ISO
troglitazone results in decreased expression of MEOX2 mRNA
CTD
PMID:28973697
NCBI chr 6:59,584,025...59,644,722
Ensembl chr 6:59,583,785...59,644,700
G
Met
MET proto-oncogene, receptor tyrosine kinase
increases expression
ISO
troglitazone results in increased expression of MET mRNA Troglitazone results in increased expression of MET mRNA
CTD
PMID:28973697 PMID:32816093
NCBI chr 4:46,756,823...46,864,041
Ensembl chr 4:46,756,506...46,870,821
G
Metap2
methionyl aminopeptidase 2
decreases expression
ISO
troglitazone results in decreased expression of METAP2 mRNA
CTD
PMID:28973697
NCBI chr 7:30,299,433...30,327,477
Ensembl chr 7:30,299,433...30,327,521
G
Mettl14
methyltransferase 14, N6-adenosine-methyltransferase non-catalytic subunit
decreases expression
ISO
troglitazone results in decreased expression of METTL14 mRNA
CTD
PMID:28973697
NCBI chr 2:214,215,165...214,231,412
Ensembl chr 2:214,215,165...214,231,412
G
Mfap1a
microfibrillar-associated protein 1A
decreases expression
ISO
troglitazone results in decreased expression of MFAP1 mRNA
CTD
PMID:28973697
NCBI chr 3:128,893,880...128,910,460
Ensembl chr 3:128,893,880...128,911,481
G
Mfap5
microfibril associated protein 5
increases expression
ISO
troglitazone results in increased expression of MFAP5 mRNA
CTD
PMID:28973697
NCBI chr 4:157,399,919...157,422,448
Ensembl chr 4:157,395,597...157,422,448
G
Mfge8
milk fat globule EGF and factor V/VIII domain containing
decreases expression
ISO
troglitazone results in decreased expression of MFGE8 mRNA
CTD
PMID:28973697
NCBI chr 1:142,474,027...142,489,431
Ensembl chr 1:142,474,028...142,489,431
G
Mfhas1
multifunctional ROCO family signaling regulator 1
decreases expression
ISO
troglitazone results in decreased expression of MFHAS1 mRNA
CTD
PMID:28973697
NCBI chr16:63,248,833...63,336,441
Ensembl chr16:63,250,455...63,336,602
G
Mfsd2a
MFSD2 lysolipid transporter A, lysophospholipid
decreases expression
ISO
troglitazone results in decreased expression of MFSD2 mRNA
CTD
PMID:25572481
NCBI chr 5:140,510,933...140,525,828
Ensembl chr 5:140,510,953...140,525,916
G
Mga
MAX dimerization protein MGA
decreases expression
ISO
troglitazone results in decreased expression of MGA mRNA
CTD
PMID:28973697
NCBI chr 3:127,300,558...127,396,694
Ensembl chr 3:127,328,264...127,394,826
G
Mgll
monoglyceride lipase
increases expression
EXP
troglitazone results in increased expression of MGLL mRNA
CTD
PMID:21515302
NCBI chr 4:122,749,436...122,851,440
Ensembl chr 4:122,749,436...122,851,440
G
Mgp
matrix Gla protein
decreases expression
EXP ISO
troglitazone results in decreased expression of MGP mRNA
CTD
PMID:21515302 PMID:25572481
NCBI chr 4:171,497,472...171,500,888
Ensembl chr 4:171,497,471...171,500,859
G
Mgrn1
mahogunin ring finger 1
decreases expression
ISO
troglitazone results in decreased expression of MGRN1 mRNA
CTD
PMID:28973697
NCBI chr10:11,142,626...11,194,773
Ensembl chr10:11,145,690...11,194,805
G
Mgst1
microsomal glutathione S-transferase 1
increases expression
ISO
troglitazone results in increased expression of MGST1 mRNA
CTD
PMID:28973697
NCBI chr 4:172,760,930...172,776,157
Ensembl chr 4:172,760,886...172,776,875
G
Mgst2
microsomal glutathione S-transferase 2
increases expression
ISO
troglitazone results in increased expression of MGST2 mRNA
CTD
PMID:28973697
NCBI chr 2:137,821,787...137,866,664
Ensembl chr 2:137,836,140...137,866,661
G
Mgst3
microsomal glutathione S-transferase 3
increases expression
ISO
troglitazone results in increased expression of MGST3 mRNA
CTD
PMID:25572481 PMID:28973697
NCBI chr13:82,059,480...82,080,418
Ensembl chr13:82,059,480...82,080,575
G
Mia3
MIA SH3 domain ER export factor 3
decreases expression
ISO
troglitazone results in decreased expression of MIA3 mRNA
CTD
PMID:28973697
NCBI chr13:97,502,040...97,547,155
Ensembl chr13:97,494,275...97,543,587
G
Miat
myocardial infarction associated transcript
increases expression
ISO
troglitazone results in increased expression of MIAT mRNA
CTD
PMID:28973697
NCBI chr12:50,075,026...50,090,259
G
Mical1
microtubule associated monooxygenase, calponin and LIM domain containing 1
increases expression
ISO
troglitazone results in increased expression of MICAL1 mRNA
CTD
PMID:19140230
NCBI chr20:46,547,983...46,568,487
Ensembl chr20:46,556,536...46,568,487
G
Mier3
MIER family member 3
decreases expression
ISO
troglitazone results in decreased expression of MIER3 mRNA
CTD
PMID:28973697
NCBI chr 2:45,021,167...45,049,745
Ensembl chr 2:45,021,283...45,049,745
G
Mindy2
MINDY lysine 48 deubiquitinase 2
decreases expression
ISO
troglitazone results in decreased expression of MINDY2 mRNA
CTD
PMID:28973697
NCBI chr 8:80,149,127...80,210,011
Ensembl chr 8:80,130,193...80,208,461
G
Mindy3
MINDY lysine 48 deubiquitinase 3
increases expression
ISO
troglitazone results in increased expression of MINDY3 mRNA
CTD
PMID:19140230
NCBI chr17:80,454,404...80,532,999
Ensembl chr17:80,454,405...80,532,960
G
Miox
myo-inositol oxygenase
increases expression
EXP
troglitazone results in increased expression of MIOX mRNA
CTD
PMID:21515302
NCBI chr 7:122,284,660...122,287,158
Ensembl chr 7:122,284,660...122,287,157
G
Mir122
microRNA 122
increases expression
ISO
Troglitazone results in increased expression of MIR122
CTD
PMID:31294483
NCBI chr18:61,028,817...61,028,901
G
Mir16-2
microRNA 16-2
increases expression
EXP
Troglitazone results in increased expression of MIR16-2 mRNA
CTD
PMID:21515302
NCBI chr 2:155,555,327...155,555,421
Ensembl chr 2:155,555,327...155,555,421
G
Mki67
marker of proliferation Ki-67
decreases expression increases expression
ISO
troglitazone results in decreased expression of MKI67 mRNA troglitazone results in increased expression of MKI67 protein
CTD
PMID:10097144 PMID:19140230
NCBI chr 1:199,926,150...199,952,847
Ensembl chr 1:199,926,150...199,952,593
G
Mkrn1
makorin ring finger protein 1
decreases expression
ISO
troglitazone results in decreased expression of MKRN1 mRNA
CTD
PMID:28973697
NCBI chr 4:69,142,710...69,170,211
Ensembl chr 4:69,142,723...69,164,020
G
Mllt6
MLLT6, PHD finger containing
decreases expression
ISO
troglitazone results in decreased expression of MLLT6 mRNA
CTD
PMID:28973697
NCBI chr10:83,152,317...83,175,264
Ensembl chr10:83,153,698...83,175,250
G
Mlx
MAX dimerization protein MLX
increases expression
ISO
troglitazone results in increased expression of MLX mRNA
CTD
PMID:28973697
NCBI chr10:86,519,517...86,524,607
Ensembl chr10:86,519,864...86,524,772
G
Mlycd
malonyl-CoA decarboxylase
increases expression
EXP
troglitazone results in increased expression of MLYCD mRNA
CTD
PMID:21515302
NCBI chr19:64,356,582...64,372,447
Ensembl chr19:64,356,223...64,372,446
G
Mme
membrane metallo-endopeptidase
increases expression
ISO
troglitazone results in increased expression of MME mRNA
CTD
PMID:28973697
NCBI chr 2:149,806,826...149,957,381
Ensembl chr 2:149,872,291...149,953,463
G
Mmp10
matrix metallopeptidase 10
decreases expression
EXP
troglitazone results in decreased expression of MMP10 mRNA
CTD
PMID:21515302
NCBI chr 8:12,974,707...12,982,613
Ensembl chr 8:12,974,707...12,982,613
G
Mmp15
matrix metallopeptidase 15
decreases expression
ISO
troglitazone results in decreased expression of MMP15 mRNA
CTD
PMID:28973697
NCBI chr19:9,669,506...9,691,000
Ensembl chr19:9,669,506...9,691,000
G
Mmp2
matrix metallopeptidase 2
multiple interactions decreases activity increases expression
ISO
troglitazone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP2 mRNA] troglitazone results in decreased activity of MMP2 protein troglitazone results in increased expression of MMP2 mRNA
CTD
PMID:18155510 PMID:28973697
NCBI chr19:30,327,643...30,355,856
Ensembl chr19:30,327,643...30,355,856
G
Mmp9
matrix metallopeptidase 9
multiple interactions decreases activity
ISO
troglitazone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA] troglitazone results in decreased activity of MMP9 protein
CTD
PMID:18155510
NCBI chr 3:174,103,474...174,111,434
Ensembl chr 3:174,084,123...174,111,442
G
Mn1
MN1 proto-oncogene, transcriptional regulator
increases expression decreases expression
ISO
troglitazone results in increased expression of MN1 mRNA troglitazone results in decreased expression of MN1 mRNA
CTD
PMID:19140230 PMID:28973697
NCBI chr12:50,841,632...50,880,795
Ensembl chr12:50,841,632...50,880,795
G
Mns1
meiosis-specific nuclear structural 1
decreases expression
EXP
troglitazone results in decreased expression of MNS1 mRNA
CTD
PMID:21515302
NCBI chr 8:82,029,587...82,050,276
Ensembl chr 8:82,029,587...82,050,274
G
Mnt
MAX network transcriptional repressor
decreases expression
ISO
troglitazone results in decreased expression of MNT mRNA
CTD
PMID:28973697
NCBI chr10:60,197,654...60,213,221
Ensembl chr10:60,197,948...60,213,209
G
Mob3b
MOB kinase activator 3B
decreases expression
ISO
troglitazone results in decreased expression of MOB3B mRNA
CTD
PMID:28973697
NCBI chr 5:54,342,509...54,534,164
Ensembl chr 5:54,338,056...54,454,678
G
Mocs1
molybdenum cofactor synthesis 1
decreases expression
ISO
troglitazone results in decreased expression of MOCS1 mRNA
CTD
PMID:28973697
NCBI chr 9:19,045,223...19,071,628
Ensembl chr 9:19,045,223...19,065,449
G
Mocs2
molybdenum cofactor synthesis 2
increases expression
EXP
troglitazone results in increased expression of MOCS2 mRNA
CTD
PMID:21515302
NCBI chr 2:48,237,655...48,249,394
Ensembl chr 2:48,237,655...48,249,394
G
Mogat1
monoacylglycerol O-acyltransferase 1
increases expression
ISO
troglitazone results in increased expression of MOGAT1 mRNA
CTD
PMID:28934090 PMID:28973697
NCBI chr 9:87,429,427...87,436,977
Ensembl chr 9:87,405,119...87,436,977
G
Mon2
MON2 homolog, regulator of endosome-to-Golgi trafficking
decreases expression
ISO
troglitazone results in decreased expression of MON2 mRNA
CTD
PMID:28973697
NCBI chr 7:60,534,772...60,613,467
Ensembl chr 7:60,534,772...60,613,467
G
Morn4
MORN repeat containing 4
increases expression
EXP
troglitazone results in increased expression of MORN4 mRNA
CTD
PMID:21515302
NCBI chr 1:250,837,639...250,847,943
Ensembl chr 1:250,837,643...250,848,026
G
Mov10
Mov10 RNA helicase
decreases expression
ISO
troglitazone results in decreased expression of MOV10 mRNA
CTD
PMID:28973697
NCBI chr 2:194,982,014...195,003,513
Ensembl chr 2:194,982,014...195,003,442
G
Mpdz
multiple PDZ domain crumbs cell polarity complex component
decreases expression
ISO
troglitazone results in decreased expression of MPDZ mRNA
CTD
PMID:28973697
NCBI chr 5:100,812,121...100,966,566
Ensembl chr 5:100,812,124...100,966,504
G
Mphosph8
M-phase phosphoprotein 8
decreases expression
ISO
troglitazone results in decreased expression of MPHOSPH8 mRNA
CTD
PMID:28973697
NCBI chr15:34,916,169...34,944,038
Ensembl chr15:34,816,701...34,944,433
G
Mpo
myeloperoxidase
decreases activity
ISO
troglitazone results in decreased activity of MPO protein
CTD
PMID:12468449
NCBI chr10:73,092,124...73,102,057
Ensembl chr10:73,092,400...73,102,056
G
Mpp2
MAGUK p55 scaffold protein 2
decreases expression
ISO
troglitazone results in decreased expression of MPP2 mRNA
CTD
PMID:19140230
NCBI chr10:87,511,638...87,544,710
Ensembl chr10:87,511,638...87,544,029
G
Mrap
melanocortin 2 receptor accessory protein
increases expression
ISO
troglitazone results in increased expression of MRAP mRNA
CTD
PMID:28973697
NCBI chr11:43,477,382...43,489,118
Ensembl chr11:43,478,001...43,489,118
G
Mrc1
mannose receptor, C type 1
increases expression
ISO
troglitazone results in increased expression of MRC1 mRNA
CTD
PMID:28973697
NCBI chr17:82,157,725...82,239,411
Ensembl chr17:82,157,705...82,239,410
G
Ms4a10
membrane spanning 4-domains A10
decreases expression
ISO
troglitazone results in decreased expression of MS4A10 mRNA
CTD
PMID:25572481
NCBI chr 1:217,034,156...217,049,369
Ensembl chr 1:217,036,206...217,049,346
G
Ms4a6a
membrane spanning 4-domains A6A
increases expression
ISO
Troglitazone results in increased expression of MS4A6A mRNA
CTD
PMID:28973697
NCBI chr 1:217,826,261...217,839,606
Ensembl chr 1:217,826,261...217,850,013
G
Msh3
mutS homolog 3
decreases expression
ISO
troglitazone results in decreased expression of MSH3 mRNA
CTD
PMID:28973697
NCBI chr 2:25,179,400...25,320,857
Ensembl chr 2:25,179,400...25,321,102
G
Msi2
musashi RNA-binding protein 2
decreases expression
ISO
troglitazone results in decreased expression of MSI2 mRNA
CTD
PMID:28973697
NCBI chr10:73,640,960...74,007,497
Ensembl chr10:73,646,139...74,007,552
G
Msl1
MSL complex subunit 1
decreases expression
ISO
troglitazone results in decreased expression of MSL1 mRNA
CTD
PMID:28973697
NCBI chr10:84,251,362...84,263,384
Ensembl chr10:84,251,642...84,261,971
G
Msl2
MSL complex subunit 2
decreases expression
ISO
troglitazone results in decreased expression of MSL2 mRNA
CTD
PMID:28973697
NCBI chr 8:110,555,579...110,642,096
Ensembl chr 8:110,555,271...110,647,889
G
Msln
mesothelin
increases expression
ISO
troglitazone results in increased expression of MSLN mRNA
CTD
PMID:19140230
NCBI chr10:15,276,489...15,285,921
Ensembl chr10:15,275,659...15,282,153
G
Msn
moesin
increases expression
EXP
troglitazone results in increased expression of MSN protein
CTD
PMID:21315101
NCBI chr X:65,005,546...65,073,512
Ensembl chr X:65,005,458...65,075,129
G
Msx1
msh homeobox 1
increases expression
ISO
troglitazone results in increased expression of MSX1 mRNA
CTD
PMID:19140230
NCBI chr14:77,185,802...77,189,735
Ensembl chr14:77,185,802...77,189,735
G
Msx2
msh homeobox 2
decreases expression
EXP
troglitazone results in decreased expression of MSX2 mRNA
CTD
PMID:21515302
NCBI chr17:11,102,284...11,107,949
Ensembl chr17:11,102,247...11,107,945
G
Mt-nd1
mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 1
increases expression
EXP
troglitazone results in increased expression of ND1 mRNA; troglitazone results in increased expression of ND1 protein
CTD
PMID:14563825
NCBI chr MT:2,740...3,694
Ensembl chr MT:2,729...3,685
G
Mt1a
metallothionein 1A
increases expression
EXP ISO
troglitazone results in increased expression of MT1A mRNA Troglitazone results in increased expression of MT1 mRNA
CTD
PMID:21515302 PMID:28973697
NCBI chr19:10,831,959...10,832,975
Ensembl chr17:79,695,809...79,696,200 Ensembl chr X:79,695,809...79,696,200 Ensembl chr19:79,695,809...79,696,200
G
Mt2
metallothionein 2
increases expression
ISO
troglitazone results in increased expression of MT2A mRNA
CTD
PMID:19631733
NCBI chr19:10,837,934...10,838,708
Ensembl chr19:10,837,927...10,838,709
G
Mtdh
metadherin
decreases expression
ISO
troglitazone results in decreased expression of MTDH mRNA
CTD
PMID:28973697
NCBI chr 7:67,192,592...67,250,819
Ensembl chr 7:67,192,393...67,249,584
G
Mthfr
methylenetetrahydrofolate reductase
increases expression
ISO
troglitazone results in increased expression of MTHFR mRNA
CTD
PMID:28973697
NCBI chr 5:163,748,346...163,768,141
Ensembl chr 5:163,748,321...163,768,105
G
Mtss1
MTSS I-BAR domain containing 1
decreases expression
ISO
troglitazone results in decreased expression of MTSS1 mRNA
CTD
PMID:28973697
NCBI chr 7:92,378,228...92,517,444
Ensembl chr 7:92,378,238...92,517,303
G
Mttp
microsomal triglyceride transfer protein
increases expression decreases expression
EXP ISO
troglitazone results in increased expression of MTTP mRNA Troglitazone results in decreased expression of MTTP mRNA
CTD
PMID:21515302 PMID:32535746
NCBI chr 2:229,286,501...229,327,650
Ensembl chr 2:229,286,501...229,327,650
G
Mtus1
microtubule associated scaffold protein 1
decreases expression
ISO
troglitazone results in decreased expression of MTUS1 mRNA
CTD
PMID:28973697
NCBI chr16:57,905,991...58,051,466
Ensembl chr16:57,906,128...58,051,474
G
Mtx3
metaxin 3
decreases expression
ISO
troglitazone results in decreased expression of MTX3 mRNA
CTD
PMID:28973697
NCBI chr 2:25,800,530...25,814,755
Ensembl chr 2:25,801,411...25,814,754
G
Muc13
mucin 13, cell surface associated
increases expression
EXP ISO
troglitazone results in increased expression of MUC13 mRNA
CTD
PMID:21515302 PMID:25572481
NCBI chr11:80,462,350...80,489,773
Ensembl chr11:80,465,737...80,485,474
G
Muc15
mucin 15, cell surface associated
increases expression
EXP
troglitazone results in increased expression of MUC15 mRNA
CTD
PMID:21515302
NCBI chr 3:117,749,161...117,761,466
Ensembl chr 3:117,749,324...117,762,101
G
Muc2
mucin 2, oligomeric mucus/gel-forming
increases expression decreases expression
ISO EXP
troglitazone results in increased expression of MUC2 mRNA troglitazone results in decreased expression of MUC2 mRNA
CTD
PMID:14634802 PMID:21515302
NCBI chr 1:206,225,775...206,261,280
Ensembl chr 1:206,229,035...206,261,280
G
Mvk
mevalonate kinase
decreases expression
ISO
troglitazone results in decreased expression of MVK mRNA
CTD
PMID:25572481
NCBI chr12:47,802,002...47,819,503
Ensembl chr12:47,802,002...47,819,503
G
Mvp
major vault protein
increases expression
ISO
troglitazone results in increased expression of MVP mRNA
CTD
PMID:19140230
NCBI chr 1:191,025,259...191,052,866
Ensembl chr 1:191,025,268...191,052,873
G
Mxd1
max dimerization protein 1
multiple interactions
ISO
[troglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of MXD1 mRNA; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of MXD1 mRNA]
CTD
PMID:20847119
NCBI chr 4:120,654,731...120,678,972
Ensembl chr 4:120,654,731...120,675,129
G
Mxd3
Max dimerization protein 3
decreases expression
ISO
troglitazone results in decreased expression of MXD3 mRNA
CTD
PMID:19140230
NCBI chr17:9,306,552...9,310,278
Ensembl chr17:9,302,321...9,310,278
G
Mxd4
Max dimerization protein 4
increases expression
ISO
troglitazone results in increased expression of MXD4 mRNA
CTD
PMID:19140230
NCBI chr14:80,786,768...80,800,790
Ensembl chr14:80,786,342...80,800,788
G
Myb
MYB proto-oncogene, transcription factor
decreases expression
ISO
troglitazone results in decreased expression of MYB mRNA; troglitazone results in decreased expression of MYB protein
CTD
PMID:12649303 PMID:17569031
NCBI chr 1:17,759,309...17,793,306
Ensembl chr 1:17,759,309...17,792,547
G
Mybl2
MYB proto-oncogene like 2
decreases expression
ISO
troglitazone results in decreased expression of MYBL2 mRNA
CTD
PMID:11834241
NCBI chr 3:172,124,765...172,153,221
Ensembl chr 3:172,116,550...172,153,221
G
Myc
MYC proto-oncogene, bHLH transcription factor
multiple interactions increases expression decreases expression
ISO
troglitazone results in increased degradation of and results in increased phosphorylation of MYC protein troglitazone results in increased expression of MYC mRNA troglitazone results in decreased expression of MYC mRNA; troglitazone results in decreased expression of MYC protein
CTD
PMID:12649303 PMID:16809887 PMID:19631733 PMID:21525782
NCBI chr 7:95,483,105...95,488,031
Ensembl chr 7:95,483,105...95,488,028
G
Myct1
myc target 1
decreases expression
ISO
troglitazone results in decreased expression of MYCT1 mRNA
CTD
PMID:28973697
NCBI chr 1:44,423,478...44,434,751
Ensembl chr 1:44,423,544...44,436,992
G
Myh10
myosin heavy chain 10
decreases expression
ISO
troglitazone results in decreased expression of MYH10 mRNA
CTD
PMID:28973697
NCBI chr10:53,891,955...54,024,032
Ensembl chr10:53,893,166...54,024,036
G
Myh14
myosin heavy chain 14
decreases expression
ISO
troglitazone results in decreased expression of MYH14 mRNA
CTD
PMID:28973697
NCBI chr 1:104,232,778...104,295,369
Ensembl chr 1:104,232,778...104,323,404
G
Myh9
myosin, heavy chain 9
decreases expression
ISO
troglitazone results in decreased expression of MYH9 mRNA
CTD
PMID:28973697
NCBI chr 7:111,224,291...111,304,963
Ensembl chr 7:111,224,291...111,304,963
G
Myo10
myosin X
increases expression decreases expression
ISO
troglitazone results in increased expression of MYO10 mRNA troglitazone results in decreased expression of MYO10 mRNA
CTD
PMID:19140230 PMID:28973697
NCBI chr 2:77,831,532...78,036,137
Ensembl chr 2:77,831,532...78,036,137
G
Myo18a
myosin XVIIIa
decreases expression
ISO
troglitazone results in decreased expression of MYO18A mRNA
CTD
PMID:28973697
NCBI chr10:63,152,303...63,253,543
Ensembl chr10:63,152,103...63,253,543
G
Mysm1
myb-like, SWIRM and MPN domains 1
decreases expression
ISO
troglitazone results in decreased expression of MYSM1 mRNA
CTD
PMID:28973697
NCBI chr 5:114,877,112...114,981,463
Ensembl chr 5:114,889,269...114,942,385
G
N4bp1
Nedd4 binding protein 1
decreases expression
ISO
troglitazone results in decreased expression of N4BP1 mRNA
CTD
PMID:28973697
NCBI chr19:36,396,082...36,446,835
Ensembl chr19:36,396,324...36,446,835
G
N4bp2
NEDD4 binding protein 2
decreases expression
ISO
troglitazone results in decreased expression of N4BP2 mRNA
CTD
PMID:28973697
NCBI chr14:42,696,415...42,819,535
Ensembl chr14:42,763,601...42,825,039
G
N4bp2l1
NEDD4 binding protein 2-like 1
increases expression decreases expression
EXP ISO
troglitazone results in increased expression of N4BP2L1 mRNA troglitazone results in decreased expression of N4BP2L1 mRNA
CTD
PMID:21515302 PMID:28973697
NCBI chr12:4,938,199...4,965,003
Ensembl chr12:4,927,142...4,963,045
G
Naa16
N(alpha)-acetyltransferase 16, NatA auxiliary subunit
decreases expression
ISO
troglitazone results in decreased expression of NAA16 mRNA
CTD
PMID:28973697
NCBI chr15:61,120,704...61,179,979
Ensembl chr15:61,120,704...61,180,146
G
Naa30
N(alpha)-acetyltransferase 30, NatC catalytic subunit
increases expression
ISO
troglitazone results in increased expression of NAA30 mRNA
CTD
PMID:28973697
NCBI chr15:24,935,060...24,954,435
Ensembl chr15:24,935,260...24,954,437
G
Naa35
N(alpha)-acetyltransferase 35, NatC auxiliary subunit
decreases expression
ISO
troglitazone results in decreased expression of NAA35 mRNA
CTD
PMID:28973697
NCBI chr17:5,039,897...5,091,916
Ensembl chr17:5,039,911...5,092,418
G
Nab2
Ngfi-A binding protein 2
decreases expression
EXP
troglitazone results in decreased expression of NAB2 mRNA
CTD
PMID:21515302
NCBI chr 7:65,382,863...65,389,527
Ensembl chr 7:65,382,863...65,389,255
G
Nabp1
nucleic acid binding protein 1
increases expression
ISO
troglitazone results in increased expression of NABP1 mRNA
CTD
PMID:28973697
NCBI chr 9:57,570,326...57,625,926
Ensembl chr 9:57,618,505...57,626,052
G
Naf1
nuclear assembly factor 1 ribonucleoprotein
decreases expression
ISO
troglitazone results in decreased expression of NAF1 mRNA
CTD
PMID:28973697
NCBI chr16:27,604,228...27,634,963
Ensembl chr16:27,603,918...27,634,963
G
Nalcn
sodium leak channel, non-selective
decreases expression
EXP
troglitazone results in decreased expression of NALCN mRNA
CTD
PMID:21515302
NCBI chr15:106,805,209...107,148,837
Ensembl chr15:106,805,209...107,147,858
G
Nampt
nicotinamide phosphoribosyltransferase
increases expression
ISO
troglitazone results in increased expression of NAMPT mRNA
CTD
PMID:19140230
NCBI chr 6:55,152,756...55,189,547
Ensembl chr 6:55,151,926...55,189,544
G
Napepld
N-acyl phosphatidylethanolamine phospholipase D
increases expression
EXP ISO
troglitazone results in increased expression of NAPEPLD mRNA
CTD
PMID:21515302 PMID:28973697
NCBI chr 4:14,251,591...14,291,010
Ensembl chr 4:14,252,692...14,291,014
G
Nars1
asparaginyl-tRNA synthetase 1
decreases expression
EXP
Troglitazone results in decreased expression of NARS1 mRNA
CTD
PMID:25596134
NCBI chr18:60,259,506...60,275,782
Ensembl chr18:60,259,516...60,275,782
G
Nasp
nuclear autoantigenic sperm protein
decreases expression
ISO
troglitazone results in decreased expression of NASP mRNA
CTD
PMID:19140230
NCBI chr 5:135,294,599...135,319,992
Ensembl chr 5:135,294,032...135,319,591
G
Nat2
N-acetyltransferase 2
increases expression
ISO
troglitazone results in increased expression of NAT2 mRNA
CTD
PMID:28973697
NCBI chr16:26,974,874...27,005,191
Ensembl chr16:26,974,601...26,976,304
G
Nat8f5
N-acetyltransferase 8 (GCN5-related) family member 5
increases expression
ISO
troglitazone results in increased expression of NAT8F5 mRNA
CTD
PMID:28973697
NCBI chr 4:119,817,788...119,842,503
Ensembl chr 4:119,816,735...119,863,953
G
Nav1
neuron navigator 1
increases expression
ISO
troglitazone results in increased expression of NAV1 mRNA
CTD
PMID:19140230
NCBI chr13:49,418,755...49,671,117
Ensembl chr13:49,418,755...49,671,004
G
Nbeal1
neurobeachin-like 1
decreases expression
ISO
troglitazone results in decreased expression of NBEAL1 mRNA
CTD
PMID:28973697
NCBI chr 9:69,069,326...69,237,932
Ensembl chr 9:69,070,247...69,231,307
G
Nbr1
NBR1, autophagy cargo receptor
decreases expression
ISO
troglitazone results in decreased expression of NBR1 mRNA
CTD
PMID:28973697
NCBI chr10:86,978,024...87,006,664
Ensembl chr10:86,977,885...87,007,012
G
Ncapg
non-SMC condensin I complex, subunit G
decreases expression
ISO
troglitazone results in decreased expression of NCAPG mRNA
CTD
PMID:19140230
NCBI chr14:69,616,473...69,645,445
Ensembl chr14:69,616,473...69,645,445
G
Ncf1
neutrophil cytosolic factor 1
multiple interactions increases expression
ISO
troglitazone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of NCF1 protein] troglitazone results in increased expression of NCF1 mRNA
CTD
PMID:11172467 PMID:28973697
NCBI chr12:28,121,816...28,131,080
Ensembl chr12:28,121,366...28,131,079
G
Nck1
NCK adaptor protein 1
decreases expression
ISO
troglitazone results in decreased expression of NCK1 mRNA
CTD
PMID:28973697
NCBI chr 8:109,897,723...109,958,247
Ensembl chr 8:109,897,724...109,958,247
G
Ncl
nucleolin
decreases expression
ISO
troglitazone results in decreased expression of NCL mRNA
CTD
PMID:28973697
NCBI chr 9:94,447,559...94,456,083
Ensembl chr 9:94,446,682...94,456,083
G
Ncoa1
nuclear receptor coactivator 1
increases response to substance multiple interactions decreases expression
ISO
NCOA1 protein results in increased susceptibility to troglitazone [troglitazone binds to PPARG protein] which affects the localization of NCOA1 protein; NCOA1 protein inhibits the reaction [RXRA protein results in decreased susceptibility to troglitazone]; RXRA protein inhibits the reaction [NCOA1 protein results in increased susceptibility to troglitazone]; troglitazone promotes the reaction [NCOA1 protein binds to and results in increased activity of PPARG protein] troglitazone results in decreased expression of NCOA1 mRNA
CTD
PMID:10871190 PMID:15581905 PMID:27551952 PMID:28973697
NCBI chr 6:32,952,090...33,229,829
Ensembl chr 6:32,952,090...33,195,924
G
Ncoa2
nuclear receptor coactivator 2
decreases expression
ISO
troglitazone results in decreased expression of NCOA2 mRNA
CTD
PMID:28973697
NCBI chr 5:10,618,712...10,852,776
Ensembl chr 5:10,618,722...10,852,776
G
Ncoa3
nuclear receptor coactivator 3
decreases expression
ISO
troglitazone results in decreased expression of NCOA3 mRNA
CTD
PMID:28973697
NCBI chr 3:175,157,824...175,237,831
Ensembl chr 3:175,157,821...175,240,631
G
Ncoa6
nuclear receptor coactivator 6
decreases expression
ISO
troglitazone results in decreased expression of NCOA6 mRNA
CTD
PMID:28973697
NCBI chr 3:164,351,062...164,422,079
Ensembl chr 3:164,351,062...164,421,991
G
Ncor1
nuclear receptor co-repressor 1
decreases expression
ISO
troglitazone results in decreased expression of NCOR1 mRNA
CTD
PMID:28973697
NCBI chr10:47,498,852...47,641,612
Ensembl chr10:47,498,852...47,640,350
G
Ncor2
nuclear receptor co-repressor 2
decreases expression
ISO
troglitazone results in decreased expression of NCOR2 mRNA
CTD
PMID:28973697
NCBI chr12:37,127,736...37,289,612
Ensembl chr12:37,127,686...37,289,612
G
Ndc1
NDC1 transmembrane nucleoporin
increases expression
ISO
troglitazone results in increased expression of NDC1 mRNA
CTD
PMID:28973697
NCBI chr 5:127,384,172...127,431,093
Ensembl chr 5:127,384,665...127,431,090
G
Ndc80
NDC80 kinetochore complex component
decreases expression
ISO
Troglitazone results in decreased expression of NDC80 mRNA
CTD
PMID:19140230
NCBI chr 9:118,853,806...118,887,582
Ensembl chr 9:118,853,806...118,887,568
G
Ndrg1
N-myc downstream regulated 1
multiple interactions increases expression decreases expression
ISO
[Troglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of NDRG1 mRNA; Troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of NDRG1 mRNA] troglitazone results in increased expression of NDRG1 mRNA troglitazone results in decreased expression of NDRG1 mRNA
CTD
PMID:19140230 PMID:20847119 PMID:28973697
NCBI chr 7:100,573,526...100,614,902
Ensembl chr 7:100,573,523...100,614,913
G
Ndrg3
NDRG family member 3
decreases expression
ISO
troglitazone results in decreased expression of NDRG3 mRNA
CTD
PMID:28973697
NCBI chr 3:166,007,556...166,070,981
Ensembl chr 3:165,890,091...166,049,887
G
Ndrg4
NDRG family member 4
increases expression
ISO
troglitazone results in increased expression of NDRG4 mRNA
CTD
PMID:17569031
NCBI chr19:9,357,470...9,393,465
Ensembl chr19:9,357,470...9,392,972
G
Ndst1
N-deacetylase and N-sulfotransferase 1
decreases expression
ISO
troglitazone results in decreased expression of NDST1 mRNA
CTD
PMID:28973697
NCBI chr18:56,407,308...56,470,007
Ensembl chr18:56,411,200...56,448,612
G
Ndst2
N-deacetylase and N-sulfotransferase 2
decreases expression
ISO
troglitazone results in decreased expression of NDST2 mRNA
CTD
PMID:28973697
NCBI chr15:3,612,775...3,623,061
Ensembl chr15:3,612,775...3,623,061
G
Nectin1
nectin cell adhesion molecule 1
decreases expression
ISO
troglitazone results in decreased expression of NECTIN1 mRNA
CTD
PMID:28973697
NCBI chr 8:52,998,662...53,061,745
Ensembl chr 8:52,998,662...53,086,664
G
Nectin3
nectin cell adhesion molecule 3
decreases expression
ISO
troglitazone results in decreased expression of NECTIN3 mRNA
CTD
PMID:28973697
NCBI chr11:67,825,296...67,931,999
Ensembl chr11:67,827,137...67,871,383
G
Nedd9
neural precursor cell expressed, developmentally down-regulated 9
decreases expression
EXP
troglitazone results in decreased expression of NEDD9 mRNA
CTD
PMID:25596134
NCBI chr17:23,495,531...23,673,780
Ensembl chr17:23,495,492...23,675,668
G
Nefm
neurofilament medium chain
decreases expression
EXP
troglitazone results in decreased expression of NEFM mRNA
CTD
PMID:21515302
NCBI chr15:46,535,857...46,541,161
Ensembl chr15:46,535,517...46,541,163
G
Neil3
nei-like DNA glycosylase 3
decreases expression
ISO
troglitazone results in decreased expression of NEIL3 mRNA
CTD
PMID:19140230
NCBI chr16:45,091,401...45,151,419
Ensembl chr16:45,092,200...45,151,205
G
Nek2
NIMA-related kinase 2
decreases expression
ISO
troglitazone results in decreased expression of NEK2 mRNA
CTD
PMID:19140230
NCBI chr13:105,936,809...105,950,054
Ensembl chr13:105,936,788...105,950,056
G
Nell2
neural EGFL like 2
decreases expression
EXP
troglitazone results in decreased expression of NELL2 mRNA
CTD
PMID:21515302
NCBI chr 7:128,222,333...128,542,127
Ensembl chr 7:128,078,103...128,651,917
G
Nfat5
nuclear factor of activated T-cells 5
decreases expression
ISO
troglitazone results in decreased expression of NFAT5 mRNA
CTD
PMID:28973697
NCBI chr19:52,108,982...52,196,418
Ensembl chr19:52,109,483...52,196,418
G
Nfatc1
nuclear factor of activated T-cells 1
decreases expression
ISO
troglitazone results in decreased expression of NFATC1 mRNA
CTD
PMID:28973697
NCBI chr18:76,321,386...76,430,997
Ensembl chr18:76,321,386...76,430,990
G
Nfatc3
nuclear factor of activated T-cells 3
decreases expression
ISO
troglitazone results in decreased expression of NFATC3 mRNA
CTD
PMID:28973697
NCBI chr19:50,870,464...50,944,992
Ensembl chr19:50,870,489...50,944,992
G
Nfe2l2
NFE2 like bZIP transcription factor 2
affects response to substance multiple interactions decreases expression
ISO EXP
NFE2L2 protein affects the susceptibility to troglitazone NFE2L2 protein promotes the reaction [troglitazone results in increased susceptibility to arsenic trioxide] troglitazone results in decreased expression of NFE2L2 mRNA
CTD
PMID:21540358 PMID:22684020 PMID:25596134
NCBI chr 3:81,001,529...81,031,165
Ensembl chr 3:81,001,529...81,029,090
G
Nfia
nuclear factor I/A
decreases expression
ISO
troglitazone results in decreased expression of NFIA mRNA
CTD
PMID:28973697
NCBI chr 5:117,359,006...117,897,391
Ensembl chr 5:117,359,077...117,891,395
G
Nfib
nuclear factor I/B
decreases expression
ISO
troglitazone results in decreased expression of NFIB mRNA
CTD
PMID:28973697
NCBI chr 5:101,805,168...102,020,618
Ensembl chr 5:101,805,168...102,019,945
G
Nfil3
nuclear factor, interleukin 3 regulated
increases expression
ISO
troglitazone results in increased expression of NFIL3 mRNA
CTD
PMID:19140230
NCBI chr17:12,432,376...12,447,605
Ensembl chr17:12,432,198...12,450,826
G
Nfix
nuclear factor I X
decreases expression
ISO
troglitazone results in decreased expression of NFIX mRNA
CTD
PMID:28973697
NCBI chr19:40,259,873...40,356,966
Ensembl chr19:40,260,084...40,353,092
G
Nfkb1
nuclear factor kappa B subunit 1
affects localization multiple interactions decreases activity decreases expression
ISO EXP
troglitazone affects the localization of NFKB1 protein troglitazone results in decreased activity of [RELA protein binds to NFKB1 protein] troglitazone results in decreased activity of NFKB1 protein troglitazone results in decreased expression of NFKB1 mRNA
CTD
PMID:17425601 PMID:20540935 PMID:21515302
NCBI chr 2:226,689,745...226,805,897
Ensembl chr 2:226,689,745...226,783,088
G
Nfkb2
nuclear factor kappa B subunit 2
decreases expression
EXP
troglitazone results in decreased expression of NFKB2 mRNA
CTD
PMID:21515302
NCBI chr 1:255,106,010...255,114,649
Ensembl chr 1:255,107,374...255,114,637
G
Nfkbia
NFKB inhibitor alpha
decreases degradation increases expression
ISO
troglitazone results in decreased degradation of NFKBIA protein troglitazone results in increased expression of NFKBIA mRNA
CTD
PMID:15949477 PMID:19631733
NCBI chr 6:78,593,844...78,597,307
Ensembl chr 6:78,593,847...78,597,072
G
Nfs1
NFS1 cysteine desulfurase
increases expression
ISO
troglitazone results in increased expression of NFS1 mRNA
CTD
PMID:12732648 PMID:28973697
NCBI chr 3:165,097,390...165,119,730
Ensembl chr 3:165,097,391...165,119,737
G
Nfx1
nuclear transcription factor, X-box binding 1
decreases expression
ISO
troglitazone results in decreased expression of NFX1 mRNA
CTD
PMID:28973697
NCBI chr 5:60,900,140...60,958,889
Ensembl chr 5:60,901,217...60,958,889
G
Ngef
neuronal guanine nucleotide exchange factor
decreases expression
ISO
troglitazone results in decreased expression of NGEF mRNA
CTD
PMID:28973697
NCBI chr 9:95,594,823...95,692,381
Ensembl chr 9:95,594,823...95,692,251
G
Nhlrc3
NHL repeat containing 3
decreases expression
ISO
troglitazone results in decreased expression of NHLRC3 mRNA
CTD
PMID:28973697
NCBI chr 2:139,678,127...139,692,423
Ensembl chr 2:139,679,866...139,692,691
G
Nhsl3
NHS like 3
decreases expression
ISO
Troglitazone results in decreased expression of NHSL3 mRNA
CTD
PMID:28973697
NCBI chr 5:146,848,747...146,877,504
Ensembl chr 5:146,848,747...146,877,504
G
Niban1
niban apoptosis regulator 1
increases expression
EXP
Troglitazone results in increased expression of NIBAN1 mRNA
CTD
PMID:21515302
NCBI chr13:66,224,219...66,377,728
Ensembl chr13:66,224,021...66,377,724
G
Nid1
nidogen 1
increases expression
ISO
troglitazone results in increased expression of NID1 mRNA
CTD
PMID:28973697
NCBI chr17:93,069,013...93,142,416
Ensembl chr17:93,069,278...93,142,386
G
Nid2
nidogen 2
increases expression
ISO EXP
troglitazone results in increased expression of NID2 mRNA
CTD
PMID:19140230 PMID:21515302
NCBI chr15:4,507,224...4,562,949
Ensembl chr15:4,506,756...4,562,949
G
Nipal3
NIPA-like domain containing 3
increases expression
ISO
troglitazone results in increased expression of NIPAL3 mRNA
CTD
PMID:28973697
NCBI chr 5:152,970,934...153,010,006
Ensembl chr 5:152,968,910...153,008,845
G
Nipbl
NIPBL, cohesin loading factor
decreases expression
ISO
troglitazone results in decreased expression of NIPBL mRNA
CTD
PMID:28973697
NCBI chr 2:59,126,676...59,314,841
Ensembl chr 2:59,126,676...59,293,277
G
Nme6
NME/NM23 nucleoside diphosphate kinase 6
increases expression
ISO
troglitazone results in increased expression of NME6 mRNA
CTD
PMID:28973697
NCBI chr 8:118,708,092...118,717,756
Ensembl chr 8:118,711,036...118,718,288
G
Nme7
NME/NM23 family member 7
increases expression
ISO
troglitazone results in increased expression of NME7 mRNA
CTD
PMID:28973697
NCBI chr13:79,190,462...79,319,890
Ensembl chr13:79,190,334...79,319,890
G
Nnmt
nicotinamide N-methyltransferase
increases expression
ISO
troglitazone results in increased expression of NNMT mRNA
CTD
PMID:28973697
NCBI chr 8:57,820,156...57,851,301
Ensembl chr 8:57,825,464...57,843,174
G
Nod2
nucleotide-binding oligomerization domain containing 2
decreases expression
EXP
troglitazone results in decreased expression of NOD2 mRNA
CTD
PMID:21515302
NCBI chr19:34,555,832...34,596,281
Ensembl chr19:34,555,832...34,722,846
G
Nol8
nucleolar protein 8
decreases expression
ISO
troglitazone results in decreased expression of NOL8 mRNA
CTD
PMID:28973697
NCBI chr17:15,196,881...15,220,265
Ensembl chr17:15,196,881...15,220,202
G
Nos2
nitric oxide synthase 2
increases expression multiple interactions increases stability decreases expression
ISO EXP
troglitazone results in increased expression of NOS2 mRNA troglitazone inhibits the reaction [IL1B protein results in increased expression of NOS2 mRNA] troglitazone results in increased stability of NOS2 mRNA troglitazone results in decreased expression of NOS2
CTD
PMID:10205228 PMID:11457450 PMID:15892897 PMID:19631733
NCBI chr10:64,313,335...64,349,221
Ensembl chr10:64,313,335...64,401,880
G
Nos3
nitric oxide synthase 3
increases expression
ISO
troglitazone results in increased expression of NOS3 mRNA; troglitazone results in increased expression of NOS3 protein
CTD
PMID:16949522
NCBI chr 4:11,686,088...11,706,604
Ensembl chr 4:11,686,268...11,706,664
G
Notch3
notch receptor 3
increases expression
ISO
troglitazone results in increased expression of NOTCH3 mRNA
CTD
PMID:17569031
NCBI chr 7:11,783,550...11,834,585
Ensembl chr 7:11,784,272...11,834,778
G
Nova1
NOVA alternative splicing regulator 1
increases expression
EXP
troglitazone results in increased expression of NOVA1 mRNA
CTD
PMID:21515302
NCBI chr 6:69,506,983...69,632,437
Ensembl chr 6:69,506,983...69,632,437
G
Nox4
NADPH oxidase 4
increases expression
ISO
troglitazone results in increased expression of NOX4 mRNA
CTD
PMID:28973697
NCBI chr 1:150,313,736...150,491,480
Ensembl chr 1:150,313,728...150,491,483
G
Npc1
NPC intracellular cholesterol transporter 1
decreases expression
ISO
troglitazone results in decreased expression of NPC1 mRNA
CTD
PMID:28973697
NCBI chr18:3,654,237...3,699,853
Ensembl chr18:3,654,237...3,699,800
G
Npc1l1
NPC1 like intracellular cholesterol transporter 1
increases expression
EXP
troglitazone results in increased expression of NPC1L1 mRNA
CTD
PMID:21515302
NCBI chr14:85,285,387...85,305,050
Ensembl chr14:85,285,390...85,305,050
G
Npm1
nucleophosmin 1
multiple interactions
ISO
[RARA gene mutant form co-treated with NPM1 gene mutant form] affects the susceptibility to troglitazone
CTD
PMID:14508522
NCBI chr10:18,245,739...18,255,913
Ensembl chr10:18,245,740...18,256,024 Ensembl chr X:18,245,740...18,256,024
G
Nppb
natriuretic peptide B
decreases expression
EXP
troglitazone results in decreased expression of NPPB mRNA
CTD
PMID:21515302
NCBI chr 5:163,699,955...163,701,314
Ensembl chr 5:163,699,839...163,701,310
G
Npr3
natriuretic peptide receptor 3
decreases expression
ISO
troglitazone results in decreased expression of NPR3 mRNA
CTD
PMID:28973697
NCBI chr 2:62,592,557...62,660,497
Ensembl chr 2:62,597,668...62,660,066
G
Npy
neuropeptide Y
decreases expression
EXP
troglitazone results in decreased expression of NPY mRNA
CTD
PMID:21515302
NCBI chr 4:80,212,111...80,219,310
Ensembl chr 4:80,212,111...80,219,310
G
Nqo2
N-ribosyldihydronicotinamide:quinone dehydrogenase 2
decreases expression
ISO
troglitazone results in decreased expression of NQO2 mRNA
CTD
PMID:28973697
NCBI chr17:31,114,825...31,144,062
Ensembl chr17:31,114,529...31,143,662
G
Nr1d1
nuclear receptor subfamily 1, group D, member 1
decreases expression
ISO
troglitazone results in decreased expression of NR1D1 mRNA
CTD
PMID:28973697
NCBI chr10:84,224,599...84,231,812
Ensembl chr10:84,224,540...84,231,812
G
Nr1h3
nuclear receptor subfamily 1, group H, member 3
multiple interactions
ISO
[Oleic Acid co-treated with troglitazone] affects the expression of NR1H3 mRNA
CTD
PMID:24534255
NCBI chr 3:97,614,616...97,632,053
Ensembl chr 3:97,614,616...97,624,532
G
Nr1i2
nuclear receptor subfamily 1, group I, member 2
multiple interactions
ISO
[Troglitazone results in increased activity of NR1I2 protein] which results in increased expression of CYP3A4 mRNA; Troglitazone binds to and results in increased activity of NR1I2 protein
CTD
PMID:17041008 PMID:33049310
NCBI chr11:75,965,717...76,006,733
Ensembl chr11:75,965,632...76,002,380
G
Nr1i3
nuclear receptor subfamily 1, group I, member 3
multiple interactions decreases expression increases expression
ISO EXP
[Oleic Acid co-treated with troglitazone] affects the expression of NR1I3 mRNA; [troglitazone results in increased activity of NR1I3 protein alternative form] which results in increased expression of CYP2B6 mRNA troglitazone results in decreased expression of NR1I3 mRNA troglitazone results in increased expression of NR1I3 mRNA
CTD
PMID:17041008 PMID:19022234 PMID:21515302 PMID:24534255
NCBI chr13:86,165,327...86,170,362
Ensembl chr13:86,165,349...86,170,370
G
Nr2c2
nuclear receptor subfamily 2, group C, member 2
decreases expression
ISO
troglitazone results in decreased expression of NR2C2 mRNA
CTD
PMID:28973697
NCBI chr 4:126,167,350...126,223,942
Ensembl chr 4:126,168,085...126,223,942
G
Nr2f2
nuclear receptor subfamily 2, group F, member 2
increases expression multiple interactions decreases expression
ISO
troglitazone results in increased expression of NR2F2 protein [troglitazone results in increased expression of NR2F2 protein] which results in decreased expression of ACOX1 mRNA troglitazone results in decreased expression of NR2F2 mRNA
CTD
PMID:12920214 PMID:28973697
NCBI chr 1:133,419,161...133,434,290
Ensembl chr 1:133,420,227...133,431,975
G
Nr3c1
nuclear receptor subfamily 3, group C, member 1
decreases expression
ISO
troglitazone results in decreased expression of NR3C1 mRNA
CTD
PMID:19140230
NCBI chr18:31,522,783...31,644,508
Ensembl chr18:31,522,783...31,643,843
G
Nr3c2
nuclear receptor subfamily 3, group C, member 2
decreases expression
ISO
troglitazone results in decreased expression of NR3C2 mRNA
CTD
PMID:28973697
NCBI chr19:47,619,853...47,964,089
Ensembl chr19:47,619,853...47,964,078
G
Nr4a1
nuclear receptor subfamily 4, group A, member 1
increases expression decreases expression
ISO EXP
troglitazone results in increased expression of NR4A1 mRNA troglitazone results in decreased expression of NR4A1 mRNA
CTD
PMID:17785466 PMID:21515302
NCBI chr 7:134,247,153...134,268,044
Ensembl chr 7:134,247,192...134,268,041
G
Nr4a2
nuclear receptor subfamily 4, group A, member 2
decreases expression
ISO
troglitazone results in decreased expression of NR4A2 mRNA
CTD
PMID:28973697
NCBI chr 3:62,098,739...62,115,926
Ensembl chr 3:62,098,743...62,106,769
G
Nr4a3
nuclear receptor subfamily 4, group A, member 3
increases expression decreases expression
ISO
troglitazone results in increased expression of NR4A3 mRNA troglitazone results in decreased expression of NR4A3 mRNA
CTD
PMID:17785466 PMID:28973697
NCBI chr 5:67,157,141...67,198,287
Ensembl chr 5:67,157,375...67,198,285
G
Nrarp
Notch-regulated ankyrin repeat protein
decreases expression
ISO
troglitazone results in decreased expression of NRARP mRNA
CTD
PMID:28973697
NCBI chr 3:28,390,745...28,393,299
Ensembl chr 3:28,390,733...28,393,453
G
Nrf1
nuclear respiratory factor 1
increases expression
EXP
troglitazone results in increased expression of NRF1 mRNA
CTD
PMID:14563825
NCBI chr 4:59,632,366...59,738,166
Ensembl chr 4:59,632,372...59,738,353
G
Nrg1
neuregulin 1
increases expression
ISO
troglitazone results in increased expression of NRG1 mRNA
CTD
PMID:19140230
NCBI chr16:65,954,084...67,007,484
Ensembl chr16:65,953,865...66,999,849
G
Nrip1
nuclear receptor interacting protein 1
decreases expression increases expression
ISO
troglitazone results in decreased expression of NRIP1 mRNA troglitazone results in increased expression of NRIP1 mRNA
CTD
PMID:12732648 PMID:28973697
NCBI chr11:28,382,835...28,466,483
Ensembl chr11:28,378,878...28,467,353
G
Nrp1
neuropilin 1
increases expression decreases expression
ISO
troglitazone results in increased expression of NRP1 mRNA troglitazone results in decreased expression of NRP1 mRNA
CTD
PMID:19140230 PMID:25572481 PMID:28973697
NCBI chr19:73,256,557...73,411,705
Ensembl chr19:73,256,557...73,411,702
G
Nrp2
neuropilin 2
decreases expression
EXP ISO
troglitazone results in decreased expression of NRP2 mRNA
CTD
PMID:21515302 PMID:28973697
NCBI chr 9:71,616,602...71,731,869
Ensembl chr 9:71,616,657...71,731,871
G
Nrxn1
neurexin 1
increases expression
ISO
troglitazone results in increased expression of NRXN1 mRNA
CTD
PMID:28973697
NCBI chr 6:8,931,360...10,077,381
Ensembl chr 6:8,935,523...10,077,374
G
Nsd1
nuclear receptor binding SET domain protein 1
decreases expression
ISO
troglitazone results in decreased expression of NSD1 mRNA
CTD
PMID:28973697
NCBI chr17:9,317,085...9,431,528
Ensembl chr17:9,317,085...9,452,250
G
Nsd3
nuclear receptor binding SET domain protein 3
decreases expression
ISO
troglitazone results in decreased expression of NSD3 mRNA
CTD
PMID:28973697
NCBI chr16:73,056,748...73,170,082
Ensembl chr16:73,061,694...73,168,130
G
Nt5e
5' nucleotidase, ecto
increases expression
ISO
troglitazone results in increased expression of NT5E mRNA
CTD
PMID:28973697
NCBI chr 8:98,150,925...98,195,646
Ensembl chr 8:98,150,900...98,195,645
G
Ntan1
N-terminal asparagine amidase
increases expression
EXP
troglitazone results in increased expression of NTAN1 protein
CTD
PMID:21315101
NCBI chr10:2,618,239...2,633,185
Ensembl chr10:2,618,235...2,633,810
G
Ntn1
netrin 1
decreases expression
ISO
troglitazone results in decreased expression of NTN1 mRNA
CTD
PMID:28973697
NCBI chr10:53,398,852...53,597,595
Ensembl chr10:53,398,852...53,584,060
G
Ntrk1
neurotrophic receptor tyrosine kinase 1
increases expression
EXP
troglitazone results in increased expression of NTRK1 mRNA
CTD
PMID:21515302
NCBI chr 2:175,534,844...175,551,664
Ensembl chr 2:175,534,844...175,551,787
G
Nuak1
NUAK family kinase 1
decreases expression
ISO
troglitazone results in decreased expression of NUAK1 mRNA
CTD
PMID:28973697
NCBI chr 7:21,217,729...21,289,608
Ensembl chr 7:21,217,681...21,289,354
G
Nuak2
NUAK family kinase 2
decreases expression
ISO
troglitazone results in decreased expression of NUAK2 mRNA
CTD
PMID:19140230
NCBI chr13:46,305,744...46,322,755
Ensembl chr13:46,305,975...46,322,748
G
Nucb2
nucleobindin 2
multiple interactions
ISO
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [troglitazone results in increased stability of NUCB2 mRNA]; troglitazone results in increased stability of and results in increased expression of NUCB2 mRNA
CTD
PMID:20427483
NCBI chr 1:180,185,121...180,221,644
Ensembl chr 1:180,199,551...180,230,116
G
Nucks1
nuclear casein kinase and cyclin-dependent kinase substrate 1
decreases expression
ISO
troglitazone results in decreased expression of NUCKS1 mRNA
CTD
PMID:28973697
NCBI chr13:45,897,275...45,926,491
Ensembl chr13:45,897,248...45,923,101
G
Nudt1
nudix hydrolase 1
decreases expression increases expression
ISO
troglitazone results in decreased expression of NUDT1 mRNA troglitazone results in increased expression of NUDT1 mRNA
CTD
PMID:19140230 PMID:28973697
NCBI chr12:19,416,411...19,423,448
Ensembl chr12:19,416,411...19,424,158
G
Nudt21
nudix hydrolase 21
decreases expression
ISO
troglitazone results in decreased expression of NUDT21 mRNA
CTD
PMID:19140230 PMID:28973697
NCBI chr19:10,980,797...10,996,903
Ensembl chr19:10,980,158...10,999,754
G
Nuf2
NUF2 component of NDC80 kinetochore complex
decreases expression
ISO
troglitazone results in decreased expression of NUF2 mRNA
CTD
PMID:19140230
NCBI chr13:84,226,448...84,290,957
Ensembl chr13:84,226,509...84,255,598
G
Nufip2
nuclear FMR1 interacting protein 2
decreases expression
ISO
troglitazone results in decreased expression of NUFIP2 mRNA
CTD
PMID:28973697
NCBI chr10:63,072,964...63,105,823
Ensembl chr10:63,073,397...63,105,823
G
Numa1
nuclear mitotic apparatus protein 1
decreases expression
ISO
troglitazone results in decreased expression of NUMA1 mRNA
CTD
PMID:28973697
NCBI chr 1:165,709,893...165,784,848
Ensembl chr 1:165,709,905...165,784,848
G
Nup107
nucleoporin 107
decreases expression
ISO
troglitazone results in decreased expression of NUP107 mRNA
CTD
PMID:19140230
NCBI chr 7:55,239,610...55,285,050
Ensembl chr 7:55,239,613...55,285,234
G
Nup58
nucleoporin 58
decreases expression
ISO
troglitazone results in decreased expression of NUP58 mRNA
CTD
PMID:28973697
NCBI chr15:38,534,340...38,583,959
Ensembl chr15:38,533,614...38,583,178
G
Nusap1
nucleolar and spindle associated protein 1
decreases expression
ISO
troglitazone results in decreased expression of NUSAP1 mRNA
CTD
PMID:19140230
NCBI chr 3:127,057,220...127,092,779
Ensembl chr 3:127,057,265...127,087,237
G
Nxpe4
neurexophilin and PC-esterase domain family member 4
decreases expression
ISO
troglitazone results in decreased expression of NXPE4 mRNA
CTD
PMID:28973697
NCBI chr 8:57,399,199...57,640,629
Ensembl chr 8:57,631,895...57,644,186
G
Oaf
out at first homolog
increases expression
ISO
troglitazone results in increased expression of OAF mRNA
CTD
PMID:28973697
NCBI chr 8:52,491,314...52,509,285
Ensembl chr 8:52,491,315...52,509,285
G
Oasl
2'-5'-oligoadenylate synthetase-like
increases expression
ISO
troglitazone results in increased expression of OASL mRNA
CTD
PMID:25572481
NCBI chr12:47,343,551...47,356,509
Ensembl chr12:47,343,551...47,356,483
G
Oasl2
2'-5' oligoadenylate synthetase-like 2
decreases expression
EXP
Troglitazone results in decreased expression of OASL2 mRNA
CTD
PMID:21515302
NCBI chr12:47,369,829...47,383,337
Ensembl chr12:47,370,028...47,383,185
G
Oat
ornithine aminotransferase
increases expression
ISO
troglitazone results in increased expression of OAT protein
CTD
PMID:18495193
NCBI chr 1:196,777,973...196,797,754
Ensembl chr 1:196,777,975...196,797,754
G
Obp1f
odorant binding protein I f
increases expression
EXP
troglitazone results in increased expression of OBP1F mRNA
CTD
PMID:21515302
NCBI chr X:45,833,861...45,839,070
G
Ociad2
OCIA domain containing 2
increases expression
ISO
troglitazone results in increased expression of OCIAD2 mRNA
CTD
PMID:28973697
NCBI chr14:35,225,291...35,243,306
Ensembl chr14:35,225,255...35,243,311
G
Ocln
occludin
decreases expression
ISO
troglitazone results in decreased expression of OCLN mRNA
CTD
PMID:28973697
NCBI chr 2:33,391,303...33,442,207
Ensembl chr 2:33,391,303...33,430,411
G
Ocrl
OCRL, inositol polyphosphate-5-phosphatase
decreases expression
ISO
troglitazone results in decreased expression of OCRL mRNA
CTD
PMID:28973697
NCBI chr X:131,955,775...132,018,298
Ensembl chr X:131,967,355...132,018,298
G
Odc1
ornithine decarboxylase 1
decreases activity increases expression
EXP
troglitazone results in decreased activity of ODC1 protein troglitazone results in increased expression of ODC1 mRNA
CTD
PMID:11346461 PMID:21515302
NCBI chr 6:46,058,439...46,065,148
Ensembl chr 6:46,058,463...46,065,146
G
Oga
O-GlcNAcase
decreases expression
ISO
Troglitazone results in decreased expression of OGA mRNA
CTD
PMID:28973697
NCBI chr 1:254,547,311...254,589,596
Ensembl chr 1:254,547,311...254,582,855
G
Ogdh
oxoglutarate dehydrogenase
decreases expression
ISO
troglitazone results in decreased expression of OGDH mRNA
CTD
PMID:28973697
NCBI chr14:85,363,949...85,431,405
Ensembl chr14:85,364,014...85,432,271
G
Ogn
osteoglycin
increases expression
ISO
troglitazone results in increased expression of OGN mRNA
CTD
PMID:28973697
NCBI chr17:15,238,500...15,259,167
Ensembl chr17:15,238,500...15,259,252
G
Oit3
oncoprotein induced transcript 3
decreases expression
EXP
troglitazone results in decreased expression of OIT3 mRNA
CTD
PMID:21515302
NCBI chr20:27,933,106...27,953,683
Ensembl chr20:27,933,106...27,953,683
G
Olfml2b
olfactomedin-like 2B
increases expression
ISO
troglitazone results in increased expression of OLFML2B mRNA
CTD
PMID:28973697
NCBI chr13:85,402,151...85,439,342
Ensembl chr13:85,402,169...85,439,342
G
Oplah
5-oxoprolinase (ATP-hydrolysing)
increases expression
EXP
troglitazone results in increased expression of OPLAH mRNA
CTD
PMID:21515302
NCBI chr 7:109,892,136...109,932,403
Ensembl chr 7:109,891,405...109,915,979
G
Optn
optineurin
decreases expression
ISO
troglitazone results in decreased expression of OPTN mRNA
CTD
PMID:28973697
NCBI chr17:78,118,847...78,169,543
Ensembl chr17:78,118,866...78,169,543
G
Or4b1d
olfactory receptor family 4 subfamily B member 1D
decreases expression
EXP
Troglitazone results in decreased expression of OR4B1D mRNA
CTD
PMID:21515302
NCBI chr 3:96,663,710...96,664,636
Ensembl chr 3:96,663,710...96,664,636
G
Or51e1
olfactory receptor family 51 subfamily E member 1
increases expression
EXP
Troglitazone results in increased expression of OR51E1 mRNA
CTD
PMID:21515302
NCBI chr 1:166,554,112...166,564,147
Ensembl chr 1:166,554,061...166,564,105
G
Or6c232-ps1
olfactory receptor family 6 subfamily C member 232, pseudogene 1
decreases expression
EXP
Troglitazone results in decreased expression of OR6C232-PS1 mRNA
CTD
PMID:21515302
NCBI chr 7:4,450,167...4,451,216
G
Orc1
origin recognition complex, subunit 1
decreases expression
ISO
troglitazone results in decreased expression of ORC1 mRNA
CTD
PMID:19140230
NCBI chr 5:128,552,975...128,581,943
Ensembl chr 5:128,552,991...128,577,071
G
Orc6
origin recognition complex, subunit 6
decreases expression
ISO
troglitazone results in decreased expression of ORC6 mRNA
CTD
PMID:19140230
NCBI chr19:37,931,085...37,938,856
Ensembl chr19:37,931,090...37,938,856
G
Orm1
orosomucoid 1
decreases expression
ISO
troglitazone results in decreased expression of ORM1 mRNA
CTD
PMID:12732648 PMID:28973697
NCBI chr 5:81,788,509...81,791,661
Ensembl chr 5:81,788,395...81,791,667
G
Osbpl5
oxysterol binding protein-like 5
decreases expression
EXP
troglitazone results in decreased expression of OSBPL5 mRNA
CTD
PMID:21515302
NCBI chr 1:208,291,441...208,362,086
Ensembl chr 1:208,291,441...208,362,169
G
Osgin1
oxidative stress induced growth inhibitor 1
decreases expression
ISO
troglitazone results in decreased expression of OSGIN1 mRNA
CTD
PMID:28973697
NCBI chr19:64,380,336...64,409,165
Ensembl chr19:64,401,173...64,409,162
G
Ostc
oligosaccharyltransferase complex non-catalytic subunit
increases expression
ISO
troglitazone results in increased expression of OSTC mRNA
CTD
PMID:28973697
NCBI chr 2:221,924,727...221,940,253
Ensembl chr 2:221,874,948...221,940,267
G
Ostn
osteocrin
increases expression decreases expression
ISO EXP
troglitazone results in increased expression of OSTN mRNA troglitazone results in decreased expression of OSTN mRNA
CTD
PMID:16981146 PMID:21515302
NCBI chr11:86,947,023...86,983,322
Ensembl chr11:86,947,313...86,973,427
G
Otc
ornithine transcarbamylase
increases expression decreases expression
ISO EXP
troglitazone results in increased expression of OTC protein troglitazone results in decreased expression of OTC protein troglitazone results in decreased expression of OTC mRNA
CTD
PMID:18495193 PMID:21315101 PMID:25572481
NCBI chr X:15,126,358...15,202,473
Ensembl chr X:15,126,358...15,239,555
G
Otud4
OTU deubiquitinase 4
decreases expression
ISO
troglitazone results in decreased expression of OTUD4 mRNA
CTD
PMID:28973697
NCBI chr19:45,141,043...45,184,136
Ensembl chr19:45,141,043...45,184,136
G
Otud7b
OTU deubiquitinase 7B
decreases expression
ISO
troglitazone results in decreased expression of OTUD7B mRNA
CTD
PMID:28973697
NCBI chr 2:186,350,811...186,411,461
Ensembl chr 2:186,350,798...186,409,440
G
P2rx6
purinergic receptor P2X 6
decreases expression
ISO
troglitazone results in decreased expression of P2RX6 mRNA
CTD
PMID:28973697
NCBI chr11:96,944,167...96,956,424
Ensembl chr11:96,944,169...96,954,646
G
P4hb
prolyl 4-hydroxylase subunit beta
increases expression
ISO
Troglitazone results in increased expression of P4HB mRNA
CTD
PMID:32535746
NCBI chr10:106,335,300...106,346,911
Ensembl chr10:106,335,300...106,346,911
G
Paics
phosphoribosylaminoimidazole carboxylase and phosphoribosylaminoimidazolesuccinocarboxamide synthase
decreases expression
ISO
troglitazone results in decreased expression of PAICS mRNA
CTD
PMID:19140230
NCBI chr14:31,553,355...31,586,843
Ensembl chr14:31,553,357...31,587,027
G
Pak3
p21 (RAC1) activated kinase 3
decreases expression increases expression
EXP ISO
troglitazone results in decreased expression of PAK3 mRNA troglitazone results in increased expression of PAK3 mRNA
CTD
PMID:21515302 PMID:28973697
NCBI chr X:111,912,967...112,171,037
Ensembl chr X:111,913,059...112,165,035
G
Pald1
phosphatase domain containing, paladin 1
decreases expression
ISO
troglitazone results in decreased expression of PALD1 mRNA
CTD
PMID:28973697
NCBI chr20:29,812,650...29,877,733
Ensembl chr20:29,812,650...29,850,063
G
Pamr1
peptidase domain containing associated with muscle regeneration 1
increases expression
ISO
troglitazone results in increased expression of PAMR1 mRNA
CTD
PMID:28973697
NCBI chr 3:109,340,411...109,443,595
Ensembl chr 3:109,341,476...109,443,585
G
Pan2
poly(A) specific ribonuclease subunit PAN2
decreases expression
ISO
troglitazone results in decreased expression of PAN2 mRNA
CTD
PMID:28973697
NCBI chr 7:1,313,654...1,332,252
Ensembl chr 7:1,313,655...1,332,252
G
Pan3
poly(A) specific ribonuclease subunit PAN3
decreases expression
ISO
troglitazone results in decreased expression of PAN3 mRNA
CTD
PMID:28973697
NCBI chr12:12,512,835...12,637,066
Ensembl chr12:12,512,835...12,631,492
G
Pank1
pantothenate kinase 1
increases expression
EXP
troglitazone results in increased expression of PANK1 mRNA
CTD
PMID:25596134
NCBI chr 1:241,737,371...241,808,126
Ensembl chr 1:241,741,083...241,807,824
G
Pappa
pappalysin 1
increases expression
ISO
troglitazone results in increased expression of PAPPA mRNA
CTD
PMID:19140230
NCBI chr 5:83,513,358...83,751,364
Ensembl chr 5:83,513,358...83,751,361
G
Papss2
3'-phosphoadenosine 5'-phosphosulfate synthase 2
decreases expression
ISO
troglitazone results in decreased expression of PAPSS2 mRNA
CTD
PMID:19140230 PMID:28973697
NCBI chr 1:239,867,597...239,952,614
Ensembl chr 1:239,867,574...239,952,616
G
Pard3
par-3 family cell polarity regulator
decreases expression
ISO
troglitazone results in decreased expression of PARD3 mRNA
CTD
PMID:28973697
NCBI chr19:71,977,420...72,527,273
Ensembl chr19:71,977,470...72,526,941
G
Parm1
prostate androgen-regulated mucin-like protein 1
increases expression
EXP
troglitazone results in increased expression of PARM1 mRNA
CTD
PMID:21515302
NCBI chr14:16,752,541...16,861,570
Ensembl chr14:16,752,541...16,881,138
G
Parp1
poly (ADP-ribose) polymerase 1
multiple interactions increases cleavage increases expression
ISO EXP
Aspirin promotes the reaction [troglitazone results in increased cleavage of PARP1 protein]; troglitazone promotes the reaction [Aspirin results in increased cleavage of PARP1 protein] troglitazone results in increased expression of PARP1 Troglitazone results in increased cleavage of PARP1 protein 2-chloro-5-nitrobenzanilide inhibits the reaction [Troglitazone results in increased expression of PARP1 mRNA]; 2-chloro-5-nitrobenzanilide inhibits the reaction [Troglitazone results in increased expression of PARP1 protein]; Troglitazone results in increased expression of and affects the cleavage of PARP1 protein
CTD
PMID:12680223 PMID:19908241 PMID:28283887
NCBI chr13:94,839,484...94,871,295
Ensembl chr13:94,839,433...94,871,567
G
Parp14
poly (ADP-ribose) polymerase family, member 14
decreases expression
ISO
troglitazone results in decreased expression of PARP14 mRNA
CTD
PMID:28973697
NCBI chr11:78,408,134...78,440,201
Ensembl chr11:78,408,058...78,440,195
G
Parp8
poly (ADP-ribose) polymerase family, member 8
decreases expression
EXP
troglitazone results in decreased expression of PARP8 mRNA
CTD
PMID:21515302
NCBI chr 2:50,408,404...50,581,513
Ensembl chr 2:50,408,404...50,581,233
G
Parva
parvin, alpha
decreases expression
ISO
troglitazone results in decreased expression of PARVA mRNA
CTD
PMID:28973697
NCBI chr 1:175,981,725...176,139,523
Ensembl chr 1:175,981,432...176,139,526
G
Pask
PAS domain containing serine/threonine kinase
decreases expression
ISO
troglitazone results in decreased expression of PASK mRNA
CTD
PMID:19140230
NCBI chr 9:101,291,673...101,333,288
Ensembl chr 9:101,291,676...101,332,504
G
Patl1
PAT1 homolog 1, processing body mRNA decay factor
decreases expression
ISO
troglitazone results in decreased expression of PATL1 mRNA
CTD
PMID:28973697
NCBI chr 1:218,255,801...218,287,662
Ensembl chr 1:218,255,848...218,287,657
G
Pbk
PDZ binding kinase
decreases expression
ISO
troglitazone results in decreased expression of PBK mRNA
CTD
PMID:19140230
NCBI chr15:44,198,506...44,209,572
Ensembl chr15:44,198,544...44,209,570
G
Pbld1
phenazine biosynthesis-like protein domain containing 1
decreases expression increases expression
EXP ISO
troglitazone results in decreased expression of PBLD mRNA troglitazone results in increased expression of PBLD mRNA
CTD
PMID:21515302 PMID:28973697
NCBI chr20:25,549,974...25,565,390
Ensembl chr20:25,549,974...25,565,226
G
Pbrm1
polybromo 1
decreases expression
ISO
troglitazone results in decreased expression of PBRM1 mRNA
CTD
PMID:28973697
NCBI chr16:6,219,933...6,319,336
Ensembl chr16:6,219,917...6,319,336
G
Pc
pyruvate carboxylase
increases expression decreases expression
ISO EXP
troglitazone results in increased expression of PC protein troglitazone results in decreased expression of PC protein
CTD
PMID:18495193 PMID:21315101
NCBI chr 1:211,228,708...211,327,792
Ensembl chr 1:211,228,731...211,329,940
G
Pcbp4
poly(rC) binding protein 4
decreases expression
ISO
troglitazone results in decreased expression of PCBP4 mRNA
CTD
PMID:28973697
NCBI chr 8:115,971,751...115,981,987
Ensembl chr 8:115,971,326...115,981,982
G
Pcdh1
protocadherin 1
decreases expression
ISO
troglitazone results in decreased expression of PCDH1 mRNA
CTD
PMID:28973697
NCBI chr18:30,258,154...30,290,828
Ensembl chr18:30,258,154...30,290,436
G
Pcdh12
protocadherin 12
decreases expression
ISO
troglitazone results in decreased expression of PCDH12 mRNA
CTD
PMID:28973697
NCBI chr18:30,354,910...30,370,485
Ensembl chr18:30,354,910...30,370,485
G
Pcif1
phosphorylated CTD interacting factor 1
decreases expression
ISO
troglitazone results in decreased expression of PCIF1 mRNA
CTD
PMID:28973697
NCBI chr 3:174,033,471...174,046,403
Ensembl chr 3:174,034,675...174,049,395
G
Pck1
phosphoenolpyruvate carboxykinase 1
increases expression multiple interactions decreases expression
ISO EXP
troglitazone results in increased expression of PCK1 mRNA [Troglitazone co-treated with 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one] results in decreased expression of PCK1 mRNA; [Troglitazone co-treated with Sirolimus] results in decreased expression of PCK1 mRNA; [Troglitazone co-treated with Wortmannin] results in decreased expression of PCK1 mRNA troglitazone results in decreased expression of PCK1 mRNA
CTD
PMID:10446394 PMID:11597575 PMID:12732648 PMID:28934090
NCBI chr 3:182,348,572...182,354,521
Ensembl chr 3:182,348,572...182,354,561
G
Pck2
phosphoenolpyruvate carboxykinase 2 (mitochondrial)
increases expression decreases expression
ISO
troglitazone results in increased expression of PCK2 mRNA troglitazone results in decreased expression of PCK2 mRNA
CTD
PMID:20846491 PMID:25572481
NCBI chr15:32,997,853...33,006,691
Ensembl chr15:32,997,834...33,016,864
G
Pcmtd2
protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2
decreases expression
ISO
troglitazone results in decreased expression of PCMTD2 mRNA
CTD
PMID:28973697
NCBI chr 3:189,337,758...189,360,525
Ensembl chr 3:189,337,816...189,357,001
G
Pcna
proliferating cell nuclear antigen
multiple interactions decreases expression
ISO EXP
[troglitazone co-treated with Diethylnitrosamine] results in increased expression of PCNA mRNA; [Urethane co-treated with troglitazone] results in increased expression of PCNA protein troglitazone results in decreased expression of PCNA mRNA; troglitazone results in decreased expression of PCNA protein [troglitazone co-treated with [Hydrochlorothiazide co-treated with Hydralazine co-treated with Reserpine]] results in decreased expression of PCNA protein
CTD
PMID:11318962 PMID:11834241 PMID:15064713 PMID:16374840 PMID:18465119 PMID:18597072 PMID:19140230 PMID:19631733 More...
NCBI chr 3:139,951,948...139,955,820
Ensembl chr 3:139,951,941...139,955,901
G
Pcolce
procollagen C-endopeptidase enhancer
increases expression
ISO
troglitazone results in increased expression of PCOLCE mRNA
CTD
PMID:28973697
NCBI chr12:24,720,972...24,727,287
Ensembl chr12:24,720,936...24,727,287
G
Pcolce2
procollagen C-endopeptidase enhancer 2
increases expression
ISO
troglitazone results in increased expression of PCOLCE2 mRNA
CTD
PMID:28973697
NCBI chr 8:105,073,086...105,130,725
Ensembl chr 8:105,073,086...105,145,160
G
Pcsk5
proprotein convertase subtilisin/kexin type 5
decreases expression
ISO
troglitazone results in decreased expression of PCSK5 mRNA
CTD
PMID:28973697
NCBI chr 1:224,263,823...224,694,350
Ensembl chr 1:224,264,678...224,694,347
G
Pcsk6
proprotein convertase subtilisin/kexin type 6
decreases expression
ISO
troglitazone results in decreased expression of PCSK6 mRNA
CTD
PMID:25572481
NCBI chr 1:128,839,742...129,038,087
Ensembl chr 1:128,839,232...129,052,128
G
Pcsk9
proprotein convertase subtilisin/kexin type 9
decreases expression
ISO
troglitazone results in decreased expression of PCSK9 mRNA
CTD
PMID:25572481
NCBI chr 5:126,440,102...126,462,507
Ensembl chr 5:126,440,102...126,462,507
G
Pcyt1b
phosphate cytidylyltransferase 1B, choline
increases expression
ISO
troglitazone results in increased expression of PCYT1B mRNA
CTD
PMID:28973697
NCBI chr X:62,371,934...62,465,460
Ensembl chr X:62,356,009...62,465,459
G
Pdcd11
programmed cell death 11
decreases expression
ISO
troglitazone results in decreased expression of PDCD11 mRNA
CTD
PMID:28973697
NCBI chr 1:255,922,198...255,963,336
Ensembl chr 1:255,922,225...255,963,336
G
Pdcd2
programmed cell death 2
decreases expression
ISO
troglitazone results in decreased expression of PDCD2 mRNA
CTD
PMID:17569031
NCBI chr 1:65,158,034...65,163,524
Ensembl chr 1:65,158,034...65,163,524
G
Pdcd2l
programmed cell death 2-like
decreases expression
ISO
troglitazone results in decreased expression of PDCD2L mRNA
CTD
PMID:28973697
NCBI chr 1:95,947,476...95,959,738
Ensembl chr 1:95,947,476...95,959,906
G
Pdcd4
programmed cell death 4
decreases expression
ISO
troglitazone results in decreased expression of PDCD4 mRNA
CTD
PMID:17569031
NCBI chr 1:262,912,659...262,949,581
Ensembl chr 1:262,926,656...262,950,189
G
Pdcd6ip
programmed cell death 6 interacting protein
decreases expression
ISO
troglitazone results in decreased expression of PDCD6IP mRNA
CTD
PMID:28973697
NCBI chr 8:122,469,223...122,524,993
Ensembl chr 8:122,469,223...122,524,993
G
Pdcd7
programmed cell death 7
decreases expression
ISO
troglitazone results in decreased expression of PDCD7 mRNA
CTD
PMID:28973697
NCBI chr 8:74,757,768...74,772,495
Ensembl chr 8:74,757,768...74,781,634
G
Pde1a
phosphodiesterase 1A
affects expression
EXP
troglitazone affects the expression of PDE1A mRNA
CTD
PMID:21515302
NCBI chr 3:85,152,053...85,432,289
Ensembl chr 3:85,154,184...85,519,212
G
Pde2a
phosphodiesterase 2A
decreases expression
ISO
troglitazone results in decreased expression of PDE2A mRNA
CTD
PMID:28973697
NCBI chr 1:165,235,623...165,327,466
Ensembl chr 1:165,235,623...165,327,466
G
Pde7b
phosphodiesterase 7B
decreases expression
ISO
troglitazone results in decreased expression of PDE7B mRNA
CTD
PMID:28973697
NCBI chr 1:16,994,072...17,312,828
Ensembl chr 1:17,002,286...17,312,456
G
Pdgfb
platelet derived growth factor subunit B
decreases expression
ISO
troglitazone results in decreased expression of PDGFB mRNA
CTD
PMID:28973697
NCBI chr 7:113,419,882...113,438,343
Ensembl chr 7:113,420,710...113,438,343
G
Pdgfrb
platelet derived growth factor receptor beta
decreases expression
ISO
troglitazone results in decreased expression of PDGFRB mRNA
CTD
PMID:28973697
NCBI chr18:56,770,348...56,809,228
Ensembl chr18:56,770,348...56,809,233
G
Pdia3
protein disulfide isomerase family A, member 3
increases expression
ISO
troglitazone results in increased expression of PDIA3 mRNA
CTD
PMID:28973697
NCBI chr 3:128,841,781...128,865,733
Ensembl chr 3:128,841,917...128,867,327
G
Pdia4
protein disulfide isomerase family A, member 4
increases expression
EXP
troglitazone results in increased expression of PDIA4 protein
CTD
PMID:21315101
NCBI chr 4:78,134,144...78,153,191
Ensembl chr 4:78,134,144...78,153,191
G
Pdia5
protein disulfide isomerase family A, member 5
decreases expression
EXP
troglitazone results in decreased expression of PDIA5 mRNA
CTD
PMID:25596134
NCBI chr11:78,777,436...78,892,370
Ensembl chr11:78,777,419...78,864,329
G
Pdilt
protein disulfide isomerase-like, testis expressed
decreases expression
ISO
troglitazone results in decreased expression of PDILT mRNA
CTD
PMID:28973697
NCBI chr 1:183,268,812...183,562,825
Ensembl chr 1:183,268,813...183,300,022
G
Pdk4
pyruvate dehydrogenase kinase 4
decreases expression increases expression
EXP ISO
troglitazone results in decreased expression of PDK4 mRNA troglitazone results in increased expression of PDK4 mRNA
CTD
PMID:14563825 PMID:16981146 PMID:21515302 PMID:25596134 PMID:25669987 PMID:27551952 More...
NCBI chr 4:34,558,327...34,568,329
Ensembl chr 4:34,556,330...34,568,381
G
Pdlim1
PDZ and LIM domain 1
decreases expression
EXP
troglitazone results in decreased expression of PDLIM1 mRNA
CTD
PMID:25596134
NCBI chr 1:248,991,818...249,040,409
Ensembl chr 1:248,991,818...249,047,379
G
Pdlim5
PDZ and LIM domain 5
decreases expression
ISO
troglitazone results in decreased expression of PDLIM5 mRNA
CTD
PMID:28973697
NCBI chr 2:233,625,478...233,793,582
Ensembl chr 2:233,628,503...233,793,528
G
Pdlim7
PDZ and LIM domain 7
increases expression
ISO
troglitazone results in increased expression of PDLIM7 mRNA
CTD
PMID:19140230
NCBI chr17:9,129,603...9,144,956
Ensembl chr17:9,129,525...9,144,956
G
Pdpk1
3-phosphoinositide dependent protein kinase-1
decreases expression
ISO
troglitazone results in decreased expression of PDPK1 mRNA
CTD
PMID:28973697
NCBI chr10:13,610,000...13,687,226
Ensembl chr10:13,610,063...13,679,181
G
Pdpr
pyruvate dehydrogenase phosphatase regulatory subunit
decreases expression
ISO
troglitazone results in decreased expression of PDPR mRNA
CTD
PMID:28973697
NCBI chr19:55,974,611...56,019,045
Ensembl chr19:55,974,550...56,019,044
G
Pds5a
PDS5 cohesin associated factor A
decreases expression
ISO
troglitazone results in decreased expression of PDS5A mRNA
CTD
PMID:28973697
NCBI chr14:42,905,734...43,004,740
Ensembl chr14:42,905,328...43,004,740
G
Pdzk1
PDZ domain containing 1
decreases expression
EXP
troglitazone results in decreased expression of PDZK1 mRNA
CTD
PMID:21515302
NCBI chr 2:187,064,995...187,096,348
Ensembl chr 2:187,065,013...187,096,806
G
Pdzk1ip1
PDZK1 interacting protein 1
decreases expression increases expression
ISO
troglitazone results in decreased expression of PDZK1IP1 mRNA troglitazone results in increased expression of PDZK1IP1 mRNA
CTD
PMID:25572481 PMID:28973697
NCBI chr 5:133,841,586...133,859,894
Ensembl chr 5:133,841,313...133,859,893
G
Pea15
proliferation and apoptosis adaptor protein 15
decreases expression
EXP
troglitazone results in decreased expression of PEA15 mRNA
CTD
PMID:21515302
NCBI chr13:87,190,189...87,199,811
Ensembl chr13:87,187,295...87,199,859
G
Peg10
paternally expressed 10
decreases expression
ISO
troglitazone results in decreased expression of PEG10 mRNA
CTD
PMID:25572481
NCBI chr 4:33,809,026...33,822,224
Ensembl chr 4:33,817,190...33,819,166 Ensembl chr 4:33,817,190...33,819,166
G
Pemt
phosphatidylethanolamine N-methyltransferase
decreases expression increases expression
ISO
troglitazone results in decreased expression of PEMT mRNA troglitazone results in increased expression of PEMT mRNA
CTD
PMID:12732648 PMID:25572481
NCBI chr10:45,275,434...45,349,651
Ensembl chr10:45,275,412...45,420,037
G
Pepd
peptidase D
increases expression
ISO
troglitazone results in increased expression of PEPD mRNA
CTD
PMID:28973697
NCBI chr 1:96,673,624...96,818,197
Ensembl chr 1:96,673,607...96,818,190
G
Per3
period circadian regulator 3
decreases expression
ISO
troglitazone results in decreased expression of PER3 mRNA
CTD
PMID:28973697
NCBI chr 5:166,740,914...166,778,243
Ensembl chr 5:166,743,050...166,777,999
G
Pex11a
peroxisomal biogenesis factor 11 alpha
increases expression
EXP
troglitazone results in increased expression of PEX11A mRNA
CTD
PMID:21515302
NCBI chr 1:143,089,410...143,096,491
Ensembl chr 1:143,089,410...143,096,645
G
Pex16
peroxisomal biogenesis factor 16
increases expression
EXP
troglitazone results in increased expression of PEX16 mRNA
CTD
PMID:21515302
NCBI chr 3:98,800,357...98,808,091
Ensembl chr 3:98,798,654...98,808,630
G
Pex6
peroxisomal biogenesis factor 6
increases expression
ISO
troglitazone results in increased expression of PEX6 mRNA
CTD
PMID:28973697
NCBI chr 9:21,755,747...21,767,939
Ensembl chr 9:21,755,751...21,767,908
G
Pf4
platelet factor 4
increases expression
ISO
troglitazone results in increased expression of PF4 mRNA
CTD
PMID:28973697
NCBI chr14:17,582,477...17,583,392
Ensembl chr14:17,582,477...17,583,392
G
Pfkfb1
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 1
increases expression
ISO
troglitazone results in increased expression of PFKFB1 mRNA
CTD
PMID:28973697
NCBI chr X:22,936,038...22,989,691
Ensembl chr X:22,937,494...22,989,704
G
Pfkl
phosphofructokinase, liver type
decreases expression
EXP
troglitazone results in decreased expression of PFKL mRNA
CTD
PMID:21515302
NCBI chr20:10,663,907...10,685,967
Ensembl chr20:10,663,955...10,685,966
G
Pgghg
protein-glucosylgalactosylhydroxylysine glucosidase
decreases expression
ISO
troglitazone results in decreased expression of PGGHG mRNA
CTD
PMID:28973697
NCBI chr 1:205,467,179...205,474,185
Ensembl chr 1:205,467,993...205,474,183
G
Pggt1b
protein geranylgeranyltransferase type I subunit beta
decreases expression
ISO
troglitazone results in decreased expression of PGGT1B mRNA
CTD
PMID:28973697
NCBI chr18:41,138,536...41,182,145
Ensembl chr18:41,139,965...41,182,139
G
Phactr2
phosphatase and actin regulator 2
decreases expression
ISO
troglitazone results in decreased expression of PHACTR2 mRNA
CTD
PMID:28973697
NCBI chr 1:9,411,412...9,680,648
Ensembl chr 1:9,418,085...9,680,583
G
Phaf1
phagophore assembly factor 1
decreases expression
ISO
Troglitazone results in decreased expression of PHAF1 mRNA
CTD
PMID:28973697
NCBI chr19:50,011,350...50,050,880
Ensembl chr19:50,011,369...50,053,987
G
Phc3
polyhomeotic homolog 3
decreases expression
ISO
troglitazone results in decreased expression of PHC3 mRNA
CTD
PMID:28973697
NCBI chr 2:114,337,180...114,412,132
Ensembl chr 2:114,337,227...114,405,816
G
Phf12
PHD finger protein 12
decreases expression
ISO
troglitazone results in decreased expression of PHF12 mRNA
CTD
PMID:28973697
NCBI chr10:63,368,547...63,417,079
Ensembl chr10:63,370,210...63,417,073
G
Phf19
PHD finger protein 19
decreases expression
ISO
troglitazone results in decreased expression of PHF19 mRNA
CTD
PMID:19140230
NCBI chr 3:38,572,766...38,604,950
Ensembl chr 3:38,572,766...38,593,854
G
Phf2
PHD finger protein 2
decreases expression
ISO
troglitazone results in decreased expression of PHF2 mRNA
CTD
PMID:28973697
NCBI chr17:15,989,594...16,057,583
Ensembl chr17:15,981,604...16,057,583
G
Phf20l1
PHD finger protein 20-like 1
decreases expression
ISO
troglitazone results in decreased expression of PHF20L1 mRNA
CTD
PMID:28973697
NCBI chr 7:100,219,598...100,285,580
Ensembl chr 7:100,219,639...100,285,580
G
Phf21a
PHD finger protein 21A
decreases expression
ISO
troglitazone results in decreased expression of PHF21A mRNA
CTD
PMID:28973697
NCBI chr 3:98,600,933...98,791,132
Ensembl chr 3:98,613,844...98,787,350
G
Phf3
PHD finger protein 3
decreases expression
ISO
troglitazone results in decreased expression of PHF3 mRNA
CTD
PMID:28973697
NCBI chr 9:40,559,929...40,632,096
Ensembl chr 9:40,559,929...40,632,056
G
Phf8
PHD finger protein 8
decreases expression
ISO
troglitazone results in decreased expression of PHF8 mRNA
CTD
PMID:28973697
NCBI chr X:23,967,126...24,066,473
Ensembl chr X:23,967,556...24,066,471
G
Phgdh
phosphoglycerate dehydrogenase
increases expression
ISO
troglitazone results in increased expression of PHGDH mRNA
CTD
PMID:19140230
NCBI chr 2:188,595,700...188,624,789
Ensembl chr 2:188,595,700...188,624,789
G
Phip
pleckstrin homology domain interacting protein
decreases expression
ISO
troglitazone results in decreased expression of PHIP mRNA
CTD
PMID:28973697
NCBI chr 8:92,656,890...92,771,098
Ensembl chr 8:92,656,890...92,771,021
G
Phkb
phosphorylase kinase regulatory subunit beta
decreases expression
ISO
troglitazone results in decreased expression of PHKB mRNA
CTD
PMID:28973697
NCBI chr19:37,179,937...37,383,979
Ensembl chr19:37,186,042...37,383,877
G
Phlda2
pleckstrin homology-like domain, family A, member 2
increases expression
ISO
troglitazone results in increased expression of PHLDA2 mRNA
CTD
PMID:19140230
NCBI chr 1:208,126,302...208,127,241
Ensembl chr 1:208,126,302...208,127,920
G
Phldb1
pleckstrin homology-like domain, family B, member 1
decreases expression
EXP
troglitazone results in decreased expression of PHLDB1 mRNA
CTD
PMID:21515302
NCBI chr 8:53,900,338...53,948,325
Ensembl chr 8:53,900,338...53,949,518
G
Phldb2
pleckstrin homology-like domain, family B, member 2
decreases expression
ISO
troglitazone results in decreased expression of PHLDB2 mRNA
CTD
PMID:25572481
NCBI chr11:68,321,738...68,540,724
Ensembl chr11:68,355,959...68,540,734
G
Phlpp1
PH domain and leucine rich repeat protein phosphatase 1
decreases expression
ISO
troglitazone results in decreased expression of PHLPP1 mRNA
CTD
PMID:28973697
NCBI chr13:22,823,132...23,045,619
Ensembl chr13:22,823,132...23,045,619
G
Phyh
phytanoyl-CoA 2-hydroxylase
decreases expression
EXP
troglitazone results in decreased expression of PHYH mRNA
CTD
PMID:21515302
NCBI chr17:78,238,747...78,255,645
Ensembl chr17:78,238,747...78,255,645
G
Pi16
peptidase inhibitor 16
increases expression
ISO
troglitazone results in increased expression of PI16 mRNA
CTD
PMID:28973697
NCBI chr20:7,377,739...7,387,003
Ensembl chr20:7,377,729...7,387,691
G
Pias1
protein inhibitor of activated STAT, 1
decreases expression
ISO
troglitazone results in decreased expression of PIAS1 mRNA
CTD
PMID:28973697
NCBI chr 8:72,233,566...72,347,085
Ensembl chr 8:72,233,566...72,334,315
G
Pid1
phosphotyrosine interaction domain containing 1
increases expression
ISO
Troglitazone results in increased expression of PID1 mRNA
CTD
PMID:32816093
NCBI chr 9:92,732,471...92,951,168
Ensembl chr 9:92,734,214...92,750,070
G
Piga
phosphatidylinositol glycan anchor biosynthesis, class A
increases expression
ISO
troglitazone results in increased expression of PIGA mRNA
CTD
PMID:28973697
NCBI chr X:33,672,832...33,687,747
Ensembl chr X:33,674,923...33,687,636
G
Pigk
phosphatidylinositol glycan anchor biosynthesis, class K
decreases expression
ISO
troglitazone results in decreased expression of PIGK mRNA
CTD
PMID:28973697
NCBI chr 2:244,289,928...244,375,394
Ensembl chr 2:244,250,621...244,376,030
G
Pigl
phosphatidylinositol glycan anchor biosynthesis, class L
increases expression decreases expression
ISO
troglitazone results in increased expression of PIGL mRNA troglitazone results in decreased expression of PIGL mRNA
CTD
PMID:28973697
NCBI chr10:47,641,478...47,699,200
Ensembl chr10:47,641,098...47,699,453
G
Pigp
phosphatidylinositol glycan anchor biosynthesis, class P
increases expression
ISO
troglitazone results in increased expression of PIGP mRNA
CTD
PMID:28973697
NCBI chr11:47,152,601...47,158,766
Ensembl chr11:47,148,465...47,160,082
G
Pigr
polymeric immunoglobulin receptor
increases expression
ISO
troglitazone results in increased expression of PIGR mRNA
CTD
PMID:28973697
NCBI chr13:44,851,001...44,879,143
Ensembl chr13:44,851,182...44,879,141
G
Pigt
phosphatidylinositol glycan anchor biosynthesis, class T
increases expression
ISO
troglitazone results in increased expression of PIGT mRNA
CTD
PMID:28973697
NCBI chr 3:173,647,104...173,656,269
Ensembl chr 3:173,641,900...173,656,268
G
Pik3ca
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
decreases expression
ISO
troglitazone results in decreased expression of PIK3CA mRNA
CTD
PMID:28973697
NCBI chr 2:117,103,643...117,177,411
Ensembl chr 2:117,143,468...117,177,411
G
Pik3r4
phosphoinositide-3-kinase, regulatory subunit 4
decreases expression
ISO
troglitazone results in decreased expression of PIK3R4 mRNA
CTD
PMID:28973697
NCBI chr 8:115,146,660...115,195,326
Ensembl chr 8:115,146,687...115,195,326
G
Pim1
Pim-1 proto-oncogene, serine/threonine kinase
decreases expression
ISO
troglitazone results in decreased expression of PIM1 mRNA
CTD
PMID:28973697
NCBI chr20:7,556,496...7,560,747
Ensembl chr20:7,556,113...7,561,764
G
Pitpnc1
phosphatidylinositol transfer protein, cytoplasmic 1
decreases expression
ISO
troglitazone results in decreased expression of PITPNC1 mRNA
CTD
PMID:28973697
NCBI chr10:92,663,260...92,928,616
Ensembl chr10:92,663,260...92,928,344
G
Pitrm1
pitrilysin metallopeptidase 1
decreases expression
ISO
troglitazone results in decreased expression of PITRM1 mRNA
CTD
PMID:28973697
NCBI chr17:68,705,699...68,737,350
Ensembl chr17:68,705,699...68,749,717
G
Pkd1
polycystin 1, transient receptor potential channel interacting
increases expression
ISO
troglitazone results in increased expression of PKD1 mRNA
CTD
PMID:19140230
NCBI chr10:14,077,733...14,125,682
Ensembl chr10:14,078,679...14,125,681
G
Pkib
cAMP-dependent protein kinase inhibitor beta
increases expression
ISO
troglitazone results in increased expression of PKIB mRNA
CTD
PMID:25572481
NCBI chr20:37,511,564...37,608,607
Ensembl chr20:37,512,822...37,608,401
G
Pklr
pyruvate kinase L/R
decreases expression
EXP ISO
troglitazone results in decreased expression of PKLR protein troglitazone results in decreased expression of PKLR mRNA
CTD
PMID:21315101 PMID:25572481
NCBI chr 2:176,840,779...176,849,637
Ensembl chr 2:176,840,764...176,849,644
G
Pkmyt1
protein kinase, membrane associated tyrosine/threonine 1
decreases expression
ISO
troglitazone results in decreased expression of PKMYT1 mRNA
CTD
PMID:19140230
NCBI chr10:13,252,805...13,263,584
Ensembl chr10:13,252,816...13,264,263
G
Pkn3
protein kinase N3
decreases expression
ISO
troglitazone results in decreased expression of PKN3 mRNA
CTD
PMID:19140230
NCBI chr 3:33,747,610...33,761,405
Ensembl chr 3:33,747,867...33,761,405
G
Pknox1
PBX/knotted 1 homeobox 1
decreases expression
ISO
troglitazone results in decreased expression of PKNOX1 mRNA
CTD
PMID:28973697
NCBI chr20:9,664,120...9,706,328
Ensembl chr20:9,664,312...9,706,349
G
Pkp4
plakophilin 4
decreases expression
ISO
troglitazone results in decreased expression of PKP4 mRNA
CTD
PMID:28973697
NCBI chr 3:64,040,995...64,244,586
Ensembl chr 3:64,141,771...64,244,586
G
Pla1a
phospholipase A1 member A
decreases expression increases expression
EXP ISO
troglitazone results in decreased expression of PLA1A mRNA troglitazone results in increased expression of PLA1A mRNA
CTD
PMID:21515302 PMID:28973697
NCBI chr11:75,825,626...75,863,296
Ensembl chr11:75,825,585...75,878,165
G
Pla2g4a
phospholipase A2 group 4A
decreases expression
ISO
troglitazone results in decreased expression of PLA2G4A mRNA
CTD
PMID:18155510
NCBI chr13:64,427,921...64,572,352
Ensembl chr13:64,427,916...64,589,641
G
Pla2g4c
phospholipase A2 group IVC
increases expression
ISO
troglitazone results in increased expression of PLA2G4C mRNA
CTD
PMID:19140230
NCBI chr 1:83,315,017...83,411,342
Ensembl chr 1:83,382,068...83,410,037
G
Pla2g6
phospholipase A2 group VI
decreases expression
ISO
troglitazone results in decreased expression of PLA2G6 mRNA
CTD
PMID:12732648
NCBI chr 7:112,731,803...112,771,978
Ensembl chr 7:112,731,803...112,771,609
G
Plaa
phospholipase A2, activating protein
decreases expression
ISO
troglitazone results in decreased expression of PLAA mRNA
CTD
PMID:28973697
NCBI chr 5:114,544,327...114,576,023
Ensembl chr 5:114,544,325...114,576,109
G
Plaat3
phospholipase A and acyltransferase 3
decreases expression
EXP
Troglitazone results in decreased expression of PLAAT3 mRNA
CTD
PMID:21515302
NCBI chr 1:214,211,755...214,245,551
Ensembl chr 1:214,211,791...214,246,763
G
Plau
plasminogen activator, urokinase
increases expression
ISO
troglitazone results in increased expression of PLAU mRNA
CTD
PMID:19140230
NCBI chr15:3,505,485...3,511,987
Ensembl chr15:3,505,487...3,512,030
G
Pld1
phospholipase D1
increases expression decreases expression
ISO
troglitazone results in increased expression of PLD1 mRNA troglitazone results in decreased expression of PLD1 mRNA
CTD
PMID:19140230 PMID:28973697
NCBI chr 2:112,777,820...112,975,857
Ensembl chr 2:112,777,951...112,976,245
G
Plec
plectin
increases expression
ISO
troglitazone results in increased expression of PLEC mRNA
CTD
PMID:19140230
NCBI chr 7:109,768,447...109,829,798
Ensembl chr 7:109,768,447...109,828,089
G
Plekhf1
pleckstrin homology and FYVE domain containing 1
decreases expression
ISO
troglitazone results in decreased expression of PLEKHF1 mRNA
CTD
PMID:28973697
NCBI chr 1:100,045,340...100,046,817
Ensembl chr 1:100,027,056...100,053,452
G
Plekhf2
pleckstrin homology and FYVE domain containing 2
increases expression
ISO
troglitazone results in increased expression of PLEKHF2 mRNA
CTD
PMID:28973697
NCBI chr 5:28,888,358...28,905,350
Ensembl chr 5:28,868,469...28,923,514
G
Plekhg3
pleckstrin homology and RhoGEF domain containing G3
decreases expression
ISO
troglitazone results in decreased expression of PLEKHG3 mRNA
CTD
PMID:28973697
NCBI chr 6:100,998,965...101,042,120
Ensembl chr 6:100,994,417...101,042,118
G
Plekhm1
pleckstrin homology and RUN domain containing M1
decreases expression
ISO
troglitazone results in decreased expression of PLEKHM1 mRNA
CTD
PMID:28973697
NCBI chr10:88,814,699...88,876,570
Ensembl chr10:88,814,699...88,862,544
G
Plin1
perilipin 1
multiple interactions increases expression
ISO
[1-Methyl-3-isobutylxanthine co-treated with INS protein co-treated with Troglitazone] results in increased expression of PLIN1 protein; [1-Methyl-3-isobutylxanthine co-treated with Troglitazone co-treated with INS protein] results in increased expression of PLIN1 mRNA Troglitazone results in increased expression of PLIN1 mRNA
CTD
PMID:25572481 PMID:27003841 PMID:28437481
NCBI chr 1:143,073,612...143,086,199
Ensembl chr 1:143,074,214...143,086,206
G
Plin2
perilipin 2
increases expression multiple interactions
ISO EXP
troglitazone results in increased expression of PLIN2 mRNA troglitazone promotes the reaction [Oleic Acid results in increased expression of PLIN2 mRNA]
CTD
PMID:24534255 PMID:25572481 PMID:25596134
NCBI chr 5:106,202,634...106,258,748
Ensembl chr 5:106,202,634...106,258,878
G
Plin4
perilipin 4
increases expression multiple interactions
ISO
troglitazone results in increased expression of PLIN4 mRNA troglitazone promotes the reaction [Oleic Acid results in increased expression of PLIN4 mRNA]
CTD
PMID:12732648 PMID:24534255 PMID:25572481
NCBI chr 9:1,016,334...1,025,249
Ensembl chr 9:1,016,302...1,025,368
G
Plin5
perilipin 5
increases expression
EXP
troglitazone results in increased expression of PLIN5 mRNA
CTD
PMID:21515302
NCBI chr 9:1,026,910...1,033,352
Ensembl chr 9:1,026,307...1,033,284
G
Plk1
polo-like kinase 1
decreases expression
ISO
troglitazone results in decreased expression of PLK1 mRNA
CTD
PMID:19140230
NCBI chr 1:186,147,658...186,157,637
Ensembl chr 1:186,147,658...186,157,637
G
Plk2
polo-like kinase 2
decreases expression
ISO
troglitazone results in decreased expression of PLK2 mRNA
CTD
PMID:19140230 PMID:20846491
NCBI chr 2:43,702,536...43,708,305
Ensembl chr 2:43,701,865...43,708,296
G
Plk3
polo-like kinase 3
increases expression
EXP
troglitazone results in increased expression of PLK3 mRNA
CTD
PMID:21515302
NCBI chr 5:135,843,725...135,848,900
Ensembl chr 5:135,843,725...135,848,900
G
Plk4
polo-like kinase 4
decreases expression
ISO
troglitazone results in decreased expression of PLK4 mRNA
CTD
PMID:19140230
NCBI chr 2:125,730,480...125,748,894
Ensembl chr 2:125,730,460...125,748,892
G
Plp1
proteolipid protein 1
decreases expression
ISO
troglitazone results in decreased expression of PLP1 mRNA
CTD
PMID:28973697
NCBI chr X:104,933,921...104,993,317
Ensembl chr X:104,975,780...104,993,314
G
Plpp3
phospholipid phosphatase 3
decreases expression
ISO
troglitazone results in decreased expression of PLPP3 mRNA
CTD
PMID:28973697
NCBI chr 5:125,156,000...125,231,119
Ensembl chr 5:125,155,945...125,235,667
G
Plscr2
phospholipid scramblase 2
decreases expression
EXP
Troglitazone results in decreased expression of PLSCR2 mRNA
CTD
PMID:21515302
NCBI chr 8:101,689,202...101,725,726
Ensembl chr 8:101,689,210...101,725,757
G
Pltp
phospholipid transfer protein
increases expression
ISO
troglitazone results in increased expression of PLTP mRNA
CTD
PMID:28973697
NCBI chr 3:173,994,162...174,011,982
Ensembl chr 3:173,994,162...174,012,505
G
Plvap
plasmalemma vesicle associated protein
increases expression
ISO
troglitazone results in increased expression of PLVAP mRNA
CTD
PMID:28973697
NCBI chr16:18,218,966...18,231,279
Ensembl chr16:18,218,967...18,231,454
G
Plxna2
plexin A2
decreases expression
ISO
troglitazone results in decreased expression of PLXNA2 mRNA
CTD
PMID:28973697
NCBI chr13:108,683,155...108,888,336
Ensembl chr13:108,691,530...108,887,453
G
Plxnc1
plexin C1
decreases expression
ISO
troglitazone results in decreased expression of PLXNC1 mRNA
CTD
PMID:17569031
NCBI chr 7:31,276,978...31,430,823
Ensembl chr 7:31,276,978...31,431,092
G
Plxnd1
plexin D1
decreases expression
ISO
troglitazone results in decreased expression of PLXND1 mRNA
CTD
PMID:28973697
NCBI chr 4:150,675,377...150,715,706
Ensembl chr 4:150,675,377...150,715,566
G
Pmaip1
phorbol-12-myristate-13-acetate-induced protein 1
decreases expression
ISO
troglitazone results in decreased expression of PMAIP1 mRNA
CTD
PMID:28934090
NCBI chr18:62,255,970...62,262,384
Ensembl chr18:62,255,598...62,262,382
G
Pmepa1
prostate transmembrane protein, androgen induced 1
decreases expression
EXP
troglitazone results in decreased expression of PMEPA1 mRNA
CTD
PMID:25596134
NCBI chr 3:182,430,193...182,478,649
Ensembl chr 3:182,430,193...182,478,649
G
Pml
PML nuclear body scaffold
decreases expression
ISO
troglitazone results in decreased expression of PML mRNA
CTD
PMID:28973697
NCBI chr 8:67,523,164...67,557,801
Ensembl chr 8:67,523,164...67,576,083
G
Pnisr
PNN interacting serine and arginine rich protein
decreases expression
ISO
troglitazone results in decreased expression of PNISR mRNA
CTD
PMID:28973697
NCBI chr 5:40,190,214...40,219,619
Ensembl chr 5:40,192,735...40,219,611
G
Pnlip
pancreatic lipase
affects expression
EXP
troglitazone affects the expression of PNLIP mRNA
CTD
PMID:21515302
NCBI chr 1:267,760,073...267,797,797
Ensembl chr 1:267,784,724...267,797,795
G
Pnpla3
patatin-like phospholipase domain containing 3
decreases expression
ISO
troglitazone results in decreased expression of PNPLA3 mRNA
CTD
PMID:12953171
NCBI chr 7:117,173,485...117,194,065
Ensembl chr 7:117,173,516...117,194,594
G
Podxl
podocalyxin-like
decreases expression
EXP ISO
troglitazone results in decreased expression of PODXL mRNA
CTD
PMID:25596134 PMID:28973697
NCBI chr 4:61,102,434...61,149,131
Ensembl chr 4:61,102,419...61,149,789
G
Pola2
DNA polymerase alpha 2, accessory subunit
decreases expression
ISO
troglitazone results in decreased expression of POLA2 mRNA
CTD
PMID:19140230
NCBI chr 1:212,656,500...212,680,667
Ensembl chr 1:212,656,501...212,680,542
G
Pold1
DNA polymerase delta 1, catalytic subunit
decreases expression
ISO
troglitazone results in decreased expression of POLD1 mRNA
CTD
PMID:19140230
NCBI chr 1:104,161,984...104,178,074
Ensembl chr 1:104,162,016...104,172,982
G
Pold3
DNA polymerase delta 3, accessory subunit
decreases expression
ISO
troglitazone results in decreased expression of POLD3 mRNA
CTD
PMID:19140230
NCBI chr 1:163,830,217...163,870,015
Ensembl chr 1:163,830,437...163,869,202
G
Pole
DNA polymerase epsilon, catalytic subunit
decreases expression
ISO
troglitazone results in decreased expression of POLE mRNA
CTD
PMID:19140230
NCBI chr12:52,005,155...52,053,761
Ensembl chr12:52,005,155...52,053,662
G
Pole2
DNA polymerase epsilon 2, accessory subunit
decreases expression
ISO
troglitazone results in decreased expression of POLE2 mRNA
CTD
PMID:19140230
NCBI chr 6:93,410,713...93,448,782
Ensembl chr 6:93,410,758...93,435,361
G
Pole4
DNA polymerase epsilon 4, accessory subunit
increases expression
ISO
troglitazone results in increased expression of POLE4 mRNA
CTD
PMID:28973697
NCBI chr 4:116,723,040...116,728,873
Ensembl chr 4:116,716,719...116,728,851
G
Polq
DNA polymerase theta
decreases expression
ISO
troglitazone results in decreased expression of POLQ mRNA
CTD
PMID:19140230
NCBI chr11:77,179,190...77,281,270
Ensembl chr11:77,179,209...77,281,268
G
Polr3a
RNA polymerase III subunit A
decreases expression
ISO
troglitazone results in decreased expression of POLR3A mRNA
CTD
PMID:28973697
NCBI chr16:56,066...95,060
Ensembl chr16:56,066...95,060
G
Polr3b
RNA polymerase III subunit B
decreases expression
ISO
troglitazone results in decreased expression of POLR3B mRNA
CTD
PMID:28973697
NCBI chr 7:20,926,866...21,030,133
Ensembl chr 7:20,926,866...21,033,654
G
Polr3k
RNA polymerase III subunit K
decreases expression
ISO
troglitazone results in decreased expression of POLR3K mRNA
CTD
PMID:19140230
NCBI chr 3:189,360,349...189,364,546
Ensembl chr 3:189,360,171...189,366,697
G
Por
cytochrome p450 oxidoreductase
increases expression
EXP ISO
troglitazone results in increased expression of POR mRNA
CTD
PMID:16597547 PMID:19631733 PMID:25572481
NCBI chr12:26,587,674...26,655,612
Ensembl chr12:26,587,674...26,635,809
G
Pot1
protection of telomeres 1
decreases expression
ISO
troglitazone results in decreased expression of POT1 mRNA
CTD
PMID:28973697
NCBI chr 4:55,170,821...55,228,588
Ensembl chr 4:55,170,821...55,228,543
G
Ppara
peroxisome proliferator activated receptor alpha
multiple interactions increases expression affects binding decreases expression
ISO
PPARA protein affects the reaction [troglitazone inhibits the reaction [TNF protein results in increased expression of CCL11 protein]] troglitazone results in increased expression of PPARA mRNA; troglitazone results in increased expression of PPARA protein troglitazone binds to PPARA protein troglitazone results in decreased expression of PPARA mRNA Oleic Acid inhibits the reaction [troglitazone results in decreased expression of PPARA mRNA]
CTD
PMID:11056218 PMID:11172467 PMID:11779144 PMID:15531761 PMID:28973697
NCBI chr 7:118,712,261...118,780,723
Ensembl chr 7:118,712,412...118,780,714
G
Pparg
peroxisome proliferator-activated receptor gamma
increases response to substance affects binding multiple interactions affects response to substance decreases activity increases phosphorylation decreases expression increases activity increases expression decreases methylation affects activity
ISO EXP
PPARG protein results in increased susceptibility to troglitazone troglitazone analog binds to PPARG protein; troglitazone binds to PPARG protein (+)-JQ1 compound inhibits the reaction [[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Troglitazone] results in increased expression of PPARG protein]; [INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Troglitazone] results in increased expression of PPARG protein; [Troglitazone binds to and results in increased activity of PPARG protein] promotes the reaction [[PPARG protein binds to CYP1A1 promoter] which results in increased expression of CYP1A1 mRNA]; [Troglitazone binds to and results in increased activity of PPARG protein] promotes the reaction [PPARG protein binds to CYP1A1 promoter]; [Troglitazone co-treated with Diethylstilbestrol] results in increased expression of PPARG protein; [Troglitazone results in increased activity of PPARG protein] which results in increased expression of CD36 mRNA; [Troglitazone results in increased activity of PPARG protein] which results in increased expression of ERO1A mRNA; [Troglitazone results in increased activity of PPARG protein] which results in increased expression of FABP4 mRNA; [Troglitazone results in increased activity of PPARG protein] which results in increased expression of UCP2 mRNA; JMJD6 mutant form inhibits the reaction [[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Troglitazone] results in increased expression of PPARG protein]; PPARG protein affects the reaction [Troglitazone results in increased activity of CYP1A1 protein]; PPARG protein affects the reaction [Troglitazone results in increased expression of CYP1A1 mRNA]; PPARG protein promotes the reaction [Troglitazone results in increased expression of PPARGC1A mRNA]; Troglitazone binds to and results in decreased activity of PPARG protein; Troglitazone binds to and results in increased activity of PPARG protein; Troglitazone promotes the reaction [PPARG protein results in increased expression of FABP4 mRNA]; Troglitazone promotes the reaction [PPARG protein results in increased expression of SORBS1 mRNA] 2-chloro-5-nitrobenzanilide inhibits the reaction [[troglitazone results in increased activity of PPARG protein] inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]]; 2-chloro-5-nitrobenzanilide inhibits the reaction [[troglitazone results in increased activity of PPARG protein] inhibits the reaction [Lipopolysaccharides results in increased secretion of TNF protein]]; 2-chloro-5-nitrobenzanilide inhibits the reaction [[troglitazone results in increased activity of PPARG protein] which results in increased expression of SFTPA1 mRNA]; [[[troglitazone binds to and results in increased activity of PPARG protein] which results in decreased localization of and results in decreased activity of SREBF1 protein] which results in decreased expression of FASN mRNA] which results in decreased abundance of Triglycerides; [troglitazone binds to and results in increased activity of PPARG mRNA] which results in decreased expression of SERPINE1 mRNA; [troglitazone binds to and results in increased activity of PPARG mRNA] which results in decreased expression of SERPINE1 protein; [troglitazone binds to and results in increased activity of PPARG protein] which results in decreased localization of and results in decreased activity of SREBF1 protein; [troglitazone binds to and results in increased activity of PPARG protein] which results in increased expression of INSIG1 protein; [troglitazone binds to and results in increased activity of PPARG protein] which results in increased expression of INSIG2 protein; [troglitazone results in increased activity of PPARG protein] inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]; [troglitazone results in increased activity of PPARG protein] inhibits the reaction [Lipopolysaccharides results in increased secretion of TNF protein]; [troglitazone results in increased activity of PPARG protein] which results in decreased susceptibility to Lipopolysaccharides; [troglitazone results in increased activity of PPARG protein] which results in increased expression of SFTPA1 mRNA; [troglitazone results in increased phosphorylation of and results in increased activity of PPARG protein] which results in decreased expression of GFAP protein; CR8 compound inhibits the reaction [troglitazone results in increased phosphorylation of PPARG protein]; troglitazone binds to and results in increased activity of PPARG protein; troglitazone promotes the reaction [CDK5 protein results in increased phosphorylation of PPARG protein]; troglitazone promotes the reaction [PPARG protein binds to GFAP promoter]; troglitazone results in increased phosphorylation of and results in increased activity of PPARG protein PPARG gene SNP affects the susceptibility to troglitazone troglitazone results in decreased activity of PPARG protein alternative form troglitazone results in increased phosphorylation of PPARG protein alternative form troglitazone results in decreased expression of PPARG mRNA troglitazone results in increased activity of PPARG protein alternative form Troglitazone results in increased expression of PPARG mRNA; Troglitazone results in increased expression of PPARG protein Troglitazone results in increased expression of PPARG mRNA; Troglitazone results in increased expression of PPARG mRNA alternative form; Troglitazone results in increased expression of PPARG protein troglitazone results in decreased methylation of PPARG promoter troglitazone affects the activity of PPARG protein 2-chloro-5-nitrobenzanilide inhibits the reaction [Troglitazone results in increased activity of PPARG protein]; [1-Methyl-3-isobutylxanthine co-treated with Troglitazone co-treated with INS protein] results in increased expression of PPARG mRNA; [2-chloro-5-nitrobenzanilide binds to and results in decreased activity of PPARG protein] inhibits the reaction [Troglitazone affects the localization of CYCS protein]; [2-chloro-5-nitrobenzanilide binds to and results in decreased activity of PPARG protein] inhibits the reaction [Troglitazone results in increased abundance of Reactive Oxygen Species]; [2-chloro-5-nitrobenzanilide binds to and results in decreased activity of PPARG protein] inhibits the reaction [Troglitazone results in increased expression of PRODH]; [2-chloro-5-nitrobenzanilide results in decreased activity of PPARG protein] inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of Troglitazone]; [[Troglitazone binds to and results in increased activity of PPARG protein] which results in decreased expression of SREBF2 protein] which results in decreased abundance of Cholesterol; [[Troglitazone binds to and results in increased activity of PPARG protein] which results in decreased expression of SREBF2 protein] which results in decreased expression of HMGCR mRNA; [[Troglitazone binds to and results in increased activity of PPARG protein] which results in decreased expression of SREBF2 protein] which results in decreased expression of LDLR mRNA; [Tetradecanoylphorbol Acetate results in increased expression of PPARG] which affects the susceptibility to Troglitazone; [Troglitazone binds to and results in increased activity of PPARG protein] which results in decreased abundance of Cholesterol; [Troglitazone binds to and results in increased activity of PPARG protein] which results in decreased degradation of CDKN1B protein; [Troglitazone binds to and results in increased activity of PPARG protein] which results in decreased expression of SREBF2 mRNA; [Troglitazone binds to and results in increased activity of PPARG protein] which results in decreased expression of SREBF2 protein; [Troglitazone binds to and results in increased activity of PPARG protein] which results in increased abundance of Cholesterol; [Troglitazone binds to and results in increased activity of PPARG protein] which results in increased expression of and results in increased ubiquitination of CDKN1B protein; [Troglitazone binds to and results in increased activity of PPARG protein] which results in increased expression of CDKN1B protein; [Troglitazone binds to and results in increased activity of PPARG protein] which results in increased expression of HMGCR mRNA; [Troglitazone binds to and results in increased activity of PPARG protein] which results in increased expression of HMGCS1 mRNA; [Troglitazone binds to and results in increased activity of PPARG protein] which results in increased susceptibility to Arsenic Trioxide; [Troglitazone binds to PPARG protein] which affects the localization of NCOA1 protein; [Troglitazone co-treated with 4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline] results in increased expression of PPARG mRNA; [Troglitazone results in increased activity of PPARG protein] inhibits the reaction [Lipopolysaccharides results in increased expression of HMGB1 mRNA]; [Troglitazone results in increased activity of PPARG protein] inhibits the reaction [Lipopolysaccharides results in increased expression of HMGB1 protein]; [Troglitazone results in increased activity of PPARG protein] which results in decreased expression of HMGB1 mRNA; [Troglitazone results in increased activity of PPARG protein] which results in decreased expression of HMGB1 protein; bisphenol A diglycidyl ether inhibits the reaction [PPARG protein results in increased susceptibility to Troglitazone]; PPARG mutant form inhibits the reaction [Troglitazone results in increased expression of VEGFA protein]; PPARG protein affects the reaction [Troglitazone results in decreased expression of SPP1 mRNA]; PPARG protein affects the reaction [Troglitazone results in increased expression of ICAM1 mRNA]; PPARG protein promotes the reaction [Troglitazone results in decreased expression of FN1 protein]; PPARG protein promotes the reaction [Troglitazone results in increased activity of DIO2 protein]; Pravastatin inhibits the reaction [[Troglitazone binds to and results in increased activity of PPARG protein] which results in increased abundance of Cholesterol]; sulindac sulfide analog inhibits the reaction [Troglitazone binds to PPARG protein]; Troglitazone binds to and results in increased activity of PPARG protein; Troglitazone inhibits the reaction [Arsenic results in decreased expression of PPARG mRNA]; Troglitazone inhibits the reaction [Arsenic results in decreased expression of PPARG protein]; Troglitazone inhibits the reaction [Rosiglitazone binds to and results in increased activity of PPARG protein]; Troglitazone inhibits the reaction [tert-Butylhydroperoxide promotes the reaction [PPARG protein binds to AMOTL2 promoter]]; Troglitazone inhibits the reaction [tert-Butylhydroperoxide promotes the reaction [PPARG protein binds to CCL2 promoter]]; Troglitazone inhibits the reaction [tert-Butylhydroperoxide promotes the reaction [PPARG protein binds to CDKN1C promoter]]; Troglitazone inhibits the reaction [tert-Butylhydroperoxide promotes the reaction [PPARG protein binds to CXCR4 promoter]]; Troglitazone inhibits the reaction [TNF protein results in decreased expression of PPARG mRNA]; Troglitazone promotes the reaction [NCOA1 protein binds to and results in increased activity of PPARG protein]; Troglitazone promotes the reaction [PPARG protein binds to PRODH promoter]; Troglitazone promotes the reaction [PPARG protein results in increased activity of [PPARG protein binds to RXRA protein]]; Troglitazone promotes the reaction [PPARG protein results in increased expression of PRODH mRNA]; Troglitazone results in increased activity of [PPARG protein binds to RXRA protein]; ZNF366 protein promotes the reaction [Troglitazone results in increased activity of [PPARG protein binds to RXRA protein]]
CTD
PMID:9709955 PMID:9836514 PMID:10097144 PMID:10662598 PMID:10871190 PMID:11034103 PMID:11089532 PMID:11113387 PMID:11162573 PMID:11172467 PMID:11318962 PMID:11343236 PMID:11401521 PMID:11426586 PMID:11683414 PMID:11752099 PMID:11779144 PMID:11911853 PMID:11916926 PMID:12044893 PMID:12065695 PMID:12475986 PMID:12732648 PMID:12824901 PMID:14618613 PMID:14634802 PMID:15150131 PMID:15211114 PMID:15345676 PMID:15383218 PMID:15581905 PMID:15618651 PMID:15641079 PMID:15705899 PMID:15729575 PMID:15824748 PMID:15908479 PMID:16149072 PMID:16249460 PMID:16303758 PMID:16368784 PMID:16374840 PMID:16483873 PMID:16513826 PMID:16813520 PMID:16945329 PMID:16946405 PMID:16981146 PMID:17143939 PMID:17409431 PMID:17452443 PMID:18155510 PMID:18162602 PMID:18308446 PMID:18665581 PMID:18704104 PMID:18799549 PMID:19036883 PMID:19122273 PMID:19248225 PMID:19577614 PMID:19682441 PMID:20008677 PMID:20847119 PMID:20860658 PMID:21153920 PMID:21354099 PMID:21515302 PMID:21543282 PMID:21617575 PMID:21877759 PMID:22108328 PMID:22684020 PMID:22710028 PMID:22953781 PMID:23108036 PMID:23277027 PMID:23391484 PMID:23964924 PMID:24481447 PMID:24559133 PMID:25019995 PMID:25596134 PMID:26117538 PMID:27003841 PMID:27551952 PMID:28283887 PMID:28571686 PMID:29421333 PMID:30328325 PMID:32822399 PMID:33049310 More...
NCBI chr 4:150,095,743...150,221,104
Ensembl chr 4:150,095,787...150,221,104
G
Ppargc1a
PPARG coactivator 1 alpha
multiple interactions increases expression decreases response to substance decreases expression increases degradation
ISO EXP
PPARG protein promotes the reaction [troglitazone results in increased expression of PPARGC1A mRNA] PPARGC1A protein results in decreased susceptibility to troglitazone PPARGC1A protein inhibits the reaction [troglitazone results in decreased expression of ATP5F1B mRNA]; PPARGC1A protein inhibits the reaction [troglitazone results in decreased expression of TFAM mRNA] troglitazone results in decreased expression of PPARGC1A protein troglitazone results in increased degradation of PPARGC1A protein
CTD
PMID:14563825 PMID:16513826 PMID:20860658
NCBI chr14:63,073,505...63,729,215
Ensembl chr14:63,273,189...63,729,213
G
Ppcs
phosphopantothenoylcysteine synthetase
increases expression
EXP
Troglitazone results in increased expression of PPCS mRNA; Troglitazone results in increased expression of PPCS protein
CTD
PMID:21315101 PMID:21515302
NCBI chr 5:138,308,394...138,312,047
Ensembl chr 5:138,308,397...138,312,012
G
Ppfia4
PTPRF interacting protein alpha 4
increases expression
ISO
troglitazone results in increased expression of PPFIA4 mRNA
CTD
PMID:28973697
NCBI chr13:48,305,844...48,354,329
Ensembl chr13:48,305,848...48,354,279
G
Ppfibp2
PPFIA binding protein 2
decreases expression
ISO
troglitazone results in decreased expression of PPFIBP2 mRNA
CTD
PMID:28973697
NCBI chr 1:170,916,649...171,062,096
Ensembl chr 1:170,916,649...171,065,618
G
Ppih
peptidylprolyl isomerase H
decreases expression
ISO
troglitazone results in decreased expression of PPIH mRNA
CTD
PMID:19140230
NCBI chr 5:138,191,624...138,209,625
Ensembl chr 5:138,191,624...138,209,580
G
Ppil1
peptidylprolyl isomerase like 1
increases expression
ISO
troglitazone results in increased expression of PPIL1 mRNA
CTD
PMID:28973697
NCBI chr20:7,303,919...7,323,962
Ensembl chr20:7,303,922...7,318,781
G
Ppl
periplakin
increases expression
ISO
troglitazone results in increased expression of PPL mRNA
CTD
PMID:28973697
NCBI chr10:10,957,388...11,003,035
Ensembl chr10:10,957,341...11,003,658
G
Ppm1k
protein phosphatase, Mg2+/Mn2+ dependent, 1K
decreases expression
ISO
troglitazone results in decreased expression of PPM1K mRNA
CTD
PMID:28973697
NCBI chr 4:88,942,226...88,969,139
Ensembl chr 4:88,942,386...88,969,136
G
Ppp1r15a
protein phosphatase 1, regulatory subunit 15A
increases expression decreases expression
ISO
troglitazone results in increased expression of PPP1R15A mRNA troglitazone results in decreased expression of PPP1R15A mRNA
CTD
PMID:19140230 PMID:28973697
NCBI chr 1:105,136,521...105,139,596
Ensembl chr 1:105,136,525...105,139,774
G
Ppp1r15b
protein phosphatase 1, regulatory subunit 15B
decreases expression
ISO
troglitazone results in decreased expression of PPP1R15B mRNA
CTD
PMID:28973697
NCBI chr13:47,130,000...47,137,805
Ensembl chr13:47,129,967...47,137,798
G
Ppp1r1a
protein phosphatase 1, regulatory (inhibitor) subunit 1A
increases expression
ISO
troglitazone results in increased expression of PPP1R1A mRNA
CTD
PMID:28934090
NCBI chr 7:136,533,031...136,540,687
Ensembl chr 7:136,523,604...136,540,683
G
Ppp2r2c
protein phosphatase 2, regulatory subunit B, gamma
decreases expression
ISO
troglitazone results in decreased expression of PPP2R2C mRNA
CTD
PMID:28934090
NCBI chr14:78,071,274...78,156,212
Ensembl chr14:78,071,274...78,156,212
G
Ppp3ca
protein phosphatase 3 catalytic subunit alpha
decreases expression
ISO
troglitazone results in decreased expression of PPP3CA mRNA
CTD
PMID:28973697
NCBI chr 2:227,839,058...228,113,560
Ensembl chr 2:227,839,062...228,113,554
G
Ppp6r3
protein phosphatase 6, regulatory subunit 3
decreases expression
ISO
troglitazone results in decreased expression of PPP6R3 mRNA
CTD
PMID:28973697
NCBI chr 1:210,122,394...210,236,839
Ensembl chr 1:210,122,394...210,236,809
G
Praf2
PRA1 domain family, member 2
decreases expression
ISO
troglitazone results in decreased expression of PRAF2 mRNA
CTD
PMID:28973697
NCBI chr X:17,445,313...17,447,950
Ensembl chr X:17,445,313...17,447,950
G
Prc1
protein regulator of cytokinesis 1
decreases expression
ISO
troglitazone results in decreased expression of PRC1 mRNA
CTD
PMID:19140230
NCBI chr 1:143,659,312...143,681,019
Ensembl chr 1:143,659,481...143,681,012
G
Prdm1
PR/SET domain 1
increases expression
ISO
troglitazone results in increased expression of PRDM1 mRNA
CTD
PMID:19140230
NCBI chr20:49,542,465...49,564,088
Ensembl chr20:49,542,465...49,564,088
G
Prdm2
PR/SET domain 2
decreases expression
ISO
troglitazone results in decreased expression of PRDM2 mRNA
CTD
PMID:28973697
NCBI chr 5:160,704,396...160,815,184
Ensembl chr 5:160,705,462...160,815,140
G
Prdx1
peroxiredoxin 1
decreases expression
ISO
troglitazone results in decreased expression of PRDX1 mRNA
CTD
PMID:19631733
NCBI chr 5:135,383,906...135,399,504
Ensembl chr 5:135,383,906...135,399,504
G
Prdx2
peroxiredoxin 2
decreases expression
ISO
troglitazone results in decreased expression of PRDX2 mRNA
CTD
PMID:19140230
NCBI chr19:40,085,788...40,091,083
Ensembl chr19:40,084,430...40,091,006
G
Prelp
proline and arginine rich end leucine rich repeat protein
decreases expression increases expression
ISO
troglitazone results in decreased expression of PRELP mRNA troglitazone results in increased expression of PRELP mRNA
CTD
PMID:28973697
NCBI chr13:47,920,480...47,943,547
Ensembl chr13:47,922,590...47,932,324
G
Prim1
DNA primase subunit 1
decreases expression
ISO
troglitazone results in decreased expression of PRIM1 mRNA
CTD
PMID:19140230
NCBI chr 7:1,031,436...1,047,134
G
Prkar2b
protein kinase cAMP-dependent type II regulatory subunit beta
decreases expression
EXP
troglitazone results in decreased expression of PRKAR2B mRNA
CTD
PMID:21515302
NCBI chr 6:54,291,143...54,381,639
Ensembl chr 6:54,291,151...54,381,411
G
Prkcb
protein kinase C, beta
increases expression
ISO
troglitazone results in increased expression of PRKCB mRNA
CTD
PMID:28973697
NCBI chr 1:186,263,397...186,594,743
Ensembl chr 1:186,263,447...186,594,740
G
Prkce
protein kinase C, epsilon
decreases expression
ISO
troglitazone results in decreased expression of PRKCE mRNA
CTD
PMID:19140230
NCBI chr 6:13,718,050...14,204,931
Ensembl chr 6:13,718,050...14,204,288
G
Prkcz
protein kinase C, zeta
increases expression
ISO
troglitazone results in increased expression of PRKCZ mRNA
CTD
PMID:28973697
NCBI chr 5:171,101,774...171,212,694
Ensembl chr 5:171,101,774...171,212,674
G
Prkd2
protein kinase D2
decreases expression
ISO
troglitazone results in decreased expression of PRKD2 mRNA
CTD
PMID:28973697
NCBI chr 1:86,640,095...86,670,476
Ensembl chr 1:86,642,629...86,670,675
G
Prkd3
protein kinase D3
decreases expression
ISO
troglitazone results in decreased expression of PRKD3 mRNA
CTD
PMID:28973697
NCBI chr 6:21,784,665...21,860,600
Ensembl chr 6:21,784,673...21,860,600
G
Prlhr
prolactin releasing hormone receptor
decreases expression
EXP
troglitazone results in decreased expression of PRLHR mRNA
CTD
PMID:21515302
NCBI chr 1:269,592,735...269,594,422
Ensembl chr 1:269,585,611...269,594,909
G
Prm2
protamine 2
decreases expression
EXP
troglitazone results in decreased expression of PRM2 mRNA
CTD
PMID:21515302
NCBI chr10:5,383,208...5,383,949
Ensembl chr10:5,379,029...5,384,004
G
Proca1
protein interacting with cyclin A1
increases expression
ISO
troglitazone results in increased expression of PROCA1 mRNA
CTD
PMID:28973697
NCBI chr10:63,588,061...63,601,011
Ensembl chr10:63,588,028...63,601,095
G
Procr
protein C receptor
increases expression
ISO
troglitazone results in increased expression of PROCR mRNA
CTD
PMID:28973697
NCBI chr 3:164,714,727...164,718,994
Ensembl chr 3:164,711,636...164,718,989
G
Prodh1
proline dehydrogenase 1
multiple interactions increases expression decreases expression
ISO
2-chloro-5-nitrobenzanilide inhibits the reaction [troglitazone results in increased expression of PRODH mRNA]; [2-chloro-5-nitrobenzanilide binds to and results in decreased activity of PPARG protein] inhibits the reaction [troglitazone results in increased expression of PRODH]; troglitazone affects the reaction [PRODH protein affects the abundance of Reactive Oxygen Species]; troglitazone promotes the reaction [PPARG protein binds to PRODH promoter]; troglitazone promotes the reaction [PPARG protein results in increased expression of PRODH mRNA]; troglitazone promotes the reaction [TP53 protein results in increased expression of PRODH mRNA]; troglitazone results in increased expression of and results in increased activity of PRODH protein troglitazone results in increased expression of PRODH; troglitazone results in increased expression of PRODH mRNA troglitazone results in decreased expression of PRODH mRNA
CTD
PMID:16303758 PMID:17535976 PMID:22108328 PMID:25572481
NCBI chr11:96,414,275...96,431,604
Ensembl chr11:96,414,224...96,433,418
G
Prom1
prominin 1
decreases expression
EXP ISO
troglitazone results in decreased expression of PROM1 mRNA
CTD
PMID:21515302 PMID:28973697
NCBI chr14:71,202,303...71,307,008
Ensembl chr14:71,202,336...71,307,002
G
Proser1
proline and serine rich 1
decreases expression
ISO
troglitazone results in decreased expression of PROSER1 mRNA
CTD
PMID:28973697
NCBI chr 2:139,692,662...139,712,048
Ensembl chr 2:139,692,662...139,712,048
G
Prox1
prospero homeobox 1
decreases expression
ISO
troglitazone results in decreased expression of PROX1 mRNA
CTD
PMID:28973697
NCBI chr13:104,196,615...104,251,007
Ensembl chr13:104,200,378...104,250,975
G
Prpf39
pre-mRNA processing factor 39
decreases expression
ISO
troglitazone results in decreased expression of PRPF39 mRNA
CTD
PMID:28973697
NCBI chr 6:88,825,227...88,851,342
Ensembl chr 6:88,825,243...88,851,341
G
Prpf4b
pre-mRNA processing factor 4B
decreases expression
ISO
Troglitazone results in decreased expression of PRPF4B mRNA
CTD
PMID:28973697
NCBI chr17:30,190,721...30,230,153
Ensembl chr17:30,193,907...30,225,420
G
Prpf6
pre-mRNA processing factor 6
decreases expression
ISO
troglitazone results in decreased expression of PRPF6 mRNA
CTD
PMID:28973697
NCBI chr 3:189,084,465...189,148,705
Ensembl chr 3:189,081,794...189,152,786
G
Prph
peripherin
increases expression
ISO
troglitazone results in increased expression of PRPH mRNA
CTD
PMID:28973697
NCBI chr 7:132,096,888...132,101,070
Ensembl chr 7:132,097,285...132,101,068
G
Prrc2a
proline-rich coiled-coil 2A
decreases expression
ISO
troglitazone results in decreased expression of PRRC2A mRNA
CTD
PMID:28973697
NCBI chr20:3,660,981...3,686,715
Ensembl chr20:3,663,400...3,678,778
G
Prrc2b
proline-rich coiled-coil 2B
decreases expression
ISO
troglitazone results in decreased expression of PRRC2B mRNA
CTD
PMID:28973697
NCBI chr 3:35,831,017...35,916,854
Ensembl chr 3:35,863,046...35,916,854
G
Prrc2c
proline-rich coiled-coil 2C
decreases expression
ISO
troglitazone results in decreased expression of PRRC2C mRNA
CTD
PMID:28973697
NCBI chr13:77,537,226...77,606,926
Ensembl chr13:77,537,814...77,607,001
G
Prss42
serine protease 42
increases expression
ISO
Troglitazone results in increased expression of PRSS42 mRNA
CTD
PMID:28973697
NCBI chr 8:119,651,173...119,656,372
Ensembl chr 8:119,650,839...119,657,909
G
Psd
pleckstrin and Sec7 domain containing
decreases expression
ISO EXP
troglitazone results in decreased expression of PSD mRNA
CTD
PMID:17569031 PMID:21515302
NCBI chr 1:255,114,703...255,130,151
Ensembl chr 1:255,114,703...255,129,553
G
Ptbp3
polypyrimidine tract binding protein 3
decreases expression
ISO
troglitazone results in decreased expression of PTBP3 mRNA
CTD
PMID:28973697
NCBI chr 5:79,108,376...79,194,533
Ensembl chr 5:79,108,376...79,194,508
G
Ptch1
patched 1
decreases expression
ISO
troglitazone results in decreased expression of PTCH1 mRNA
CTD
PMID:28973697
NCBI chr17:1,548,449...1,613,461
Ensembl chr17:1,548,449...1,613,461
G
Pter
phosphotriesterase related
increases expression
ISO
troglitazone results in increased expression of PTER mRNA
CTD
PMID:28973697
NCBI chr17:80,967,463...81,028,707
Ensembl chr17:80,967,477...81,030,099
G
Ptgs1
prostaglandin-endoperoxide synthase 1
decreases expression
ISO
troglitazone results in decreased expression of PTGS1 mRNA
CTD
PMID:19631733
NCBI chr 3:39,981,419...40,002,993
Ensembl chr 3:39,981,415...40,002,990
G
Ptgs2
prostaglandin-endoperoxide synthase 2
decreases expression increases expression multiple interactions
ISO EXP
troglitazone results in decreased expression of PTGS2 troglitazone results in decreased expression of PTGS2 mRNA; troglitazone results in decreased expression of PTGS2 protein Troglitazone results in increased expression of PTGS2 mRNA; Troglitazone results in increased expression of PTGS2 protein 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [troglitazone results in increased expression of PTGS2 mRNA] troglitazone results in increased expression of PTGS2 mRNA; troglitazone results in increased expression of PTGS2 protein Troglitazone inhibits the reaction [[PAR-1-activating peptide results in increased expression of PTGS2 protein] which results in increased abundance of Dinoprostone]; Troglitazone inhibits the reaction [PAR-1-activating peptide results in increased expression of PTGS2 protein]
CTD
PMID:10866999 PMID:15641079 PMID:15892897 PMID:16374840 PMID:16446079 PMID:16597547 PMID:19140230 PMID:19954759 PMID:32816093 More...
NCBI chr13:64,714,063...64,722,320
Ensembl chr13:64,713,619...64,722,320
G
Ptpn2
protein tyrosine phosphatase, non-receptor type 2
increases expression
ISO
Troglitazone results in increased expression of PTPN2 mRNA
CTD
PMID:31294483
NCBI chr18:63,498,890...63,564,571
Ensembl chr18:63,498,890...63,564,481
G
Ptprb
protein tyrosine phosphatase, receptor type, B
decreases expression
ISO
troglitazone results in decreased expression of PTPRB mRNA
CTD
PMID:28973697
NCBI chr 7:53,816,197...53,920,760
Ensembl chr 7:53,816,097...53,920,760
G
Ptpre
protein tyrosine phosphatase, receptor type, E
decreases expression
ISO
troglitazone results in decreased expression of PTPRE mRNA
CTD
PMID:28973697
NCBI chr 1:199,774,195...199,924,646
Ensembl chr 1:199,774,198...199,922,242
G
Ptprf
protein tyrosine phosphatase, receptor type, F
decreases expression
ISO
troglitazone results in decreased expression of PTPRF mRNA
CTD
PMID:28973697
NCBI chr 5:137,027,376...137,109,405
Ensembl chr 5:137,028,164...137,095,426
G
Ptprg
protein tyrosine phosphatase, receptor type, G
decreases expression
ISO
troglitazone results in decreased expression of PTPRG mRNA
CTD
PMID:28973697
NCBI chr15:15,298,669...15,982,581
Ensembl chr15:15,302,133...15,982,668
G
Ptprk
protein tyrosine phosphatase, receptor type, K
decreases expression
ISO
troglitazone results in decreased expression of PTPRK mRNA
CTD
PMID:28973697
NCBI chr 1:18,557,091...19,056,297
Ensembl chr 1:18,558,365...19,056,107
G
Pttg1
PTTG1 regulator of sister chromatid separation, securin
decreases expression
ISO
troglitazone results in decreased expression of PTTG1 mRNA
CTD
PMID:19140230
NCBI chr10:28,394,940...28,406,410
Ensembl chr10:28,394,814...28,406,309
G
Pum1
pumilio RNA-binding family member 1
decreases expression
ISO
troglitazone results in decreased expression of PUM1 mRNA
CTD
PMID:28973697
NCBI chr 5:148,120,712...148,238,468
Ensembl chr 5:148,121,254...148,238,466
G
Pum2
pumilio RNA-binding family member 2
decreases expression
ISO
troglitazone results in decreased expression of PUM2 mRNA
CTD
PMID:28973697
NCBI chr 6:37,182,130...37,262,223
Ensembl chr 6:37,182,013...37,262,223
G
Pura
purine rich element binding protein A
decreases expression
ISO
troglitazone results in decreased expression of PURA mRNA
CTD
PMID:28973697
NCBI chr18:28,159,103...28,179,539
Ensembl chr18:28,125,126...28,211,111
G
Pwwp2a
PWWP domain containing 2A
decreases expression
ISO
troglitazone results in decreased expression of PWWP2A mRNA
CTD
PMID:28973697
NCBI chr10:28,654,272...28,696,693
Ensembl chr10:28,656,994...28,696,693
G
Pwwp3a
PWWP domain containing 3A, DNA repair factor
decreases expression
ISO
Troglitazone results in decreased expression of PWWP3A mRNA
CTD
PMID:28973697
NCBI chr 7:10,115,865...10,132,696
Ensembl chr 7:10,115,866...10,130,925
G
Pxdn
peroxidasin
decreases expression
ISO
troglitazone results in decreased expression of PXDN mRNA
CTD
PMID:28973697
NCBI chr 6:52,308,347...52,385,943
Ensembl chr 6:52,308,364...52,385,942
G
Pxn
paxillin
decreases expression
ISO
troglitazone results in decreased expression of PXN mRNA
CTD
PMID:28973697
NCBI chr12:46,721,546...46,768,706
Ensembl chr12:46,721,546...46,768,697
G
Pygl
glycogen phosphorylase L
decreases expression
EXP
troglitazone results in decreased expression of PYGL mRNA; troglitazone results in decreased expression of PYGL protein
CTD
PMID:21315101 PMID:21515302
NCBI chr 6:94,433,558...94,476,219
Ensembl chr 6:94,426,346...94,476,269
G
Qki
QKI, KH domain containing RNA binding
decreases expression increases expression
ISO
troglitazone results in decreased expression of QKI mRNA Troglitazone results in increased expression of QKI mRNA
CTD
PMID:12732648 PMID:28973697
NCBI chr 1:52,935,357...53,047,338
Ensembl chr 1:52,935,382...53,047,337
G
Qpct
glutaminyl-peptide cyclotransferase
increases expression
ISO
troglitazone results in increased expression of QPCT mRNA
CTD
PMID:28973697
NCBI chr 6:21,716,824...21,748,895
Ensembl chr 6:21,716,824...21,748,895
G
Qrfpr
pyroglutamylated RFamide peptide receptor
decreases expression
EXP
troglitazone results in decreased expression of QRFPR mRNA
CTD
PMID:21515302
NCBI chr 2:120,981,235...121,025,020
Ensembl chr 2:120,981,235...121,025,020
G
Qser1
glutamine and serine rich 1
decreases expression
ISO
troglitazone results in decreased expression of QSER1 mRNA
CTD
PMID:28973697
NCBI chr 3:111,592,377...111,658,825
Ensembl chr 3:111,595,171...111,657,103
G
Qsox1
quiescin sulfhydryl oxidase 1
increases expression
ISO
troglitazone results in increased expression of QSOX1 mRNA
CTD
PMID:19140230
NCBI chr13:70,500,060...70,537,711
Ensembl chr13:70,500,060...70,537,733
G
Qtrt2
queuine tRNA-ribosyltransferase accessory subunit 2
decreases expression
ISO
troglitazone results in decreased expression of QTRT2 mRNA
CTD
PMID:28973697
NCBI chr11:70,312,352...70,343,139
Ensembl chr11:70,312,378...70,343,128
G
R3hdm1
R3H domain containing 1
decreases expression
ISO
troglitazone results in decreased expression of R3HDM1 mRNA
CTD
PMID:28973697
NCBI chr13:42,148,281...42,286,311
Ensembl chr13:42,148,290...42,286,311
G
Rab11b
RAB11B, member RAS oncogene family
decreases expression
ISO
troglitazone results in decreased expression of RAB11B mRNA
CTD
PMID:28973697
NCBI chr 7:15,223,613...15,236,754
Ensembl chr 7:15,223,534...15,236,756
G
Rab19
RAB19, member RAS oncogene family
decreases expression
EXP
troglitazone results in decreased expression of RAB19 mRNA
CTD
PMID:21515302
NCBI chr 4:69,123,962...69,133,691
Ensembl chr 4:69,123,924...69,134,383
G
Rab22a
RAB22A, member RAS oncogene family
decreases expression
ISO
troglitazone results in decreased expression of RAB22A mRNA
CTD
PMID:28973697
NCBI chr 3:182,877,746...182,924,400
Ensembl chr 3:182,877,998...182,924,400
G
Rab26
RAB26, member RAS oncogene family
decreases expression
ISO
troglitazone results in decreased expression of RAB26 mRNA
CTD
PMID:19140230
NCBI chr10:14,057,942...14,062,602
Ensembl chr10:14,057,942...14,062,577
G
Rab27b
RAB27B, member RAS oncogene family
decreases expression
ISO
troglitazone results in decreased expression of RAB27B mRNA
CTD
PMID:28934090
NCBI chr18:65,870,230...66,069,597
Ensembl chr18:65,876,342...66,067,700
G
Rab2a
RAB2A, member RAS oncogene family
decreases expression
ISO
troglitazone results in decreased expression of RAB2A mRNA
CTD
PMID:28973697
NCBI chr 5:26,473,424...26,537,441
Ensembl chr 5:26,473,548...26,538,488
G
Rab43
RAB43, member RAS oncogene family
decreases expression
ISO
troglitazone results in decreased expression of RAB43 mRNA
CTD
PMID:28973697
NCBI chr 4:121,806,992...121,826,694
Ensembl chr 4:121,806,992...121,854,561
G
Rab6b
RAB6B, member RAS oncogene family
decreases expression
ISO
troglitazone results in decreased expression of RAB6B mRNA
CTD
PMID:28973697
NCBI chr 8:112,574,223...112,642,911
Ensembl chr 8:112,574,167...112,642,907
G
Rad23a
RAD23 homolog A, nucleotide excision repair protein
increases expression
ISO
troglitazone results in increased expression of RAD23A mRNA
CTD
PMID:19631733
NCBI chr19:40,219,235...40,225,543
Ensembl chr19:40,219,636...40,225,543
G
Rad50
RAD50 double strand break repair protein
increases expression decreases expression
ISO
troglitazone results in increased expression of RAD50 mRNA troglitazone results in decreased expression of RAD50 mRNA
CTD
PMID:19631733 PMID:28973697
NCBI chr10:38,310,147...38,362,100
Ensembl chr10:38,310,147...38,362,100
G
Rad51
RAD51 recombinase
decreases expression
ISO
troglitazone results in decreased expression of RAD51 mRNA
CTD
PMID:19140230
NCBI chr 3:126,554,210...126,578,888
Ensembl chr 3:126,554,190...126,579,469
G
Rad51ap1
RAD51 associated protein 1
decreases expression
ISO
troglitazone results in decreased expression of RAD51AP1 mRNA
CTD
PMID:19140230
NCBI chr 4:161,445,610...161,458,661
Ensembl chr 4:161,445,512...161,458,680
G
Rad51c
RAD51 paralog C
decreases expression
ISO
troglitazone results in decreased expression of RAD51C mRNA
CTD
PMID:19140230
NCBI chr10:72,702,299...72,728,980
Ensembl chr10:72,702,299...72,729,143
G
Rad51d
RAD51 paralog D
increases expression
ISO
troglitazone results in increased expression of RAD51D mRNA
CTD
PMID:28973697
NCBI chr10:68,303,350...68,322,002
Ensembl chr10:68,238,273...68,321,902
G
Rad52
RAD52 homolog, DNA repair protein
decreases expression
ISO
troglitazone results in decreased expression of RAD52 mRNA
CTD
PMID:28973697
NCBI chr 4:154,778,320...154,802,002
Ensembl chr 4:154,778,320...154,800,021
G
Rad54l
RAD54 like
decreases expression
ISO
troglitazone results in decreased expression of RAD54L mRNA
CTD
PMID:19140230
NCBI chr 5:134,812,158...134,841,821
Ensembl chr 5:134,811,532...134,841,425
G
Raf1
Raf-1 proto-oncogene, serine/threonine kinase
multiple interactions
ISO
[troglitazone co-treated with Diethylnitrosamine] results in decreased expression of RAF1 mRNA
CTD
PMID:18597072
NCBI chr 4:150,352,158...150,412,813
Ensembl chr 4:150,352,160...150,412,813
G
Rai14
retinoic acid induced 14
decreases expression
ISO
troglitazone results in decreased expression of RAI14 mRNA
CTD
PMID:28973697
NCBI chr 2:61,273,439...61,411,141
Ensembl chr 2:61,273,439...61,409,791
G
Ralgapa2
Ral GTPase activating protein catalytic subunit alpha 2
decreases expression
ISO
troglitazone results in decreased expression of RALGAPA2 mRNA
CTD
PMID:28973697
NCBI chr 3:154,112,005...154,392,070
Ensembl chr 3:154,112,014...154,392,138
G
Ramp3
receptor activity modifying protein 3
decreases expression
ISO
troglitazone results in decreased expression of RAMP3 mRNA
CTD
PMID:28973697
NCBI chr14:85,741,314...85,758,813
Ensembl chr14:85,755,211...85,758,818
G
Ran
RAN, member RAS oncogene family
increases expression
ISO
troglitazone results in increased expression of RAN mRNA
CTD
PMID:28973697
NCBI chr12:33,311,155...33,314,339
Ensembl chr12:33,311,158...33,314,317
G
Ranbp1
RAN binding protein 1
decreases expression
ISO
troglitazone results in decreased expression of RANBP1 mRNA
CTD
PMID:19140230
NCBI chr11:96,246,912...96,255,145
Ensembl chr11:96,246,740...96,255,145
G
Ranbp10
RAN binding protein 10
decreases expression
ISO
troglitazone results in decreased expression of RANBP10 mRNA
CTD
PMID:28973697
NCBI chr19:50,565,924...50,626,720
Ensembl chr19:50,565,924...50,626,886
G
Ranbp2
RAN binding protein 2
multiple interactions
ISO
troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of RANBP2 mRNA]
CTD
PMID:20847119
NCBI chr20:26,984,520...27,036,573
Ensembl chr20:26,985,275...27,036,571
G
Rap1b
RAP1B, member of RAS oncogene family
increases expression
ISO
troglitazone results in increased expression of RAP1B mRNA
CTD
PMID:28973697
NCBI chr 7:55,308,922...55,342,217
Ensembl chr 7:55,308,922...55,342,217
G
Rap1gap
Rap1 GTPase-activating protein
increases expression
ISO
troglitazone results in increased expression of RAP1GAP mRNA
CTD
PMID:25572481
NCBI chr 5:155,157,511...155,222,622
Ensembl chr 5:155,157,558...155,222,622
G
Rara
retinoic acid receptor, alpha
multiple interactions
ISO
[RARA gene mutant form co-treated with NPM1 gene mutant form] affects the susceptibility to troglitazone
CTD
PMID:14508522
NCBI chr10:84,379,780...84,424,371
Ensembl chr10:84,389,622...84,425,160
G
Rarb
retinoic acid receptor, beta
decreases expression
EXP
troglitazone results in decreased expression of RARB mRNA
CTD
PMID:21515302
NCBI chr15:10,837,252...11,482,037
Ensembl chr15:11,131,358...11,482,040
G
Rarres2
retinoic acid receptor responder 2
increases expression
ISO
troglitazone results in increased expression of RARRES2 mRNA
CTD
PMID:28973697
NCBI chr 4:78,853,450...78,856,652
Ensembl chr 4:78,853,453...78,856,457
G
Rasd1
ras related dexamethasone induced 1
increases expression decreases expression
ISO
troglitazone results in increased expression of RASD1 mRNA troglitazone results in decreased expression of RASD1 mRNA
CTD
PMID:12732648 PMID:25572481
NCBI chr10:45,265,975...45,275,279
Ensembl chr10:45,265,979...45,267,710
G
Rasgrp2
RAS guanyl releasing protein 2
increases expression
ISO
troglitazone results in increased expression of RASGRP2 mRNA
CTD
PMID:28973697
NCBI chr 1:213,135,034...213,152,246
Ensembl chr 1:213,136,015...213,151,884
G
Rasgrp3
RAS guanyl releasing protein 3
decreases expression
ISO
troglitazone results in decreased expression of RASGRP3 mRNA
CTD
PMID:28973697
NCBI chr 6:25,647,386...25,745,952
Ensembl chr 6:25,647,386...25,710,591
G
Rasip1
Ras interacting protein 1
increases expression
ISO
troglitazone results in increased expression of RASIP1 mRNA
CTD
PMID:17569031
NCBI chr 1:105,233,599...105,246,028
Ensembl chr 1:105,233,599...105,246,028
G
Rassf2
Ras association domain family member 2
decreases expression
ISO
troglitazone results in decreased expression of RASSF2 mRNA
CTD
PMID:17569031
NCBI chr 3:139,697,187...139,733,402
Ensembl chr 3:139,697,187...139,733,368
G
Rassf5
Ras association domain family member 5
decreases expression
ISO
troglitazone results in decreased expression of RASSF5 mRNA
CTD
PMID:17569031
NCBI chr13:45,189,768...45,255,277
Ensembl chr13:45,189,804...45,255,277
G
Rassf9
Ras association domain family member 9
decreases expression
EXP
troglitazone results in decreased expression of RASSF9 mRNA
CTD
PMID:21515302
NCBI chr 7:39,486,257...39,518,090
Ensembl chr 7:39,409,870...39,519,675
G
Rb1
RB transcriptional corepressor 1
multiple interactions increases expression decreases phosphorylation increases phosphorylation decreases expression
ISO
Aspirin inhibits the reaction [troglitazone results in decreased expression of RB1 protein modified form]; Aspirin promotes the reaction [troglitazone results in increased expression of RB1 protein]; troglitazone inhibits the reaction [Aspirin results in decreased expression of RB1 protein modified form]; troglitazone promotes the reaction [Aspirin results in increased expression of RB1 protein]; troglitazone results in decreased phosphorylation of and results in decreased expression of RB1 protein troglitazone results in decreased phosphorylation of RB1 protein troglitazone results in increased phosphorylation of RB1 protein troglitazone results in decreased expression of RB protein modified form; troglitazone results in decreased expression of RB1 protein modified form troglitazone results in decreased expression of RB1 mRNA
CTD
PMID:11343236 PMID:11741176 PMID:11834241 PMID:12595159 PMID:15729575 PMID:19908241 PMID:28973697 More...
NCBI chr15:54,780,858...54,911,989
Ensembl chr15:54,780,858...54,911,857
G
Rbbp8
RB binding protein 8, endonuclease
increases expression
ISO
troglitazone results in increased expression of RBBP8 mRNA
CTD
PMID:28973697
NCBI chr18:3,198,188...3,263,643
Ensembl chr18:3,197,310...3,263,985
G
Rbfox2
RNA binding fox-1 homolog 2
decreases expression
ISO
troglitazone results in decreased expression of RBFOX2 mRNA
CTD
PMID:28973697
NCBI chr 7:110,691,230...110,934,901
Ensembl chr 7:110,691,230...110,934,987
G
Rbis
ribosomal biogenesis factor
increases expression
ISO
Troglitazone results in increased expression of RBIS mRNA
CTD
PMID:28973697
NCBI chr 2:88,702,599...88,718,587
Ensembl chr 2:88,702,536...88,719,527
G
Rbl1
RB transcriptional corepressor like 1
decreases expression
ISO
troglitazone results in decreased expression of RBL1 mRNA
CTD
PMID:19140230
NCBI chr 3:166,226,187...166,289,862
Ensembl chr 3:166,226,198...166,289,376
G
Rbl2
RB transcriptional corepressor like 2
decreases expression
ISO
troglitazone results in decreased expression of RBL2 mRNA
CTD
PMID:28973697
NCBI chr19:32,049,690...32,096,467
Ensembl chr19:32,049,691...32,096,411
G
Rbm19
RNA binding motif protein 19
decreases expression
ISO
troglitazone results in decreased expression of RBM19 mRNA
CTD
PMID:28973697
NCBI chr12:42,026,277...42,111,530
Ensembl chr12:42,026,278...42,111,530
G
Rbm20
RNA binding motif protein 20
decreases expression
ISO
troglitazone results in decreased expression of RBM20 mRNA
CTD
PMID:28973697
NCBI chr 1:262,671,311...262,912,551
Ensembl chr 1:262,688,978...262,891,364
G
Rbm33
RNA binding motif protein 33
decreases expression
ISO
troglitazone results in decreased expression of RBM33 mRNA
CTD
PMID:28973697
NCBI chr 4:7,714,660...7,825,469
Ensembl chr 4:7,720,180...7,820,882
G
Rbm4
RNA binding motif protein 4
increases expression
ISO
troglitazone results in increased expression of RBM4 mRNA
CTD
PMID:28973697
NCBI chr 1:211,507,845...211,516,907
Ensembl chr 1:211,506,343...211,516,891
G
Rbm6
RNA binding motif protein 6
decreases expression
ISO
troglitazone results in decreased expression of RBM6 mRNA
CTD
PMID:28973697
NCBI chr 8:117,327,607...117,431,397
Ensembl chr 8:117,331,325...117,431,397
G
Rbms1
RNA binding motif, single stranded interacting protein 1
decreases expression
ISO
troglitazone results in decreased expression of RBMS1 mRNA
CTD
PMID:28973697
NCBI chr 3:65,604,475...65,829,072
Ensembl chr 3:65,606,358...65,829,013
G
Rbms3
RNA binding motif, single stranded interacting protein 3
decreases expression
ISO
troglitazone results in decreased expression of RBMS3 mRNA
CTD
PMID:28973697
NCBI chr 8:125,183,311...125,970,239
Ensembl chr 8:125,183,315...126,503,586
G
Rbp7
retinol binding protein 7
increases expression
ISO
troglitazone results in increased expression of RBP7 mRNA
CTD
PMID:28973697
NCBI chr 5:165,169,700...165,177,427
Ensembl chr 5:165,172,785...165,177,399
G
Rbpj
recombination signal binding protein for immunoglobulin kappa J region
decreases expression
ISO
troglitazone results in decreased expression of RBPJ mRNA
CTD
PMID:28973697
NCBI chr14:61,551,366...61,736,220
Ensembl chr14:61,551,366...61,736,307
G
Rcan1
regulator of calcineurin 1
increases expression
ISO
troglitazone results in increased expression of RCAN1 mRNA
CTD
PMID:28973697
NCBI chr11:45,108,123...45,188,065
Ensembl chr11:45,108,124...45,118,236
G
Rcc2
regulator of chromosome condensation 2
decreases expression
ISO
troglitazone results in decreased expression of RCC2 mRNA
CTD
PMID:28973697
NCBI chr 5:158,277,476...158,300,294
Ensembl chr 5:158,277,476...158,300,294
G
Rcor1
REST corepressor 1
decreases expression
ISO
troglitazone results in decreased expression of RCOR1 mRNA
CTD
PMID:28973697
NCBI chr 6:135,890,851...135,967,367
Ensembl chr 6:135,890,851...135,967,367
G
Rcor2
REST corepressor 2
increases expression
EXP
troglitazone results in increased expression of RCOR2 mRNA
CTD
PMID:21515302
NCBI chr 1:213,882,585...213,890,022
Ensembl chr 1:213,878,519...213,890,022
G
Rcor3
REST corepressor 3
decreases expression
ISO
troglitazone results in decreased expression of RCOR3 mRNA
CTD
PMID:28973697
NCBI chr13:106,156,166...106,196,542
Ensembl chr13:106,157,232...106,196,575
G
Recql4
RecQ like helicase 4
decreases expression
ISO
troglitazone results in decreased expression of RECQL4 mRNA
CTD
PMID:19140230
NCBI chr 7:110,304,092...110,311,426
Ensembl chr 7:110,304,094...110,311,258
G
Reep3
receptor accessory protein 3
multiple interactions
ISO
troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of REEP3 mRNA]
CTD
PMID:20847119
NCBI chr20:21,492,695...21,575,138
Ensembl chr20:21,492,721...21,577,521
G
Reep5
receptor accessory protein 5
increases expression
ISO
troglitazone results in increased expression of REEP5 mRNA
CTD
PMID:28973697
NCBI chr18:26,219,528...26,257,505
Ensembl chr18:26,219,530...26,250,660
G
Reg3b
regenerating family member 3 beta
increases expression
EXP
troglitazone results in increased expression of REG3B mRNA
CTD
PMID:11854617
NCBI chr 4:112,419,776...112,423,014
Ensembl chr 4:112,419,776...112,423,014
G
Reg4
regenerating family member 4
decreases expression
EXP
troglitazone results in decreased expression of REG4 mRNA
CTD
PMID:21515302
NCBI chr 2:188,507,684...188,521,990
Ensembl chr 2:188,507,684...188,521,990
G
Rela
RELA proto-oncogene, NF-kB subunit
affects localization multiple interactions decreases activity
ISO
troglitazone affects the localization of RELA protein troglitazone results in decreased activity of [RELA protein binds to NFKB1 protein] troglitazone results in decreased activity of RELA protein
CTD
PMID:15949477 PMID:17425601 PMID:20540935
NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:212,333,035...212,364,817
G
Rell1
RELT-like 1
decreases expression
ISO
troglitazone results in decreased expression of RELL1 mRNA
CTD
PMID:28973697
NCBI chr14:44,672,121...44,732,081
Ensembl chr14:44,672,224...44,732,088
G
Reps1
RALBP1 associated Eps domain containing 1
decreases expression
ISO
troglitazone results in decreased expression of REPS1 mRNA
CTD
PMID:28973697
NCBI chr 1:14,517,589...14,595,404
Ensembl chr 1:14,517,589...14,595,404
G
Rere
arginine-glutamic acid dipeptide repeats
decreases expression
ISO
troglitazone results in decreased expression of RERE mRNA
CTD
PMID:28973697
NCBI chr 5:166,048,770...166,380,559
Ensembl chr 5:166,048,844...166,380,558
G
Rest
RE1-silencing transcription factor
decreases expression
ISO
troglitazone results in decreased expression of REST mRNA
CTD
PMID:28973697
NCBI chr14:31,213,415...31,233,451
Ensembl chr14:31,213,415...31,248,662
G
Retsat
retinol saturase
increases expression
EXP
troglitazone results in increased expression of RETSAT mRNA
CTD
PMID:21515302
NCBI chr 4:106,211,459...106,220,222
Ensembl chr 4:106,211,436...106,229,552
G
Rev1
REV1, DNA directed polymerase
decreases expression
ISO
troglitazone results in decreased expression of REV1 mRNA
CTD
PMID:28973697
NCBI chr 9:47,773,907...47,847,554
Ensembl chr 9:47,773,907...47,847,332
G
Rfc1
replication factor C subunit 1
decreases expression
ISO
troglitazone results in decreased expression of RFC1 mRNA
CTD
PMID:28973697
NCBI chr14:43,319,768...43,395,028
Ensembl chr14:43,319,935...43,395,026
G
Rfc2
replication factor C subunit 2
decreases expression
ISO
troglitazone results in decreased expression of RFC2 mRNA
CTD
PMID:19140230
NCBI chr12:27,756,920...27,770,049
Ensembl chr12:27,756,922...27,770,025
G
Rfc3
replication factor C subunit 3
decreases expression
ISO
troglitazone results in decreased expression of RFC3 mRNA
CTD
PMID:19140230
NCBI chr12:5,836,546...5,847,331
Ensembl chr12:5,836,553...5,847,340
G
Rfc4
replication factor C subunit 4
decreases expression
ISO
troglitazone results in decreased expression of RFC4 mRNA
CTD
PMID:19140230
NCBI chr11:91,254,273...91,268,727
Ensembl chr11:91,254,243...91,268,730
G
Rfc5
replication factor C subunit 5
decreases expression
ISO
troglitazone results in decreased expression of RFC5 mRNA
CTD
PMID:19140230
NCBI chr12:44,868,322...44,877,879
Ensembl chr12:44,862,329...44,878,151
G
RFFL
ring finger and FYVE like domain containing E3 ubiquitin protein ligase
increases expression
ISO
Troglitazone results in increased expression of RAD51D mRNA
CTD
PMID:28973697
G
Rflna
refilin A
decreases expression
ISO
Troglitazone results in decreased expression of RFLNA mRNA
CTD
PMID:28973697
NCBI chr12:37,294,643...37,323,373
Ensembl chr12:37,294,643...37,303,535
G
Rftn1
raftlin lipid raft linker 1
decreases expression
ISO
troglitazone results in decreased expression of RFTN1 mRNA
CTD
PMID:28973697
NCBI chr 9:18,302,143...18,499,819
Ensembl chr 9:18,285,934...18,499,819
G
Rfx1
regulatory factor X1
decreases expression
ISO
troglitazone results in decreased expression of RFX1 mRNA
CTD
PMID:28973697
NCBI chr19:40,966,102...40,996,809
Ensembl chr19:40,966,102...40,996,809
G
Rfx7
regulatory factor X, 7
decreases expression
ISO
troglitazone results in decreased expression of RFX7 mRNA
CTD
PMID:28973697
NCBI chr 8:82,134,747...82,219,898
Ensembl chr 8:82,134,747...82,219,898
G
Rgcc
regulator of cell cycle
decreases expression
ISO
troglitazone results in decreased expression of RGCC mRNA
CTD
PMID:25572481 PMID:28934090
NCBI chr15:61,071,574...61,084,408
Ensembl chr15:61,071,574...61,084,408
G
Rgs16
regulator of G-protein signaling 16
decreases expression
ISO
troglitazone results in decreased expression of RGS16 mRNA
CTD
PMID:28973697
NCBI chr13:68,421,480...68,443,312
Ensembl chr13:68,438,120...68,443,313
G
Rgs2
regulator of G-protein signaling 2
decreases expression
ISO EXP
troglitazone results in decreased expression of RGS2 mRNA
CTD
PMID:12732648 PMID:21515302
NCBI chr13:58,350,063...58,352,666
Ensembl chr13:58,349,163...58,352,697
G
Rgs4
regulator of G-protein signaling 4
decreases expression increases expression
ISO EXP
troglitazone results in decreased expression of RGS4 mRNA troglitazone results in increased expression of RGS4 mRNA
CTD
PMID:19140230 PMID:21515302 PMID:28973697
NCBI chr13:84,469,593...84,475,884
Ensembl chr13:84,469,593...84,475,884
G
Rhob
ras homolog family member B
increases expression decreases expression
ISO
troglitazone results in increased expression of RHOB mRNA troglitazone results in decreased expression of RHOB mRNA
CTD
PMID:19140230 PMID:28973697
NCBI chr 6:37,083,030...37,085,204
Ensembl chr 6:37,075,015...37,112,772
G
Rhof
ras homolog family member F, filopodia associated
increases expression
ISO
troglitazone results in increased expression of RHOF mRNA
CTD
PMID:19140230
NCBI chr12:39,082,413...39,107,528
Ensembl chr12:39,091,979...39,107,528
G
Rictor
RPTOR independent companion of MTOR, complex 2
multiple interactions decreases expression
ISO
[troglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of RICTOR mRNA; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of RICTOR mRNA] troglitazone results in decreased expression of RICTOR mRNA
CTD
PMID:20847119 PMID:28973697
NCBI chr 2:57,539,279...57,631,291
Ensembl chr 2:57,539,311...57,631,288
G
Rif1
replication timing regulatory factor 1
decreases expression
ISO
troglitazone results in decreased expression of RIF1 mRNA
CTD
PMID:28973697
NCBI chr 3:56,963,840...57,017,106
Ensembl chr 3:56,963,854...57,017,106
G
Rinl
Ras and Rab interactor-like
increases expression
ISO
troglitazone results in increased expression of RINL mRNA
CTD
PMID:25572481
NCBI chr 1:93,204,543...93,215,851
Ensembl chr 1:93,204,789...93,215,851
G
Riox1
ribosomal oxygenase 1
multiple interactions decreases expression
ISO
troglitazone inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of RIOX1 mRNA] troglitazone results in decreased expression of RIOX1 mRNA
CTD
PMID:20847119 PMID:28973697
NCBI chr 6:109,310,748...109,313,365
Ensembl chr 6:109,286,568...109,314,355
G
Ripk2
receptor-interacting serine-threonine kinase 2
increases expression
ISO
troglitazone results in increased expression of RIPK2 mRNA
CTD
PMID:19140230
NCBI chr 5:34,428,573...34,459,808
Ensembl chr 5:34,428,573...34,459,663
G
Ripk4
receptor-interacting serine-threonine kinase 4
decreases expression
ISO
troglitazone results in decreased expression of RIPK4 mRNA
CTD
PMID:28973697
NCBI chr11:50,591,926...50,614,169
Ensembl chr11:50,591,936...50,614,169
G
Ripor1
RHO family interacting cell polarization regulator 1
decreases expression
ISO
troglitazone results in decreased expression of RIPOR1 mRNA
CTD
PMID:28973697
NCBI chr19:50,387,447...50,416,323
Ensembl chr19:50,387,523...50,416,319
G
Rlim
ring finger protein, LIM domain interacting
decreases expression
ISO
Troglitazone results in decreased expression of RLIM mRNA
CTD
PMID:28973697
NCBI chr X:73,048,983...73,070,302
Ensembl chr X:73,054,098...73,069,992
G
Rmnd5a
required for meiotic nuclear division 5 homolog A
decreases expression
ISO
troglitazone results in decreased expression of RMND5A mRNA
CTD
PMID:28973697
NCBI chr 4:104,934,160...104,991,088
Ensembl chr 4:104,934,160...104,991,088
G
Rnase1
ribonuclease A family member 1, pancreatic
decreases expression
EXP
Troglitazone results in decreased expression of RNASE1 mRNA
CTD
PMID:21515302
NCBI chr15:26,835,436...26,837,145
Ensembl chr15:26,835,463...26,837,248
G
Rnase3
ribonuclease A family member 3
affects expression
EXP
Troglitazone affects the expression of RNASE3 mRNA
CTD
PMID:21515302
NCBI chr15:26,985,399...26,986,269
Ensembl chr15:26,985,271...26,986,400
G
Rnase4
ribonuclease A family member 4
decreases expression increases expression
ISO
troglitazone results in decreased expression of RNASE4 mRNA troglitazone results in increased expression of RNASE4 mRNA
CTD
PMID:25572481 PMID:28973697
NCBI chr15:26,786,287...26,803,634
Ensembl chr15:26,786,079...26,803,639
G
Rnaseh2a
ribonuclease H2, subunit A
decreases expression
ISO
troglitazone results in decreased expression of RNASEH2A mRNA
CTD
PMID:19140230
NCBI chr19:40,091,206...40,100,904
Ensembl chr19:40,091,210...40,100,899
G
Rnd1
Rho family GTPase 1
decreases expression
EXP
troglitazone results in decreased expression of RND1 mRNA
CTD
PMID:25596134
NCBI chr 7:131,700,321...131,707,392
Ensembl chr 7:131,700,321...131,707,392
G
Rnd3
Rho family GTPase 3
decreases expression
EXP
troglitazone results in decreased expression of RND3 mRNA
CTD
PMID:25596134
NCBI chr 3:55,981,142...55,998,494
Ensembl chr 3:55,980,355...55,998,536
G
Rnf144b
ring finger protein 144B
decreases expression
ISO
troglitazone results in decreased expression of RNF144B mRNA
CTD
PMID:28973697
NCBI chr17:17,637,564...17,786,685
Ensembl chr17:17,639,079...17,769,037
G
Rnf169
ring finger protein 169
decreases expression
ISO
troglitazone results in decreased expression of RNF169 mRNA
CTD
PMID:28973697
NCBI chr 1:163,662,582...163,724,154
Ensembl chr 1:163,666,592...163,723,897
G
Rnf216
ring finger protein 216
decreases expression
ISO
troglitazone results in decreased expression of RNF216 mRNA
CTD
PMID:28973697
NCBI chr12:16,568,327...16,689,868
Ensembl chr12:16,568,347...16,690,989
G
Rnf217
ring finger protein 217
decreases expression
ISO
troglitazone results in decreased expression of RNF217 mRNA
CTD
PMID:28973697
NCBI chr 1:27,835,741...27,927,805
Ensembl chr 1:27,835,148...27,928,044
G
Rnf225
ring finger protein 225
decreases expression
ISO
troglitazone results in decreased expression of RNF225 mRNA
CTD
PMID:28973697
NCBI chr 1:82,615,787...82,618,456
Ensembl chr 1:82,615,787...82,618,456
G
Rnf26
ring finger protein 26
decreases expression
ISO
troglitazone results in decreased expression of RNF26 mRNA
CTD
PMID:28973697
NCBI chr 8:53,351,388...53,353,586
Ensembl chr 8:53,341,487...53,355,777
G
Rnf44
ring finger protein 44
decreases expression
ISO
troglitazone results in decreased expression of RNF44 mRNA
CTD
PMID:28973697
NCBI chr17:9,925,100...9,939,496
Ensembl chr17:9,930,375...9,939,478
G
Rnf6
ring finger protein 6
decreases expression
ISO
troglitazone results in decreased expression of RNF6 mRNA
CTD
PMID:28973697
NCBI chr12:13,929,160...13,940,663
Ensembl chr12:13,931,074...13,940,652
G
Rnmt
RNA (guanine-7-) methyltransferase
decreases expression
ISO
troglitazone results in decreased expression of RNMT mRNA
CTD
PMID:28973697
NCBI chr18:64,156,067...64,179,601
Ensembl chr18:64,156,154...64,179,500
G
Rock1
Rho-associated coiled-coil containing protein kinase 1
increases expression
ISO
troglitazone results in increased expression of ROCK1 mRNA
CTD
PMID:19140230
NCBI chr18:1,387,360...1,509,218
Ensembl chr18:1,387,360...1,509,147
G
Ropn1l
rhophilin associated tail protein 1-like
decreases expression
EXP
troglitazone results in decreased expression of ROPN1L mRNA
CTD
PMID:21515302
NCBI chr 2:84,153,529...84,164,216
Ensembl chr 2:84,153,529...84,164,415
G
Rora
RAR-related orphan receptor A
decreases expression
ISO
troglitazone results in decreased expression of RORA mRNA
CTD
PMID:28973697
NCBI chr 8:78,182,710...78,915,730
Ensembl chr 8:78,182,620...78,915,730
G
Rpa1
replication protein A1
decreases expression
ISO
troglitazone results in decreased expression of RPA1 mRNA
CTD
PMID:19140230
NCBI chr10:60,647,185...60,698,279
Ensembl chr10:60,647,185...60,698,279
G
Rpa2
replication protein A2
decreases expression
ISO
troglitazone results in decreased expression of RPA2 mRNA
CTD
PMID:19140230
NCBI chr 5:150,260,668...150,271,329
Ensembl chr 5:150,260,723...150,271,546
G
Rpa3
replication protein A3
decreases expression
ISO
troglitazone results in decreased expression of RPA3 mRNA
CTD
PMID:19140230
NCBI chr 4:37,270,966...37,273,997
Ensembl chr 4:37,270,966...37,274,183
G
Rpl13a
ribosomal protein L13A
decreases expression increases expression
ISO
troglitazone results in decreased expression of RPL13A mRNA troglitazone results in increased expression of RPL13A mRNA
CTD
PMID:19631733 PMID:28973697
NCBI chr 1:104,746,223...104,748,975
Ensembl chr 1:104,746,223...104,748,914
G
Rpl14
ribosomal protein L14
decreases expression
ISO
troglitazone results in decreased expression of RPL14 mRNA
CTD
PMID:28973697
NCBI chr 8:129,163,620...129,166,745
Ensembl chr 8:129,163,317...129,167,459
G
Rplp0
ribosomal protein lateral stalk subunit P0
decreases phosphorylation
ISO
troglitazone results in decreased phosphorylation of RPLP0 protein
CTD
PMID:16893617
NCBI chr12:46,715,121...46,718,390
Ensembl chr12:46,715,124...46,718,422
G
Rprd1a
regulation of nuclear pre-mRNA domain containing 1A
increases expression
ISO
troglitazone results in increased expression of RPRD1A mRNA
CTD
PMID:28973697
NCBI chr18:16,066,169...16,114,102
Ensembl chr18:16,066,169...16,114,282
G
Rprd1b
regulation of nuclear pre-mRNA domain containing 1B
decreases expression
ISO
troglitazone results in decreased expression of RPRD1B mRNA
CTD
PMID:28973697
NCBI chr 3:167,102,909...167,149,184
Ensembl chr 3:167,102,859...167,206,374
G
Rprd2
regulation of nuclear pre-mRNA domain containing 2
decreases expression
ISO
troglitazone results in decreased expression of RPRD2 mRNA
CTD
PMID:28973697
NCBI chr 2:186,000,375...186,056,943
Ensembl chr 2:186,000,316...186,056,943
G
Rps6kb1
ribosomal protein S6 kinase B1
multiple interactions
ISO
troglitazone results in decreased activity of and results in decreased phosphorylation of RPS6KB1 protein
CTD
PMID:16825603
NCBI chr10:71,817,794...71,865,211
Ensembl chr10:71,815,614...71,865,238
G
Rpusd2
RNA pseudouridine synthase domain containing 2
multiple interactions
ISO
troglitazone inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of RPUSD2 mRNA]
CTD
PMID:20847119
NCBI chr 3:126,471,620...126,476,869
Ensembl chr 3:126,471,579...126,477,180
G
Rragc
Ras-related GTP binding C
increases expression
ISO
troglitazone results in increased expression of RRAGC mRNA
CTD
PMID:19140230
NCBI chr 5:141,433,014...141,452,546
Ensembl chr 5:141,433,040...141,452,548
G
Rrbp1
ribosome binding protein 1
decreases expression
ISO
troglitazone results in decreased expression of RRBP1 mRNA
CTD
PMID:28973697
NCBI chr 3:151,768,386...151,830,255
Ensembl chr 3:151,768,386...151,830,255
G
Rreb1
ras responsive element binding protein 1
increases expression
ISO
troglitazone results in increased expression of RREB1 mRNA
CTD
PMID:28973697
NCBI chr17:27,082,217...27,208,061
Ensembl chr17:27,082,227...27,208,061
G
Rrm1
ribonucleotide reductase catalytic subunit M1
decreases expression
ISO
troglitazone results in decreased expression of RRM1 mRNA
CTD
PMID:19140230
NCBI chr 1:166,235,904...166,260,206
Ensembl chr 1:166,235,900...166,260,944
G
Rrm2
ribonucleotide reductase regulatory subunit M2
decreases expression
ISO
troglitazone results in decreased expression of RRM2 mRNA
CTD
PMID:19140230
NCBI chr 6:47,044,755...47,075,370
Ensembl chr 6:47,067,690...47,075,370
G
Rsbn1
round spermatid basic protein 1
decreases expression
ISO
troglitazone results in decreased expression of RSBN1 mRNA
CTD
PMID:28973697
NCBI chr 2:194,105,058...194,159,142
Ensembl chr 2:194,105,061...194,159,142
G
Rsf1
remodeling and spacing factor 1
decreases expression
ISO
troglitazone results in decreased expression of RSF1 mRNA
CTD
PMID:28973697
NCBI chr 1:161,303,596...161,426,326
Ensembl chr 1:161,303,660...161,420,290
G
Rsph3
radial spoke head 3
increases expression
ISO
troglitazone results in increased expression of RSPH3 mRNA
CTD
PMID:28973697
NCBI chr 1:49,506,988...49,565,740
Ensembl chr 1:49,506,830...49,559,257
G
Rsrc2
arginine and serine rich coiled-coil 2
decreases expression
EXP
troglitazone results in decreased expression of RSRC2 mRNA
CTD
PMID:25596134
NCBI chr12:38,500,709...38,520,715
Ensembl chr12:38,500,770...38,520,707
G
RT1-A2
RT1 class Ia, locus A2
decreases expression
ISO
Troglitazone results in decreased expression of H2-T23 mRNA
CTD
PMID:12732648
NCBI chr20:4,872,720...4,876,425
G
Runx1
RUNX family transcription factor 1
decreases expression increases expression
EXP ISO
troglitazone results in decreased expression of RUNX1 mRNA Troglitazone results in increased expression of RUNX1 mRNA
CTD
PMID:19140230 PMID:21515302
NCBI chr11:45,325,778...45,560,300
Ensembl chr11:45,329,044...45,564,925
G
Runx2
RUNX family transcription factor 2
decreases expression
ISO
troglitazone results in decreased expression of RUNX2 mRNA
CTD
PMID:16813520 PMID:19122273
NCBI chr 9:23,661,278...23,990,248
Ensembl chr 9:23,664,952...23,990,027
G
Rusc2
RUN and SH3 domain containing 2
increases expression
ISO
troglitazone results in increased expression of RUSC2 mRNA
CTD
PMID:28973697
NCBI chr 5:62,424,185...62,471,317
Ensembl chr 5:62,444,665...62,471,314
G
Rxfp2
relaxin family peptide receptor 2
decreases expression
EXP
troglitazone results in decreased expression of RXFP2 mRNA
CTD
PMID:21515302
NCBI chr12:9,961,175...10,023,098
Ensembl chr12:9,961,175...10,023,098
G
Rxra
retinoid X receptor alpha
multiple interactions decreases response to substance increases expression decreases expression
ISO
NCOA1 protein inhibits the reaction [RXRA protein results in decreased susceptibility to troglitazone]; RXRA protein inhibits the reaction [BRD8 protein results in increased susceptibility to troglitazone]; RXRA protein inhibits the reaction [CREBBP protein results in increased susceptibility to troglitazone]; RXRA protein inhibits the reaction [NCOA1 protein results in increased susceptibility to troglitazone]; troglitazone promotes the reaction [PPARG protein results in increased activity of [PPARG protein binds to RXRA protein]]; troglitazone results in increased activity of [PPARG protein binds to RXRA protein]; ZNF366 protein promotes the reaction [troglitazone results in increased activity of [PPARG protein binds to RXRA protein]] troglitazone results in increased expression of RXRA mRNA troglitazone results in decreased expression of RXRA mRNA
CTD
PMID:15581905 PMID:20008677 PMID:24559133 PMID:28973697
NCBI chr 3:31,387,892...31,474,415
Ensembl chr 3:31,388,223...31,474,417
G
S100a1
S100 calcium binding protein A1
decreases expression
EXP
troglitazone results in decreased expression of S100A1 mRNA
CTD
PMID:21515302
NCBI chr 2:178,291,503...178,296,346
Ensembl chr 2:178,291,503...178,296,346
G
S100a10
S100 calcium binding protein A10
increases expression
ISO
troglitazone results in increased expression of S100A10 mRNA
CTD
PMID:28973697
NCBI chr 2:181,904,454...181,913,101
Ensembl chr 2:181,904,261...181,913,103
G
S100a8
S100 calcium binding protein A8
increases expression multiple interactions
ISO
troglitazone results in increased expression of S100A8 mRNA Troglitazone results in increased expression of S100A8 mRNA [Troglitazone co-treated with Buthionine Sulfoximine] results in increased expression of S100A8 mRNA
CTD
PMID:28138970 PMID:31294483
NCBI chr 2:178,464,095...178,465,223
Ensembl chr 2:178,464,702...178,465,221
G
S100a9
S100 calcium binding protein A9
multiple interactions increases expression
ISO
[Troglitazone co-treated with Buthionine Sulfoximine] results in increased expression of S100A9 mRNA Troglitazone results in increased expression of S100A9 mRNA
CTD
PMID:31294483
NCBI chr 2:178,487,941...178,490,622
Ensembl chr 2:178,487,941...178,490,870
G
S1pr3
sphingosine-1-phosphate receptor 3
increases expression decreases expression
ISO
troglitazone results in increased expression of S1PR3 mRNA troglitazone results in decreased expression of S1PR3 mRNA
CTD
PMID:19140230 PMID:28973697
NCBI chr17:13,932,773...13,946,213
Ensembl chr17:13,928,444...13,947,197
G
Saa4
serum amyloid A4
decreases expression
ISO
troglitazone results in decreased expression of SAA4 mRNA
CTD
PMID:25572481
NCBI chr 1:106,383,856...106,388,158
Ensembl chr 1:106,383,856...106,387,354
G
Safb
scaffold attachment factor B
decreases expression
ISO
troglitazone results in decreased expression of SAFB mRNA
CTD
PMID:28973697
NCBI chr 9:1,504,657...1,525,545
Ensembl chr 9:1,504,456...1,525,781
G
Safb2
scaffold attachment factor B2
decreases expression
ISO
troglitazone results in decreased expression of SAFB2 mRNA
CTD
PMID:28973697
NCBI chr 9:1,482,985...1,504,142
Ensembl chr 9:1,479,061...1,504,142
G
Samd8
sterile alpha motif domain containing 8
decreases expression
ISO
troglitazone results in decreased expression of SAMD8 mRNA
CTD
PMID:28973697
NCBI chr15:2,561,435...2,611,702
Ensembl chr15:2,561,435...2,607,052
G
Sap30
Sin3A associated protein 30
decreases expression
ISO
troglitazone results in decreased expression of SAP30 mRNA
CTD
PMID:28973697
NCBI chr16:37,758,494...37,763,825
Ensembl chr16:37,757,656...37,763,823
G
Sardh
sarcosine dehydrogenase
increases expression
ISO
troglitazone results in increased expression of SARDH protein
CTD
PMID:18495193
NCBI chr 3:30,908,621...30,973,409
Ensembl chr 3:30,908,621...30,972,137
G
Sash1
SAM and SH3 domain containing 1
decreases expression
ISO
troglitazone results in decreased expression of SASH1 mRNA
CTD
PMID:28973697
NCBI chr 1:4,940,207...5,238,777
Ensembl chr 1:4,940,207...5,238,530
G
Sat1
spermidine/spermine N1-acetyl transferase 1
increases expression
EXP
troglitazone results in increased expression of SAT1 mRNA
CTD
PMID:25596134
NCBI chr X:44,008,089...44,011,376
Ensembl chr X:44,006,781...44,011,374
G
Sbno1
strawberry notch homolog 1
decreases expression
ISO
troglitazone results in decreased expression of SBNO1 mRNA
CTD
PMID:28973697
NCBI chr12:37,835,306...37,895,861
Ensembl chr12:37,846,514...37,891,231
G
Scaf11
SR-related CTD-associated factor 11
decreases expression
ISO
troglitazone results in decreased expression of SCAF11 mRNA
CTD
PMID:28973697
NCBI chr 7:129,450,872...129,503,280
Ensembl chr 7:129,417,955...129,503,280
G
Scaf8
SR-related CTD-associated factor 8
decreases expression
ISO
troglitazone results in decreased expression of SCAF8 mRNA
CTD
PMID:28973697
NCBI chr 1:46,132,972...46,321,162
Ensembl chr 1:46,132,873...46,261,174
G
Scaper
S-phase cyclin A-associated protein in the ER
decreases expression
ISO
troglitazone results in decreased expression of SCAPER mRNA
CTD
PMID:28973697
NCBI chr 8:64,828,789...65,228,240
Ensembl chr 8:64,828,789...65,228,453
G
Scara3
scavenger receptor class A, member 3
increases expression
ISO
troglitazone results in increased expression of SCARA3 mRNA
CTD
PMID:28973697
NCBI chr15:44,315,422...44,348,416
Ensembl chr15:44,315,422...44,348,551
G
Scarb1
scavenger receptor class B, member 1
increases expression
ISO
troglitazone results in increased expression of SCARB1 mRNA
CTD
PMID:12732648 PMID:28973697
NCBI chr12:36,957,302...37,023,982
Ensembl chr12:36,957,496...37,023,980
G
Scd
stearoyl-CoA desaturase
decreases expression increases expression
ISO EXP
troglitazone results in decreased expression of SCD1 mRNA troglitazone results in increased expression of SCD mRNA
CTD
PMID:12372423 PMID:12732648 PMID:12953171 PMID:15763435
NCBI chr 1:253,218,968...253,232,101
Ensembl chr 1:253,218,970...253,231,785
G
Scd2
stearoyl-Coenzyme A desaturase 2
increases expression
ISO
troglitazone results in increased expression of SCD mRNA
CTD
PMID:28973697
NCBI chr 1:253,118,377...253,131,436
Ensembl chr 1:253,117,655...253,128,874
G
Scgn
secretagogin, EF-hand calcium binding protein
increases expression
ISO
troglitazone results in increased expression of SCGN mRNA
CTD
PMID:28934090
NCBI chr17:41,534,558...41,576,525
Ensembl chr17:41,534,497...41,576,522
G
Scly
selenocysteine lyase
increases expression
EXP
troglitazone results in increased expression of SCLY protein
CTD
PMID:21315101
NCBI chr 9:99,337,796...99,358,487
Ensembl chr 9:99,327,873...99,358,487
G
Scn3a
sodium voltage-gated channel alpha subunit 3
decreases expression
EXP
troglitazone results in decreased expression of SCN3A mRNA
CTD
PMID:21515302
NCBI chr 3:70,554,496...70,666,198
Ensembl chr 3:70,556,224...70,666,198
G
Scn4a
sodium voltage-gated channel alpha subunit 4
increases expression
ISO
troglitazone results in increased expression of SCN4A mRNA
CTD
PMID:28934090
NCBI chr10:91,745,459...91,796,452
Ensembl chr10:91,746,715...91,796,324
G
Scrg1
stimulator of chondrogenesis 1
affects expression
EXP
troglitazone affects the expression of SCRG1 mRNA
CTD
PMID:21515302
NCBI chr16:37,770,739...37,799,010
Ensembl chr16:37,770,739...37,799,010
G
Scyl3
SCY1 like pseudokinase 3
decreases expression
ISO
troglitazone results in decreased expression of SCYL3 mRNA
CTD
PMID:28973697
NCBI chr13:78,811,595...78,836,202
Ensembl chr13:78,811,741...78,836,204
G
Sdc4
syndecan 4
decreases expression
ISO
troglitazone results in decreased expression of SDC4 mRNA
CTD
PMID:28973697
NCBI chr 3:173,574,239...173,592,923
Ensembl chr 3:173,574,239...173,593,670
G
Sde2
SDE2 telomere maintenance homolog
decreases expression
ISO
troglitazone results in decreased expression of SDE2 mRNA
CTD
PMID:28973697
NCBI chr13:95,110,598...95,126,929
Ensembl chr13:95,110,698...95,126,927
G
Sdf2l1
stromal cell-derived factor 2-like 1
increases expression
EXP ISO
troglitazone results in increased expression of SDF2L1 mRNA
CTD
PMID:25596134 PMID:28973697
NCBI chr11:97,376,878...97,379,120
Ensembl chr11:97,376,878...97,379,120
G
Sdha
succinate dehydrogenase complex flavoprotein subunit A
increases expression
EXP
troglitazone results in increased expression of SDHA protein
CTD
PMID:21315101
NCBI chr 1:30,764,553...30,789,523
Ensembl chr 1:30,764,590...30,790,121
G
Sdk2
sidekick cell adhesion molecule 2
increases expression
ISO
troglitazone results in increased expression of SDK2 mRNA
CTD
PMID:28973697
NCBI chr10:99,324,047...99,601,683
Ensembl chr10:99,324,047...99,601,683
G
Sec24a
SEC24 homolog A, COPII coat complex component
decreases expression
ISO
troglitazone results in decreased expression of SEC24A mRNA
CTD
PMID:28973697
NCBI chr10:36,450,043...36,525,303
Ensembl chr10:36,450,043...36,525,303
G
Sec24b
SEC24 homolog B, COPII coat complex component
decreases expression
ISO
troglitazone results in decreased expression of SEC24B mRNA
CTD
PMID:28973697
NCBI chr 2:221,236,897...221,306,986
Ensembl chr 2:221,236,898...221,306,919
G
Sec61a1
SEC61 translocon subunit alpha 1
increases expression
ISO
troglitazone results in increased expression of SEC61A1 mRNA
CTD
PMID:28973697
NCBI chr 4:122,530,785...122,545,141
Ensembl chr 4:122,530,789...122,545,141
G
Selenbp1
selenium binding protein 1
decreases expression
ISO
Troglitazone results in decreased expression of SELENBP1 mRNA
CTD
PMID:12732648
NCBI chr 2:185,183,022...185,193,612
Ensembl chr 2:185,183,004...185,194,295
G
Selenoi
selenoprotein I
decreases expression
ISO
troglitazone results in decreased expression of SELENOI mRNA
CTD
PMID:28973697
NCBI chr 6:31,792,972...31,831,170
Ensembl chr 6:31,792,973...31,831,523
G
Sema3c
semaphorin 3C
increases expression
ISO
troglitazone results in increased expression of SEMA3C mRNA
CTD
PMID:19140230
NCBI chr 4:18,538,452...18,702,453
Ensembl chr 4:18,538,454...18,701,740
G
Sema4a
semaphorin 4A
decreases expression
EXP
troglitazone results in decreased expression of SEMA4A mRNA
CTD
PMID:21515302
NCBI chr 2:176,194,248...176,215,752
Ensembl chr 2:176,194,255...176,212,258
G
Sema6b
semaphorin 6B
decreases expression multiple interactions
ISO
troglitazone results in decreased expression of SEMA6B mRNA; troglitazone results in decreased expression of SEMA6B protein alitretinoin promotes the reaction [troglitazone results in decreased expression of SEMA6B mRNA]; alitretinoin promotes the reaction [troglitazone results in decreased expression of SEMA6B protein]
CTD
PMID:16525649
NCBI chr 9:1,038,103...1,055,063
Ensembl chr 9:1,038,103...1,048,868
G
Sema7a
semaphorin 7A (John Milton Hagen blood group)
decreases expression
ISO
troglitazone results in decreased expression of SEMA7A mRNA
CTD
PMID:28973697
NCBI chr 8:67,244,318...67,267,060
Ensembl chr 8:67,243,824...67,267,058
G
Senp7
SUMO specific peptidase 7
decreases expression
ISO
troglitazone results in decreased expression of SENP7 mRNA
CTD
PMID:28973697
NCBI chr11:57,892,801...58,053,213
Ensembl chr11:57,787,914...58,033,766
G
Septin11
septin 11
increases expression
ISO
Troglitazone results in increased expression of SEPTIN11 mRNA
CTD
PMID:28973697
NCBI chr14:15,119,760...15,275,222
Ensembl chr14:15,128,951...15,275,200
G
Septin6
septin 6
decreases expression
ISO
Troglitazone results in decreased expression of SEPTIN6 mRNA
CTD
PMID:17569031
NCBI chr X:121,018,951...121,157,677
Ensembl chr X:121,018,944...121,095,792
G
Serbp1
Serpine1 mRNA binding protein 1
decreases expression
ISO
troglitazone results in decreased expression of SERBP1 mRNA
CTD
PMID:28973697
NCBI chr 4:97,731,200...97,748,438
Ensembl chr 4:97,731,277...97,751,518
G
Serinc2
serine incorporator 2
decreases expression
EXP
troglitazone results in decreased expression of SERINC2 mRNA
CTD
PMID:21515302
NCBI chr 5:147,876,477...147,898,797
Ensembl chr 5:147,876,477...147,902,765
G
Serinc3
serine incorporator 3
decreases expression
ISO
troglitazone results in decreased expression of SERINC3 mRNA
CTD
PMID:17569031
NCBI chr 3:172,721,208...172,749,853
Ensembl chr 3:172,721,321...172,740,765
G
Serpina12
serpin family A member 12
decreases expression
ISO
troglitazone results in decreased expression of SERPINA12 mRNA
CTD
PMID:28973697
NCBI chr 6:128,717,334...128,732,049
Ensembl chr 6:128,717,334...128,732,049
G
Serpina4
serpin family A member 4
decreases expression
ISO
troglitazone results in decreased expression of SERPINA4 mRNA
CTD
PMID:25572481
NCBI chr 6:128,764,738...128,773,858
Ensembl chr 6:128,764,769...128,776,028
G
Serpina9
serpin family A member 9
decreases expression
ISO
troglitazone results in decreased expression of SERPINA9 mRNA
CTD
PMID:28973697
NCBI chr 6:128,683,650...128,700,784
Ensembl chr 6:128,683,664...128,700,784
G
Serpinb1a
serpin family B member 1A
increases expression
ISO
troglitazone results in increased expression of SERPINB1 mRNA
CTD
PMID:28973697
NCBI chr17:31,799,446...31,807,853
Ensembl chr17:31,799,415...31,808,166
G
Serpinb5
serpin family B member 5
increases expression
EXP
troglitazone results in increased expression of SERPINB5 mRNA
CTD
PMID:21515302
NCBI chr13:23,500,203...23,520,401
Ensembl chr13:23,500,198...23,520,400
G
Serpind1
serpin family D member 1
decreases expression
ISO
troglitazone results in decreased expression of SERPIND1 mRNA
CTD
PMID:28973697
NCBI chr11:97,168,753...97,179,830
Ensembl chr11:97,168,754...97,179,755
G
Serpine1
serpin family E member 1
multiple interactions decreases expression decreases secretion increases expression
ISO EXP
Genistein promotes the reaction [Troglitazone inhibits the reaction [TNF protein results in increased secretion of SERPINE1 protein]]; Troglitazone inhibits the reaction [TNF protein results in increased expression of SERPINE1 mRNA]; Troglitazone inhibits the reaction [TNF protein results in increased secretion of SERPINE1 protein]; Troglitazone promotes the reaction [[Oleic Acid co-treated with INS protein] results in increased expression of SERPINE1 mRNA]; Troglitazone promotes the reaction [[Oleic Acid co-treated with INS protein] results in increased expression of SERPINE1 protein] [troglitazone binds to and results in increased activity of PPARG mRNA] which results in decreased expression of SERPINE1 mRNA; [troglitazone binds to and results in increased activity of PPARG mRNA] which results in decreased expression of SERPINE1 protein; [troglitazone binds to and results in increased activity of TGFB1 mRNA] which results in decreased expression of SERPINE1 mRNA; [troglitazone co-treated with [Hydrochlorothiazide co-treated with Hydralazine co-treated with Reserpine]] results in decreased expression of SERPINE1 mRNA; [troglitazone co-treated with [Hydrochlorothiazide co-treated with Hydralazine co-treated with Reserpine]] results in decreased expression of SERPINE1 protein troglitazone results in decreased expression of SERPINE1 mRNA; troglitazone results in decreased expression of SERPINE1 protein troglitazone results in decreased secretion of SERPINE1 protein troglitazone results in increased expression of SERPINE1 mRNA
CTD
PMID:10768100 PMID:11292061 PMID:11318962 PMID:14534369 PMID:19140230 PMID:19631733 PMID:21515302 More...
NCBI chr12:25,237,977...25,248,356
Ensembl chr12:25,237,952...25,248,357
G
Serpine2
serpin family E member 2
increases expression
ISO EXP
troglitazone results in increased expression of SERPINE2 mRNA
CTD
PMID:19140230 PMID:21515302
NCBI chr 9:88,573,138...88,637,252
Ensembl chr 9:88,573,149...88,637,202
G
Serpinf1
serpin family F member 1
decreases expression increases expression
ISO
troglitazone results in decreased expression of SERPINF1 mRNA troglitazone results in increased expression of SERPINF1 mRNA
CTD
PMID:25572481 PMID:28973697
NCBI chr10:60,748,504...60,760,898
Ensembl chr10:60,748,506...60,760,898
G
Serpinf2
serpin family F member 2
decreases expression
ISO
troglitazone results in decreased expression of SERPINF2 mRNA
CTD
PMID:25572481
NCBI chr10:60,770,698...60,778,782
Ensembl chr10:60,770,698...60,778,996
G
Serping1
serpin family G member 1
increases expression
ISO
troglitazone results in increased expression of SERPING1 mRNA
CTD
PMID:28973697
NCBI chr 3:90,249,410...90,259,299
Ensembl chr 3:90,249,423...90,258,717
G
Sertad1
SERTA domain containing 1
increases expression
ISO
troglitazone results in increased expression of SERTAD1 mRNA
CTD
PMID:28973697
NCBI chr 1:91,903,297...91,906,565
Ensembl chr 1:91,891,814...91,907,001
G
Sesn1
sestrin 1
decreases expression
ISO EXP
troglitazone results in decreased expression of SESN1 mRNA
CTD
PMID:17569031 PMID:25596134 PMID:28973697
NCBI chr20:46,876,918...46,970,010
Ensembl chr20:46,876,895...46,970,010
G
Sesn2
sestrin 2
increases expression
ISO
troglitazone results in increased expression of SESN2 mRNA
CTD
PMID:19140230
NCBI chr 5:149,986,304...150,005,255
Ensembl chr 5:149,986,317...150,005,255
G
Sesn3
sestrin 3
decreases expression
ISO
troglitazone results in decreased expression of SESN3 mRNA
CTD
PMID:17569031
NCBI chr 8:19,415,307...19,470,943
Ensembl chr 8:19,415,347...19,466,904
G
Setd1b
SET domain containing 1B, histone lysine methyltransferase
decreases expression
ISO
troglitazone results in decreased expression of SETD1B mRNA
CTD
PMID:28973697
NCBI chr12:39,056,809...39,082,399
Ensembl chr12:39,058,262...39,082,566
G
Setdb2
SET domain bifurcated histone lysine methyltransferase 2
decreases expression
ISO
troglitazone results in decreased expression of SETDB2 mRNA
CTD
PMID:28973697
NCBI chr15:37,731,029...37,782,790
Ensembl chr15:37,664,556...37,780,138
G
Sf1
splicing factor 1
decreases expression
ISO
troglitazone results in decreased expression of SF1 mRNA
CTD
PMID:28973697
NCBI chr 1:213,090,256...213,112,688
Ensembl chr 1:213,099,260...213,113,590
G
Sf3a2
splicing factor 3A subunit 2
decreases expression
ISO
troglitazone results in decreased expression of SF3A2 mRNA
CTD
PMID:28973697
NCBI chr 7:9,560,182...9,566,205
Ensembl chr 7:9,560,182...9,566,205
G
Sf3b1
splicing factor 3b, subunit 1
decreases expression
ISO
troglitazone results in decreased expression of SF3B1 mRNA
CTD
PMID:28973697
NCBI chr 9:63,986,829...64,026,723
Ensembl chr 9:63,986,829...64,026,719
G
Sf3b2
splicing factor 3b, subunit 2
decreases expression
ISO
troglitazone results in decreased expression of SF3B2 mRNA
CTD
PMID:28973697
NCBI chr 1:211,999,777...212,040,686
Ensembl chr 1:211,999,778...212,020,113
G
Sfmbt1
Scm-like with four mbt domains 1
decreases expression
ISO
troglitazone results in decreased expression of SFMBT1 mRNA
CTD
PMID:28973697
NCBI chr16:5,896,686...6,016,311
Ensembl chr16:5,897,187...6,011,934
G
Sfrp2
secreted frizzled-related protein 2
increases expression
ISO
troglitazone results in increased expression of SFRP2 mRNA
CTD
PMID:28973697
NCBI chr 2:171,387,536...171,395,081
Ensembl chr 2:171,387,385...171,395,079
G
Sftpa1
surfactant protein A1
multiple interactions
EXP
2-chloro-5-nitrobenzanilide inhibits the reaction [[troglitazone results in increased activity of PPARG protein] which results in increased expression of SFTPA1 mRNA]; [troglitazone results in increased activity of PPARG protein] which results in increased expression of SFTPA1 mRNA
CTD
PMID:21153920
NCBI chr16:17,042,264...17,045,770
Ensembl chr16:17,042,255...17,045,769
G
Sgcg
sarcoglycan, gamma
decreases expression
EXP
troglitazone results in decreased expression of SGCG mRNA
CTD
PMID:21515302
NCBI chr15:39,564,920...39,611,149
Ensembl chr15:39,564,923...39,611,149
G
Sgk1
serum/glucocorticoid regulated kinase 1
increases expression
ISO
troglitazone results in increased expression of SGK1 mRNA
CTD
PMID:28973697
NCBI chr 1:24,799,391...24,916,886
Ensembl chr 1:24,799,396...24,807,231
G
Sgk2
serum/glucocorticoid regulated kinase 2
increases expression
EXP ISO
troglitazone results in increased expression of SGK2 mRNA
CTD
PMID:21515302 PMID:25572481 PMID:28973697
NCBI chr 3:172,063,625...172,089,000
Ensembl chr 3:172,063,776...172,089,011
G
Sgo1
shugoshin 1
decreases expression
ISO
troglitazone results in decreased expression of SGO1 mRNA
CTD
PMID:19140230
NCBI chr 9:6,908,661...6,943,483
Ensembl chr 9:6,908,661...6,924,415
G
Sgo2
shugoshin 2
decreases expression
ISO
troglitazone results in decreased expression of SGO2 mRNA
CTD
PMID:19140230
NCBI chr 9:67,032,083...67,067,439
Ensembl chr 9:67,042,833...67,068,152
G
Sgpl1
sphingosine-1-phosphate lyase 1
decreases expression
ISO
troglitazone results in decreased expression of SGPL1 mRNA
CTD
PMID:28973697
NCBI chr20:29,590,652...29,637,064
Ensembl chr20:29,592,721...29,667,753
G
Sh2d4a
SH2 domain containing 4A
decreases expression
ISO
troglitazone results in decreased expression of SH2D4A mRNA
CTD
PMID:28973697
NCBI chr16:26,106,721...26,176,069
Ensembl chr16:26,106,730...26,175,974
G
Sh3bp5
SH3-domain binding protein 5
decreases expression
ISO
troglitazone results in decreased expression of SH3BP5 mRNA
CTD
PMID:28973697
NCBI chr16:6,589,877...6,676,524
Ensembl chr16:6,589,877...6,655,211
G
Sh3d19
SH3 domain containing 19
decreases expression
ISO
troglitazone results in decreased expression of SH3D19 mRNA
CTD
PMID:28973697
NCBI chr 2:173,654,234...173,814,030
Ensembl chr 2:173,654,420...173,814,025
G
Sh3pxd2a
SH3 and PX domains 2A
increases expression
ISO
troglitazone results in increased expression of SH3PXD2A mRNA
CTD
PMID:28973697
NCBI chr 1:256,094,991...256,301,120
Ensembl chr 1:256,094,991...256,300,967
G
Sh3rf1
SH3 domain containing ring finger 1
decreases expression
ISO
troglitazone results in decreased expression of SH3RF1 mRNA
CTD
PMID:28973697
NCBI chr16:33,746,396...33,912,127
Ensembl chr16:33,746,396...33,912,153
G
Shisa5
shisa family member 5
decreases expression
ISO
troglitazone results in decreased expression of SHISA5 mRNA
CTD
PMID:17569031
NCBI chr 8:118,569,975...118,584,880
Ensembl chr 8:118,569,975...118,584,880
G
Shmt1
serine hydroxymethyltransferase 1
increases expression
ISO
troglitazone results in increased expression of SHMT1 mRNA
CTD
PMID:28973697
NCBI chr10:45,968,959...45,990,341
Ensembl chr10:45,960,434...45,997,326
G
Shprh
SNF2 histone linker PHD RING helicase
decreases expression
ISO
troglitazone results in decreased expression of SHPRH mRNA
CTD
PMID:28973697
NCBI chr 1:7,349,073...7,422,804
Ensembl chr 1:7,320,395...7,422,794
G
Shroom1
shroom family member 1
decreases expression
ISO
troglitazone results in decreased expression of SHROOM1 mRNA
CTD
PMID:28973697
NCBI chr10:38,121,971...38,134,832
Ensembl chr10:38,122,500...38,132,435
G
Shroom2
shroom family member 2
decreases expression
ISO
troglitazone results in decreased expression of SHROOM2 mRNA
CTD
PMID:28973697
NCBI chr X:25,308,163...25,480,194
Ensembl chr X:25,308,163...25,479,385
G
Shroom4
shroom family member 4
decreases expression
ISO
troglitazone results in decreased expression of SHROOM4 mRNA
CTD
PMID:28973697
NCBI chr X:18,537,371...18,748,665
Ensembl chr X:18,540,913...18,748,700
G
Siah2
siah E3 ubiquitin protein ligase 2
decreases expression
ISO
troglitazone results in decreased expression of SIAH2 mRNA
CTD
PMID:28973697
NCBI chr 2:145,063,847...145,081,675
Ensembl chr 2:145,063,857...145,081,873
G
Sik1
salt-inducible kinase 1
decreases expression
ISO
troglitazone results in decreased expression of SIK1 mRNA
CTD
PMID:28973697
NCBI chr20:9,947,104...9,958,729
Ensembl chr20:9,947,105...9,958,698
G
Sik3
SIK family kinase 3
decreases expression
ISO
troglitazone results in decreased expression of SIK3 mRNA
CTD
PMID:28973697
NCBI chr 8:55,208,969...55,419,138
Ensembl chr 8:55,208,815...55,419,138
G
Sike1
suppressor of IKBKE 1
decreases expression
ISO
troglitazone results in decreased expression of SIKE1 mRNA
CTD
PMID:28973697
NCBI chr 2:193,206,490...193,214,321
Ensembl chr 2:193,206,490...193,217,004
G
Simc1
SUMO-interacting motifs containing 1
decreases expression
ISO
troglitazone results in decreased expression of SIMC1 mRNA
CTD
PMID:28973697
NCBI chr17:10,066,855...10,112,010
Ensembl chr17:10,066,855...10,120,237
G
Sin3a
SIN3 transcription regulator family member A
decreases expression
ISO
troglitazone results in decreased expression of SIN3A mRNA
CTD
PMID:28973697
NCBI chr 8:66,377,471...66,432,150
Ensembl chr 8:66,381,657...66,434,542
G
Sipa1l1
signal-induced proliferation-associated 1 like 1
decreases expression
ISO
troglitazone results in decreased expression of SIPA1L1 mRNA
CTD
PMID:28973697
NCBI chr 6:107,570,569...107,849,613
Ensembl chr 6:107,737,392...107,848,160
G
Sipa1l2
signal-induced proliferation-associated 1 like 2
decreases expression
ISO
troglitazone results in decreased expression of SIPA1L2 mRNA
CTD
PMID:28973697
NCBI chr19:70,287,134...70,437,810
Ensembl chr19:70,287,147...70,437,773
G
Sirpa
signal-regulatory protein alpha
decreases expression
EXP
troglitazone results in decreased expression of SIRPA mRNA
CTD
PMID:21515302
NCBI chr 3:137,272,932...137,311,279
Ensembl chr 3:137,273,042...137,311,279
G
Six1
SIX homeobox 1
decreases expression
ISO
troglitazone results in decreased expression of SIX1 mRNA
CTD
PMID:28973697
NCBI chr 6:97,482,617...97,487,853
Ensembl chr 6:97,482,617...97,487,853
G
Skic2
SKI2 subunit of superkiller complex
decreases expression
ISO
Troglitazone results in decreased expression of SKIC2 mRNA
CTD
PMID:28973697
NCBI chr20:3,987,130...3,997,887
Ensembl chr20:3,987,058...3,997,857
G
Skp2
S-phase kinase associated protein 2
decreases response to substance decreases expression
ISO
SKP2 protein results in decreased susceptibility to troglitazone troglitazone results in decreased expression of SKP2 mRNA; troglitazone results in decreased expression of SKP2 protein
CTD
PMID:12717389 PMID:14618613 PMID:19140230
NCBI chr 2:59,888,406...59,916,471
Ensembl chr 2:59,888,413...59,916,438
G
Slain1
SLAIN motif family, member 1
decreases expression
EXP
troglitazone results in decreased expression of SLAIN1 mRNA
CTD
PMID:21515302
NCBI chr15:86,897,476...86,957,113
Ensembl chr15:86,897,476...86,957,113
G
Slbp
stem-loop histone mRNA binding protein
decreases expression
ISO
troglitazone results in decreased expression of SLBP mRNA
CTD
PMID:19140230
NCBI chr14:81,295,479...81,306,446
Ensembl chr14:81,296,223...81,306,447
G
Slc10a1
solute carrier family 10 member 1
decreases expression multiple interactions
ISO
troglitazone results in decreased expression of SLC10A1 mRNA Troglitazone inhibits the reaction [SLC10A1 protein results in increased uptake of Dehydroepiandrosterone Sulfate]; Troglitazone inhibits the reaction [SLC10A1 protein results in increased uptake of Taurocholic Acid]; Troglitazone inhibits the reaction [SLC10A1 protein results in increased uptake of Taurolithocholic Acid]
CTD
PMID:25572481 PMID:34079822
NCBI chr 6:106,344,319...106,357,944
Ensembl chr 6:106,344,319...106,357,944
G
Slc10a2
solute carrier family 10 member 2
decreases expression increases expression multiple interactions
EXP ISO
troglitazone results in decreased expression of SLC10A2 mRNA troglitazone results in increased expression of SLC10A2 mRNA Troglitazone inhibits the reaction [SLC10A2 protein results in increased uptake of Taurocholic Acid]; Troglitazone inhibits the reaction [SLC10A2 protein results in increased uptake of Taurolithocholic Acid]
CTD
PMID:21515302 PMID:28973697 PMID:34079822
NCBI chr16:91,088,089...91,111,025
Ensembl chr16:91,076,423...91,111,025
G
Slc10a6
solute carrier family 10 member 6
multiple interactions
ISO
Troglitazone inhibits the reaction [SLC10A6 protein results in increased uptake of Dehydroepiandrosterone Sulfate]; Troglitazone inhibits the reaction [SLC10A6 protein results in increased uptake of Taurolithocholic Acid]
CTD
PMID:34079822
NCBI chr14:6,385,348...6,407,532
Ensembl chr14:6,385,537...6,408,894
G
Slc12a1
solute carrier family 12 member 1
decreases expression
EXP
troglitazone results in decreased expression of SLC12A1 mRNA
CTD
PMID:21515302
NCBI chr 3:132,859,581...132,936,354
Ensembl chr 3:132,859,590...132,936,340
G
Slc12a8
solute carrier family 12, member 8
increases expression
EXP
troglitazone results in increased expression of SLC12A8 mRNA
CTD
PMID:25596134
NCBI chr11:80,622,000...80,771,674
Ensembl chr11:80,622,000...80,771,659
G
Slc16a2
solute carrier family 16 member 2
decreases expression
ISO
troglitazone results in decreased expression of SLC16A2 mRNA
CTD
PMID:28973697
NCBI chr X:72,791,096...72,914,299
Ensembl chr X:72,781,876...72,914,498
G
Slc16a5
solute carrier family 16 member 5
increases expression
ISO
troglitazone results in increased expression of SLC16A5 mRNA
CTD
PMID:28973697
NCBI chr10:101,206,371...101,220,300
Ensembl chr10:101,206,398...101,220,300
G
Slc17a2
solute carrier family 17, member 2
increases expression
ISO
troglitazone results in increased expression of SLC17A2 mRNA
CTD
PMID:28973697
NCBI chr17:41,748,195...41,767,601
Ensembl chr17:41,748,195...41,764,180
G
Slc17a4
solute carrier family 17, member 4
decreases expression
ISO
troglitazone results in decreased expression of SLC17A4 mRNA
CTD
PMID:25572481
NCBI chr17:41,629,417...41,646,623
Ensembl chr17:41,629,447...41,646,624
G
Slc17a8
solute carrier family 17 member 8
decreases expression
EXP
troglitazone results in decreased expression of SLC17A8 mRNA
CTD
PMID:21515302
NCBI chr 7:25,881,557...25,936,837
Ensembl chr 7:25,881,557...25,935,410
G
Slc19a1
solute carrier family 19 member 1
increases expression
ISO
troglitazone results in increased expression of SLC19A1 mRNA
CTD
PMID:28973697
NCBI chr20:11,583,928...11,601,959
Ensembl chr20:11,583,929...11,601,488
G
Slc19a2
solute carrier family 19 member 2
decreases expression
ISO
troglitazone results in decreased expression of SLC19A2 mRNA
CTD
PMID:28973697
NCBI chr13:79,135,118...79,149,316
Ensembl chr13:79,135,059...79,149,315
G
Slc20a1
solute carrier family 20 member 1
decreases expression
ISO
troglitazone results in decreased expression of SLC20A1 mRNA
CTD
PMID:28973697
NCBI chr 3:136,880,360...136,894,255
Ensembl chr 3:136,880,290...136,894,249
G
Slc22a1
solute carrier family 22 member 1
decreases expression
ISO
troglitazone results in decreased expression of SLC22A1 mRNA
CTD
PMID:25572481
NCBI chr 1:50,624,339...50,651,437
Ensembl chr 1:50,624,377...50,651,436
G
Slc22a22
solute carrier family 22 member 22
decreases expression
EXP ISO
Troglitazone results in decreased expression of SLC22A22 mRNA Troglitazone results in decreased expression of SLC22A10 mRNA
CTD
PMID:21515302 PMID:25572481
NCBI chr 7:90,610,007...90,639,718
Ensembl chr 7:90,610,009...90,639,695
G
Slc22a23
solute carrier family 22, member 23
increases expression decreases expression
EXP ISO
troglitazone results in increased expression of SLC22A23 mRNA troglitazone results in decreased expression of SLC22A23 mRNA
CTD
PMID:21515302 PMID:28973697
NCBI chr17:30,749,445...30,915,139
Ensembl chr17:30,749,445...30,915,139
G
Slc22a4
solute carrier family 22 member 4
increases expression
ISO
troglitazone results in increased expression of SLC22A4 mRNA
CTD
PMID:19140230
NCBI chr10:38,634,098...38,687,409
Ensembl chr10:38,634,098...38,679,920
G
Slc22a5
solute carrier family 22 member 5
increases expression
EXP ISO
troglitazone results in increased expression of SLC22A5 mRNA
CTD
PMID:21515302 PMID:28973697
NCBI chr10:38,509,072...38,536,240
Ensembl chr10:38,509,072...38,536,077
G
Slc22a7
solute carrier family 22 member 7
decreases expression
ISO
troglitazone results in decreased expression of SLC22A7 mRNA
CTD
PMID:28973697
NCBI chr 9:22,044,672...22,052,051
Ensembl chr 9:22,045,435...22,051,681
G
Slc23a2
solute carrier family 23 member 2
decreases expression
ISO
troglitazone results in decreased expression of SLC23A2 mRNA
CTD
PMID:28973697
NCBI chr 3:139,755,583...139,913,304
Ensembl chr 3:139,755,584...139,847,343
G
Slc24a2
solute carrier family 24 member 2
decreases expression
EXP
troglitazone results in decreased expression of SLC24A2 mRNA
CTD
PMID:21515302
NCBI chr 5:106,543,867...106,787,810
Ensembl chr 5:106,543,874...106,787,780
G
Slc25a10
solute carrier family 25 member 10
decreases expression
ISO
troglitazone results in decreased expression of SLC25A10 mRNA
CTD
PMID:19140230
NCBI chr10:106,264,396...106,271,895
Ensembl chr10:106,264,344...106,273,498
G
Slc25a20
solute carrier family 25 member 20
increases expression
EXP
troglitazone results in increased expression of SLC25A20 mRNA
CTD
PMID:21515302 PMID:25596134
NCBI chr 8:118,243,573...118,265,027
Ensembl chr 8:118,243,519...118,265,027
G
Slc25a23
solute carrier family 25 member 23
decreases expression
ISO
troglitazone results in decreased expression of SLC25A23 mRNA
CTD
PMID:28973697
NCBI chr 9:1,969,633...1,985,365
Ensembl chr 9:1,969,357...1,985,365
G
Slc25a25
solute carrier family 25 member 25
increases expression
ISO
troglitazone results in increased expression of SLC25A25 mRNA
CTD
PMID:28973697
NCBI chr 3:36,106,448...36,139,812
Ensembl chr 3:36,106,449...36,140,011
G
Slc25a30
solute carrier family 25, member 30
decreases expression
ISO
troglitazone results in decreased expression of SLC25A30 mRNA
CTD
PMID:28973697
NCBI chr15:57,486,346...57,508,981
Ensembl chr15:57,486,350...57,502,690
G
Slc25a34
solute carrier family 25, member 34
increases expression
EXP
troglitazone results in increased expression of SLC25A34 mRNA
CTD
PMID:21515302
NCBI chr 5:159,215,120...159,219,892
Ensembl chr 5:159,215,120...159,219,892
G
Slc25a42
solute carrier family 25, member 42
increases expression decreases expression
EXP ISO
troglitazone results in increased expression of SLC25A42 mRNA troglitazone results in decreased expression of SLC25A42 mRNA
CTD
PMID:21515302 PMID:28973697
NCBI chr16:19,247,874...19,286,598
Ensembl chr16:19,247,725...19,270,976
G
Slc27a2
solute carrier family 27 member 2
increases expression
EXP
troglitazone results in increased expression of SLC27A2 mRNA
CTD
PMID:21515302
NCBI chr 3:134,258,101...134,295,581
Ensembl chr 3:134,258,101...134,295,581
G
Slc29a1
solute carrier family 29 member 1
decreases expression
ISO
troglitazone results in decreased expression of SLC29A1 mRNA
CTD
PMID:28973697
NCBI chr 9:22,897,099...22,911,640
Ensembl chr 9:22,902,471...22,914,620
G
Slc2a1
solute carrier family 2 member 1
decreases expression increases expression multiple interactions
ISO EXP
troglitazone results in decreased expression of SLC2A1 mRNA troglitazone results in increased expression of SLC2A1 mRNA; troglitazone results in increased expression of SLC2A1 protein [troglitazone results in increased expression of SLC2A1 mRNA] which results in increased uptake of Glucose; [troglitazone results in increased expression of SLC2A1 protein] which results in increased uptake of Glucose
CTD
PMID:8895337 PMID:9544743 PMID:9589670 PMID:10726906 PMID:11162573 PMID:28973697 More...
NCBI chr 5:138,002,522...138,030,742
Ensembl chr 5:138,002,522...138,030,742
G
Slc2a12
solute carrier family 2 member 12
decreases expression
ISO
troglitazone results in decreased expression of SLC2A12 mRNA
CTD
PMID:28973697
NCBI chr 1:24,623,558...24,683,577
Ensembl chr 1:24,589,707...24,694,290
G
Slc2a2
solute carrier family 2 member 2
decreases expression
EXP
troglitazone results in decreased expression of SLC2A2 mRNA
CTD
PMID:21515302
NCBI chr 2:113,537,884...113,568,422
Ensembl chr 2:113,537,972...113,568,467
G
Slc2a3
solute carrier family 2 member 3
multiple interactions
ISO
[troglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of SLC2A3 mRNA; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of SLC2A3 mRNA]
CTD
PMID:20847119
NCBI chr 4:157,632,887...157,698,034
Ensembl chr 4:157,632,887...157,646,186
G
Slc2a4
solute carrier family 2 member 4
increases expression affects localization
EXP ISO
troglitazone results in increased expression of SLC2A4 mRNA; troglitazone results in increased expression of SLC2A4 protein troglitazone affects the localization of SLC2A4 protein
CTD
PMID:11334413 PMID:11947963 PMID:24559133
NCBI chr10:55,164,721...55,170,289
Ensembl chr10:55,164,721...55,170,270
G
Slc2a4rg
SLC2A4 regulator
decreases expression
ISO
Troglitazone results in decreased expression of SLC2A4RG mRNA
CTD
PMID:19140230
NCBI chr 3:188,871,509...188,874,652
G
Slc2a5
solute carrier family 2 member 5
decreases expression
EXP
troglitazone results in decreased expression of SLC2A5 protein
CTD
PMID:11244250
NCBI chr 5:165,857,412...165,892,928
Ensembl chr 5:165,866,172...165,894,038
G
Slc2a9
solute carrier family 2 member 9
decreases expression
ISO
troglitazone results in decreased expression of SLC2A9 mRNA
CTD
PMID:28973697
NCBI chr14:76,540,649...76,674,277
Ensembl chr14:76,540,571...76,674,277
G
Slc30a2
solute carrier family 30 member 2
increases expression
EXP
troglitazone results in increased expression of SLC30A2 mRNA
CTD
PMID:21515302
NCBI chr 5:151,843,451...151,855,674
Ensembl chr 5:151,843,389...151,855,670
G
Slc30a7
solute carrier family 30 member 7
decreases expression
ISO
troglitazone results in decreased expression of SLC30A7 mRNA
CTD
PMID:28973697
NCBI chr 2:206,544,800...206,607,087
Ensembl chr 2:206,544,800...206,607,043
G
Slc34a2
solute carrier family 34 member 2
increases expression
EXP
troglitazone results in increased expression of SLC34A2 mRNA
CTD
PMID:21515302
NCBI chr14:62,123,313...62,153,020
Ensembl chr14:62,123,316...62,143,360
G
Slc38a2
solute carrier family 38, member 2
decreases expression
ISO
troglitazone results in decreased expression of SLC38A2 mRNA
CTD
PMID:28973697
NCBI chr 7:129,730,450...129,742,619
Ensembl chr 7:129,730,450...129,742,619
G
Slc38a3
solute carrier family 38, member 3
decreases expression
ISO
troglitazone results in decreased expression of SLC38A3 mRNA
CTD
PMID:25572481
NCBI chr 8:117,202,534...117,220,310
Ensembl chr 8:117,202,536...117,218,630
G
Slc3a2
solute carrier family 3 member 2
increases expression decreases expression
ISO
troglitazone results in increased expression of SLC3A2 mRNA troglitazone results in decreased expression of SLC3A2 mRNA
CTD
PMID:19140230 PMID:28973697
NCBI chr 1:215,033,601...215,048,064
Ensembl chr 1:215,033,601...215,048,064
G
Slc4a11
solute carrier family 4 member 11
increases expression
ISO
troglitazone results in increased expression of SLC4A11 mRNA
CTD
PMID:28973697
NCBI chr 3:138,353,305...138,365,983
Ensembl chr 3:138,353,305...138,365,754
G
Slc5a1
solute carrier family 5 member 1
decreases expression
EXP
troglitazone results in decreased expression of SLC5A1 mRNA; troglitazone results in decreased expression of SLC5A1 protein
CTD
PMID:11244250
NCBI chr14:81,778,495...81,843,084
Ensembl chr14:81,778,348...81,846,624
G
Slc5a5
solute carrier family 5 member 5
multiple interactions increases expression
ISO
[troglitazone co-treated with Tretinoin] results in increased expression of SLC5A5 mRNA troglitazone results in increased expression of SLC5A5 mRNA
CTD
PMID:15785241 PMID:16954431
NCBI chr16:18,580,705...18,590,692
Ensembl chr16:18,580,705...18,590,691
G
Slc66a1
solute carrier family 66 member 1
decreases expression
ISO
Troglitazone results in decreased expression of SLC66A1 mRNA
CTD
PMID:28973697
NCBI chr 5:156,821,084...156,835,558
Ensembl chr 5:156,825,590...156,835,473
G
Slc6a1
solute carrier family 6 member 1
decreases expression
ISO
troglitazone results in decreased expression of SLC6A1 mRNA
CTD
PMID:25572481
NCBI chr 4:149,004,447...149,037,840
Ensembl chr 4:149,004,635...149,037,839
G
Slc6a12
solute carrier family 6 member 12
decreases expression
ISO
troglitazone results in decreased expression of SLC6A12 mRNA
CTD
PMID:28973697
NCBI chr 4:156,257,518...156,275,870
Ensembl chr 4:156,254,208...156,275,879
G
Slc6a13
solute carrier family 6 member 13
increases expression
EXP
troglitazone results in increased expression of SLC6A13 mRNA
CTD
PMID:21515302
NCBI chr 4:156,211,381...156,248,491
Ensembl chr 4:156,211,462...156,248,489
G
Slc6a18
solute carrier family 6 member 18
decreases expression
EXP
troglitazone results in decreased expression of SLC6A18 mRNA
CTD
PMID:21515302
NCBI chr 1:31,436,577...31,450,478
Ensembl chr 1:31,436,630...31,450,478
G
Slc6a9
solute carrier family 6 member 9
decreases expression
EXP
troglitazone results in decreased expression of SLC6A9 mRNA
CTD
PMID:25596134
NCBI chr 5:136,660,022...136,694,173
Ensembl chr 5:136,659,948...136,694,172
G
Slc7a10
solute carrier family 7 member 10
increases expression
ISO
troglitazone results in increased expression of SLC7A10 mRNA
CTD
PMID:28973697
NCBI chr 1:96,966,030...96,982,020
Ensembl chr 1:96,966,076...96,982,018
G
Slc7a11
solute carrier family 7 member 11
increases expression
ISO
Troglitazone results in increased expression of SLC7A11 mRNA
CTD
PMID:32816093
NCBI chr 2:136,532,912...136,668,560
Ensembl chr 2:136,532,246...136,695,695
G
Slc7a2
solute carrier family 7 member 2
decreases expression
ISO
troglitazone results in decreased expression of SLC7A2 mRNA
CTD
PMID:28973697
NCBI chr16:58,115,991...58,174,256
Ensembl chr16:58,120,968...58,174,256
G
Slc7a6
solute carrier family 7 member 6
decreases expression
ISO
troglitazone results in decreased expression of SLC7A6 mRNA
CTD
PMID:19140230
NCBI chr19:50,982,459...51,010,140
Ensembl chr19:50,984,132...51,010,134
G
Slc7a7
solute carrier family 7 member 7
increases expression
ISO
troglitazone results in increased expression of SLC7A7 mRNA
CTD
PMID:28973697
NCBI chr15:31,792,122...31,852,732
Ensembl chr15:31,792,125...31,835,683
G
Slc8b1
solute carrier family 8 member B1
decreases expression
ISO
troglitazone results in decreased expression of SLC8B1 mRNA
CTD
PMID:28973697
NCBI chr12:41,690,333...41,713,657
Ensembl chr12:41,690,334...41,713,601
G
Slc9a1
solute carrier family 9 member A1
decreases activity
ISO
troglitazone results in decreased activity of SLC9A1 protein
CTD
PMID:15501982
NCBI chr 5:150,859,412...150,913,525
Ensembl chr 5:150,860,228...150,913,517
G
Slc9a9
solute carrier family 9 member A9
increases expression
ISO
troglitazone results in increased expression of SLC9A9 mRNA
CTD
PMID:28973697
NCBI chr 8:104,112,279...104,675,944
Ensembl chr 8:104,112,559...104,676,891
G
Slco1a1
solute carrier organic anion transporter family, member 1a1
decreases expression
EXP
Troglitazone results in decreased expression of SLCO1A1 mRNA
CTD
PMID:27765674
NCBI chr 4:176,606,924...176,682,027
Ensembl chr 4:176,607,687...176,681,992
G
Slco1a4
solute carrier organic anion transporter family, member 1a4
increases expression
EXP
troglitazone results in increased expression of SLCO1A4 mRNA
CTD
PMID:21515302
NCBI chr 4:176,441,104...176,495,846
Ensembl chr 4:176,441,104...176,495,816
G
Slco3a1
solute carrier organic anion transporter family, member 3a1
decreases expression
EXP
troglitazone results in decreased expression of SLCO3A1 mRNA
CTD
PMID:21515302
NCBI chr 1:137,516,037...137,797,836
Ensembl chr 1:137,505,158...137,797,836
G
Slco4a1
solute carrier organic anion transporter family, member 4a1
decreases expression
ISO
troglitazone results in decreased expression of SLCO4A1 mRNA
CTD
PMID:28973697
NCBI chr 3:187,936,735...187,955,873
Ensembl chr 3:187,936,820...187,955,871
G
Slf2
SMC5-SMC6 complex localization factor 2
decreases expression
ISO
troglitazone results in decreased expression of SLF2 mRNA
CTD
PMID:28973697
NCBI chr 1:253,731,979...253,794,577
Ensembl chr 1:253,732,025...253,794,577
G
Slit2
slit guidance ligand 2
decreases expression
EXP
troglitazone results in decreased expression of SLIT2 mRNA
CTD
PMID:21515302
NCBI chr14:66,829,661...67,168,517
Ensembl chr14:66,829,661...67,167,146
G
Slit3
slit guidance ligand 3
increases expression
ISO
troglitazone results in increased expression of SLIT3 mRNA
CTD
PMID:28973697
NCBI chr10:20,075,929...20,660,704
Ensembl chr10:20,076,021...20,660,704
G
Slk
STE20-like kinase
decreases expression
ISO
troglitazone results in decreased expression of SLK mRNA
CTD
PMID:28973697
NCBI chr 1:256,415,013...256,470,942
Ensembl chr 1:256,415,013...256,467,829
G
Slpi
secretory leukocyte peptidase inhibitor
decreases expression
ISO
Troglitazone results in decreased expression of SLPI mRNA
CTD
PMID:32816093
NCBI chr 3:173,501,573...173,503,822
Ensembl chr 3:173,501,573...173,503,822
G
Sltm
SAFB-like, transcription modulator
multiple interactions
ISO
[troglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of SLTM mRNA; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of SLTM mRNA]
CTD
PMID:20847119
NCBI chr 8:80,096,555...80,142,668
Ensembl chr 8:80,097,652...80,142,671
G
Slu7
SLU7 homolog, splicing factor
decreases expression
ISO
troglitazone results in decreased expression of SLU7 mRNA
CTD
PMID:28973697
NCBI chr10:28,406,908...28,425,253
Ensembl chr10:28,409,846...28,425,250
G
Smad2
SMAD family member 2
multiple interactions
ISO
troglitazone inhibits the reaction [TGFB2 protein results in increased phosphorylation of and affects the localization of SMAD2 protein]
CTD
PMID:18253093
NCBI chr18:72,124,792...72,193,345
Ensembl chr18:72,124,863...72,187,388
G
Smad3
SMAD family member 3
multiple interactions decreases expression
ISO EXP
troglitazone inhibits the reaction [TGFB2 protein results in increased phosphorylation of and affects the localization of SMAD3 protein] troglitazone results in decreased expression of SMAD3 mRNA
CTD
PMID:18253093 PMID:21515302
NCBI chr 8:73,022,204...73,132,324
Ensembl chr 8:73,024,760...73,132,324
G
Smad4
SMAD family member 4
decreases expression
ISO
troglitazone results in decreased expression of SMAD4 mRNA
CTD
PMID:28973697
NCBI chr18:69,518,988...69,549,684
Ensembl chr18:69,518,988...69,549,684
G
Smad6
SMAD family member 6
increases expression
ISO
troglitazone results in increased expression of SMAD6 mRNA
CTD
PMID:28973697
NCBI chr 8:73,345,457...73,414,985
Ensembl chr 8:73,345,460...73,414,149
G
Smap2
small ArfGAP2
decreases expression
ISO
troglitazone results in decreased expression of SMAP2 mRNA
CTD
PMID:28973697
NCBI chr 5:139,815,737...139,862,156
Ensembl chr 5:139,815,739...139,862,126
G
Smarcc1
SWI/SNF related BAF chromatin remodeling complex subunit C1
decreases expression
ISO
troglitazone results in decreased expression of SMARCC1 mRNA
CTD
PMID:28973697
NCBI chr 8:118,986,917...119,093,161
Ensembl chr 8:118,989,516...119,093,152
G
Smarcc2
SWI/SNF related BAF chromatin remodeling complex subunit C2
decreases expression
ISO
troglitazone results in decreased expression of SMARCC2 mRNA
CTD
PMID:28973697
NCBI chr 7:1,466,223...1,494,627
Ensembl chr 7:1,466,454...1,494,626
G
Smc1a
structural maintenance of chromosomes 1A
decreases expression
ISO
troglitazone results in decreased expression of SMC1A mRNA
CTD
PMID:28973697
NCBI chr X:24,582,732...24,627,462
Ensembl chr X:24,582,690...24,627,462
G
Smc2
structural maintenance of chromosomes 2
decreases expression
ISO
troglitazone results in decreased expression of SMC2 mRNA
CTD
PMID:19140230
NCBI chr 5:71,592,428...71,648,636
Ensembl chr 5:71,602,308...71,648,632
G
Smc3
structural maintenance of chromosomes 3
decreases expression
ISO
troglitazone results in decreased expression of SMC3 mRNA
CTD
PMID:28973697
NCBI chr 1:262,606,731...262,649,832
Ensembl chr 1:262,607,080...262,649,825
G
Smc4
structural maintenance of chromosomes 4
decreases expression
ISO
troglitazone results in decreased expression of SMC4 mRNA
CTD
PMID:19140230
NCBI chr 2:155,550,262...155,578,695
Ensembl chr 2:155,550,262...155,581,937
G
Smco4
single-pass membrane protein with coiled-coil domains 4
increases expression
ISO
troglitazone results in increased expression of SMCO4 mRNA
CTD
PMID:28973697
NCBI chr 8:20,594,633...20,646,916
Ensembl chr 8:20,627,338...20,646,916
G
Smg6
SMG6 nonsense mediated mRNA decay factor
decreases expression
ISO
troglitazone results in decreased expression of SMG6 mRNA
CTD
PMID:28973697
NCBI chr10:60,284,628...60,512,738
Ensembl chr10:60,284,628...60,512,733
G
Smg7
SMG7 nonsense mediated mRNA decay factor
decreases expression
ISO
troglitazone results in decreased expression of SMG7 mRNA
CTD
PMID:28973697
NCBI chr13:67,536,016...67,600,624
Ensembl chr13:67,536,044...67,600,437
G
Smim3
small integral membrane protein 3
decreases expression
EXP
troglitazone results in decreased expression of SMIM3 mRNA
CTD
PMID:21515302
NCBI chr18:56,200,458...56,252,778
Ensembl chr18:56,200,459...56,227,379
G
Smndc1
survival motor neuron domain containing 1
decreases expression
ISO
troglitazone results in decreased expression of SMNDC1 mRNA
CTD
PMID:28973697
NCBI chr 1:262,395,034...262,406,104
Ensembl chr 1:262,386,590...262,405,707
G
Smoc1
SPARC related modular calcium binding 1
increases expression
EXP
troglitazone results in increased expression of SMOC1 mRNA
CTD
PMID:21515302
NCBI chr 6:106,432,592...106,593,956
Ensembl chr 6:106,432,603...106,593,956
G
Smpx
small muscle protein, X-linked
decreases expression
EXP
troglitazone results in decreased expression of SMPX mRNA
CTD
PMID:21515302
NCBI chr X:41,049,354...41,107,323
Ensembl chr X:41,049,356...41,107,137
G
Snai2
snail family transcriptional repressor 2
decreases expression
ISO
troglitazone results in decreased expression of SNAI2 mRNA
CTD
PMID:28973697
NCBI chr11:99,686,934...99,690,349
Ensembl chr11:99,686,934...99,690,349
G
Snap23
synaptosome associated protein 23
increases expression
ISO
troglitazone results in increased expression of SNAP23 mRNA
CTD
PMID:28973697
NCBI chr 3:127,966,184...127,999,929
Ensembl chr 3:127,967,886...127,998,067
G
Snhg11
small nucleolar RNA host gene 11
increases expression
ISO
troglitazone results in increased expression of SNHG11 mRNA
CTD
PMID:28973697
NCBI chr 3:167,451,272...167,456,945
G
Snn
stannin
increases expression
ISO
troglitazone results in increased expression of SNN mRNA
CTD
PMID:28973697
NCBI chr10:5,079,885...5,088,565
Ensembl chr 1:82,440,586...82,441,390 Ensembl chr10:82,440,586...82,441,390
G
Snrk
SNF related kinase
decreases expression
ISO
troglitazone results in decreased expression of SNRK mRNA
CTD
PMID:28973697
NCBI chr 8:130,657,204...130,711,461
Ensembl chr 8:130,657,266...130,711,457
G
Snrnp200
small nuclear ribonucleoprotein U5 subunit 200
decreases expression
ISO
troglitazone results in decreased expression of SNRNP200 mRNA
CTD
PMID:19140230
NCBI chr 3:134,882,173...134,911,512
Ensembl chr 3:134,882,173...134,911,500
G
Snrnp70
small nuclear ribonucleoprotein U1 subunit 70
decreases expression
ISO
troglitazone results in decreased expression of SNRNP70 mRNA
CTD
PMID:28973697
NCBI chr 1:104,992,518...105,012,851
Ensembl chr 1:104,992,442...105,012,851
G
Snrpa
small nuclear ribonucleoprotein polypeptide A
decreases expression
ISO
troglitazone results in decreased expression of SNRPA mRNA
CTD
PMID:19140230
NCBI chr 1:91,609,419...91,618,119
Ensembl chr 1:91,609,420...91,618,042
G
Snrpd1
small nuclear ribonucleoprotein D1 polypeptide
increases expression
ISO
troglitazone results in increased expression of SNRPD1 mRNA
CTD
PMID:28973697
NCBI chr18:1,969,351...1,980,207
Ensembl chr18:1,969,674...1,980,207
G
Sntg2
syntrophin, gamma 2
decreases expression
ISO
troglitazone results in decreased expression of SNTG2 mRNA
CTD
PMID:28973697
NCBI chr 6:52,529,481...52,730,972
Ensembl chr 6:52,529,481...52,730,972
G
Snx10
sorting nexin 10
increases expression
EXP
troglitazone results in increased expression of SNX10 mRNA
CTD
PMID:21515302
NCBI chr 4:81,943,262...82,007,667
Ensembl chr 4:81,943,287...82,007,651
G
Snx16
sorting nexin 16
decreases expression
ISO
troglitazone results in decreased expression of SNX16 mRNA
CTD
PMID:28973697
NCBI chr 2:93,242,779...93,265,048
Ensembl chr 2:93,243,494...93,265,050
G
Snx21
sorting nexin family member 21
increases expression
ISO
troglitazone results in increased expression of SNX21 mRNA
CTD
PMID:28973697
NCBI chr 3:173,941,634...173,951,571
G
Snx27
sorting nexin 27
decreases expression
ISO
troglitazone results in decreased expression of SNX27 mRNA
CTD
PMID:28973697
NCBI chr 2:184,824,930...184,907,931
Ensembl chr 2:184,806,844...184,907,931
G
Soat1
sterol O-acyltransferase 1
increases expression
EXP
troglitazone results in increased expression of SOAT1 mRNA
CTD
PMID:21515302
NCBI chr13:71,105,178...71,147,776
Ensembl chr13:71,105,178...71,147,672
G
Soat2
sterol O-acyltransferase 2
increases expression
EXP
troglitazone results in increased expression of SOAT2 mRNA
CTD
PMID:21515302
NCBI chr 7:135,160,424...135,173,521
Ensembl chr 7:135,160,402...135,173,513
G
Socs1
suppressor of cytokine signaling 1
increases expression
ISO
Troglitazone results in increased expression of SOCS1 mRNA
CTD
PMID:31294483
NCBI chr10:5,389,574...5,391,265
Ensembl chr10:5,389,334...5,391,847
G
Socs3
suppressor of cytokine signaling 3
increases expression
ISO
Troglitazone results in increased expression of SOCS3 mRNA
CTD
PMID:31294483
NCBI chr10:103,692,579...103,695,975
Ensembl chr10:103,690,976...103,704,825
G
Socs7
suppressor of cytokine signaling 7
decreases expression
ISO
troglitazone results in decreased expression of SOCS7 mRNA
CTD
PMID:28973697
NCBI chr10:82,848,525...82,885,201
Ensembl chr10:82,848,612...82,885,201
G
Sod1
superoxide dismutase 1
decreases expression increases expression
ISO
troglitazone results in decreased expression of SOD1; troglitazone results in decreased expression of SOD1 mRNA troglitazone results in increased expression of SOD1 mRNA; troglitazone results in increased expression of SOD1 protein
CTD
PMID:11172467 PMID:19631733 PMID:20860658
NCBI chr11:42,942,742...42,948,399
Ensembl chr11:42,942,678...42,948,399
G
Sod2
superoxide dismutase 2
multiple interactions decreases expression increases expression affects response to substance
EXP ISO
[SOD2 co-treated with CYP3A4] affects the susceptibility to troglitazone troglitazone results in decreased expression of SOD2; troglitazone results in decreased expression of SOD2 mRNA; troglitazone results in decreased expression of SOD2 protein troglitazone results in increased expression of SOD2 mRNA troglitazone results in increased expression of SOD2 protein SOD2 protein affects the reaction [troglitazone results in increased abundance of Superoxides] SOD2 protein affects the susceptibility to troglitazone 2-chloro-5-nitrobenzanilide inhibits the reaction [troglitazone results in decreased expression of SOD2 mRNA]; 2-chloro-5-nitrobenzanilide inhibits the reaction [troglitazone results in decreased expression of SOD2 protein]
CTD
PMID:12732648 PMID:17150972 PMID:18495193 PMID:19140230 PMID:19501153 PMID:20860658 PMID:23964924 PMID:28973697 More...
NCBI chr 1:50,043,323...50,050,168
Ensembl chr 1:50,043,325...50,050,168
G
Sod3
superoxide dismutase 3
decreases expression
ISO
troglitazone results in decreased expression of SOD3 mRNA
CTD
PMID:28973697
NCBI chr14:62,822,865...62,828,602
Ensembl chr14:62,811,177...62,829,125
G
Son
SON DNA and RNA binding protein
decreases expression
ISO
troglitazone results in decreased expression of SON mRNA
CTD
PMID:28973697
NCBI chr11:44,336,818...44,409,127
Ensembl chr11:44,377,976...44,409,127
G
Sorbs1
sorbin and SH3 domain containing 1
multiple interactions increases expression decreases expression
ISO EXP
troglitazone promotes the reaction [PPARG protein results in increased expression of SORBS1 mRNA] troglitazone results in increased expression of SORBS1 mRNA troglitazone results in decreased expression of SORBS1 mRNA
CTD
PMID:10871190 PMID:12732648 PMID:21515302 PMID:28973697
NCBI chr 1:249,057,324...249,279,703
Ensembl chr 1:249,057,324...249,279,608
G
Sort1
sortilin 1
decreases expression
ISO
troglitazone results in decreased expression of SORT1 mRNA
CTD
PMID:19140230
NCBI chr 2:198,609,466...198,690,481
Ensembl chr 2:198,612,148...198,690,481
G
Sos1
SOS Ras/Rac guanine nucleotide exchange factor 1
decreases expression
ISO
troglitazone results in decreased expression of SOS1 mRNA
CTD
PMID:28973697
NCBI chr 6:20,286,117...20,363,350
Ensembl chr 6:20,286,117...20,363,350
G
Sox4
SRY-box transcription factor 4
decreases expression
ISO
troglitazone results in decreased expression of SOX4 mRNA
CTD
PMID:28973697
NCBI chr17:35,876,298...35,881,004
Ensembl chr17:35,875,756...35,884,024
G
Sox5
SRY-box transcription factor 5
decreases expression
ISO
troglitazone results in decreased expression of SOX5 mRNA
CTD
PMID:28973697
NCBI chr 4:178,512,272...179,467,686
Ensembl chr 4:178,512,272...178,938,495
G
Sox6
SRY-box transcription factor 6
decreases expression
ISO
troglitazone results in decreased expression of SOX6 mRNA
CTD
PMID:28973697
NCBI chr 1:179,157,678...179,769,243
Ensembl chr 1:179,163,566...179,711,727
G
Sox7
SRY-box transcription factor 7
decreases expression
ISO
troglitazone results in decreased expression of SOX7 mRNA
CTD
PMID:28973697
NCBI chr15:42,356,405...42,363,166
Ensembl chr15:42,356,289...42,363,164
G
Sox9
SRY-box transcription factor 9
increases expression
ISO
troglitazone results in increased expression of SOX9 mRNA
CTD
PMID:19140230
NCBI chr10:98,305,744...98,311,250
Ensembl chr10:98,305,744...98,311,250
G
Sp1
Sp1 transcription factor
decreases expression increases degradation multiple interactions
ISO
troglitazone results in decreased expression of SP1 protein troglitazone results in increased degradation of SP1 protein [troglitazone results in increased degradation of SP1 protein] which results in decreased expression of AR mRNA troglitazone results in decreased expression of SP1 mRNA
CTD
PMID:15908479 PMID:17409431 PMID:28973697
NCBI chr 7:135,419,864...135,450,513
Ensembl chr 7:135,420,050...135,450,513
G
Sp110
SP110 nuclear body protein
decreases expression
ISO
troglitazone results in decreased expression of SP110 mRNA
CTD
PMID:17569031
NCBI chr 9:93,648,574...93,673,476
Ensembl chr 9:93,648,575...93,670,659
G
Spag5
sperm associated antigen 5
decreases expression
ISO
troglitazone results in decreased expression of SPAG5 mRNA
CTD
PMID:19140230
NCBI chr10:63,693,300...63,714,813
Ensembl chr10:63,696,466...63,714,811
G
Sparcl1
SPARC like 1
decreases expression
ISO
troglitazone results in decreased expression of SPARCL1 mRNA
CTD
PMID:25572481 PMID:28973697
NCBI chr14:5,937,484...5,968,532
Ensembl chr14:5,914,535...5,969,120
G
Spata13
spermatogenesis associated 13
decreases expression
ISO
troglitazone results in decreased expression of SPATA13 mRNA
CTD
PMID:28973697
NCBI chr15:38,954,585...39,083,752
Ensembl chr15:38,810,386...39,083,755
G
Spata2L
spermatogenesis associated 2-like
decreases expression
ISO
troglitazone results in decreased expression of SPATA2L mRNA
CTD
PMID:28973697
NCBI chr19:68,177,599...68,182,122
Ensembl chr19:68,176,615...68,182,069
G
Spc24
SPC24 component of NDC80 kinetochore complex
increases expression
ISO
troglitazone results in increased expression of SPC24 mRNA
CTD
PMID:28973697
NCBI chr 8:28,576,409...28,581,481
Ensembl chr 8:28,576,409...28,581,299
G
Speg
striated muscle enriched protein kinase
increases expression
EXP
troglitazone results in increased expression of SPEG mRNA
CTD
PMID:21515302
NCBI chr 9:84,314,387...84,371,816
Ensembl chr 9:84,314,387...84,371,813
G
Spen
spen family transcriptional repressor
decreases expression
ISO
troglitazone results in decreased expression of SPEN mRNA
CTD
PMID:28973697
NCBI chr 5:159,058,258...159,131,789
Ensembl chr 5:159,058,258...159,165,934
G
Spp1
secreted phosphoprotein 1
multiple interactions decreases expression increases expression
ISO EXP
PPARG protein affects the reaction [troglitazone results in decreased expression of SPP1 mRNA]; troglitazone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of SPP1 mRNA] troglitazone results in increased expression of SPP1 mRNA
CTD
PMID:11426586 PMID:19122273 PMID:21515302 PMID:25572481
NCBI chr14:5,613,569...5,620,695
Ensembl chr14:5,613,576...5,619,820
G
Spp2
secreted phosphoprotein 2
decreases expression
ISO
troglitazone results in decreased expression of SPP2 mRNA
CTD
PMID:25572481
NCBI chr 9:96,454,636...96,474,453
Ensembl chr 9:96,454,957...96,474,452
G
Spred1
sprouty-related, EVH1 domain containing 1
decreases expression
ISO
troglitazone results in decreased expression of SPRED1 mRNA
CTD
PMID:28973697
NCBI chr 3:124,437,230...124,504,358
Ensembl chr 3:124,437,230...124,504,358
G
Spred3
sprouty-related, EVH1 domain containing 3
increases expression
ISO
troglitazone results in increased expression of SPRED3 mRNA
CTD
PMID:17569031
NCBI chr 1:93,586,259...93,597,692
Ensembl chr 1:93,586,259...93,598,254
G
Spry4
sprouty RTK signaling antagonist 4
increases expression
ISO
troglitazone results in increased expression of SPRY4 mRNA
CTD
PMID:17569031
NCBI chr18:30,687,633...30,702,546
Ensembl chr18:30,687,039...30,704,173
G
Spryd7
SPRY domain containing 7
increases expression
ISO
troglitazone results in increased expression of SPRYD7 mRNA
CTD
PMID:28973697
NCBI chr15:39,883,237...39,903,770
Ensembl chr15:39,883,238...39,903,674
G
Sptbn2
spectrin, beta, non-erythrocytic 2
decreases expression
ISO
troglitazone results in decreased expression of SPTBN2 mRNA
CTD
PMID:28973697
NCBI chr 1:211,432,373...211,473,016
Ensembl chr 1:211,432,373...211,473,306
G
Sqle
squalene epoxidase
decreases expression
ISO
troglitazone results in decreased expression of SQLE mRNA
CTD
PMID:25572481
NCBI chr 7:92,758,175...92,773,049
Ensembl chr 7:92,757,409...92,773,050
G
Sqstm1
sequestosome 1
increases expression
ISO
troglitazone results in increased expression of SQSTM1 mRNA
CTD
PMID:19140230
NCBI chr10:35,026,598...35,037,750
Ensembl chr10:35,026,598...35,037,750
G
Srebf1
sterol regulatory element binding transcription factor 1
multiple interactions decreases expression increases expression
EXP ISO
[[[troglitazone binds to and results in increased activity of PPARG protein] which results in decreased localization of and results in decreased activity of SREBF1 protein] which results in decreased expression of FASN mRNA] which results in decreased abundance of Triglycerides; [troglitazone binds to and results in increased activity of PPARG protein] which results in decreased localization of and results in decreased activity of SREBF1 protein troglitazone results in decreased expression of SREBF1 mRNA [1-Methyl-3-isobutylxanthine co-treated with troglitazone co-treated with INS protein] results in increased expression of SREBF1 mRNA Troglitazone results in increased expression of SREBF1 mRNA
CTD
PMID:10900012 PMID:19140230 PMID:19248225 PMID:22953781 PMID:23277027 PMID:27003841 More...
NCBI chr10:45,507,152...45,529,164
Ensembl chr10:45,507,152...45,529,164
G
Srebf2
sterol regulatory element binding transcription factor 2
multiple interactions
ISO
[[troglitazone binds to and results in increased activity of PPARG protein] which results in decreased expression of SREBF2 protein] which results in decreased abundance of Cholesterol; [[troglitazone binds to and results in increased activity of PPARG protein] which results in decreased expression of SREBF2 protein] which results in decreased expression of HMGCR mRNA; [[troglitazone binds to and results in increased activity of PPARG protein] which results in decreased expression of SREBF2 protein] which results in decreased expression of LDLR mRNA; [troglitazone binds to and results in increased activity of PPARG protein] which results in decreased expression of SREBF2 mRNA; [troglitazone binds to and results in increased activity of PPARG protein] which results in decreased expression of SREBF2 protein
CTD
PMID:16946405
NCBI chr 7:115,542,774...115,600,945
Ensembl chr 7:115,543,290...115,600,943
G
Srpk2
SRSF protein kinase 2
decreases expression
ISO
troglitazone results in decreased expression of SRPK2 mRNA
CTD
PMID:28973697
NCBI chr 4:12,356,983...12,548,345
Ensembl chr 4:12,357,053...12,548,342
G
Srpx
sushi-repeat-containing protein, X-linked
increases expression
ISO
troglitazone results in increased expression of SRPX mRNA
CTD
PMID:25572481 PMID:28973697
NCBI chr X:15,349,498...15,420,389
Ensembl chr X:15,349,440...15,420,392
G
Srpx2
sushi-repeat-containing protein, X-linked 2
increases expression
ISO
troglitazone results in increased expression of SRPX2 mRNA
CTD
PMID:25572481
NCBI chr X:101,399,748...101,425,486
Ensembl chr X:101,399,853...101,425,484
G
Srrm1
serine and arginine repetitive matrix 1
decreases expression
ISO
troglitazone results in decreased expression of SRRM1 mRNA
CTD
PMID:28973697
NCBI chr 5:152,843,167...152,875,554
Ensembl chr 5:152,843,169...152,875,436
G
Srrm2
serine/arginine repetitive matrix 2
decreases expression
ISO
troglitazone results in decreased expression of SRRM2 mRNA
CTD
PMID:28973697
NCBI chr10:13,320,059...13,353,337
Ensembl chr10:13,320,059...13,353,337
G
Srsf4
serine and arginine rich splicing factor 4
decreases expression
ISO
troglitazone results in decreased expression of SRSF4 mRNA
CTD
PMID:28973697
NCBI chr 5:149,345,538...149,373,309
Ensembl chr 5:149,345,422...149,374,609
G
Srxn1
sulfiredoxin 1
increases expression
ISO
troglitazone results in increased expression of SRXN1 mRNA
CTD
PMID:19140230
NCBI chr 3:161,064,812...161,070,372
Ensembl chr 3:161,059,931...161,088,765
G
Ssbp3
single stranded DNA binding protein 3
decreases expression
ISO
troglitazone results in decreased expression of SSBP3 mRNA
CTD
PMID:28973697
NCBI chr 5:126,920,145...127,057,968
Ensembl chr 5:126,919,120...127,056,799
G
Ssh2
slingshot protein phosphatase 2
decreases expression
ISO
troglitazone results in decreased expression of SSH2 mRNA
CTD
PMID:28973697
NCBI chr10:62,555,388...62,807,457
Ensembl chr10:62,555,460...62,807,453
G
Sstr3
somatostatin receptor 3
decreases expression
EXP
troglitazone results in decreased expression of SSTR3 mRNA
CTD
PMID:21515302
NCBI chr 7:111,973,049...111,980,250
Ensembl chr 7:111,972,811...111,997,368
G
St14
ST14 transmembrane serine protease matriptase
increases expression
EXP
troglitazone results in increased expression of ST14 mRNA
CTD
PMID:21515302
NCBI chr 8:37,798,994...37,839,881
Ensembl chr 8:37,798,995...37,855,652
G
St3gal1
ST3 beta-galactoside alpha-2,3-sialyltransferase 1
multiple interactions
ISO
[Troglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of ST3GAL1 mRNA; Troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ST3GAL1 mRNA]
CTD
PMID:20847119
NCBI chr 7:100,734,300...100,802,443
Ensembl chr 7:100,734,300...100,745,242
G
St3gal5
ST3 beta-galactoside alpha-2,3-sialyltransferase 5
increases expression
EXP
troglitazone results in increased expression of ST3GAL5 mRNA
CTD
PMID:21515302
NCBI chr 4:105,692,840...105,750,774
Ensembl chr 4:105,692,840...105,750,775
G
Stard4
StAR-related lipid transfer domain containing 4
decreases expression
ISO
troglitazone results in decreased expression of STARD4 mRNA
CTD
PMID:28973697
NCBI chr18:25,088,831...25,104,172
Ensembl chr18:25,091,255...25,104,172
G
Stard5
StAR-related lipid transfer domain containing 5
decreases expression
ISO
troglitazone results in decreased expression of STARD5 mRNA
CTD
PMID:28973697
NCBI chr 1:147,015,304...147,025,170
Ensembl chr 1:147,015,299...147,026,351
G
Stat1
signal transducer and activator of transcription 1
increases expression
ISO
troglitazone results in increased expression of STAT1 mRNA
CTD
PMID:12732648
NCBI chr 9:56,911,522...56,951,926
Ensembl chr 9:56,911,523...57,077,346
G
Stat3
signal transducer and activator of transcription 3
increases expression increases phosphorylation multiple interactions
ISO
Troglitazone results in increased expression of STAT3 mRNA Troglitazone results in increased phosphorylation of STAT3 protein [Troglitazone co-treated with Buthionine Sulfoximine] results in increased phosphorylation of STAT3 protein
CTD
PMID:31294483
NCBI chr10:86,311,528...86,363,513
Ensembl chr10:86,311,535...86,363,359
G
Stat5a
signal transducer and activator of transcription 5A
increases expression
ISO
troglitazone results in increased expression of STAT5A mRNA
CTD
PMID:19140230
NCBI chr10:86,285,859...86,310,187
Ensembl chr10:86,285,547...86,310,184
G
Stat5b
signal transducer and activator of transcription 5B
decreases expression
ISO
troglitazone results in decreased expression of STAT5B mRNA
CTD
PMID:28973697
NCBI chr10:86,205,148...86,276,178
Ensembl chr10:86,207,293...86,275,990
G
Stc1
stanniocalcin 1
increases expression decreases expression
ISO
troglitazone results in increased expression of STC1 mRNA troglitazone results in decreased expression of STC1 mRNA
CTD
PMID:19140230 PMID:25572481
NCBI chr15:50,709,439...50,720,093
Ensembl chr15:50,709,415...50,720,082
G
Stc2
stanniocalcin 2
increases expression
ISO EXP
troglitazone results in increased expression of STC2 mRNA
CTD
PMID:19140230 PMID:20846491 PMID:21515302
NCBI chr10:16,755,508...16,765,275
Ensembl chr10:16,755,267...16,767,447
G
Steap4
STEAP4 metalloreductase
decreases expression
EXP ISO
troglitazone results in decreased expression of STEAP4 mRNA
CTD
PMID:21515302 PMID:28934090
NCBI chr 4:27,032,096...27,054,769
Ensembl chr 4:27,009,584...27,067,105
G
Stil
STIL, centriolar assembly protein
decreases expression
ISO
troglitazone results in decreased expression of STIL mRNA
CTD
PMID:19140230
NCBI chr 5:133,757,598...133,810,493
Ensembl chr 5:133,760,417...133,810,494
G
Stk17b
serine/threonine kinase 17b
increases expression
ISO
troglitazone results in increased expression of STK17B mRNA
CTD
PMID:28973697
NCBI chr 9:62,801,912...62,832,511
Ensembl chr 9:62,803,005...62,832,511
G
Stk24
serine/threonine kinase 24
decreases expression
ISO
troglitazone results in decreased expression of STK24 mRNA
CTD
PMID:28973697
NCBI chr15:104,770,556...104,866,524
Ensembl chr15:104,773,569...104,865,975
G
Stk32a
serine/threonine kinase 32A
increases expression
ISO
troglitazone results in increased expression of STK32A mRNA
CTD
PMID:25572481
NCBI chr18:35,509,791...35,620,421
Ensembl chr18:35,509,982...35,628,985
G
Stmn1
stathmin 1
decreases expression
ISO
troglitazone results in decreased expression of STMN1 mRNA
CTD
PMID:19140230
NCBI chr 5:151,964,308...151,970,843
Ensembl chr 5:151,964,351...151,970,842
G
Stmn4
stathmin 4
decreases expression
EXP
troglitazone results in decreased expression of STMN4 mRNA
CTD
PMID:21515302
NCBI chr15:44,716,825...44,734,776
Ensembl chr15:44,716,880...44,742,086
G
Sts
steroid sulfatase
decreases expression
ISO
troglitazone results in decreased expression of STS mRNA
CTD
PMID:28973697
NCBI chr X:46,102,524...46,110,868
Ensembl chr X:46,102,548...46,111,104
G
Stx11
syntaxin 11
increases expression
ISO
troglitazone results in increased expression of STX11 mRNA
CTD
PMID:19140230
NCBI chr 1:9,111,216...9,140,227
Ensembl chr 1:9,107,796...9,178,455
G
Stx1a
syntaxin 1A
increases expression
ISO
troglitazone results in increased expression of STX1A mRNA
CTD
PMID:19140230
NCBI chr12:27,278,517...27,306,547
Ensembl chr12:27,278,517...27,306,471
G
Stx3
syntaxin 3
increases expression
ISO
Troglitazone results in increased expression of STX3 mRNA
CTD
PMID:19140230
NCBI chr 1:217,940,697...218,114,865
Ensembl chr 1:217,909,169...218,110,466
G
Stx4
syntaxin 4
decreases expression
ISO
troglitazone results in decreased expression of STX4 mRNA
CTD
PMID:28973697
NCBI chr 1:191,880,549...191,890,333
Ensembl chr 1:191,881,559...191,896,774
G
Sugp2
SURP and G patch domain containing 2
decreases expression
ISO
troglitazone results in decreased expression of SUGP2 mRNA
CTD
PMID:28973697
NCBI chr16:19,193,910...19,225,364
Ensembl chr16:19,198,831...19,225,292
G
Sulf1
sulfatase 1
decreases expression
EXP
troglitazone results in decreased expression of SULF1 mRNA
CTD
PMID:21515302
NCBI chr 5:11,145,950...11,308,622
Ensembl chr 5:11,145,950...11,308,643
G
Sulf2
sulfatase 2
decreases expression increases expression
EXP ISO
troglitazone results in decreased expression of SULF2 mRNA troglitazone results in increased expression of SULF2 mRNA
CTD
PMID:25596134 PMID:28973697
NCBI chr 3:175,241,322...175,323,808
Ensembl chr 3:175,241,322...175,323,651
G
Sult1a1
sulfotransferase family 1A member 1
increases sulfation decreases expression
ISO EXP
SULT1A1 protein results in increased sulfation of troglitazone troglitazone results in decreased expression of SULT1A1 protein
CTD
PMID:11181495 PMID:21315101
NCBI chr 1:190,702,592...190,706,112
Ensembl chr 1:190,702,592...190,706,131
G
Sult2a2
sulfotransferase family 2A, dehydroepiandrosterone (DHEA)-preferring, member 2
increases expression
EXP
Troglitazone results in increased expression of SULT2A2 mRNA
CTD
PMID:21515302
NCBI chr 1:85,037,518...85,104,532
Ensembl chr 1:84,962,100...85,104,511
G
Sun2
Sad1 and UNC84 domain containing 2
decreases expression
ISO
troglitazone results in decreased expression of SUN2 mRNA
CTD
PMID:28973697
NCBI chr 7:113,155,766...113,172,950
Ensembl chr 7:113,155,766...113,172,940
G
Supt20h
SPT20 homolog, SAGA complex component
decreases expression
ISO
troglitazone results in decreased expression of SUPT20 mRNA
CTD
PMID:28973697
NCBI chr 2:141,047,479...141,080,656
Ensembl chr 2:141,047,477...141,081,361
G
Supt6h
SPT6 homolog, histone chaperone and transcription elongation factor
decreases expression
ISO
troglitazone results in decreased expression of SUPT6H mRNA
CTD
PMID:28973697
NCBI chr10:63,601,990...63,638,851
Ensembl chr10:63,601,993...63,638,851
G
Suv39h1
SUV39H1 histone lysine methyltransferase
decreases expression
ISO
Troglitazone results in decreased expression of SUV39H1 mRNA
CTD
PMID:19140230
NCBI chr X:17,093,059...17,105,942
Ensembl chr X:17,092,986...17,105,942
G
Suv39h1-ps1
SUV39H1 histone lysine methyltransferase, pseudogene 1
decreases expression
ISO
troglitazone results in decreased expression of SUV39H1 mRNA
CTD
PMID:19140230
NCBI chr X:146,828,818...146,831,485
G
Svep1
sushi, von Willebrand factor type A, EGF and pentraxin domain containing 1
increases expression
ISO
troglitazone results in increased expression of SVEP1 mRNA
CTD
PMID:28973697
NCBI chr 5:77,606,523...77,783,292
Ensembl chr 5:77,606,523...77,783,711
G
Svil
supervillin
increases expression
ISO
troglitazone results in increased expression of SVIL mRNA
CTD
PMID:19140230
NCBI chr17:57,343,910...57,539,508
Ensembl chr17:57,343,910...57,462,660
G
Syncrip
synaptotagmin binding, cytoplasmic RNA interacting protein
decreases expression
ISO
troglitazone results in decreased expression of SYNCRIP mRNA
CTD
PMID:28973697
NCBI chr 8:98,282,358...98,315,412
Ensembl chr 8:98,282,358...98,315,386
G
Syne1
spectrin repeat containing nuclear envelope protein 1
decreases expression
ISO
troglitazone results in decreased expression of SYNE1 mRNA
CTD
PMID:28973697
NCBI chr 1:43,917,640...44,388,802
Ensembl chr 1:43,895,994...44,388,721
G
Syne2
spectrin repeat containing nuclear envelope protein 2
decreases expression
ISO
troglitazone results in decreased expression of SYNE2 mRNA
CTD
PMID:28973697
NCBI chr 6:100,272,729...100,586,364
Ensembl chr 6:100,272,729...100,583,723
G
Syt7
synaptotagmin 7
decreases expression
ISO
troglitazone results in decreased expression of SYT7 mRNA
CTD
PMID:25572481
NCBI chr 1:216,456,148...216,518,718
Ensembl chr 1:216,456,259...216,518,718
G
Sytl5
synaptotagmin-like 5
decreases expression
EXP
troglitazone results in decreased expression of SYTL5 mRNA
CTD
PMID:21515302
NCBI chr X:15,461,215...15,702,660
Ensembl chr X:15,460,472...15,550,471
G
Szt2
SZT2 subunit of KICSTOR complex
decreases expression
ISO
troglitazone results in decreased expression of SZT2 mRNA
CTD
PMID:28973697
NCBI chr 5:137,182,648...137,229,349
Ensembl chr 5:137,182,648...137,229,419
G
Taar7a
trace amine-associated receptor 7a
increases expression
EXP
Troglitazone results in increased expression of TAAR7A mRNA
CTD
PMID:21515302
NCBI chr 1:23,270,177...23,271,253
Ensembl chr 1:23,270,177...23,271,253
G
Tab3
TGF-beta activated kinase 1 (MAP3K7) binding protein 3
decreases expression
ISO
troglitazone results in decreased expression of TAB3 mRNA
CTD
PMID:28973697
NCBI chr X:53,923,473...53,995,777
Ensembl chr X:53,923,492...53,995,610
G
Taf1
TATA-box binding protein associated factor 1
decreases expression increases degradation
ISO
troglitazone results in decreased expression of TAF1 protein troglitazone results in increased degradation of TAF1 protein
CTD
PMID:17409431
NCBI chr X:70,680,901...70,756,535
Ensembl chr X:70,680,906...70,756,735
G
Taf4
TATA-box binding protein associated factor 4
decreases expression
ISO
troglitazone results in decreased expression of TAF4 mRNA
CTD
PMID:28973697
NCBI chr 3:187,395,632...187,461,042
Ensembl chr 3:187,395,632...187,461,123
G
Taf5
TATA-box binding protein associated factor 5
decreases expression
ISO
troglitazone results in decreased expression of TAF5 mRNA
CTD
PMID:19140230
NCBI chr 1:255,899,774...255,915,259
Ensembl chr 1:255,899,770...255,915,268
G
Tafa3
TAFA chemokine like family member 3
decreases expression
ISO
Troglitazone results in decreased expression of TAFA3 mRNA
CTD
PMID:28973697
NCBI chr 2:194,952,499...194,968,776
Ensembl chr 2:194,954,998...194,962,061
G
Tagln
transgelin
decreases expression
EXP
troglitazone results in decreased expression of TAGLN mRNA
CTD
PMID:21515302
NCBI chr 8:55,121,647...55,127,121
Ensembl chr 8:55,121,301...55,127,563
G
Taldo1
transaldolase 1
increases expression decreases expression
ISO EXP
troglitazone results in increased expression of TALDO1 mRNA troglitazone results in decreased expression of TALDO1 mRNA
CTD
PMID:12732648 PMID:25596134
NCBI chr 1:205,923,196...205,933,526
Ensembl chr 1:205,923,165...205,933,535
G
Tanc1
tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1
decreases expression
ISO
troglitazone results in decreased expression of TANC1 mRNA
CTD
PMID:28973697
NCBI chr 3:64,508,037...64,741,826
Ensembl chr 3:64,508,085...64,741,825
G
Taok1
TAO kinase 1
decreases expression
ISO
troglitazone results in decreased expression of TAOK1 mRNA
CTD
PMID:28973697
NCBI chr10:62,871,198...62,989,049
Ensembl chr10:62,871,198...62,957,595
G
Taok3
TAO kinase 3
decreases expression
ISO
troglitazone results in decreased expression of TAOK3 mRNA
CTD
PMID:28973697
NCBI chr12:44,973,180...45,134,439
Ensembl chr12:44,973,180...45,134,439
G
Tardbp
TAR DNA binding protein
decreases expression
ISO
troglitazone results in decreased expression of TARDBP mRNA
CTD
PMID:28973697
NCBI chr 5:164,330,452...164,348,435
Ensembl chr 5:164,334,924...164,345,204
G
Tat
tyrosine aminotransferase
increases expression
EXP
troglitazone results in increased expression of TAT mRNA
CTD
PMID:21515302
NCBI chr19:54,856,604...54,867,168
Ensembl chr19:54,856,563...54,867,482
G
Tbc1d17
TBC1 domain family, member 17
decreases expression
ISO
troglitazone results in decreased expression of TBC1D17 mRNA
CTD
PMID:28973697
NCBI chr 1:104,461,266...104,469,615
Ensembl chr 1:104,461,267...104,469,489
G
Tbc1d21
TBC1 domain family, member 21
decreases expression
EXP
troglitazone results in decreased expression of TBC1D21 mRNA
CTD
PMID:21515302
NCBI chr 8:67,657,409...67,669,558
Ensembl chr 8:67,657,410...67,669,558
G
Tbc1d2b
TBC1 domain family, member 2B
decreases expression
ISO
troglitazone results in decreased expression of TBC1D2B mRNA
CTD
PMID:28973697
NCBI chr 8:99,626,019...99,694,669
Ensembl chr 8:99,626,019...99,694,637
G
Tbc1d30
TBC1 domain family, member 30
decreases expression
ISO
troglitazone results in decreased expression of TBC1D30 mRNA
CTD
PMID:28973697
NCBI chr 7:58,665,054...58,754,427
Ensembl chr 7:58,665,054...58,754,614
G
Tbc1d31
TBC1 domain family, member 31
increases expression
ISO
troglitazone results in increased expression of TBC1D31 mRNA
CTD
PMID:28973697
NCBI chr 7:91,316,905...91,396,434
Ensembl chr 7:91,316,921...91,396,434
G
Tbc1d4
TBC1 domain family, member 4
decreases expression
ISO
troglitazone results in decreased expression of TBC1D4 mRNA
CTD
PMID:28973697
NCBI chr15:84,670,756...84,848,876
Ensembl chr15:84,670,756...84,848,693
G
Tbcel
tubulin folding cofactor E-like
decreases expression
ISO
troglitazone results in decreased expression of TBCEL mRNA
CTD
PMID:28973697
NCBI chr 8:51,692,660...51,751,560
Ensembl chr 8:51,694,930...51,751,560
G
Tbl1xr1
TBL1X/Y related 1
decreases expression
ISO
troglitazone results in decreased expression of TBL1XR1 mRNA
CTD
PMID:28973697
NCBI chr 2:106,718,811...106,857,989
Ensembl chr 2:106,730,665...106,857,989
G
Tbpl1
TATA-box binding protein like 1
decreases expression
ISO
troglitazone results in decreased expression of TBPL1 mRNA
CTD
PMID:28973697
NCBI chr 1:24,597,028...24,622,445
Ensembl chr 1:24,597,074...24,622,439
G
Tbx3
T-box transcription factor 3
increases expression
ISO
troglitazone results in increased expression of TBX3 mRNA
CTD
PMID:17569031
NCBI chr12:42,540,378...42,555,490
Ensembl chr12:42,540,378...42,554,171
G
Tbxa2r
thromboxane A2 receptor
multiple interactions decreases expression decreases activity
ISO
troglitazone inhibits the reaction [TBXA2R protein results in increased transport of Calcium] troglitazone results in decreased expression of TBXA2R mRNA alternative form troglitazone results in decreased activity of TBXA2R protein
CTD
PMID:16499875
NCBI chr 7:9,034,077...9,041,489
Ensembl chr 7:9,034,108...9,038,905
G
Tcf20
transcription factor 20
decreases expression
ISO
troglitazone results in decreased expression of TCF20 mRNA
CTD
PMID:28973697
NCBI chr 7:115,833,523...116,009,790
Ensembl chr 7:115,834,416...115,931,915
G
Tcf24
transcription factor 24
decreases expression
ISO
troglitazone results in decreased expression of TCF24 mRNA
CTD
PMID:28973697
NCBI chr 5:14,057,482...14,064,615
Ensembl chr 5:14,058,039...14,063,345
G
Tcf4
transcription factor 4
decreases expression
ISO
troglitazone results in decreased expression of TCF4 mRNA
CTD
PMID:28973697
NCBI chr18:65,216,840...65,563,186
Ensembl chr18:65,216,849...65,558,401
G
Tcf7l1
transcription factor 7 like 1
decreases expression
ISO
troglitazone results in decreased expression of TCF7L1 mRNA
CTD
PMID:28973697
NCBI chr 4:106,238,892...106,404,012
Ensembl chr 4:106,238,896...106,403,421
G
Tcof1
treacle ribosome biogenesis factor 1
decreases expression
ISO
troglitazone results in decreased expression of TCOF1 mRNA
CTD
PMID:28973697
NCBI chr18:56,537,437...56,570,727
Ensembl chr18:56,537,437...56,570,727
G
Tcp11l2
t-complex 11 like 2
decreases expression
ISO
troglitazone results in decreased expression of TCP11L2 mRNA
CTD
PMID:28973697
NCBI chr 7:21,037,955...21,072,857
Ensembl chr 7:21,037,958...21,064,681
G
Tdrp
testis development related protein
increases expression
ISO
troglitazone results in increased expression of TDRP mRNA
CTD
PMID:28973697
NCBI chr16:82,326,837...82,354,861
Ensembl chr16:82,314,220...82,354,861
G
Tek
TEK receptor tyrosine kinase
multiple interactions increases expression
ISO
[Urethane co-treated with troglitazone] results in increased expression of TEK mRNA troglitazone results in increased expression of TEK mRNA
CTD
PMID:17569031 PMID:18465119
NCBI chr 5:114,722,815...114,849,535
Ensembl chr 5:114,723,006...114,849,991
G
Ten1
TEN1 subunit of CST complex
increases expression
ISO
troglitazone results in increased expression of TEN1 mRNA
CTD
PMID:28973697
NCBI chr10:101,930,212...101,951,932
Ensembl chr10:101,930,222...101,953,979
G
Tert
telomerase reverse transcriptase
decreases expression
ISO
troglitazone results in decreased expression of TERT mRNA
CTD
PMID:20650001
NCBI chr 1:31,465,766...31,488,650
Ensembl chr 1:31,466,056...31,488,111
G
Tex10
testis expressed 10
decreases expression
ISO
troglitazone results in decreased expression of TEX10 mRNA
CTD
PMID:28973697
NCBI chr 5:67,557,770...67,603,904
Ensembl chr 5:67,557,770...67,603,904
G
Tfam
transcription factor A, mitochondrial
multiple interactions decreases expression
ISO
benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [troglitazone results in decreased expression of TFAM mRNA]; PPARGC1A protein inhibits the reaction [troglitazone results in decreased expression of TFAM mRNA]
CTD
PMID:20860658
NCBI chr20:17,355,373...17,367,422
Ensembl chr20:17,355,363...17,369,877
G
Tfap2a
transcription factor AP-2 alpha
decreases expression multiple interactions
ISO
Troglitazone results in decreased expression of TFAP2A mRNA; Troglitazone results in decreased expression of TFAP2A protein [Troglitazone co-treated with 4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline] affects the expression of TFAP2A mRNA; [Troglitazone co-treated with 4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline] results in decreased expression of TFAP2A protein
CTD
PMID:32822399
NCBI chr17:24,230,064...24,253,219
Ensembl chr17:24,229,910...24,253,219
G
Tfap4
transcription factor AP-4
decreases expression
ISO
troglitazone results in decreased expression of TFAP4 mRNA
CTD
PMID:28973697
NCBI chr10:11,507,242...11,525,794
Ensembl chr10:11,485,565...11,525,794
G
Tfrc
transferrin receptor
increases expression
ISO
troglitazone results in increased expression of TFRC mRNA
CTD
PMID:28973697
NCBI chr11:81,668,478...81,690,318
Ensembl chr11:81,668,478...81,690,318
G
Tgfa
transforming growth factor alpha
increases expression
ISO
troglitazone results in increased expression of TGFA mRNA
CTD
PMID:19022234
NCBI chr 4:120,175,549...120,258,342
Ensembl chr 4:120,175,593...120,258,339
G
Tgfb1
transforming growth factor, beta 1
multiple interactions decreases expression
ISO EXP
Troglitazone inhibits the reaction [Glucose results in increased expression of TGFB1 mRNA]; Troglitazone inhibits the reaction [Glucose results in increased secretion of TGFB1 protein]; Troglitazone inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 mRNA]; Troglitazone inhibits the reaction [TGFB1 protein results in increased expression of CCN2 mRNA]; Troglitazone inhibits the reaction [TGFB1 protein results in increased expression of CCN2 protein]; Troglitazone inhibits the reaction [TGFB1 protein results in increased expression of FN1 mRNA]; Troglitazone inhibits the reaction [TGFB1 protein results in increased expression of FN1 protein] [troglitazone co-treated with Diethylnitrosamine] results in increased expression of TGFB1 mRNA troglitazone results in decreased expression of TGFB1 [troglitazone binds to and results in increased activity of TGFB1 mRNA] which results in decreased expression of SERPINE1 mRNA troglitazone results in decreased expression of TGFB1 mRNA
CTD
PMID:11318962 PMID:17056281 PMID:17199790 PMID:17611328 PMID:18162602 PMID:18597072 PMID:19429239 More...
NCBI chr 1:90,324,312...90,340,627
Ensembl chr 1:90,324,046...90,340,899
G
Tgfb2
transforming growth factor, beta 2
multiple interactions decreases response to substance increases expression
ISO EXP
Troglitazone inhibits the reaction [TGFB2 protein results in increased expression of COL1A1 mRNA]; Troglitazone inhibits the reaction [TGFB2 protein results in increased expression of FN1 mRNA]; Troglitazone inhibits the reaction [TGFB2 protein results in increased expression of FN1 protein]; Troglitazone inhibits the reaction [TGFB2 protein results in increased phosphorylation of and affects the localization of SMAD2 protein]; Troglitazone inhibits the reaction [TGFB2 protein results in increased phosphorylation of and affects the localization of SMAD3 protein] troglitazone results in decreased susceptibility to TGFB2 protein troglitazone results in increased expression of TGFB2 mRNA
CTD
PMID:17569031 PMID:18253093 PMID:21515302
NCBI chr13:100,691,540...100,793,227
Ensembl chr13:100,692,953...100,792,856
G
Tgfb3
transforming growth factor, beta 3
decreases expression
EXP
troglitazone results in decreased expression of TGFB3 mRNA
CTD
PMID:21515302
NCBI chr 6:111,435,170...111,457,646
Ensembl chr 6:111,435,170...111,456,946
G
Tgfbr2
transforming growth factor, beta receptor 2
decreases expression
ISO
troglitazone results in decreased expression of TGFBR2 mRNA
CTD
PMID:25572481
NCBI chr 8:124,672,677...124,761,741
Ensembl chr 8:124,674,986...124,761,469
G
Tgfbr3
transforming growth factor beta receptor 3
decreases expression
ISO
troglitazone results in decreased expression of TGFBR3 mRNA
CTD
PMID:28973697
NCBI chr14:2,634,294...2,810,269
Ensembl chr14:2,634,188...2,810,271
G
Tgm2
transglutaminase 2
decreases expression
EXP
troglitazone results in decreased expression of TGM2 mRNA
CTD
PMID:21515302
NCBI chr 3:167,192,612...167,221,845
Ensembl chr 3:167,192,612...167,304,240
G
Tgoln2
trans-golgi network protein 2
decreases expression
ISO
troglitazone results in decreased expression of TGOLN1 mRNA
CTD
PMID:28973697
NCBI chr 4:106,221,503...106,229,360
Ensembl chr 4:106,221,509...106,229,262
G
Tgs1
trimethylguanosine synthase 1
decreases expression
ISO
troglitazone results in decreased expression of TGS1 mRNA
CTD
PMID:28973697
NCBI chr 5:21,322,492...21,356,017
Ensembl chr 5:21,322,492...21,356,017
G
Thbd
thrombomodulin
decreases expression
ISO
troglitazone results in decreased expression of THBD mRNA
CTD
PMID:28973697
NCBI chr 3:156,316,526...156,320,178
Ensembl chr 3:156,306,632...156,320,582
G
Them7
thioesterase superfamily member 7
increases expression
ISO
Troglitazone results in increased expression of THEM7 mRNA
CTD
PMID:28973697
NCBI chr 3:112,120,929...112,358,940
Ensembl chr 3:112,120,937...112,289,569
G
Thra
thyroid hormone receptor alpha
decreases activity decreases expression
EXP ISO
troglitazone results in decreased activity of THRA protein troglitazone results in decreased expression of THRA mRNA
CTD
PMID:16023420 PMID:28973697
NCBI chr10:84,198,141...84,225,659
Ensembl chr10:84,197,011...84,225,657
G
Thrap3
thyroid hormone receptor associated protein 3
decreases expression
ISO
troglitazone results in decreased expression of THRAP3 mRNA
CTD
PMID:28973697
NCBI chr 5:143,729,821...143,772,105
Ensembl chr 5:143,730,596...143,771,983
G
Thrsp
thyroid hormone responsive
decreases expression increases expression
ISO
troglitazone results in decreased expression of THRSP mRNA troglitazone results in increased expression of THRSP mRNA
CTD
PMID:25572481 PMID:28973697
NCBI chr 1:161,134,640...161,138,964
Ensembl chr 1:161,133,453...161,139,827
G
Timeless
timeless circadian regulator
decreases expression
ISO
troglitazone results in decreased expression of TIMELESS mRNA
CTD
PMID:19140230
NCBI chr 7:1,239,388...1,263,344
Ensembl chr 7:1,239,450...1,263,337
G
Timm50
translocase of inner mitochondrial membrane 50
increases expression
EXP
troglitazone results in increased expression of TIMM50 protein
CTD
PMID:21315101
NCBI chr 1:92,702,437...92,710,311
Ensembl chr 1:92,702,437...92,710,311
G
Timp1
TIMP metallopeptidase inhibitor 1
multiple interactions increases expression
ISO
troglitazone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of TIMP1 mRNA] Troglitazone results in increased expression of TIMP1 mRNA
CTD
PMID:18155510 PMID:31294483
NCBI chr X:3,766,509...3,772,578
Ensembl chr X:3,766,510...3,771,135
G
Timp2
TIMP metallopeptidase inhibitor 2
increases expression
ISO
troglitazone results in increased expression of TIMP2 mRNA
CTD
PMID:28973697
NCBI chr10:104,041,604...104,089,214
Ensembl chr10:104,041,604...104,089,214
G
Tinagl1
tubulointerstitial nephritis antigen-like 1
increases expression
EXP
troglitazone results in increased expression of TINAGL1 mRNA
CTD
PMID:21515302
NCBI chr 5:147,797,884...147,807,925
Ensembl chr 5:147,797,892...147,807,871
G
Tinf2
TERF1 interacting nuclear factor 2
increases expression
ISO
troglitazone results in increased expression of TINF2 mRNA
CTD
PMID:19140230
NCBI chr15:33,140,611...33,146,930
Ensembl chr15:33,140,714...33,146,930
G
Tjp1
tight junction protein 1
decreases expression multiple interactions
ISO
troglitazone results in decreased expression of TJP1 mRNA Troglitazone results in increased expression of and affects the localization of TJP1 protein
CTD
PMID:28973697 PMID:40024757
NCBI chr 1:128,260,330...128,505,018
Ensembl chr 1:128,260,330...128,505,158
G
Tk1
thymidine kinase 1
decreases expression increases expression
ISO EXP
troglitazone results in decreased expression of TK1 mRNA troglitazone results in increased expression of TK1 mRNA
CTD
PMID:19140230 PMID:21515302
NCBI chr10:103,533,449...103,544,818
Ensembl chr10:103,533,449...103,556,228
G
Tkfc
triokinase and FMN cyclase
decreases expression
ISO
troglitazone results in decreased expression of TKFC mRNA
CTD
PMID:25572481
NCBI chr 1:216,664,446...216,677,815
Ensembl chr 1:216,661,477...216,677,928
G
Tle1
TLE family member 1, transcriptional corepressor
decreases expression
ISO
troglitazone results in decreased expression of TLE1 mRNA
CTD
PMID:28973697
NCBI chr 5:90,898,182...90,982,118
Ensembl chr 5:90,898,182...90,980,928
G
Tle4
TLE family member 4, transcriptional corepressor
decreases expression
ISO
troglitazone results in decreased expression of TLE4 mRNA
CTD
PMID:28973697
NCBI chr 1:221,086,250...221,222,826
Ensembl chr 1:221,086,253...221,222,826
G
Tlk2
tousled-like kinase 2
decreases expression
ISO
troglitazone results in decreased expression of TLK2 mRNA
CTD
PMID:28973697
NCBI chr10:90,648,623...90,748,427
Ensembl chr10:90,653,851...90,748,428
G
Tln1
talin 1
decreases expression
ISO
troglitazone results in decreased expression of TLN1 mRNA
CTD
PMID:28973697
NCBI chr 5:62,583,730...62,613,687
Ensembl chr 5:62,583,731...62,613,687
G
Tm6sf1
transmembrane 6 superfamily member 1
increases expression
ISO
troglitazone results in increased expression of TM6SF1 mRNA
CTD
PMID:28973697
NCBI chr 1:145,209,052...145,237,725
Ensembl chr 1:145,209,585...145,237,715
G
Tmc4
transmembrane channel-like 4
decreases expression
EXP
troglitazone results in decreased expression of TMC4 mRNA
CTD
PMID:21515302
NCBI chr 1:74,455,135...74,467,043
Ensembl chr 1:74,454,909...74,467,043
G
Tmcc1
transmembrane and coiled-coil domain family 1
decreases expression
ISO
troglitazone results in decreased expression of TMCC1 mRNA
CTD
PMID:28973697
NCBI chr 4:150,738,966...150,912,256
Ensembl chr 4:150,738,973...150,912,256
G
Tmcc3
transmembrane and coiled-coil domain family 3
decreases expression increases expression
ISO
troglitazone results in decreased expression of TMCC3 mRNA troglitazone results in increased expression of TMCC3 mRNA
CTD
PMID:28973697
NCBI chr 7:30,781,452...31,058,888
Ensembl chr 7:30,897,991...31,058,889
G
Tmed3
transmembrane p24 trafficking protein 3
increases expression
ISO
troglitazone results in increased expression of TMED3 mRNA
CTD
PMID:28973697
NCBI chr 8:99,121,361...99,129,653
Ensembl chr 8:99,121,361...99,129,215
G
Tmed7
transmembrane p24 trafficking protein 7
increases expression
ISO
troglitazone results in increased expression of TMED7 mRNA
CTD
PMID:28973697
NCBI chr18:41,505,167...41,512,243
Ensembl chr18:41,478,539...41,512,243
G
Tmem120a
transmembrane protein 120A
increases expression
ISO
troglitazone results in increased expression of TMEM120A mRNA
CTD
PMID:28973697
NCBI chr12:26,578,859...26,587,524
Ensembl chr12:26,578,859...26,587,524
G
Tmem14c
transmembrane protein 14C
increases expression
EXP
troglitazone results in increased expression of TMEM14C mRNA
CTD
PMID:21515302
NCBI chr17:23,939,501...23,945,622
Ensembl chr17:23,939,509...23,959,055
G
Tmem176a
transmembrane protein 176A
increases expression
ISO
troglitazone results in increased expression of TMEM176A mRNA
CTD
PMID:28973697
NCBI chr 4:79,101,946...79,109,499
Ensembl chr 4:79,101,857...79,111,175
G
Tmem177
transmembrane protein 177
multiple interactions
ISO
[troglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of TMEM177 mRNA; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of TMEM177 mRNA]
CTD
PMID:20847119
NCBI chr13:33,576,704...33,580,129
Ensembl chr13:33,574,281...33,582,159
G
Tmem186
transmembrane protein 186
decreases expression
ISO
troglitazone results in decreased expression of TMEM186 mRNA
CTD
PMID:28973697
NCBI chr10:7,489,599...7,492,917
Ensembl chr10:7,489,567...7,493,201
G
Tmem204
transmembrane protein 204
decreases expression
ISO
troglitazone results in decreased expression of TMEM204 mRNA
CTD
PMID:28973697
NCBI chr10:14,581,025...14,608,878
Ensembl chr10:14,581,026...14,606,427
G
Tmem41b
transmembrane protein 41B
decreases expression
ISO
troglitazone results in decreased expression of TMEM41B mRNA
CTD
PMID:28973697
NCBI chr 1:173,447,362...173,461,760
Ensembl chr 1:173,447,367...173,461,597
G
Tmem45b
transmembrane protein 45b
increases expression
ISO
troglitazone results in increased expression of TMEM45B mRNA
CTD
PMID:28973697
NCBI chr 8:38,123,423...38,168,599
Ensembl chr 8:38,123,423...38,168,599
G
Tmem54
transmembrane protein 54
increases expression
EXP
troglitazone results in increased expression of TMEM54 mRNA
CTD
PMID:21515302
NCBI chr 5:146,733,557...146,740,048
Ensembl chr 5:146,733,511...146,740,047
G
Tmem69
transmembrane protein 69
increases expression
ISO
troglitazone results in increased expression of TMEM69 mRNA
CTD
PMID:28973697
NCBI chr 5:135,241,557...135,247,323
Ensembl chr 5:135,241,560...135,247,215
G
Tmem82
transmembrane protein 82
increases expression
ISO
troglitazone results in increased expression of TMEM82 mRNA
CTD
PMID:28973697
NCBI chr 5:159,210,531...159,214,462
G
Tmem86a
transmembrane protein 86A
increases expression
ISO
troglitazone results in increased expression of TMEM86A mRNA
CTD
PMID:28973697
NCBI chr 1:106,732,168...106,736,518
Ensembl chr 1:106,661,042...106,736,516
G
Tmem97
transmembrane protein 97
decreases expression
ISO
troglitazone results in decreased expression of TMEM97 mRNA
CTD
PMID:19140230
NCBI chr10:63,936,276...63,945,359
Ensembl chr10:63,936,271...63,945,818
G
Tmem98
transmembrane protein 98
increases expression
ISO
troglitazone results in increased expression of TMEM98 mRNA
CTD
PMID:28973697
NCBI chr10:66,293,895...66,304,806
Ensembl chr10:66,293,867...66,304,803
G
Tmod1
tropomodulin 1
increases expression
ISO
troglitazone results in increased expression of TMOD1 mRNA
CTD
PMID:19140230
NCBI chr 5:65,112,062...65,189,563
Ensembl chr 5:65,134,132...65,189,561
G
Tmpo
thymopoietin
decreases expression
ISO
troglitazone results in decreased expression of TMPO mRNA
CTD
PMID:28973697
NCBI chr 7:27,529,977...27,554,980
Ensembl chr 7:27,529,978...27,554,937
G
Tmsb4x
thymosin beta 4, X-linked
decreases expression
EXP
troglitazone results in decreased expression of TMSB4X mRNA
CTD
PMID:21515302
NCBI chr X:30,761,611...30,763,612
Ensembl chr X:30,761,612...30,763,613
G
Tmt1b
thiol methyltransferase 1B
increases expression
EXP
Troglitazone results in increased expression of TMT1B mRNA
CTD
PMID:21515302
NCBI chr 7:1,973,334...1,975,980
Ensembl chr 7:1,973,337...1,975,980
G
Tmx3
thioredoxin-related transmembrane protein 3
decreases expression
ISO
troglitazone results in decreased expression of TMX3 mRNA
CTD
PMID:28973697
NCBI chr18:86,021,137...86,054,025
Ensembl chr18:86,021,084...86,054,198
G
Tnf
tumor necrosis factor
multiple interactions decreases activity increases expression decreases expression decreases response to substance
ISO EXP
Genistein promotes the reaction [troglitazone inhibits the reaction [TNF protein results in increased secretion of SERPINE1 protein]]; PPARA protein affects the reaction [troglitazone inhibits the reaction [TNF protein results in increased expression of CCL11 protein]]; T 0070907 inhibits the reaction [troglitazone inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]]; T 0070907 inhibits the reaction [troglitazone inhibits the reaction [Lipopolysaccharides results in increased secretion of TNF protein]]; troglitazone inhibits the reaction [Lipopolysaccharides results in increased secretion of TNF protein]; troglitazone inhibits the reaction [TNF protein inhibits the reaction [INS protein results in increased expression of CEBPA mRNA]]; troglitazone inhibits the reaction [TNF protein inhibits the reaction [INS protein results in increased uptake of Deoxyglucose]]; troglitazone inhibits the reaction [TNF protein inhibits the reaction [INS protein results in increased uptake of Glucose]]; troglitazone inhibits the reaction [TNF protein results in decreased expression of PPARG mRNA]; troglitazone inhibits the reaction [TNF protein results in increased expression of CCL11 mRNA]; troglitazone inhibits the reaction [TNF protein results in increased expression of CCL11 protein]; troglitazone inhibits the reaction [TNF protein results in increased expression of CCL2 protein]; troglitazone inhibits the reaction [TNF protein results in increased expression of SERPINE1 mRNA]; troglitazone inhibits the reaction [TNF protein results in increased secretion of SERPINE1 protein]; troglitazone promotes the reaction [[IFNG protein co-treated with TNF protein] results in increased expression of CDKN1A mRNA] troglitazone results in decreased activity of TNF protein troglitazone results in increased expression of TNF mRNA 2-chloro-5-nitrobenzanilide inhibits the reaction [[Troglitazone results in increased activity of PPARG protein] inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]]; 2-chloro-5-nitrobenzanilide inhibits the reaction [[Troglitazone results in increased activity of PPARG protein] inhibits the reaction [Lipopolysaccharides results in increased secretion of TNF protein]]; [Troglitazone results in increased activity of PPARG protein] inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]; [Troglitazone results in increased activity of PPARG protein] inhibits the reaction [Lipopolysaccharides results in increased secretion of TNF protein] troglitazone results in decreased expression of TNF mRNA; troglitazone results in decreased expression of TNF protein troglitazone results in decreased susceptibility to TNF protein troglitazone inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]; troglitazone inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein]
CTD
PMID:7956951 PMID:9502777 PMID:10441511 PMID:10807946 PMID:11328671 PMID:11911853 PMID:14534369 PMID:15531761 PMID:16483873 PMID:19631733 PMID:21153920 PMID:22124178 More...
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303
G
Tnfaip2
TNF alpha induced protein 2
decreases expression
EXP
troglitazone results in decreased expression of TNFAIP2 mRNA
CTD
PMID:21515302
NCBI chr 6:136,297,388...136,311,106
Ensembl chr 6:136,298,082...136,311,106
G
Tnfaip3
TNF alpha induced protein 3
increases expression
ISO
troglitazone results in increased expression of TNFAIP3 mRNA
CTD
PMID:19140230
NCBI chr 1:15,528,921...15,543,993
Ensembl chr 1:15,528,921...15,543,979
G
Tnfaip6
TNF alpha induced protein 6
increases expression
ISO
Troglitazone results in increased expression of TNFAIP6 mRNA
CTD
PMID:19140230 PMID:32816093
NCBI chr 3:56,911,398...56,930,797
Ensembl chr 3:56,911,252...56,930,796
G
Tnfaip8l1
TNF alpha induced protein 8 like 1
decreases expression
ISO
troglitazone results in decreased expression of TNFAIP8L1 mRNA
CTD
PMID:28973697
NCBI chr 9:1,075,724...1,088,256
Ensembl chr 9:1,055,801...1,092,803
G
Tnfaip8l2
TNF alpha induced protein 8 like 2
increases expression
ISO
troglitazone results in increased expression of TNFAIP8L2 mRNA
CTD
PMID:28973697
NCBI chr 2:185,399,442...185,415,798
Ensembl chr 2:185,397,029...185,418,455
G
Tnfrsf10b
TNF receptor superfamily member 10b
increases expression
ISO
troglitazone results in increased expression of TNFRSF10A mRNA
CTD
PMID:19140230
NCBI chr15:51,249,883...51,278,091
Ensembl chr15:51,250,112...51,278,082
G
Tnfrsf11b
TNF receptor superfamily member 11B
decreases expression
ISO
troglitazone results in decreased expression of TNFRSF11B mRNA
CTD
PMID:16813520 PMID:25572481
NCBI chr 7:87,456,318...87,484,324
Ensembl chr 7:87,456,319...87,485,075
G
Tnfrsf21
TNF receptor superfamily member 21
increases expression
ISO
troglitazone results in increased expression of TNFRSF21 mRNA
CTD
PMID:19140230
NCBI chr 9:25,376,400...25,451,323
Ensembl chr 9:25,376,400...25,451,323
G
Tnfrsf9
TNF receptor superfamily member 9
decreases expression
EXP
troglitazone results in decreased expression of TNFRSF9 mRNA
CTD
PMID:21515302
NCBI chr 5:166,664,494...166,690,834
Ensembl chr 5:166,664,494...166,690,831
G
Tnfsf10
TNF superfamily member 10
increases response to substance decreases expression
ISO
troglitazone results in increased susceptibility to TNFSF10 protein troglitazone results in decreased expression of TNFSF10 mRNA
CTD
PMID:16820965 PMID:19631733
NCBI chr 2:112,136,550...112,155,903
G
Tnfsf11
TNF superfamily member 11
decreases expression
ISO
troglitazone results in decreased expression of TNFSF11 mRNA
CTD
PMID:16813520
NCBI chr15:60,083,008...60,114,479
Ensembl chr15:60,083,008...60,114,479
G
Tnfsf9
TNF superfamily member 9
decreases expression
EXP
troglitazone results in decreased expression of TNFSF9 mRNA
CTD
PMID:21515302
NCBI chr 9:2,031,011...2,033,345
Ensembl chr 9:2,030,953...2,033,339
G
Tnks2
tankyrase 2
decreases expression
ISO
troglitazone results in decreased expression of TNKS2 mRNA
CTD
PMID:28973697
NCBI chr 1:243,980,432...244,033,629
Ensembl chr 1:243,980,414...244,033,634
G
Tnpo1
transportin 1
decreases expression
ISO
troglitazone results in decreased expression of TNPO1 mRNA
CTD
PMID:28973697
NCBI chr 2:31,941,731...32,034,366
Ensembl chr 2:31,941,731...32,034,326
G
Tnpo2
transportin 2
decreases expression
ISO
troglitazone results in decreased expression of TNPO2 mRNA
CTD
PMID:28973697
NCBI chr19:40,004,271...40,024,565
Ensembl chr19:40,004,275...40,024,187
G
Tnrc18
trinucleotide repeat containing 18
decreases expression
ISO
troglitazone results in decreased expression of TNRC18 mRNA
CTD
PMID:28973697
NCBI chr12:16,868,930...16,965,224
Ensembl chr12:16,868,978...16,965,217
G
Tnrc6a
trinucleotide repeat containing adaptor 6A
decreases expression
ISO
troglitazone results in decreased expression of TNRC6A mRNA
CTD
PMID:28973697
NCBI chr 1:186,992,457...187,146,764
Ensembl chr 1:186,992,504...187,146,756
G
Tnrc6b
trinucleotide repeat containing adaptor 6B
decreases expression
ISO
troglitazone results in decreased expression of TNRC6B mRNA
CTD
PMID:28973697
NCBI chr 7:114,132,574...114,350,010
Ensembl chr 7:114,132,573...114,342,973
G
Tnrc6c
trinucleotide repeat containing adaptor 6C
decreases expression
ISO
troglitazone results in decreased expression of TNRC6C mRNA
CTD
PMID:28973697
NCBI chr10:103,367,498...103,478,246
Ensembl chr10:103,367,647...103,478,246
G
Tob2
transducer of ERBB2, 2
decreases expression
ISO
troglitazone results in decreased expression of TOB2 mRNA
CTD
PMID:28973697
NCBI chr 7:115,242,843...115,251,563
Ensembl chr 7:115,239,895...115,258,155
G
Tomm20
translocase of outer mitochondrial membrane 20
increases expression
ISO
troglitazone results in increased expression of TOMM20 mRNA
CTD
PMID:28973697
NCBI chr19:71,822,429...71,832,420
Ensembl chr19:71,822,411...71,832,510
G
Top2a
DNA topoisomerase II alpha
decreases expression
ISO
troglitazone results in decreased expression of TOP2A mRNA
CTD
PMID:19140230
NCBI chr10:84,441,954...84,473,093
Ensembl chr10:84,441,954...84,473,366
G
Topbp1
DNA topoisomerase II binding protein 1
decreases expression
ISO
troglitazone results in decreased expression of TOPBP1 mRNA
CTD
PMID:19140230
NCBI chr 8:112,766,791...112,815,203
Ensembl chr 8:112,766,508...112,810,540
G
Tor3a
torsin family 3, member A
increases expression
EXP ISO
troglitazone results in increased expression of TOR3A mRNA
CTD
PMID:21515302 PMID:28973697
NCBI chr13:71,324,073...71,348,625
Ensembl chr13:71,324,076...71,348,624
G
Tp53
tumor protein p53
increases response to substance increases expression multiple interactions decreases expression
ISO EXP
TP53 protein results in increased susceptibility to troglitazone troglitazone results in increased expression of TP53 mRNA; troglitazone results in increased expression of TP53 protein troglitazone promotes the reaction [TP53 protein results in increased expression of PRODH mRNA] troglitazone results in decreased expression of TP53 mRNA
CTD
PMID:11068018 PMID:12595159 PMID:12824901 PMID:15767042 PMID:16303758 PMID:16374840 PMID:17143939 PMID:19631733 More...
NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,798,851...54,810,299
G
Tp53inp1
tumor protein p53 inducible nuclear protein 1
decreases expression
ISO
troglitazone results in decreased expression of TRP53INP1 mRNA
CTD
PMID:17569031
NCBI chr 5:29,051,267...29,069,486
Ensembl chr 5:29,051,264...29,069,484
G
Tp63
tumor protein p63
multiple interactions decreases expression
ISO
[Troglitazone co-treated with 4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline] results in decreased expression of TP63 mRNA; [Troglitazone co-treated with 4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline] results in decreased expression of TP63 protein Troglitazone results in decreased expression of TP63 mRNA; Troglitazone results in decreased expression of TP63 protein
CTD
PMID:32822399
NCBI chr11:88,343,647...88,554,543
Ensembl chr11:88,343,651...88,554,177
G
Tpbg
trophoblast glycoprotein
increases expression
ISO
troglitazone results in increased expression of TPBG mRNA
CTD
PMID:19140230
NCBI chr 8:95,673,993...95,677,364
Ensembl chr 8:95,629,267...95,678,394
G
Tpcn1
two pore segment channel 1
decreases expression
ISO
troglitazone results in decreased expression of TPCN1 mRNA
CTD
PMID:28973697
NCBI chr12:41,633,399...41,690,200
Ensembl chr12:41,633,398...41,690,200
G
Tpd52l1
TPD52 like 1
decreases expression
ISO
troglitazone results in decreased expression of TPD52L1 mRNA
CTD
PMID:19140230
NCBI chr 1:27,991,114...28,109,767
Ensembl chr 1:27,991,131...28,110,158
G
Tpk1
thiamin pyrophosphokinase 1
increases expression
ISO
troglitazone results in increased expression of TPK1 mRNA
CTD
PMID:28973697
NCBI chr 4:73,170,125...73,557,683
Ensembl chr 4:73,170,125...73,557,783
G
Tpm1
tropomyosin 1
multiple interactions
ISO
troglitazone promotes the reaction [Diethylnitrosamine results in increased expression of TPM1 mRNA]
CTD
PMID:18597072
NCBI chr 8:76,516,654...76,543,661
Ensembl chr 8:76,511,871...76,543,468
G
Tpmt
thiopurine S-methyltransferase
decreases expression increases expression
EXP ISO
troglitazone results in decreased expression of TPMT protein troglitazone results in increased expression of TPMT mRNA
CTD
PMID:21315101 PMID:28973697
NCBI chr17:17,850,308...17,868,976
Ensembl chr17:17,850,279...17,868,976
G
Tpo
thyroid peroxidase
decreases expression
EXP
troglitazone results in decreased expression of TPO mRNA
CTD
PMID:21515302
NCBI chr 6:52,425,998...52,495,793
Ensembl chr 6:52,426,010...52,495,793
G
Tpr
translocated promoter region, nuclear basket protein
decreases expression
ISO
troglitazone results in decreased expression of TPR mRNA
CTD
PMID:28973697
NCBI chr13:64,974,419...65,037,604
Ensembl chr13:64,974,419...65,037,602
G
Tpsab1
tryptase alpha/beta 1
increases expression
ISO
troglitazone results in increased expression of TPSAB1 mRNA
CTD
PMID:28973697
NCBI chr10:14,864,887...14,867,302
Ensembl chr10:14,864,887...14,867,302
G
Tpst1
tyrosylprotein sulfotransferase 1
increases expression
ISO
troglitazone results in increased expression of TPST1 mRNA
CTD
PMID:28973697
NCBI chr12:32,180,688...32,247,478
Ensembl chr12:32,180,936...32,241,821
G
Tpx2
TPX2, microtubule nucleation factor
decreases expression
ISO
troglitazone results in decreased expression of TPX2 mRNA
CTD
PMID:19140230
NCBI chr 3:161,778,709...161,820,941
Ensembl chr 3:161,778,742...161,820,724
G
Trak1
trafficking kinesin protein 1
increases expression
ISO
troglitazone results in increased expression of TRAK1 mRNA
CTD
PMID:19140230
NCBI chr 8:129,861,967...130,016,870
Ensembl chr 8:129,861,977...130,016,870
G
Tram2
translocation associated membrane protein 2
decreases expression
ISO
troglitazone results in decreased expression of TRAM2 mRNA
CTD
PMID:28973697
NCBI chr 9:30,915,624...30,995,162
Ensembl chr 9:30,915,624...30,995,162
G
Trib3
tribbles pseudokinase 3
increases expression decreases expression
ISO
troglitazone results in increased expression of TRIB3 mRNA troglitazone results in decreased expression of TRIB3 mRNA
CTD
PMID:19140230 PMID:25572481 PMID:28973697
NCBI chr 3:161,269,939...161,275,533
Ensembl chr 3:161,269,955...161,274,802
G
Trim17
tripartite motif-containing 17
multiple interactions
ISO
2-chloro-5-nitrobenzanilide inhibits the reaction [troglitazone promotes the reaction [Diethylhexyl Phthalate results in increased expression of TRIM17 protein]]; troglitazone promotes the reaction [Diethylhexyl Phthalate results in increased expression of TRIM17 protein]
CTD
PMID:21856391
NCBI chr10:44,242,688...44,250,504
Ensembl chr10:44,240,184...44,250,494
G
Trim2
tripartite motif-containing 2
increases expression
ISO
troglitazone results in increased expression of TRIM2 mRNA
CTD
PMID:28973697
NCBI chr 2:171,798,654...171,950,193
Ensembl chr 2:171,798,660...171,913,468
G
Trim26
tripartite motif-containing 26
decreases expression
ISO
troglitazone results in decreased expression of TRIM26 mRNA
CTD
PMID:28973697
NCBI chr20:1,711,564...1,736,389
Ensembl chr20:1,715,005...1,736,623
G
Trim27
tripartite motif-containing 27
decreases expression
ISO
troglitazone results in decreased expression of TRIM27 mRNA
CTD
PMID:28973697
NCBI chr17:48,233,999...48,246,348
Ensembl chr17:48,234,002...48,246,348
G
Trim29
tripartite motif-containing 29
decreases expression multiple interactions
ISO
Troglitazone results in decreased expression of TRIM29 mRNA [Troglitazone co-treated with 4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline] affects the expression of TRIM29 mRNA; [Troglitazone co-treated with 4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline] results in decreased expression of TRIM29 protein
CTD
PMID:32822399
NCBI chr 8:52,579,175...52,603,919
Ensembl chr 8:52,579,175...52,603,919
G
Trim33
tripartite motif-containing 33
decreases expression
ISO
troglitazone results in decreased expression of TRIM33 mRNA
CTD
PMID:28973697
NCBI chr 2:193,495,743...193,588,595
Ensembl chr 2:193,500,755...193,581,156
G
Trim38
tripartite motif containing 38
increases expression
ISO
troglitazone results in increased expression of TRIM38 mRNA
CTD
PMID:25572481
NCBI chr17:41,774,419...41,787,709
G
Trim56
tripartite motif containing 56
decreases expression
ISO
Troglitazone results in decreased expression of TRIM56 mRNA
CTD
PMID:28973697
NCBI chr12:25,193,224...25,204,032
Ensembl chr12:25,188,167...25,206,855
G
Trim80
tripartite motif protein 80
decreases expression
EXP
Troglitazone results in decreased expression of TRIM80 mRNA
CTD
PMID:21515302
NCBI chr10:101,181,797...101,190,122
Ensembl chr10:101,181,353...101,190,122
G
Trio
trio Rho guanine nucleotide exchange factor
decreases expression
ISO
troglitazone results in decreased expression of TRIO mRNA
CTD
PMID:28973697
NCBI chr 2:80,235,485...80,531,824
Ensembl chr 2:80,235,485...80,531,612
G
Trip12
thyroid hormone receptor interactor 12
decreases expression
ISO
troglitazone results in decreased expression of TRIP12 mRNA
CTD
PMID:28973697
NCBI chr 9:93,364,791...93,491,015
Ensembl chr 9:93,364,791...93,490,159
G
Trip13
thyroid hormone receptor interactor 13
decreases expression
ISO
troglitazone results in decreased expression of TRIP13 mRNA
CTD
PMID:19140230
NCBI chr 1:31,185,700...31,230,638
Ensembl chr 1:31,185,594...31,230,634
G
Trip6
thyroid hormone receptor interactor 6
decreases expression
ISO
troglitazone results in decreased expression of TRIP6 mRNA
CTD
PMID:19140230
NCBI chr12:25,022,959...25,027,366
Ensembl chr12:25,022,909...25,027,363
G
Trpc3
transient receptor potential cation channel, subfamily C, member 3
decreases expression
ISO
troglitazone results in decreased expression of TRPC3 mRNA
CTD
PMID:28973697
NCBI chr 2:121,409,436...121,487,095
Ensembl chr 2:121,409,436...121,475,823
G
Trpv4
transient receptor potential cation channel, subfamily V, member 4
increases expression
ISO
troglitazone results in increased expression of TRPV4 mRNA
CTD
PMID:28973697
NCBI chr12:47,599,161...47,638,143
Ensembl chr12:47,599,035...47,638,143
G
Tsc1
TSC complex subunit 1
decreases expression
ISO
troglitazone results in decreased expression of TSC1 mRNA
CTD
PMID:28973697
NCBI chr 3:32,367,434...32,416,565
Ensembl chr 3:32,367,670...32,416,568
G
Tsc22d1
TSC22 domain family, member 1
increases expression
ISO
troglitazone results in increased expression of TSC22D1 mRNA
CTD
PMID:19140230
NCBI chr15:58,159,612...58,260,244
Ensembl chr15:58,159,952...58,183,322
G
Tshz1
teashirt zinc finger homeobox 1
decreases expression
ISO
troglitazone results in decreased expression of TSHZ1 mRNA
CTD
PMID:28973697
NCBI chr18:79,651,256...79,727,662
Ensembl chr18:79,651,256...79,727,662
G
Tsku
tsukushi, small leucine rich proteoglycan
increases expression
EXP
troglitazone results in increased expression of TSKU mRNA
CTD
PMID:21515302
NCBI chr 1:162,071,459...162,082,972
Ensembl chr 1:162,064,126...162,089,272
G
Tspan3
tetraspanin 3
decreases expression
ISO
troglitazone results in decreased expression of TSPAN3 mRNA
CTD
PMID:19140230
NCBI chr 8:65,442,100...65,465,961
Ensembl chr 8:65,442,101...65,465,844
G
Tst
thiosulfate sulfurtransferase
decreases expression
ISO
troglitazone results in decreased expression of TST mRNA
CTD
PMID:12732648
NCBI chr 7:111,828,557...111,836,980
Ensembl chr 7:111,828,558...111,837,116
G
Ttc19
tetratricopeptide repeat domain 19
increases expression
ISO
troglitazone results in increased expression of TTC19 mRNA
CTD
PMID:28973697
NCBI chr10:47,469,043...47,496,923
Ensembl chr10:47,469,043...47,517,286
G
Ttc28
tetratricopeptide repeat domain 28
decreases expression
ISO
troglitazone results in decreased expression of TTC28 mRNA
CTD
PMID:28973697
NCBI chr12:51,002,816...51,443,461
Ensembl chr12:51,005,089...51,443,531
G
Ttc38
tetratricopeptide repeat domain 38
decreases expression
ISO
troglitazone results in decreased expression of TTC38 mRNA
CTD
PMID:28973697
NCBI chr 7:118,805,115...118,828,449
Ensembl chr 7:118,804,047...118,828,453
G
Ttc39c
tetratricopeptide repeat domain 39C
decreases expression
ISO
troglitazone results in decreased expression of TTC39C mRNA
CTD
PMID:28973697
NCBI chr18:4,043,364...4,162,660
Ensembl chr18:4,080,391...4,165,315
G
Ttc41
tetratricopeptide repeat domain 41
decreases expression
ISO
Troglitazone results in decreased expression of NT5DC3 mRNA
CTD
PMID:28973697
NCBI chr 7:23,012,439...23,075,715
Ensembl chr 7:23,011,740...23,075,716
G
Ttf2
transcription termination factor 2
decreases expression
ISO
troglitazone results in decreased expression of TTF2 mRNA
CTD
PMID:19140230
NCBI chr 2:191,054,942...191,086,331
Ensembl chr 2:191,054,966...191,086,386
G
Ttk
Ttk protein kinase
decreases expression
ISO
troglitazone results in decreased expression of TTK mRNA
CTD
PMID:19140230
NCBI chr 8:93,632,678...93,672,664
Ensembl chr 8:93,634,319...93,672,664
G
Ttpa
alpha tocopherol transfer protein
increases expression
EXP
troglitazone results in increased expression of TTPA protein
CTD
PMID:21315101
NCBI chr 5:38,294,415...38,315,471
Ensembl chr 5:38,292,665...38,315,804
G
Tubgcp6
tubulin gamma complex component 6
decreases expression
ISO
troglitazone results in decreased expression of TUBGCP6 mRNA
CTD
PMID:28973697
NCBI chr 7:122,057,328...122,078,639
Ensembl chr 7:122,057,328...122,078,490
G
Tug1
taurine up-regulated 1
decreases expression
ISO
troglitazone results in decreased expression of TUG1 mRNA
CTD
PMID:28973697
NCBI chr14:82,743,501...82,750,534
Ensembl chr14:82,746,113...82,750,534
G
Txn1
thioredoxin 1
increases expression
ISO
troglitazone results in increased expression of TXN mRNA
CTD
PMID:19022234
NCBI chr 5:77,507,455...77,519,685
Ensembl chr 5:77,507,321...77,520,307
G
Txn2
thioredoxin 2
increases expression multiple interactions increases oxidation
ISO
troglitazone results in increased expression of TXN2 protein mito-carboxy proxyl inhibits the reaction [troglitazone results in increased oxidation of TXN2 protein]
CTD
PMID:17975114 PMID:18495193
NCBI chr 7:111,377,338...111,390,940
Ensembl chr 7:111,386,805...111,390,022
G
Txnip
thioredoxin interacting protein
increases expression decreases expression
EXP ISO
troglitazone results in increased expression of TXNIP mRNA troglitazone results in decreased expression of TXNIP mRNA
CTD
PMID:21515302 PMID:25572481 PMID:25669987 PMID:28973697
NCBI chr 2:186,781,933...186,785,736
Ensembl chr 2:186,781,163...186,785,731
G
Txnl1
thioredoxin-like 1
decreases expression
ISO
troglitazone results in decreased expression of TXNL1 mRNA
CTD
PMID:28973697
NCBI chr18:59,397,275...59,428,072
Ensembl chr18:59,398,535...59,435,518
G
Tyms
thymidylate synthetase
decreases expression
ISO
troglitazone results in decreased expression of TYMS mRNA
CTD
PMID:19140230
NCBI chr 9:120,760,057...120,776,149
Ensembl chr 9:120,763,386...120,776,097
G
Tyrobp
transmembrane immune signaling adaptor Tyrobp
increases expression
ISO
troglitazone results in increased expression of TYROBP mRNA
CTD
PMID:28973697
NCBI chr 1:94,800,372...94,804,307
Ensembl chr 1:94,800,117...94,804,299
G
U2surp
U2 snRNP-associated SURP domain containing
decreases expression
ISO
troglitazone results in decreased expression of U2SURP mRNA
CTD
PMID:28973697
NCBI chr 8:104,898,580...104,963,642
Ensembl chr 8:104,898,425...104,955,422
G
Uap1l1
UDP-N-acetylglucosamine pyrophosphorylase 1 like 1
increases expression
ISO
troglitazone results in increased expression of UAP1L1 mRNA
CTD
PMID:28973697
NCBI chr 3:28,570,854...28,579,766
Ensembl chr 3:28,573,358...28,578,630
G
Ubap2l
ubiquitin associated protein 2-like
decreases expression
ISO
troglitazone results in decreased expression of UBAP2L mRNA
CTD
PMID:28973697
NCBI chr 2:177,736,378...177,791,746
Ensembl chr 2:177,736,696...177,791,646
G
Ube2c
ubiquitin-conjugating enzyme E2C
decreases expression
ISO
troglitazone results in decreased expression of UBE2C mRNA
CTD
PMID:19140230
NCBI chr 3:173,925,975...173,928,375
Ensembl chr 3:173,925,934...173,932,678
G
Ube2g2
ubiquitin-conjugating enzyme E2G 2
increases expression
ISO
troglitazone results in increased expression of UBE2G2 mRNA
CTD
PMID:28973697
NCBI chr20:10,983,322...11,005,060
Ensembl chr20:10,983,325...11,005,187
G
Ube2h
ubiquitin-conjugating enzyme E2H
decreases expression
ISO
troglitazone results in decreased expression of UBE2H mRNA
CTD
PMID:28973697
NCBI chr 4:59,802,102...59,897,583
Ensembl chr 4:59,802,102...59,897,583
G
Ube2r2
ubiquitin-conjugating enzyme E2R 2
decreases expression
ISO
troglitazone results in decreased expression of UBE2R2 mRNA
CTD
PMID:28973697
NCBI chr 5:61,082,552...61,141,099
Ensembl chr 5:61,082,552...61,141,452
G
Ube2w
ubiquitin-conjugating enzyme E2W
increases expression
ISO
troglitazone results in increased expression of UBE2W mRNA
CTD
PMID:28973697
NCBI chr 5:7,474,039...7,531,526
Ensembl chr 5:7,474,003...7,598,245
G
Ube3a
ubiquitin protein ligase E3A
decreases expression
ISO
troglitazone results in decreased expression of UBE3A mRNA
CTD
PMID:28973697
NCBI chr 1:119,204,244...119,297,097
Ensembl chr 1:119,206,148...119,297,097
G
Ube4a
ubiquitination factor E4A
increases expression
ISO
troglitazone results in increased expression of UBE4A mRNA
CTD
PMID:28973697
NCBI chr 8:54,132,799...54,174,921
Ensembl chr 8:54,132,801...54,174,835
G
Ube4b
ubiquitination factor E4B
decreases expression
ISO
troglitazone results in decreased expression of UBE4B mRNA
CTD
PMID:28973697
NCBI chr 5:165,049,897...165,153,572
Ensembl chr 5:165,049,897...165,153,572
G
Ubfd1
ubiquitin family domain containing 1
increases expression
ISO
troglitazone results in increased expression of UBFD1 mRNA
CTD
PMID:28973697
NCBI chr 1:186,057,267...186,068,832
Ensembl chr 1:186,057,123...186,066,103
G
Ubn1
ubinuclein 1
decreases expression
ISO
troglitazone results in decreased expression of UBN1 mRNA
CTD
PMID:28973697
NCBI chr10:11,003,036...11,038,466
Ensembl chr10:11,003,036...11,038,466
G
Ubr4
ubiquitin protein ligase E3 component n-recognin 4
decreases expression
ISO
troglitazone results in decreased expression of UBR4 mRNA
CTD
PMID:28973697
NCBI chr 5:156,919,029...157,027,127
Ensembl chr 5:156,919,085...157,027,127
G
Ucp2
uncoupling protein 2
multiple interactions increases expression decreases expression
ISO EXP
[troglitazone results in increased activity of PPARG protein] which results in increased expression of UCP2 mRNA troglitazone results in increased expression of UCP2 mRNA troglitazone results in decreased expression of UCP2 mRNA
CTD
PMID:9268716 PMID:11056218 PMID:11089532 PMID:12953171 PMID:21515302 PMID:28973697 More...
NCBI chr 1:164,251,373...164,257,742
Ensembl chr 1:164,251,373...164,257,743
G
Ucp3
uncoupling protein 3
affects expression increases expression decreases expression multiple interactions
ISO EXP
troglitazone affects the expression of UCP3 mRNA troglitazone results in increased expression of UCP3 mRNA troglitazone results in decreased expression of UCP3 mRNA Oleic Acid inhibits the reaction [troglitazone results in decreased expression of UCP3 mRNA]
CTD
PMID:10909982 PMID:11056218 PMID:11118623 PMID:12920214
NCBI chr 1:164,227,910...164,240,893
Ensembl chr 1:164,227,882...164,241,210
G
Ugdh
UDP-glucose 6-dehydrogenase
increases expression
ISO
troglitazone results in increased expression of UGDH mRNA
CTD
PMID:28973697
NCBI chr14:43,202,480...43,226,002
Ensembl chr14:43,202,356...43,226,629
G
Ugp2
UDP-glucose pyrophosphorylase 2
decreases expression
ISO
troglitazone results in decreased expression of UGP2 mRNA
CTD
PMID:28973697
NCBI chr14:99,657,637...99,698,573
Ensembl chr14:99,657,639...99,698,002
G
Ugt1a1
UDP glucuronosyltransferase family 1 member A1
increases glucuronidation increases expression
ISO
UGT1A1 protein results in increased glucuronidation of troglitazone troglitazone results in increased expression of UGT1A1 mRNA
CTD
PMID:11201174 PMID:25572481
NCBI chr 9:96,249,143...96,256,264
Ensembl chr 9:96,144,786...96,256,264
G
Ugt1a5
UDP glucuronosyltransferase family 1 member A5
decreases expression increases expression
ISO
troglitazone results in decreased expression of UGT1A4 mRNA troglitazone results in increased expression of UGT1A4 mRNA
CTD
PMID:19631733
NCBI chr 9:96,210,053...96,256,264
Ensembl chr 9:96,144,786...96,256,264
G
Ugt2b
UDP glycosyltransferase 2 family, polypeptide B
increases glucuronidation
EXP
UGT2B protein results in increased glucuronidation of troglitazone
CTD
PMID:11201174
NCBI chr14:20,985,449...21,006,267
Ensembl chr14:20,985,108...21,020,850
G
Uhrf1
ubiquitin-like with PHD and ring finger domains 1
decreases expression
ISO
troglitazone results in decreased expression of UHRF1 mRNA
CTD
PMID:19140230
NCBI chr 9:1,220,162...1,241,792
Ensembl chr 9:1,222,063...1,241,792
G
Ulk1
unc-51 like autophagy activating kinase 1
decreases expression
ISO
troglitazone results in decreased expression of ULK1 mRNA
CTD
PMID:28973697
NCBI chr12:51,511,492...51,537,746
Ensembl chr12:51,511,492...51,537,746
G
Umps
uridine monophosphate synthetase
multiple interactions
ISO
[troglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of UMPS mRNA; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of UMPS mRNA]
CTD
PMID:20847119
NCBI chr11:80,311,269...80,321,678
Ensembl chr11:80,311,214...80,327,828
G
Unc5b
unc-5 netrin receptor B
increases expression decreases expression
EXP ISO
troglitazone results in increased expression of UNC5B mRNA troglitazone results in decreased expression of UNC5B mRNA
CTD
PMID:21515302 PMID:28973697
NCBI chr20:29,240,639...29,307,270
Ensembl chr20:29,240,650...29,307,270
G
Ung
uracil-DNA glycosylase
decreases expression increases expression
ISO
troglitazone results in decreased expression of UNG mRNA troglitazone results in increased expression of UNG mRNA
CTD
PMID:19631733
NCBI chr12:48,145,838...48,154,789
Ensembl chr12:48,145,838...48,155,257
G
Upb1
beta-ureidopropionase 1
decreases expression
ISO
troglitazone results in decreased expression of UPB1 mRNA
CTD
PMID:25572481
NCBI chr20:13,216,693...13,243,016
Ensembl chr20:13,216,691...13,277,562
G
Upf1
UPF1, RNA helicase and ATPase
decreases expression
ISO
troglitazone results in decreased expression of UPF1 mRNA
CTD
PMID:28973697
NCBI chr16:19,110,531...19,131,327
Ensembl chr16:19,110,538...19,131,327
G
Upf2
UPF2, regulator of nonsense mediated mRNA decay
decreases expression
ISO
troglitazone results in decreased expression of UPF2 mRNA
CTD
PMID:28973697
NCBI chr17:77,133,975...77,245,266
Ensembl chr17:77,134,716...77,245,704
G
Upf3b
UPF3B, regulator of nonsense mediated mRNA decay
decreases expression
ISO
troglitazone results in decreased expression of UPF3B mRNA
CTD
PMID:28973697
NCBI chr X:121,200,993...121,219,059
Ensembl chr X:121,200,993...121,218,921
G
Uqcrc1
ubiquinol-cytochrome c reductase core protein 1
increases expression
ISO
troglitazone results in increased expression of UQCRC1 protein
CTD
PMID:18495193
NCBI chr 8:118,468,223...118,479,968
Ensembl chr 8:118,468,200...118,479,964
G
Ush1c
USH1 protein network component harmonin
decreases expression
EXP
troglitazone results in decreased expression of USH1C mRNA
CTD
PMID:21515302
NCBI chr 1:105,831,719...105,880,082
Ensembl chr 1:105,831,723...105,880,082
G
Usp2
ubiquitin specific peptidase 2
increases expression
EXP
troglitazone results in increased expression of USP2 mRNA
CTD
PMID:21515302
NCBI chr 8:53,308,264...53,336,800
Ensembl chr 8:53,308,303...53,336,794
G
Usp24
ubiquitin specific peptidase 24
decreases expression
ISO
troglitazone results in decreased expression of USP24 mRNA
CTD
PMID:28973697
NCBI chr 5:126,309,396...126,439,147
Ensembl chr 5:126,309,597...126,439,135
G
Usp6nl
USP6 N-terminal like
decreases expression
ISO
troglitazone results in decreased expression of USP6NL mRNA
CTD
PMID:28973697
NCBI chr17:76,737,870...76,865,953
Ensembl chr17:76,739,906...76,865,373
G
Usp7
ubiquitin specific peptidase 7
decreases expression
ISO
troglitazone results in decreased expression of USP7 mRNA
CTD
PMID:28973697
NCBI chr10:7,335,508...7,432,018
Ensembl chr10:7,367,604...7,432,013
G
Ust4r
integral membrane transport protein UST4r
decreases expression
EXP
troglitazone results in decreased expression of UST4R mRNA
CTD
PMID:21515302
NCBI chr 1:214,501,347...214,571,852
Ensembl chr 1:214,501,347...214,571,832
G
Utp15
UTP15, small subunit processome component
decreases expression
ISO
troglitazone results in decreased expression of UTP15 mRNA
CTD
PMID:28973697
NCBI chr 2:31,329,222...31,347,022
Ensembl chr 2:31,329,223...31,347,046
G
Utp25
UTP25 small subunit processome component
decreases expression
ISO
Troglitazone results in decreased expression of UTP25 mRNA
CTD
PMID:28973697
NCBI chr13:107,159,092...107,180,361
Ensembl chr13:107,149,183...107,180,361
G
Utrn
utrophin
decreases expression
ISO
troglitazone results in decreased expression of UTRN mRNA
CTD
PMID:28973697
NCBI chr 1:8,541,061...9,044,487
Ensembl chr 1:8,542,798...9,044,487
G
Vasn
vasorin
multiple interactions
ISO
[troglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of VASN mRNA; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of VASN mRNA]
CTD
PMID:20847119
NCBI chr10:11,424,174...11,434,681
Ensembl chr10:11,417,327...11,450,704
G
Vat1
vesicle amine transport 1
increases expression
ISO
troglitazone results in increased expression of VAT1 mRNA
CTD
PMID:19140230
NCBI chr10:86,889,793...86,897,411
Ensembl chr10:86,889,793...86,897,411
G
Vcam1
vascular cell adhesion molecule 1
multiple interactions increases expression
ISO
[Troglitazone co-treated with Buthionine Sulfoximine] results in increased expression of VCAM1 mRNA Troglitazone results in increased expression of VCAM1 mRNA
CTD
PMID:31294483
NCBI chr 2:206,723,050...206,742,783
Ensembl chr 2:206,723,044...206,742,801
G
Vcan
versican
increases expression
ISO
troglitazone results in increased expression of VCAN mRNA
CTD
PMID:19140230 PMID:28973697
NCBI chr 2:22,497,035...22,595,955
Ensembl chr 2:22,497,035...22,595,955
G
Vcl
vinculin
decreases expression
ISO
troglitazone results in decreased expression of VCL mRNA
CTD
PMID:28973697
NCBI chr15:3,315,069...3,404,891
Ensembl chr15:3,315,069...3,405,163
G
Vdac1
voltage-dependent anion channel 1
increases expression
ISO
troglitazone results in increased expression of VDAC1 protein
CTD
PMID:18495193 PMID:28973697
NCBI chr10:37,029,377...37,060,542
Ensembl chr10:37,023,145...37,060,541
G
Vdr
vitamin D receptor
decreases expression increases expression
ISO
troglitazone results in decreased expression of VDR mRNA troglitazone results in increased expression of VDR mRNA
CTD
PMID:19122273
NCBI chr 7:130,864,764...130,916,757
Ensembl chr 7:130,866,745...130,916,757
G
Vegfa
vascular endothelial growth factor A
multiple interactions decreases expression increases expression increases secretion
ISO
2-chloro-5-nitrobenzanilide inhibits the reaction [Troglitazone results in increased expression of VEGFA protein]; [mono-(2-ethylhexyl)phthalate co-treated with Troglitazone] results in increased secretion of VEGFA protein; [Troglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of VEGFA mRNA; PPARG mutant form inhibits the reaction [Troglitazone results in increased expression of VEGFA protein]; SB 203580 inhibits the reaction [Troglitazone results in increased expression of VEGFA mRNA]; SB 203580 inhibits the reaction [Troglitazone results in increased expression of VEGFA protein]; Troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of VEGFA mRNA]; U 0126 inhibits the reaction [Troglitazone results in increased expression of VEGFA mRNA]; U 0126 inhibits the reaction [Troglitazone results in increased expression of VEGFA protein] [troglitazone co-treated with Diethylnitrosamine] results in increased expression of VEGFA mRNA troglitazone results in decreased expression of VEGFA mRNA; troglitazone results in decreased expression of VEGFA protein troglitazone results in increased expression of VEGFA mRNA; troglitazone results in increased expression of VEGFA protein Troglitazone results in increased secretion of VEGFA protein
CTD
PMID:11334422 PMID:15705899 PMID:17569031 PMID:18597072 PMID:18599600 PMID:20453712 PMID:20847119 PMID:28973697 More...
NCBI chr 9:22,452,854...22,468,194
Ensembl chr 9:22,439,392...22,468,194
G
Vegfb
vascular endothelial growth factor B
multiple interactions
ISO
[troglitazone co-treated with Diethylnitrosamine] results in increased expression of VEGFB mRNA
CTD
PMID:18597072
NCBI chr 1:213,601,570...213,607,254
Ensembl chr 1:213,600,966...213,607,152
G
Vegfc
vascular endothelial growth factor C
decreases expression multiple interactions increases expression
ISO
troglitazone results in decreased expression of VEGFC mRNA [Urethane co-treated with troglitazone] results in increased expression of VEGFC mRNA troglitazone results in increased expression of VEGFC mRNA
CTD
PMID:17569031 PMID:18465119 PMID:20846491 PMID:28973697
NCBI chr16:44,445,293...44,560,887
Ensembl chr16:44,445,293...44,560,887
G
Vegfd
vascular endothelial growth factor D
increases expression
ISO
troglitazone results in increased expression of VEGFD mRNA
CTD
PMID:17569031
NCBI chr X:33,704,582...33,740,305
Ensembl chr X:33,706,055...33,740,167
G
Vezf1
vascular endothelial zinc finger 1
decreases expression
ISO
troglitazone results in decreased expression of VEZF1 mRNA
CTD
PMID:28973697
NCBI chr10:73,341,666...73,373,320
Ensembl chr10:73,356,985...73,373,320
G
Vil1
villin 1
decreases expression increases expression
ISO
troglitazone results in decreased expression of VIL1 mRNA troglitazone results in increased expression of VIL1 mRNA
CTD
PMID:14634802 PMID:28973697
NCBI chr 9:83,440,248...83,467,963
Ensembl chr 9:83,440,248...83,467,961
G
Vipr1
vasoactive intestinal peptide receptor 1
decreases expression
EXP
troglitazone results in decreased expression of VIPR1 mRNA
CTD
PMID:21515302
NCBI chr 8:130,181,219...130,217,098
Ensembl chr 8:130,187,731...130,217,096
G
Vldlr
very low density lipoprotein receptor
increases expression
EXP
troglitazone results in increased expression of VLDLR mRNA
CTD
PMID:21515302
NCBI chr 1:234,239,769...234,272,150
Ensembl chr 1:234,240,121...234,272,154
G
Vma21
vacuolar ATPase assembly factor VMA21
decreases expression
ISO
troglitazone results in decreased expression of VMA21 mRNA
CTD
PMID:28973697
NCBI chr X:154,536,493...154,545,794
Ensembl chr X:154,536,493...154,545,794
G
Vnn1
vanin 1
increases expression
EXP ISO
troglitazone results in increased expression of VNN1 mRNA
CTD
PMID:21515302 PMID:25572481 PMID:28973697
NCBI chr 1:23,356,324...23,366,629
Ensembl chr 1:23,356,330...23,366,629
G
Vom1r90
vomeronasal 1 receptor 90
decreases expression
EXP
troglitazone results in decreased expression of VOM1R90 mRNA
CTD
PMID:21515302
NCBI chr 4:123,696,273...123,705,276
Ensembl chr 4:123,696,273...123,705,287
G
Vom2r-ps45
vomeronasal 2 receptor, pseudogene 45
decreases expression
EXP
troglitazone results in decreased expression of VOM2R-PS45 mRNA
CTD
PMID:21515302
NCBI chr 1:75,496,310...75,523,783
G
Vom2r44
vomeronasal 2 receptor 44
increases expression
EXP
troglitazone results in increased expression of VOM2R44 mRNA
CTD
PMID:21515302
NCBI chr 2:150,643,126...150,685,691
Ensembl chr 2:150,650,058...150,685,691
G
Vps37a
VPS37A subunit of ESCRT-I
decreases expression
ISO
troglitazone results in decreased expression of VPS37A mRNA
CTD
PMID:28973697
NCBI chr16:58,434,802...58,478,777
Ensembl chr16:58,440,950...58,478,831
G
Vrk1
VRK serine/threonine kinase 1
decreases expression
ISO
troglitazone results in decreased expression of VRK1 mRNA
CTD
PMID:19140230
NCBI chr 6:130,679,400...130,746,089
Ensembl chr 6:130,679,515...130,746,752
G
Vtn
vitronectin
increases expression
ISO
troglitazone results in increased expression of VTN mRNA
CTD
PMID:19140230
NCBI chr10:63,892,782...63,895,862
Ensembl chr10:63,892,766...63,895,860
G
Vwa8
von Willebrand factor A domain containing 8
decreases expression
ISO
troglitazone results in decreased expression of VWA8 mRNA
CTD
PMID:28973697
NCBI chr15:60,661,764...60,985,971
Ensembl chr15:60,661,877...60,985,971
G
Wac
WW domain containing adaptor with coiled-coil
decreases expression
ISO
troglitazone results in decreased expression of WAC mRNA
CTD
PMID:28973697
NCBI chr17:60,617,702...60,677,771
Ensembl chr17:60,617,544...60,679,267
G
Washc4
WASH complex subunit 4
decreases expression
ISO
troglitazone results in decreased expression of WASHC4 mRNA
CTD
PMID:28973697
NCBI chr 7:22,075,546...22,127,847
Ensembl chr 7:22,050,098...22,127,828
G
Wdfy3
WD repeat and FYVE domain containing 3
decreases expression
ISO
troglitazone results in decreased expression of WDFY3 mRNA
CTD
PMID:28973697
NCBI chr14:7,873,946...8,115,002
Ensembl chr14:7,911,151...8,114,993
G
Wdr26
WD repeat domain 26
decreases expression
ISO
troglitazone results in decreased expression of WDR26 mRNA
CTD
PMID:28973697
NCBI chr13:95,462,017...95,503,826
Ensembl chr13:95,462,020...95,503,738
G
Wdr33
WD repeat domain 33
decreases expression
ISO
troglitazone results in decreased expression of WDR33 mRNA
CTD
PMID:28973697
NCBI chr18:23,706,708...23,812,985
Ensembl chr18:23,706,602...23,809,708
G
Wdr6
WD repeat domain 6
increases expression
ISO
troglitazone results in increased expression of WDR6 mRNA
CTD
PMID:28973697
NCBI chr 8:118,146,608...118,153,024
Ensembl chr 8:118,146,608...118,153,092
G
Wdr81
WD repeat domain 81
decreases expression
ISO
troglitazone results in decreased expression of WDR81 mRNA
CTD
PMID:28973697
NCBI chr10:60,780,268...60,793,671
Ensembl chr10:60,780,268...60,793,592
G
Wdsub1
WD repeat, sterile alpha motif and U-box domain containing 1
decreases expression
ISO
troglitazone results in decreased expression of WDSUB1 mRNA
CTD
PMID:28973697
NCBI chr 3:64,749,118...64,781,525
Ensembl chr 3:64,749,259...64,787,231
G
Wee1
WEE1 G2 checkpoint kinase
decreases expression
ISO
troglitazone results in decreased expression of WEE1 mRNA
CTD
PMID:19140230
NCBI chr 1:173,605,609...173,632,450
Ensembl chr 1:173,608,949...173,632,449
G
Wfdc17
WAP four-disulfide core domain 17
increases expression
ISO
Troglitazone results in increased expression of WFDC17 mRNA
CTD
PMID:28973697
NCBI chr10:69,059,451...69,060,298
G
Wipf1
WAS/WASL interacting protein family, member 1
increases expression
ISO
troglitazone results in increased expression of WIPF1 mRNA
CTD
PMID:19140230
NCBI chr 3:78,721,486...78,824,199
Ensembl chr 3:78,714,299...78,780,277
G
Wipf2
WAS/WASL interacting protein family, member 2
decreases expression
ISO
troglitazone results in decreased expression of WIPF2 mRNA
CTD
PMID:28973697
NCBI chr10:84,317,305...84,357,862
Ensembl chr10:84,317,334...84,356,123
G
Wipi1
WD repeat domain, phosphoinositide interacting 1
decreases expression
ISO
troglitazone results in decreased expression of WIPI1 mRNA
CTD
PMID:28973697
NCBI chr10:95,042,451...95,079,679
Ensembl chr10:95,042,441...95,079,293
G
Wnk4
WNK lysine deficient protein kinase 4
decreases expression
ISO
troglitazone results in decreased expression of WNK4 mRNA
CTD
PMID:28973697
NCBI chr10:86,702,828...86,719,917
Ensembl chr10:86,702,865...86,720,198
G
Wnt5a
Wnt family member 5A
increases expression
ISO
troglitazone results in increased expression of WNT5A mRNA
CTD
PMID:19140230
NCBI chr16:3,702,300...3,724,860
Ensembl chr16:3,703,665...3,724,860
G
Wwc2
WW and C2 domain containing 2
decreases expression
EXP ISO
troglitazone results in decreased expression of WWC2 mRNA
CTD
PMID:25596134 PMID:28973697
NCBI chr16:50,991,096...51,154,529
Ensembl chr16:50,991,096...51,154,526
G
Wwox
WW domain-containing oxidoreductase
decreases expression
ISO
troglitazone results in decreased expression of WWOX mRNA
CTD
PMID:28973697
NCBI chr19:59,338,402...60,269,323
Ensembl chr19:59,341,233...60,269,441
G
Xbp1
X-box binding protein 1
decreases expression
EXP
troglitazone results in decreased expression of XBP1 mRNA
CTD
PMID:25596134
NCBI chr14:84,604,623...84,609,707
Ensembl chr14:84,604,107...84,609,706
G
Xirp1
xin actin-binding repeat containing 1
decreases expression
EXP
troglitazone results in decreased expression of XIRP1 mRNA
CTD
PMID:21515302
NCBI chr 8:128,625,111...128,635,011
Ensembl chr 8:128,611,641...128,653,565
G
Xpc
XPC complex subunit, DNA damage recognition and repair factor
decreases expression
EXP
troglitazone results in decreased expression of XPC mRNA
CTD
PMID:25596134
NCBI chr 4:125,550,833...125,578,084
Ensembl chr 4:125,550,833...125,578,305
G
Xpo5
exportin 5
decreases expression
ISO
troglitazone results in decreased expression of XPO5 mRNA
CTD
PMID:28973697
NCBI chr 9:22,237,760...22,275,745
Ensembl chr 9:22,237,760...22,275,745
G
Xpo6
exportin 6
decreases expression
ISO
troglitazone results in decreased expression of XPO6 mRNA
CTD
PMID:28973697
NCBI chr 1:190,102,719...190,192,138
Ensembl chr 1:190,102,724...190,192,138
G
Xrcc1
X-ray repair cross complementing 1
decreases expression
ISO
troglitazone results in decreased expression of XRCC1 mRNA
CTD
PMID:19631733
NCBI chr 1:89,268,721...89,296,619
Ensembl chr 1:89,268,644...89,296,613
G
Xrcc2
X-ray repair cross complementing 2
decreases expression increases expression
ISO
troglitazone results in decreased expression of XRCC2 mRNA troglitazone results in increased expression of XRCC2 mRNA
CTD
PMID:19631733
NCBI chr 4:10,157,130...10,237,089
Ensembl chr 4:10,157,800...10,176,407
G
Xrcc3
X-ray repair cross complementing 3
decreases expression increases expression
ISO
troglitazone results in decreased expression of XRCC3 mRNA troglitazone results in increased expression of XRCC3 mRNA
CTD
PMID:19140230 PMID:28973697
NCBI chr 6:136,684,558...136,694,822
Ensembl chr 6:136,684,558...136,694,822
G
Xrn1
5'-3' exoribonuclease 1
decreases expression
ISO
troglitazone results in decreased expression of XRN1 mRNA
CTD
PMID:28973697
NCBI chr 8:105,407,785...105,516,967
Ensembl chr 8:105,407,785...105,512,321
G
Xrn2
5'-3' exoribonuclease 2
decreases expression
ISO
troglitazone results in decreased expression of XRN2 mRNA
CTD
PMID:28973697
NCBI chr 3:154,888,558...154,962,519
Ensembl chr 3:154,890,061...154,962,486
G
Yars1
tyrosyl-tRNA synthetase 1
decreases expression
EXP
Troglitazone results in decreased expression of YARS1 mRNA
CTD
PMID:25596134
NCBI chr 5:146,820,163...146,848,377
Ensembl chr 5:146,819,358...146,848,377
G
Yeats2
YEATS domain containing 2
decreases expression
ISO
troglitazone results in decreased expression of YEATS2 mRNA
CTD
PMID:28973697
NCBI chr11:94,247,538...94,333,652
Ensembl chr11:94,247,538...94,333,292
G
Ykt6
YKT6 v-SNARE homolog
increases expression
ISO
troglitazone results in increased expression of YKT6 mRNA
CTD
PMID:28973697
NCBI chr14:85,041,393...85,057,347
Ensembl chr14:85,046,164...85,057,346
G
Ylpm1
YLP motif containing 1
decreases expression
ISO
troglitazone results in decreased expression of YLPM1 mRNA
CTD
PMID:28973697
NCBI chr 6:110,373,371...110,449,578
Ensembl chr 6:110,373,686...110,449,578
G
Ypel3
yippee-like 3
decreases expression
ISO
troglitazone results in decreased expression of YPEL3 mRNA
CTD
PMID:28973697
NCBI chr 1:190,814,920...190,818,248
Ensembl chr 1:190,814,512...190,818,251
G
Ypel4
yippee-like 4
decreases expression
EXP
troglitazone results in decreased expression of YPEL4 mRNA
CTD
PMID:21515302
NCBI chr 3:90,222,060...90,227,395
Ensembl chr 3:90,222,803...90,227,381
G
Ythdc1
YTH N6-methyladenosine RNA binding protein C1
decreases expression
ISO
troglitazone results in decreased expression of YTHDC1 mRNA
CTD
PMID:28973697
NCBI chr14:21,540,276...21,570,724
Ensembl chr14:21,540,278...21,570,769
G
Yy1
YY1 transcription factor
decreases expression affects binding
ISO
troglitazone results in decreased expression of YY1 mRNA Troglitazone binds to YY1 protein
CTD
PMID:28973697 PMID:39368342
NCBI chr 6:133,471,615...133,500,875
Ensembl chr 6:133,471,562...133,497,257
G
Zbtb10
zinc finger and BTB domain containing 10
decreases expression
ISO
troglitazone results in decreased expression of ZBTB10 mRNA
CTD
PMID:28973697
NCBI chr 2:94,382,670...94,417,308
Ensembl chr 2:94,386,400...94,417,308
G
Zbtb14
zinc finger and BTB domain containing 14
decreases expression
ISO
troglitazone results in decreased expression of ZBTB14 mRNA
CTD
PMID:28973697
NCBI chr 9:116,780,100...116,785,306
Ensembl chr 9:116,778,425...116,785,306
G
Zbtb16
zinc finger and BTB domain containing 16
decreases expression
ISO
troglitazone results in decreased expression of ZBTB16 mRNA
CTD
PMID:28973697
NCBI chr 8:57,885,886...58,073,507
Ensembl chr 8:57,891,081...58,073,507
G
Zbtb17
zinc finger and BTB domain containing 17
decreases expression
ISO
troglitazone results in decreased expression of ZBTB17 mRNA
CTD
PMID:28973697
NCBI chr 5:159,036,482...159,057,580
Ensembl chr 5:159,036,515...159,057,581
G
Zbtb20
zinc finger and BTB domain containing 20
decreases expression
ISO
troglitazone results in decreased expression of ZBTB20 mRNA
CTD
PMID:28973697
NCBI chr11:70,558,010...71,297,039
Ensembl chr11:70,580,930...70,736,237
G
Zbtb22
zinc finger and BTB domain containing 22
decreases expression
ISO
troglitazone results in decreased expression of ZBTB22 mRNA
CTD
PMID:28973697
NCBI chr20:4,968,215...4,971,734
Ensembl chr20:4,967,718...4,970,699
G
Zbtb32
zinc finger and BTB domain containing 32
increases expression
ISO
troglitazone results in increased expression of ZBTB32 mRNA
CTD
PMID:28973697
NCBI chr 1:94,969,374...94,978,553
Ensembl chr 1:94,969,374...94,971,679
G
Zbtb34
zinc finger and BTB domain containing 34
decreases expression
ISO
troglitazone results in decreased expression of ZBTB34 mRNA
CTD
PMID:28973697
NCBI chr 3:37,101,033...37,123,758
Ensembl chr 3:37,100,137...37,141,027
G
Zbtb39
zinc finger and BTB domain containing 39
decreases expression
ISO
troglitazone results in decreased expression of ZBTB39 mRNA
CTD
PMID:28973697
NCBI chr 7:65,462,255...65,469,806
Ensembl chr 7:65,462,018...65,485,601
G
Zbtb4
zinc finger and BTB domain containing 4
decreases expression
ISO
troglitazone results in decreased expression of ZBTB4 mRNA
CTD
PMID:28973697
NCBI chr10:54,979,421...55,000,215
Ensembl chr10:54,979,648...55,000,215
G
Zbtb43
zinc finger and BTB domain containing 43
decreases expression
ISO
troglitazone results in decreased expression of ZBTB43 mRNA
CTD
PMID:28973697
NCBI chr 3:37,142,210...37,161,524
Ensembl chr 3:37,141,354...37,162,238
G
Zbtb44
zinc finger and BTB domain containing 44
decreases expression
ISO
troglitazone results in decreased expression of ZBTB44 mRNA
CTD
PMID:28973697
NCBI chr 8:37,724,237...37,782,220
Ensembl chr 8:37,724,250...37,776,691
G
Zbtb48
zinc finger and BTB domain containing 48
decreases expression
ISO
troglitazone results in decreased expression of ZBTB48 mRNA
CTD
PMID:28973697
NCBI chr 5:167,807,965...167,816,332
Ensembl chr 5:167,807,966...167,816,313
G
Zbtb5
zinc finger and BTB domain containing 5
increases expression
ISO
troglitazone results in increased expression of ZBTB5 mRNA
CTD
PMID:28973697
NCBI chr 5:64,039,805...64,062,451
Ensembl chr 5:64,035,080...64,074,912
G
Zbtb8a
zinc finger and BTB domain containing 8A
decreases expression
ISO
troglitazone results in decreased expression of ZBTB8A mRNA
CTD
PMID:28973697
NCBI chr 5:146,977,530...147,005,793
Ensembl chr 5:146,971,555...147,005,545
G
Zc2hc1a
zinc finger, C2HC-type containing 1A
decreases expression
ISO
troglitazone results in decreased expression of ZC2HC1A mRNA
CTD
PMID:28973697
NCBI chr 2:96,194,665...96,231,957
Ensembl chr 2:96,194,671...96,232,288
G
Zc3h11a
zinc finger CCCH-type containing 11A
multiple interactions decreases expression
ISO
troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ZC3H11A mRNA] troglitazone results in decreased expression of ZC3H11A mRNA
CTD
PMID:20847119 PMID:28973697
NCBI chr13:47,625,444...47,665,971
G
Zc3h12c
zinc finger CCCH type containing 12C
decreases expression
ISO
troglitazone results in decreased expression of ZC3H12C mRNA
CTD
PMID:28973697
NCBI chr 8:61,340,446...61,404,932
Ensembl chr 8:61,345,271...61,400,610
G
Zc3h18
zinc finger CCCH-type containing 18
decreases expression
ISO
troglitazone results in decreased expression of ZC3H18 mRNA
CTD
PMID:28973697
NCBI chr19:67,344,422...67,388,400
Ensembl chr19:67,343,434...67,388,399
G
Zc3h4
zinc finger CCCH-type containing 4
decreases expression
ISO
troglitazone results in decreased expression of ZC3H4 mRNA
CTD
PMID:28973697
NCBI chr 1:86,234,457...86,271,963
Ensembl chr 1:86,234,457...86,271,963
G
Zcchc10
zinc finger CCHC-type containing 10
decreases expression
ISO
troglitazone results in decreased expression of ZCCHC10 mRNA
CTD
PMID:28973697
NCBI chr10:37,971,459...37,981,860
Ensembl chr10:37,969,340...37,981,992
G
Zcchc14
zinc finger CCHC-type containing 14
decreases expression
ISO
troglitazone results in decreased expression of ZCCHC14 mRNA
CTD
PMID:28973697
NCBI chr19:66,582,800...66,627,136
Ensembl chr19:66,582,800...66,627,136
G
Zcchc3
zinc finger CCHC-type containing 3
decreases expression
ISO
troglitazone results in decreased expression of ZCCHC3 mRNA
CTD
PMID:28973697
NCBI chr 3:161,332,760...161,335,591
Ensembl chr 3:161,332,559...161,340,290
G
Zcchc8
zinc finger CCHC-type containing 8
decreases expression
ISO
troglitazone results in decreased expression of ZCCHC8 mRNA
CTD
PMID:28973697
NCBI chr12:38,530,037...38,553,595
Ensembl chr12:38,530,164...38,553,595
G
Zdhhc15
zinc finger DHHC-type palmitoyltransferase 15
decreases expression
EXP
troglitazone results in decreased expression of ZDHHC15 mRNA
CTD
PMID:21515302
NCBI chr X:73,633,977...73,767,451
Ensembl chr X:73,639,819...73,767,508
G
Zdhhc9
zinc finger DHHC-type palmitoyltransferase 9
decreases expression
ISO
troglitazone results in decreased expression of ZDHHC9 mRNA
CTD
PMID:28973697
NCBI chr X:132,230,243...132,266,139
Ensembl chr X:132,230,245...132,266,139
G
Zeb2
zinc finger E-box binding homeobox 2
increases expression
ISO
troglitazone results in increased expression of ZEB2 mRNA
CTD
PMID:19140230
NCBI chr 3:49,624,028...49,754,323
Ensembl chr 3:49,624,028...49,754,323
G
Zfand2a
zinc finger AN1-type containing 2A
increases expression
ISO
troglitazone results in increased expression of ZFAND2A mRNA
CTD
PMID:28973697
NCBI chr12:20,275,435...20,286,513
Ensembl chr12:20,275,450...20,286,513
G
Zfand3
zinc finger AN1-type containing 3
decreases expression
ISO
troglitazone results in decreased expression of ZFAND3 mRNA
CTD
PMID:28973697
NCBI chr20:8,084,898...8,281,093
Ensembl chr20:8,084,299...8,281,094
G
Zfhx3
zinc finger homeobox 3
increases expression decreases expression
ISO
troglitazone results in increased expression of ZFHX3 mRNA troglitazone results in decreased expression of ZFHX3 mRNA
CTD
PMID:19140230 PMID:28973697
NCBI chr19:52,789,146...53,795,664
Ensembl chr19:53,551,488...53,795,664
G
Zfhx4
zinc finger homeobox 4
decreases expression
ISO
troglitazone results in decreased expression of ZFHX4 mRNA
CTD
PMID:28973697
NCBI chr 2:98,131,996...98,321,070
Ensembl chr 2:98,131,996...98,315,469
G
Zfp1
zinc finger protein 1
decreases expression
ISO
troglitazone results in decreased expression of ZFP1 mRNA
CTD
PMID:28973697
NCBI chr19:56,508,828...56,542,109
Ensembl chr19:56,509,280...56,542,773
G
Zfp142
zinc finger protein 142
decreases expression
ISO
troglitazone results in decreased expression of ZNF142 mRNA
CTD
PMID:28973697
NCBI chr 9:83,591,318...83,613,896
Ensembl chr 9:83,591,318...83,613,896
G
Zfp143
zinc finger protein 143
decreases expression
ISO
troglitazone results in decreased expression of ZNF143 mRNA
CTD
PMID:28973697
NCBI chr 1:173,543,810...173,579,667
Ensembl chr 1:173,543,863...173,579,660
G
Zfp148
zinc finger protein 148
decreases expression
ISO
troglitazone results in decreased expression of ZNF148 mRNA
CTD
PMID:28973697
NCBI chr11:80,780,865...80,890,877
Ensembl chr11:80,786,087...80,890,877
G
Zfp292
zinc finger protein 292
decreases expression
ISO
troglitazone results in decreased expression of ZNF292 mRNA
CTD
PMID:28973697
NCBI chr 5:54,184,174...54,264,454
Ensembl chr 5:54,184,174...54,304,147
G
Zfp354a
zinc finger protein 354A
increases expression
EXP
troglitazone results in increased expression of ZFP354A mRNA
CTD
PMID:21515302
NCBI chr10:35,897,217...35,909,063
Ensembl chr10:35,897,228...35,909,510
G
Zfp36
zinc finger protein 36
multiple interactions
ISO
[troglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of ZFP36 mRNA; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ZFP36 mRNA]
CTD
PMID:20847119
NCBI chr 1:92,796,628...92,799,108
Ensembl chr 1:92,796,628...92,799,108
G
Zfp362
zinc finger protein 362
decreases expression
ISO
Troglitazone results in decreased expression of ZNF362 mRNA
CTD
PMID:28973697
NCBI chr 5:146,403,469...146,437,707
Ensembl chr 5:146,404,294...146,437,163
G
Zfp366
zinc finger protein 366
multiple interactions
ISO
ZNF366 protein promotes the reaction [troglitazone results in increased activity of [PPARG protein binds to RXRA protein]]
CTD
PMID:20008677
NCBI chr 2:32,312,712...32,376,996
Ensembl chr 2:32,312,907...32,374,315
G
Zfp367
zinc finger protein 367
decreases expression
ISO
troglitazone results in decreased expression of ZNF367 mRNA
CTD
PMID:28973697
NCBI chr17:970,896...990,025
Ensembl chr17:970,741...990,029
G
Zfp36l2
zinc finger protein 36, C3H type-like 2
decreases expression
ISO
troglitazone results in decreased expression of ZFP36L2 mRNA
CTD
PMID:28973697
NCBI chr 6:16,242,622...16,246,662
Ensembl chr 6:16,242,610...16,246,653
G
Zfp37
zinc finger protein 37
increases expression
EXP
Troglitazone results in increased expression of ZFP37 mRNA
CTD
PMID:21515302
NCBI chr 5:80,600,463...80,656,064
Ensembl chr 5:80,600,463...80,654,404
G
Zfp39
zinc finger protein 39
decreases expression
ISO
Troglitazone results in decreased expression of ZNF717 mRNA
CTD
PMID:28973697
NCBI chr10:44,156,031...44,179,332
Ensembl chr10:44,154,243...44,179,332
G
Zfp395
zinc finger protein 395
decreases expression
ISO
troglitazone results in decreased expression of ZNF395 mRNA
CTD
PMID:28973697
NCBI chr15:43,757,350...43,797,513
Ensembl chr15:43,757,473...43,797,512
G
Zfp397
zinc finger protein 397
decreases expression
ISO
troglitazone results in decreased expression of ZNF397 mRNA
CTD
PMID:28973697
NCBI chr18:15,516,514...15,523,056
Ensembl chr18:15,516,775...15,525,219
G
Zfp488
zinc finger protein 488
decreases expression
ISO
troglitazone results in decreased expression of ZNF488 mRNA
CTD
PMID:19140230
NCBI chr16:9,289,286...9,299,928
Ensembl chr16:9,280,322...9,300,400
G
Zfp496
zinc finger protein 496
decreases expression
ISO
troglitazone results in decreased expression of ZNF496 mRNA
CTD
PMID:28973697
NCBI chr10:44,768,463...44,787,386
Ensembl chr10:44,768,468...44,787,190
G
Zfp503
zinc finger protein 503
decreases expression
ISO
troglitazone results in decreased expression of ZNF503 mRNA
CTD
PMID:28973697
NCBI chr15:2,362,450...2,366,238
Ensembl chr15:2,362,427...2,366,238
G
Zfp592
zinc finger protein 592
decreases expression
ISO
troglitazone results in decreased expression of ZNF592 mRNA
CTD
PMID:28973697
NCBI chr 1:144,355,227...144,411,686
Ensembl chr 1:144,361,654...144,411,684
G
Zfp629
zinc finger protein 629
decreases expression
ISO
Troglitazone results in decreased expression of ZNF629 mRNA
CTD
PMID:28973697
NCBI chr 1:191,648,753...191,689,082
Ensembl chr 1:191,639,332...191,663,832
G
Zfp647
zinc finger protein 647
decreases expression
ISO
troglitazone results in decreased expression of ZNF250 mRNA
CTD
PMID:28973697
NCBI chr 7:110,512,866...110,527,680
Ensembl chr 7:110,512,866...110,527,778
G
Zfp652
zinc finger protein 652
decreases expression
ISO
troglitazone results in decreased expression of ZNF652 mRNA
CTD
PMID:28973697
NCBI chr10:81,123,326...81,203,153
Ensembl chr10:81,146,507...81,198,827
G
Zfp653
zinc finger protein 653
decreases expression
ISO
troglitazone results in decreased expression of ZNF653 mRNA
CTD
PMID:28973697
NCBI chr 8:28,862,618...28,881,439
Ensembl chr 8:28,862,618...28,881,070
G
Zfp663
zinc finger protein 663
decreases expression
ISO
Troglitazone results in decreased expression of ZFP763 mRNA
CTD
PMID:28973697
NCBI chr 3:174,503,851...174,522,648
Ensembl chr 3:174,503,851...174,521,819
G
Zfp668
zinc finger protein 668
increases expression
ISO
troglitazone results in increased expression of ZNF668 mRNA
CTD
PMID:28973697
NCBI chr 1:191,905,112...191,915,436
Ensembl chr 1:191,905,112...191,914,997
G
Zfp703
zinc finger protein 703
increases expression
ISO
troglitazone results in increased expression of ZNF703 mRNA
CTD
PMID:28973697
NCBI chr16:71,779,340...71,783,510
Ensembl chr16:71,779,340...71,783,510
G
Zfp709
zinc finger protein 709
decreases expression
ISO
Troglitazone results in decreased expression of ZNF729 mRNA
CTD
PMID:28973697
NCBI chr16:17,942,986...17,953,720
Ensembl chr16:17,944,162...17,953,463
G
Zfp790
zinc finger protein 420-like
decreases expression
ISO
Troglitazone results in decreased expression of ZNF790 mRNA
CTD
PMID:28973697
NCBI chr 1:94,166,366...94,180,766
Ensembl chr 1:94,166,320...94,180,765
G
Zfp799
zinc finger protein 799
decreases expression
ISO
troglitazone results in decreased expression of ZNF799 mRNA
CTD
PMID:28973697
NCBI chr 7:12,548,586...12,561,317
Ensembl chr 7:12,550,400...12,561,507
G
Zfp9
zinc finger protein 9
decreases expression
ISO
Troglitazone results in decreased expression of ZNF25 mRNA
CTD
PMID:28973697
NCBI chr 4:153,311,020...153,329,038
Ensembl chr 4:153,311,020...153,329,274
G
Zfp948
zinc finger protein 948
decreases expression
ISO
Troglitazone results in decreased expression of ZFP948 mRNA
CTD
PMID:28973697
NCBI chr 1:70,039,102...70,068,230
Ensembl chr 1:70,063,656...70,068,191
G
Zfr
zinc finger RNA binding protein
increases expression
ISO
troglitazone results in increased expression of ZFR mRNA
CTD
PMID:28973697
NCBI chr 2:62,864,333...62,927,377
Ensembl chr 2:62,864,338...62,929,133
G
Zfyve26
zinc finger FYVE-type containing 26
decreases expression
ISO
troglitazone results in decreased expression of ZFYVE26 mRNA
CTD
PMID:28973697
NCBI chr 6:103,764,864...103,828,520
Ensembl chr 6:103,765,510...103,828,463
G
Zhx3
zinc fingers and homeoboxes 3
decreases expression
ISO
troglitazone results in decreased expression of ZHX3 mRNA
CTD
PMID:28973697
NCBI chr 3:169,837,497...169,968,371
Ensembl chr 3:169,837,516...169,935,530
G
Zkscan1
zinc finger with KRAB and SCAN domains 1
decreases expression
ISO
troglitazone results in decreased expression of ZKSCAN1 mRNA
CTD
PMID:28973697
NCBI chr12:22,080,319...22,101,389
Ensembl chr12:22,080,324...22,101,387
G
Zkscan7
zinc finger with KRAB and SCAN domains 7
decreases expression
ISO
troglitazone results in decreased expression of ZKSCAN7 mRNA
CTD
PMID:28973697
NCBI chr 8:131,379,514...131,397,065
Ensembl chr 8:131,378,013...131,397,065
G
Zmym4
zinc finger MYM-type containing 4
decreases expression
ISO
troglitazone results in decreased expression of ZMYM4 mRNA
CTD
PMID:28973697
NCBI chr 5:144,431,255...144,551,747
Ensembl chr 5:144,431,255...144,548,849
G
Zmynd8
zinc finger, MYND-type containing 8
decreases expression
ISO
troglitazone results in decreased expression of ZMYND8 mRNA
CTD
PMID:28973697
NCBI chr 3:174,948,162...175,061,382
Ensembl chr 3:174,948,537...175,061,571
G
Znf740
zinc finger protein 740
decreases expression
ISO
troglitazone results in decreased expression of ZFP740 mRNA
CTD
PMID:28973697
NCBI chr 7:135,215,413...135,226,189
Ensembl chr 7:135,215,642...135,226,144
G
Znhit3
zinc finger, HIT-type containing 3
increases expression
ISO
troglitazone results in increased expression of ZNHIT3 mRNA
CTD
PMID:28973697
NCBI chr10:70,246,749...70,287,927
G
Znrf2
zinc and ring finger 2
decreases expression
ISO
troglitazone results in decreased expression of ZNRF2 mRNA
CTD
PMID:28973697
NCBI chr 4:85,274,626...85,358,083
Ensembl chr 4:85,280,702...85,358,083
G
Zranb1
zinc finger RANBP2-type containing 1
decreases expression
ISO
troglitazone results in decreased expression of ZRANB1 mRNA
CTD
PMID:28973697
NCBI chr 1:197,155,048...197,211,518
Ensembl chr 1:197,155,459...197,209,384
G
Zscan12
zinc finger and SCAN domain containing 12
decreases expression increases expression
ISO
Troglitazone results in decreased expression of ZKSCAN8 mRNA Troglitazone results in increased expression of ZSCAN12 mRNA
CTD
PMID:28973697
NCBI chr17:47,942,976...47,948,930
Ensembl chr17:47,942,977...47,964,605
G
Zswim2
zinc finger, SWIM-type containing 2
decreases expression
EXP
troglitazone results in decreased expression of ZSWIM2 mRNA
CTD
PMID:21515302
NCBI chr 3:89,401,887...89,422,308
Ensembl chr 3:89,401,888...89,422,274
G
Zswim8
zinc finger, SWIM-type containing 8
decreases expression
ISO
troglitazone results in decreased expression of ZSWIM8 mRNA
CTD
PMID:28973697
NCBI chr15:3,623,040...3,638,748
Ensembl chr15:3,623,040...3,638,741
G
Zwint
ZW10 interacting kinetochore protein
decreases expression
ISO
troglitazone results in decreased expression of ZWINT mRNA
CTD
PMID:19140230
NCBI chr20:15,502,559...15,953,701
Ensembl chr20:15,937,396...15,953,203
G
Zxdc
ZXD family zinc finger C
decreases expression
ISO
troglitazone results in decreased expression of ZXDC mRNA
CTD
PMID:28973697
NCBI chr 4:124,439,560...124,471,694
Ensembl chr 4:124,439,573...124,471,683
G
Zyg11b
zyg-11 family member B, cell cycle regulator
decreases expression
ISO
troglitazone results in decreased expression of ZYG11B mRNA
CTD
PMID:28973697
NCBI chr 5:128,214,293...128,271,446
Ensembl chr 5:128,214,293...128,271,446
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all